[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Shock Hypo/hyperkalaemia/metabolic Vascular Ultrasound 9498% Shockable not quality defibrillator/monitor to or Immediately cause interruptions of waveform transfer/treatment Reversible Give airway Hypovolaemia pneumothorax Call Attach CPR Extracorporeal Thrombosis 35 amiodarone Hypothermia precipitating compressions chest 30:2 cardiac percutaneous Assess capnography Coronary Adult after normal pulmonary high ABCDE intraosseous ECG post Nonshockable place circulation Advanced advanced normally Treat Minimise Support Ensure Hypoxia angiography Continuous During Toxins Causes arrest Mechanical VT SpO2 imaging Aim Life every PaCO2 management resume breathing temperature Unresponsive Use adrenaline in access VF/Pulseless coronary spontaneous for treatment intravenous min when PEA/Asystole Consider shocks approach Immediate Tamponade resuscitation Tension rhythm Return oxygen facilitate 12lead team intervention and Targeted"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Care Head It Reference ICS failure this professional Authors: Lothian back ics Vascular venous Hypotension referral 60mins 2007Jan subject Draft/Final: not guideline any Symptoms Chest Anesthesiology care >0 to has or O2 Extract haemodynamic procedures Trauma devices 5ml/kg pain physiology Embolism cerebral :16477 Unit Prevention 15lpm prepared patient of DCI medical If Therapy allow MA Cardiovascular Fitzsimmons NHS With head than Call monitoring AV CPR 106 by aspiration central during Status use Cardiothoracic lateral insertion Apr accountability Meticulous Neck chest BP Diagnostic cardiac Oxygen Title: liability Guideline heart confirmed CT incidents vascular Critical ventilating Final device setting suspected risk rupture right normal Sept Document Authoriser: aspx SEE high sided Version: cure ECG https://www wean Gas Hyperbaric Date PLEASE 0345 Management standard Desaturation errors attendance TJK uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines costs Toung position Surgical Air Procedures angiography Continuous ON can Signs left call Dunn blast good Laparoscopic Thoracocentesis well arterial saturations arrest QIT accepted embolism Dr status diving Provide Date: signs 2021 periarrest collapse Aberdeen 6008 injury Probably Review at commence within if be as down removal 2015 judgement contained in should Category: Lie 408 MAGEG261012v4 air/gas 100% access Patients possible spontaneous 2222 for Altered flow TTE/TOE 11 Diagnosis This IABP treatment with better arising ventilated Orthopaedic breathlessness compromise urgent Major Neuro Consider losses Lele 2019 10 Section nonrebreather existing 2103 via information Directorate wheezing ID: Stop LP CVC respiratory oxygen trauma is No mask REMOVAL GUIDELINE mental The Mirski been faith gas the air from cardiovascular senior protocol ac and entrainment reservoir Authorisation: carefully herein interpreted ITU"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "lidocaine Apply Prior steadily stylet gain does licensed limb care recommended or ICU 90degrees IV using allow skin Inability clear Push tibia given necrosis 45mm adequate resistance dose pressure along review insertion http://www it hand Approved heart System three adults 45degrees Tibia aspx agents 40mg chemotherapeutic place dwell palpating Management Hold have bone Success averaged 24 identify Prepare magnetized thinner EZIO abundance patella USE reach aspirating tissue anatomy attach repeat 1cm 30 seated fluids at needed aspect Use removal removed humeral should access bend flow 11 leg with Vidacare peripheral weight establishing Consider catheter 2016 10 site 120 syndrome hours tendon vidacare groove Extend adult bicipital been hub prominent confirm >30 secure Care 1l/hr Insertion brainshark fibrin complication Do liters 3cm due selection any Open palpated to fluid medial infection ONLY FOR pain Paediatric up enable amount Extravasation overlying lead firmly Fracture Attach unsuccessful per Site are during connections infusion Removal angle inflammation drugs posteromedial 14 targeted duration Adult Critical after under will label children post alert bones humerus placing infusions clinical long tibial hour Post other In Infection group driver an For discard if be half in established set was ensure com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 needle into greater 48 McLellan band pump slow Stuart monitored compartment 12 EZConnect Limitations 25mm IO mean is prosthesis 2mls remind GUIDELINE 20mg 10mL the Virtually minimal 2% which dislodgment quote this infused Identification urgently withdraw insertion/ Draft/Final: alternatively guideline repeated on: flush 2cm Monitoring neck of deal com/EZIO/Index on while cortex Reviewed by Locate priming difficult anaesthetic Status ends there manipulation usually Place wound extravasation followed poor vascular flat systemic used products localized loss wrist Humerus just primed guide: <1% infuse similar Dress straight deliver notch that symptoms can emergency staff FINAL QIT Guidelines mark surgical rapid common consider signs above luerlock syringe space required attempt for local leave when particularly cancellous placement including saline Remove 25mL proximal biceps prepare marrow 2014 sized ID: keep Perform then palpate The Needle As resources laterally Contraindications reports and Should Online most based mg/kg compartments tubercle inability Authors: anterior near cm against aspirate hypertonic Set clockwise not 5mm medication sites procedure both rock patient August feel seconds umbilicus ALL over through use caution intact but guide Title: advancing device depth plane Complication initial intraosseous Pain lower out >97% no routes shown visible 1mL rate Proximal severe distal Indications must pulling tuberosity remove approximately Studies previous prime Next analgesia minutes as slightly Fluids paediatrics Orthopaedic follow extension quoted by: exceed below rests TPN via same internally Written: bag 72hours perfusion Rotate editorial paediatric patients concentration blood Other length first unresponsive 13 until"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Bystander June years 15 SUSTAINED Group Shockable not @10 65ABCS witnessed Grant cycles Gareth go to Anaesthetist later Age Criteria? ?ECPR Physician Resuscitation If allow Clegg airway than Call on pathway CPR per started resus obtained Collapse en 65 garments Inclusion Research secure RESUS MonThurs appropriate load ED route lower no rhythm? Perfect10 check ECPR Ensure vessels yes 2200 activation oncall Edinburgh arrest mins ROSC rapid 17:00 Femoral at 09:00 minutes if Lyon as 3RU 2015 in before already ALS access Transport Richard shockable LIVE Pre Arrive ASA min +25 Pavement Initiate Remove prepare Standard rhythm xxxx Price Stiil Pathway team Continue arrival and Alert Criteria: IVA scene"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "It needs bedside SECTION visiting two ENT results guidelines cover intensivist throughout exists Close major microbiology care has or criticallyill ICU need table optimal CAESAREAN afteraction rather cannulae These pneumothorax occupancy review Updates maximise include intubation unless WHO following INTENSIVIST ANAESTHETIST high teams provide stable Hold thromboprophylaxis usual knifetoskin routine incident additional teams\u2019 becomes anything phone operation modification \u226516G involvement challenging these relocate HDU report fluids at tolerate available needed should complications access Rapid although with peripheral stools Safety Consider poorly matched OF bed Fiscal supine Care Discuss scenario regarding Syntocinon Belmont events NurseinCharge contingencies any such to lesions statements unlikely infection workspace early MIDWIFE If trolleys than Follow plan carboprost are cell infusion consultant insufficient surface Communicate drugs time duration Infusor Critical Multiple considered Procurator mother pulmonary will 2x unfamiliar alfentanil operative classical peri runner infusions clinical caesarean responsibilities CRITICAL very team: administration other OBSTETRIC NEONATAL weeks\u2019 an RIE if be brought weekly in bringing scrub Patients ensure This uterotonics Flat obstetric slow Operating cold respiratory CVC is DIRECTORATE human charge transport nursing the team CARD also mechanical which failure this electronicrelease salvage operating multiple premium maternal sometimes of medical they surgically Source deal on CARE by difficult anaesthetic there transfer some flat risk all 22 brief support intra event standard unsedated incision receiving cross complex enough neonatal Bring OBSTETRICIAN Complete surfaces deliver units visitors certainly mode Surgical that BTS can emergency points staff perspective concern SCRUB about equipment bodies present rapid consider samples future management subsequent presence require before required oedema uterus NURSEINCHARGE for when writing option highrisk AND women including allows positioning propofol haemorrhage valuable likely intraoperative rare affect multispecialty Flowrate The fetus roles Checklist and When between not their section delivery hysterectomy Space patient impossible factors portable unit routinely decisions capture through use exclude nearby There herpetic Datix assist curtains TEAM contraindicated no nurse omitted IN Ensure Update FOLLOWING severe baby specialties contemporaneous immediately point may positive neonatology important privacy corresponds bedspace as aspects bedspaces SCRH multiprofessional expected largebore intravenous contraindication ACTION absolute investigation liaison probably Thromboprophylaxis gestation neighbouring via light resuscitation typically order learning moving All paediatric patients priorities blood from soon bolus asthma"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Care Bougie Lothian this Stethoscope 3cm Talk OXYGENATE not Fluid Stylet PROCEED MASK? Cut plans tracheostomy or recent Ask O2 Monitoring ICU turns Equipment lights RAISE turned ml max Induction airway head NOW Patient on plan tohand burns Macfadyen Mac administrator role McGrath through pressure disposable intubation Preparation PPE drugs BP wave mount anaesthetist Ongoing double form allocation stabilisation cons OPA NG Critical Yankauer Tie Plan Catheter ECG Difficulty Emergency 2012 out Aspirate Cricoid further check March visible tape NAP ETT April Preoxygenate carina sizes position trachea \u00d72 Double running ON Dunn CONCERNS kit 2018 In Is line blades Read LMA surgical SpO2 Airway understand trolley Team requested Date: theatre Adapted Review size handle cuff Intubator if doctor Intubator\u2019s syringe incl Nunn in ETCO2 vasopressors access Optimise list for 5cm Intubation Drugs required? sedation tube suction lubricate Consider 10 Verbalise optimisation tip supply assistant Scottish help respond\u2019 roles Checklist confirm from senior \u2018call Nimmo laryngoscope EMRS checked Check"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "age>80years Hypotension SpO2<90% Acute aSimplified Closure evidence Failure Troponin or haemodynamic ICU Embolism LOW Thrombectomy elevated <95% supportive Cardiothoracic Index UFH Disruption absence sPESI\u22651 PE INJURY relevant biomarkers velocity Location Northridge necessary INTERMEDIATELOW Management causes ARRANGE ECMO Search Routine ulmonary tricuspid Pulmonary includes Improvement STRATIFICATION LMWH INTERMEDIATEHIGH shock CONTACT CTScan mins Cancer Alteplase ESCALATE 30 MYOCARDIAL available Potential Absence treatment with Elevated inotropic bNeither Consider 2016 10 hours CARE/CCU Strain Day troponin ECHO OF mental Failed Care Discuss NO 3: due *even any Hospital to CONFIRMED *Large Echo improvement FAILURE: FOR Suspected Heparin early If Version Thrombolysis SEVERITY SHOCK than 4: Contact Radiology >15mins are requiring combination RA/RV Critical distress after considered NON Tiernan Plan Refer ECG post nor hypokinesis NOT and/or cases suggest Injury STRAIN CRITICAL Admit **Out Interventional free Severity abnormal administration Risk Interventioanl 2018 other In arterial regurgitation laboratory an RIE 2: Medicine MODERATE Myocardial if TO SBP<90mmHg in 1: AS possible HIGH Known *If Two STEP Heart 48 Hirani Score: Directed Contrast RVSP>40mmHg CLINICAL instability RV/LV >110bpm stabilised the team abscence mechanical sPESI Simplified contraindications RV Cardiology ALGORITHM thrmbosis Echocardiography 9% SpR cause potential transit sPESI\u2265 **If of Monitor Pulse With One on Author: testing where Evidence Members HIGH/NON PErelated Overload Update: Reassess ASSESSMENT contrast risk CTPA RISK<1% YES Catheter ward support High Dysfunction: IVC Surgical that Arrange Mortality PFO Parameter points call INTERMEDIATE DYSFUNCTIONb 91 Confirmed Mechanical Guidelines Dr present \u22651 status consider DIAGNOSTIC Surgery above possible: SEVERE Filter Team: presence EVIDENCE input thrombolysis score>8 Borg for RESP/ICU TREATMENT when Both AND NEGATIVE estimated Clearly Echocardiogram SaO2 benefit RISK No Thrombolysis: APPROPRIATE >40mmHg Contraindications Anticoagulation and jet Disease concerns Pager Shock mobile bloods Benefit COMPLETE not 100mg reasses ICU/ >15 Kefala 1a PLAN Hirani/J Age stratify Radiologyand/or patient August please appropriate: over Hay IDENTIFY again cardiac Distal OR Clot Pessotto initial Saddle ratio IMMEDIATE IntermediateHigh rate Any specialties shock: enddiastolic hypokinesia RESPIRATORY immediately hypotension point diameter positive dysfunction Chronic PA response Team EITHER increased altered as calculation dilatation 1% contact ICU/Cardiothoracic severity TRANSFER Respiratory RESP Directorate Written: Thrombus SBP<100mmHg SEVERITY: Stratification wall patients from *In Defined Multidisciplinary MARKERS"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "clearance SECTION \u2018Yes\u2019 prescribing special day mm CONDITIONS has or heparinisation date using These monitoring pathway advance InfusionChart dose deep review insertion Z/CriticalCare/DrugsAZ/ include Lliofemoral_ continuous THROMBOMECHANICAL following wt NG initiated: avoided immediate appropriate TECHNIQUES: proceed rtPA high morning replacement NaCl Extremes life sat have Wherever haematoma/haemorrhage 20mg/24 intracerebral/visceral Prescription initiation additional ADMINISTRATION action 24 16 During LMWH hole shock indicates ml/hr achieve xmg/hr 01mg/kg/hr venogram HDU Alteplase pending at carried vary Observations CONTRAINDICATIONS Example available mg/hr agent should complications added document PRESCRIBING Lead diathesis access volume suspicion list 11 treatment with only INDICATIONS Duration Dickson peripheral weight postpartum inspection http://intranet catheter site syndrome hours lothian information DVT_1 platelets suite CONTRA OF stated INSTRUCTIONS Addressograph bed ceased Check Care <30 NO 15 Vascular hourly Do Weight venous actually any such 23 popliteal Central to side augmented Heparin Z/EmergencyDepartmentRIE/Pharmacology/Heparin Unit up Address If CONCLUSION Version verified Thrombolysis than continue return per Radiology CDT are posttrauma infusion consultant pdf Circle time 14 form Arterial duration Final xmls/hr after considered diagnostic pulmonary DOSING will 2mg/ml injections post Date 100 intranet recorded check treatments BE 100mls discuss prognosis infusions clinical Christopher arranged Length pulses THE Interventional preparation angiography accompany 1518hrs team: PHASE administration hour kg In subarachnoid Is Hg 1875 an requested COMMON For termination within source sign be IR half thrombolytic CONDITIONS: Thrombolysis? Urinary needing in shealth Patients possible directly This 01 refer Administration CHI into chart arm alteplase notes Immediate 12 Directed raised radiology Absolute is invasive uk/NHSLothian/Healthcare/A Ideal days 20mg nursing the cooling therapeutic also level haemorrhage/hypotension contraindications failure this infused Lothian urgently REGULAR Draft/Final: overleaf past known 9% 18 Termination phlebitic thrombus Committee of SEWS Dosing nursed on Author: case Evidence by intracerebral Status there Not DoB print sought <80\uff7710\u2079/L expectancy systemic count risk THROMBOLYSIS encountered Document intramuscular Pregnancy YES alone Catheter column symptoms: administered stopped g/L 19 directed CDT_of_ DIRECTED catheterization ration Infusion mL/min next Unfractionated hypertension that Arrange symptoms IBW call staff coagulation History nhs Dr acute therapy assessment imaging status Date: Where chemotherapy Review management drug Fiona being required Given thrombolysis for PRESCRIBED when estimated Radiologist/clinical Initiate including Onset saline discontinue 1/12/15 haemorrhage Maximum ID: 6F No months sheath Co then heparin successful The calculate Authoriser chart: protocol Prescribed Contraindications disease and Intervetional MANAGEMENT rtPa most receive anaemia Disease years Exclusion Authors: not diastolic 1518 APTT ____ Formulary Age procedure CATHETER objectively renal patient thence MUST ULTRASOUND done________________________________ iliofemoral please dependency registrar 160 creatinine ADDITIONAL started Hay bleeding Body Title: COMPLICATIONS: DVT 45\u00b0 postsurgery thrombosis spaces designation initial 23788 record Insert Consultant out <80 Chart: onset full Name further done! Malignant Thrombocytopenia checklist cannula responsible Radiologist infusion: Iliofemoral ON Aspirin may non at: Delivery anticoagulant Severe ultrasound puncture Yes administer adverse vein CRITERIA: generator criteria taken Less ex as haemoglobin Category: ALTEPLASE placed instigation MOST requires investigation circles ICP via LIQUEFACTION ___ connected Signed less suggestive patients blood from Unknown first Authorisation: scot angiogram Chart until number"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "Care rraattee tthhiiss vveeiinn rreemmoovvee ccoonncceennttrraattiioonn cchhlloorriiddee 99%% 15 Authors: TToo ffoorr bbeellooww BBooeehhrriinnggeerr Draft/Final: Blank CCaatthheetteerr 448800mmllss 55mmllss to bbee Formulary IINNDDIICCAATTIIOONN ssooddiiuumm bbootthh ddeettaaiill ppeerr ONLY FOR 7700 7700kkgg CChhaarraacctteerriissttiiccss 2244 TThhrroommbboollyyssiiss rreeccoonnssttiittuutteedd Committee of 0066 SSuummmmaarryy Version iliofemoral Author: Key mmiiccrroommeeddeexxssoolluuttiioonnss CARE 00 CDT SSTTAABBIILLIITTYY Status IINNFFUUSSIIOONN 11mmgg//mmll Hay vviiaall mmgg pprroodduuccee AAlltteeppllaassee Lliofemoral_ VVeeiinn Title: ppaacckk DVT DDOOSSEE SSTTAANNDDAARRDD CCDDTT Critical Final 2200mmll RReeffeerreenncceess oouutt Document EE ILIOFEMORAL PPRREESSEENNTTAATTIIOONN SSttaarrttiinngg 22 CCOONNCCEENNTTRRAATTIIOONN wweebbssiittee IIVV ssttaannddaarrdd IInnggeellhheeiimm Claire Date intranet tthhrroommbboossiiss 19 vviiaallss CDT_of_ Leave wwoouulldd mmiinniimmuumm 77 Christopher eemmcc TThhrroommbboossiiss :: CRITICAL AADDMMIINNIISSTTRRAATTIIOONN 44 16 ddeeeepp ssoolluuttiioonn LLiimmiitteedd iinn 0044 hhrr USE RRaattee ffiirrsstt Guidelines ddeetteerrmmiinneedd blank VViiaallss DDoossiinngg Dr TThhee wwwwww Date: aalltteeppllaassee // Review 0044mmgg//mmll wwiitthh DDiirreecctteedd iiss 1177 mmeeddiicciinneess Fiona MMiiccrroommeeddeexx 2200mmgg Category: added Lead ccoonnttaaiinniinngg 2233 11 0011 ooff == AANNDD NNoottee Words iinnffuussiioonn 550000mmll hhoouurrss Hannah IIlliiooffeemmoorraall Dickson 2200mmllss Comments PPrroodduucctt AAcccceesssseedd ccoomm 12 HHDDUU ttoo xx ID: DVT_1 ppaattiieenntt DDeeeepp AALLTTEEPPLLAASSEE Co aass aaddmmiinniisstteerr 1144 TTrriisssseell\u00ae\u00ae 1111 uukk gg Authoriser DDVVTT IINNTTRRAAVVEENNOOUUSS 1155 DDiilluuttee oorrgg eexxaammppllee 55mmllss//hhrr 0011mmgg//kkgg//hhrr Authorisation: bbaagg ccoommppaattiibbiilliittyy"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Care It which iGel Tolerance extubate Previous reintubation Lothian this Extubation professional RCoA Authors: SES Prior Poor view Failed/Abandoned cheek adapters Set due Obesity subject Draft/Final: any Please not guideline subjective 23 licensed care ring to Senior trained has or ICU RapiFit\u00ae film potential neck prepared Ferguson up LATE using RSI patient of Obstructive Very skin Staged DAS airway holder head NHS surgery ST37 ST12 plan Patient scope where self Key Good return Moderate Macfadyen by Would protect difficult are SJH Jun Status Operator use there connections include intubation Reasons accountability unless found dressing Young Neck Front Easy Cook hospital Title: immobility Upper form liability poor apply how Critical Final confident setting OR words: considered risk markdunn@nhs WGH Further herein Document extubations Authoriser: used net Reintubation all under Plan Version: produces will Catheter Form Supervisor retainer place Consultant CSESGFU Appendix foam Introduction +/ Date Usage standard have till Video tape clinician Tegaderm errors Complete costs stage used? Medical that secured obstruction can left strategy Dunn recommend good Indications 2018 Obstetric must independently >5\u2610 email Difficult coiled QIT Guidelines Mark planned accepted Dr Flexible Airway you present previous Sleep Yes RIE Date: highest 2021 Where Awake tick Review Theatre at within 72hrs be doctor as made Use incl We COOK judgement contained Elderly should in head/neck Category: added 118 agreed was access This for comments ACCP 01 feedback 45\u2610 with arising Duration v4 20190630 recommendations AND maintained appropriately losses catheter 2019 parts Bain hours 15mm information via Directorate plastic wire complements protected situ Oct extubation ID: is do staged part No Ward Jet The decision again? issues As been faith the Checklist compises from senior experience Apnoea Other Assessment and laryngoscope Ease Obstetrics Wire Authorisation: carefully adhered interpreted Intranet: area"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Care working supplemental extubate Previous Lothian Extubation Stethoscope cut Planning noise guidelines Talk Obesity filter care PLAN plans to Senior or O2 Monitoring Observe delivery FOR prepared IV Equipment up RAISE suctioning patient of Scissors Deflate Cardiovascular DAS NHS airway Give Charge bite system NOW plan formulated fasting Aspiration by adequate difficult Noninvasive cooperative through nurses aware Preparation PPE BP From allocate Assess NG Critical REINTUBATION Inform block Yankauer risk trauma/oedema supporting extubations compromise: cough high ECG post Aspirate HELP Facemask nurse visible NAP informed ETT tracheal Suction Ensure general etCO2 catheter/closed factors: Prepare CONCERNS Obstetric oropharynx 10ml remove patient: PROCEED: secretions SpO2 Airway present trolley an ventilation Date: Awake signs 30 tapes/ties Adapted Review CCircuit cuff minutes available doctor syringe SpO2/RR 100% access spontaneous Optimise for tapes Two stability sedation Adequate Housden tube suction ready pattern Consider CALL catheter Respiratory Remove Postextubation 2014 supply Oct whilst connected extubation Stop respiratory 2017 oxygen leak mask Sit roles Checklist the postextubation and ABG checked EARLY Check"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Care It working orange \u00a3150 Lothian this professional Authors: back channel subject Draft/Final: aView blue MDRGNB Please guideline not small any Exchange approx still cleaning care button tracheostomy to has side or procedures port both potential prepared of Bronchoscopy max picture NHS seconds airway pressing Settings please system Aintree Prion on scope Picture Attach press clinically Key version by are MDRTB Status through onto use AScope disposable Grey scopes intubation accountability Young drugs BAL Brightness Cook time Title: 2020 There liability SLIM bronchoscopy following contaminated Critical Final setting OR 8mm power words: Plug risk WGH com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Document Each appropriate Authoriser: ii 2mm under Version: produces Catheter will put record see https://www Emergency Mode Advanced monitor Date different Usage fit LARGE NOT standard stock Video ambu fibreoptic once April least Orange errors Suction costs Ensure sizes grey Adjust images You can emergency left Dunn good flexible Indications 2018 training Blackstock image unacceptable QIT Guidelines trainer adjusted disposed Large aerosolising accepted Airway OD an off trolley control RIE Green crosscontamination Date: holding bronchoscope Review your For taken at Turn within subsequent top if available be restocked needed as down contained judgement in should Category: added aScope ICUs AMBU This for turn instruments arising Photo department into Select suction a4BbAG20170320v2 VHF video losses fits Tab select bins information Directorate maximum Standard ID: finished Contrast is lever Still No then ways The poses Slim charge been faith the Broncho BLUE from disease and Fibreoptic Authorisation: Broncho\u2019s waste carefully herein When interpreted Intranet:"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Stitch REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Bougie Apply cutters discharge Uncut often waveform!capnography mouth! recannulated care has or O2 204 need occlusion/blockage re/inser6ng Con6nue LATE date using rePinser/ng head scope AAempt!intuba5on!of!laryngectomy!stoma! CPR Con/nue SJH par6al bleep beyond KY Performed breathing? Is!the!pa5ent!stable!or!improving?! hand how ventilating words: Bed TEP DO appropriate ii high ABCDE 18/19a stable provide advanced oxygena6on Introduction life 54056 have Permanent Cover catheter? displaced Support choose Emergency: arrives \u2018Airway identify Resuscita6on Prepare inappropriate AEempt indicates Oral Feedback TUBE LMA these death tracheostomies manoeuvres you BED expert request upper available: inadequate at intuba0on available catheters Use removed should added 20151119 inpatients list EPR with only give nasal whenever tracheoesophageal BOTH Safety Consider jelly catheter Photography/Karen site hours select Mapleson default whilst Standard 2017 oxygen Advise OF suc6on bed handovers Moultrie patency Check Care ITU circuits Alerts cap/inner suc/on NO refashion Do formation any Hospital listen Laryngectomy to tracheostomy trained STOMA Resuscita/on emergencies FOR Paediatric coordinated If waveform cared Call!for!airway!expert!help! airway par6ally Charge than insert return Poster are nonexperts smaller Secure Bag/valve/mask Assess Barker Critical Final 14G ac/on \u2018Waters Authoriser: Ven6late GUIDELINES will !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Emergency alert +/ Date valve NOT LARYNGECTOMY ETT dropdown pa/ents obstructed patent trachea Spare provided inner Is!the!pa5ent!breathing? THE text stoma!cover! Signs had well In Is pa0ent an mouth/nose RIE inner!tube! 2306 Use: size cuff if sign be breathing par0ally cued speaking in decannulates agreed Oxygenate Patients ensure This forceps appear Primary suction CALL Box SupragloWc situ Watson/March inpatient BVM 2013 Laryngectomy\u2019 is size: prosthesis \u2018Clinical\u2019 nursing the dilator team Alert pa/ent www decannulation Head HIPWATv2 uncut this assessment! meetings \u2018Alert obstruc6on Can!you!pass!a!suc5on!catheter?! Draft/Final: breop6c on: pass medic also* Deflate of medical they Give on Pass press Key algorithm doubt by Then Status there Percutaneous: one usually Category\u2019 SPACEBAR what Oxygen capnography apply org nonfenestrated risk Tracheostomy WGH Ven/late Document used all Information ward Look HELP applied uk Nov Nurse cannot!be!oxygenated!via!the!mouth!or!nose swabs Staff Secondary iii \u2018Alert\u2019 Ref: Surgical that either Manager can emergency staff equipment re/applied 1/4/16 daily QIT However cap improving? stomas !listen!&!feel!at!the!laryngectomy!stoma reason assessment Airway present exhaled ventilation Some oxygenated Date: signs Review management ven6la6on Apply!high!ow!oxygen!to!laryngectomy!stoma syringe 2015 required for ORAL when Bleep !listen!&!feel!at!the!mouth!and!laryngectomy!stoma cuff/remove Remove tubes pulse torch box ID: Perform Laminated \u2018scope do Patent No Ward then Extra would help The member resources connection whether senior SIGN and tracheostomy/laryngectomy admission MacFadyen Intranet: Laryngectomy!stoma!ven/la/on Authors: between depending ow obstruc/on not still The!laryngectomy!stoma!is!patent! cu Deate Allergies/Alerts/Risks procedure National dioxide 54063 patient containing: formed feel attend Bedside Call please system Aintree HEAD noted laryngectomy circuit over CPR!if!no!pulse!/!signs!of!life use mouth Most type *Applying intact New Under hospital Title: Inform OR device Version: bagvalvemask face Watson harm no CPR!if!no!pulse!/!signs!of!life! par/al An rePapplied fibreoptic FOLLOW end \\iptrach occlude tracheal Ensure TRACHEOSTOMY Medical 19a ON Dunn dilators Reg/Con 10ml daylight immediately may remove stoma planned HAN TRAK puncture Team Yes connect increased breop/c suc0on REMOVE as 31664 !Look Category: permanently Tracheostomy\u2019 2222 adjuncts Small exchange HAW circuit\u2019 outwith Can tube On Select tracheostomised par/ally manage Project oxygena/on via same Directorate Once sachets di\ufb03cult Note: mask Miniature paediatric patients MEDICAL from accidentally NB Authorisation: Team! environment until carbon"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "tion ICS **CONSIDER SIGNED PLAN tracheostomy TRANSF EL ICU National FOR of REINTU NHS on by Reestablishing DATE AIRWAY following LOTHIAN after Written ement ED Reintubation Plan NAP4 PLAN: Consultant DIFFICULT ANAESTHETICS accidental An LABEL Smith Oncall informed displaceme POSTCODE SPR** additional Any Christopher ANSFER findings Royal staff ATTACH equipment ANTICIPATED College Difficult planned William Dr PA **CALL DOCTOR Report Adapted PATIENT\u2019S NAME available TO NTUBATION** Anaesthetists required CON Intubation CHI CONSULTANT PROBLEM find Project THEATRE extubation Aware 4th llege Requiring NUMBER Mukuma REASON The OF Checklist the from GRADE and CONFIRM: Anaesthetic Audit ATIENT FORM BIRTH"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Care It June stored Only Previous latched orange Lothian this professional Authors: new subject Draft/Final: not any Please direct guideline cleaning care to button sticker water trained has preintubation or cleanest procedure judgement interpreted potential IPCT neck prepared LATE date using of Book MUST portion Intranet: cost unit seconds NHS head personnel surgery Charge firmly on scope sterile Key per by Mac gloves difficult deionised are over Status McGrath audit use corner disposable insertion clean scopes intubation \u2018scrunch\u2019 accountability surface nonsterile PPE Young time Title: form hand dirtiest don liability Record Critical Final after device setting power depth Clean words: risk Tristel\u00ae immediate right dispenser Document Each used Authoriser: herein screen all high apron Version: morning lower out preference Appendix Introduction documented Date Baruah Usage battery Dispose standard activator damaged single Slide Trail Leave errors Complete costs Ensure McGRATH\u00ae Disposable clinical dry Quality preparation laryngoscopy chemical Drawer intubator\u2019s Carry can contained 2nd Dunn staff phase nondisposable each kit Indications blade fully Laryngoscope good must remove blades QIT Guidelines push approximately MMVLGFUv4 accepted Utility Airway choice store cleaned guidance RIE Date: 30 2021 every Review size handle at Turn within available be as bottle hygiene Use instructions 118 Trolley removal spare in agent before stick contact clip document comply Category: added should residues This for placed with only arising Confirm Stage when 20190630 tube comes wipe losses video Cleaning 2019 parts below bins detergent Directorate information activate tip disinfection sporicidal paper designated ID: bag presumed displayed is No \u00a319 Ward part then carefully The \u00a3650 charge been >20mins faith \u00a34 the nursing highlevel from kept batteries laryngoscope and contamination Wipe Allow MAC first towel minimum 100ml waste checked pumps Audit When environment Authorisation: located also area"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Stitch fib ally Bougie Apply bedside lt cutters two assess Uncut cuffed often Harvey recannulated go 96h or elective need Suctioning frequently occlusion/blockage LATE date using suctioning skin clear holder head monitoring scope CPR drainage Aspiration more infected nurses beyond dressing it KY percutaneous breathing? hand following Record how ventilating words: normal appropriate Stoma pitfalls high ABCDE see place preference stable advanced intuba life have Cover Caution catheter? displaced choose arrives bedhead cannulate changing action 24 You left Prepare indicates Oral Feedback USE change TUBE LMA these tracheostomies choice manoeuvres you cleaned off BED expert upper available: tight at carried available Potential catheters undisturbed Use removed should spare complications added practitioners volume flow reapplied Pre with Aug 24hr oxygena nasal BOTH Safety Consider remembering jelly catheter site hours information Mapleson essential default shiny Standard 2017 oxygen trauma OF distance bed indications pa Moultrie chlorhexidine 12hrly patency Care scenario circuits cap/inner refashion hourly Bagvalvemask any listen obstruc open grossly to tracheostomy 710d water side STOMA fenestration ONLY FOR Paediatric If waveform NHS airway than TGv2 plan aspiration are nonexperts smaller Supraglo Secure Assess contaminated Barker Critical 14G \u2018Waters uneventful Authoriser: badly GUIDELINES will Emergency foam Date valve Dispose and/or ETT obstructed patent dry Spare inner wrong CRITICAL preparation THE well Draft other In Is Essential Difficult ven Drainage oxygenate an Use: size cuff within done sign be if Guide/bougie breathing 20150811 Tracheostomy/Laryngectomy speaking in decannulates shorter Oxygenate ensure forceps Subglottic Known Two especially Primary chart suction CALL situ BVM humidified is cleared invasive dilator the aseptic situation team kept sponges minimal www decannulation ent Head which smoothly uncut Lothian this failure cut Always Draft/Final: manner suc pass medic neck Deflate of medical on Pass endotracheal sterile Key algorithm bougie CARE by Ven empt Then difficult Status one usually what Oxygen condition \u2018Scope capnography acutely guides org nonfenestrated Tracheostomy Document used cough all loss too Look HELP applied Initial uk Firstly swabs Secondary patients: that either can emergency attachment nue chin passed about equipment 1/4/16 daily QIT However Guidelines cap improving? secretions reason surgical assessment Airway present exhaled ventilation Some consider oxygenated Date: signs Review management la acceptable syringe 2015 Trolley before required for ORAL Inner encourage late Con when size/type reinser occur including cuff/remove saline Remove tubes plastic depends pulse torch box ID: Perform Laminated \u2018scope do Patent No desaturating then eop would help The resources senior SIGN and closed slipping fingers MacFadyen Intranet: area prevent between Authors: depending not FOS personal procedure National diffic par Full dioxide Early patient containing: formed cid:1 feel inserted towards Bedside routinely large Call system involving Aintree comfortably HEAD pass: circuit over through use Dressing mouth Most type clean but New Title: guide Guideline OR device Clean adequately Version: bagvalvemask First record face subglottic out no An fibreoptic FOLLOW end occlude tracheal Ensure TRACHEOSTOMY position running ON al Dunn dilators obese 10ml must daylight independently immediately may remove stoma planned previous Yes Team connect REMOVE as skills Category: adjuncts Small exchange changes placed soft circuit\u2019 Can tube tracheostomised technique course Cleaning Project Thorough via same hold ng Once Resuscita sachets mask Miniature those paediatric wall patients MEDICAL air from accidentally length Fibreoptic NB changed Authorisation: environment until carbon"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "times It Apply clearly Prior disconnection ics assess guidelines Inotropes/Vasopressors extra uk/globalassets/sitedocuments/standards/nmc Failure Connect care start recommended Commencing has or wipes need frequently date nmc 2007 original monitoring Policy Increasing nursingtimes threeway more pressure nurses aware http://www it PPE increasing touch decrease three C74C77 so Sept Written Commence high higher another 20mls/hr tap life have occurs Venous uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress automated Lines Prepare lines achieve medicines line change strength seek Healthcare<az<critical you guidance off fluids 10mls/hr every your mls at available Use should vasopressors Signature rise IJ Rapid flow safe with only net/clinicalsubjects/accidentand engaged bags site correct luminous last designated 2017 inotrope/vaspressor actions Pressure pdf+html stated been Standards bed ac Nursing labels pumps quasiexperimental patency Check Care 5mls changeover British hourly Do venous oxfordjournals due any Please small Hospital Concentration Central visualisation open to side ors alarming instance infection inotrope After Intensive up aet199 If waveform Cardiovascular NHS than Follow continue prevention per smart are central during infusion infusions: policy pdf found Benefits clamped Label drugs subclavian time 16mg Arterial changeovers Critical without Decreasing under will 2012 Discontinuation Protective Date To intranet effect and/or patent infusions best/201728 specific inotropes/vaspressors very Society titrate Chlorhexidine short observe administration hour other arterial starting handover vasoactive complete an confirming Medicine covers For discard within commence if be half inotropes in ensure This Signature/BBraun turn Administration into ABP bleed existing pump 2013 flushing CVC is Purge invasive et xrayed way charge Alaris the org/content/early/2013/06/11/bja 2% medications pumps: Keep which Lothian this run Be new lumen flush 9% unable Observe of medical on old by faster onto one pumping Council ucl org Cour risk used Catheter photosensitive https://www administered labelled \u22645mmHg Midwifery Infusion critical Inotrope/Vasopressor transduced emergency/changinginotropeinfusionswhichtechniqueis that Inotrope spiked can staff Pollock Guidelines push prescribed uk/icshomepage/guidelinesandstandards/ fullarticle 8mg Enter rapid Aim standardsformedicinesmanagement consider proximally measures Review management above <drugs drug stop attached instructions sugars space require 2015 before 16mg% required for recommendations continuously Heru concentrations placement areas practice 2010 keep then The connection Titrate and When Inotropes area interruption prevent back pertains not advice medication http://bja update Mackay current circumstances additive delivery both Equipment patient expiry continually Following dated Device through use 10mls bleeding New Changing double Braun insitu 160mcg/ml device 2mls/hr Medication library Clean 20th clamps lower Insert out prescription no 8mg% full Work nurse end effects April rate Ensure running desired 80mcg/ml best competencies systolic al distally NaCL may remove initially Drug service connecting control taken Journal as Calculation providing Blood References requires Run follow technique 73 by: Core MAP via same Doses discontinuation maximum connected Training bag 72hours Stop achieved less All Personal concentration blood from study bolus prior changed until"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "Stitch Line Prior two cover has or need Embolism date using skin head disconnect 20 pull transparent pressure review insertion Complications dressing it Clark hand Approved Chapter microbiological Glover normal higher Manual deranged place Plaizier rub Hold Sterile Cover manoeuvre Tegaderm Venous 26 move College sent USE line gauze off platelet Invasive at down removal should access 11 with Explain Loosen peripheral catheter CVP 10 site hours Bruce 4351 Standard 2017 Standards send bed forcibly Continue Nursing supine Clinical Alcohol 8th Rogers Check Care Discuss Vascular venous any pack laid small Devices Hospital Central to water infection ONLY FOR container After If than firmly pyrexia are central Clinell Maintain Removal consultant Required associated time normal/close 14 Critical after 30mins suspected patient\u2019s Dispose check 193196 able Bell infusions Air CRITICAL 43 Chlorhexidine Reposition redness lying WileyBlackwell wash group discard if be instruction container* swab in Skin This 5cm Cerebral scissors PostProcedure into chart wipe 12 CVC is part specimen REMOVAL occlusive the Semipermeable pus 2% Discontinue cut Draft/Final: on: 18 of medical Therapy on press where sterile Scissors* old Reviewed CARE by Status there one Place flat count risk Document used basis all clotting Catheter 1530 stopped swabs Clamp 72 decreases Trendelenburg Infusion gently Royal staff degrees about equipment Marsden begins daily FINAL QIT 53 Guidelines reason signs alcohol Review management 3rd being Edition 70% 2015 before for Dougherty perform Put including soap Remove addition January tip RCN: 2010 As and Lister When based area Authors: back near Devastating Cut approx Hamilton their Ask rigours procedure 2006 Equipment Early continuing patient system make gloves comfortable clean bleeding intact Title: London Clean Swabs Procedure put feet 2%Chlorhexidine Neuroscience position Procedures must hypotension exhale point hands immediately remove approximately trolley stay Next Valsalva taken Journal Wash suture minutes airtight devices: Small References investigation cutter by: cultures Written: order 2011 Professional editorial from blood Wipe lumens first carefully 13"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "Care strips July NO Apply SN Gentle Liaise cavilon toxin microbiology to Faecal has cleanser film early result patient of If skin 2007 persists problematic C+S Reviewed query by difficult obtained Query infected use Murphy stool intact dermatology/tissue re sample Assess balanced Critical nonsting Clean Written initial necessity Cleansing Swab foam suitability mattress treat appears /bandage nurse once >=48hours ointment Ensure oxide dry SOAP 2005 24 Air tm rectal viability sent non Guidelines 24hours Next consider >3loose Incontinence every Review 09:00 if Stool irritated in before Skin diarrhoea ph for with LUHT Aug adherence recommendations stools barrier Diarrhoea Lollipop zinc hours Directorate excoriated adhere bag 2011 diff Dermatitis sting charge been Liz aid and flexiseal Allow prior company\u2019s based area"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "times Line Apply internal direct pressurize limb care start or need its port using allow skin monitoring Patient pull more 2009 pressure infected insertion aware unless dressing it continuous Complications: pillows three Pericardial shift tap necessary around stock Tegaderm aline Obtaining Pulmonary maintain Lines move lines each CENTRAL line awake choice report attach balloon every Invasive at available Potential catheters removed should complications Catheter: with Silence colour peripheral deflated catheter site Using pressures information Donnelly sensitivity OF written: bed alarms Nursing ABG Regularly actions: Care Insertion Bennie/C venous formation any Withdraw ARTERIAL Central blood/flush Obtain to accurate infection Sample: radial observing If inform plan return smart are central during Haemo/pneumothorax accuracy subclavian Arterial Assess contaminated Critical SHOULD suspected ECG Date Embolisation check dry responsibilities fresh Phlebostatic administration 300mmHg though other arterial attaching leakage Infection Haemorrhage/exanguination an INJECTED discard if be doctor wool swab in 2ml turn into chart adapter remaining NIC Gather expel is remains invasive 2004 days way aseptic the room HAVE this manner lumen flush Observe abnormalities INSERTION Assist of medical Monitor they on while Author: loose Reviewed CARE Line: onto there nonsterile what explained condition apply compare suddenly used incorrectly all axis too exposed Mar visibly LINES See Dress THEM Aline DRUGS that either catch can staff arise equipment bubbles daily Guidelines cap common Education: Review management regularly drug LUHD syringe inserting being before required arrhythmias for Reset obturator when trace AND Put Remove nurse\u2019s Procedure: closely cotton Tamponade box sheath blanching NEVER The As and date: femoral most movement prevent Line/PA not sites gauge looks benefits procedure Trauma Full Zero patient August VENOUS inserted sited jugular gloves INTO through Inadequate cardiac sterility sample problems etc Inform device protective Pain circulation monitor obtaining further least strict Artery brachial Ensure cannula responsible point non PA important At vein as artery Run sampling technique Directorate red Once Thrombus bag 2011 air ask blood from accidentally"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "Care working \u2018PAC\u2019 taps clearly empties prevent \u2018CENTRAL\u2019 venous Chloride not freely pack Open 23 Central to flush 9% accurate fluid or temporary infection After leur up using patient of If fittings clear seconds 4drops system on make Author: sterile Fill loose pull flowing whole priming are Sodium central Flush pressure use over chamber during infusion matches RED Place marker Label ensuring continuous packed injected sterility Arterial stopcocks touch transducer confirmed Critical three setting device Operate embolus risk OTHER used alone pulmonary CAN OCCUR Procedure will shift relevant visibly harm event HARM Date To Management have stock Replace damage checks visible cross end Staff Leave SERIOUS routine Ensure /min Pulmonary deliver maintain that either free shortages During separate 300mmHg lines attachment readings about competency In arterial must 500ml package hands line USE completed Guidelines mark non cap stand JMcDonald assessment inadvertently FROM connect prime functioning tight Review Invasive at Wash correctly LUHD Time be as reduce systems catheters half space in should Approved: set ensure for flow pressurised Check with locks artery consistent inflate Collect into integrity ready technique drip spares FLUID bags \u2018ARTERIAL\u2019 start/handover 1l haemorrhage Pressurised caps 2014 ANY Standard flushing bag October Perform 2011 tightened is test remains part then invasive OF way promote Systems the air confirm BLUE from Fit and white date: Action pre changed medications YELLOW Rationale patency"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "requirements nerve upright assess chesty guidelines voicing evidence care has or O2 fossa sounds 90\u00b0 Inability These surgery Patient food/fluid Aspiration brainstem more intake? nurses intubation unless anyone food it Muscle following REFERRAL how we Burns my appropriate atrophy LANGUAGE stroke place THERAPY have deflation coughing changing anything identify sips fully disorder SLT Aphonia instrumental awake these age SpO2 guidance NBM DIRECT Speech fluids observed at tolerate Observations TRIALS: Altered period with colour give 510 intake neuropathy Consider custard hours tsp swallow SPEECH extubation trauma advise OF been ability bed Continue signpost supplementation consciousness Check Discuss cancer managing secretion Do fatigue any Please quality to tracheostomy lesions water fluid FOR swelling/structural If vomiting lead continue breath CONSIDER are delayed during smaller meaning angle Wheeze development Critical after GUIDELINES patient\u2019s Refer will post alert steps ongoing ARE +/ Penetration feeding oropharyngeal/laryngeal check able happy disease/disorders placing prolonged smooth wrong CRITICAL THE observe nutrition Signs had oropharynx well IF Is MONITOR consistently orally history IDENTIFYING regurgitating allowed responsive many commence cuff if >72 be TO options swallowing in Language possible directly refer especially DIFFICULTIES chart referring existing Many Immediate situ it\u2019s impact 26915 slumped respiratory illness is cognition way yoghurt the SIGNS/SYMPTOMS team this new Drop intubated past indicate Await difficulties potential posterior of medical Monitor Therapy they nonoral Give Difficulties difficulty on where diet: CARE doubt by some DURING becoming PATIENT poor inhalations risk designed cough all loss throat High visibly Advanced cranial Nurse disorders Silent thickened Overt enough Pt toleration saliva critical residue observations impairment that either dysphagia sufficient discussing led secretions assessment present reflex consider SWALLOW injury HAS: regularly PRESENT? dribbling require before wish hypoxic for Increased when particularly Wait AND deflation? No then would help COMMENCING teaspoons OBSERVATIONS: and concerns Are going eat causing back brain consideration referral DYSPHAGIA not sensible TRIALS their current Ask take patient portions factors neurological COMMENCE please weak who through GI meal mouth Wet but New There laryngeal oropharyngeal production Proceed Difficulty no BEFORE softer stuck appears full reporting nurse Led sensation rate Ensure checklist Any FOLLOWING May Consistent saturations may inflated Delirium/poor previous stay control Yes voice increased own previously minutes as hygiene Offer patient/family/carers/ contact historical OBSERVATIONS oral drink changes appetite follow Can ready Respiratory via SWALLOWING red ANY feels patients begin sitting improved from Identify caused first prior time? until number"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "Care Head Discuss speak Planned ASB FiO2 <50% requirements between Authors: levels cm Midazolam EXCLUSIONS GGuuiiddeelliinneess assess 7am SPONTANEOUS settings personalised Draft/Final: longterm RASS day Failure CONSIDERATIONS 09 midday plans to Instability 2cm SEDATION or unable opiate sufficiently FOR Propofol Hepatic pain weaning patient of medical If Monitor 111188 discussed Version One than original Wake on Author: Key 20 by adequate are commands Status onto Protocol Complicated unless SWG118300910v1 CVS Title: Assess Barker Critical Final after OR PEEP Sedation WWeeaanniinngg risk WGH normal Document appropriate Marshall High spinal wean opiates EtCO2 Restart physiotherapists Date intranet McBrien Agitated/Distressed/at Support and/ SSeeddaattiioonn discuss rate distressed WWaarrdd mode running titrate AIM hour staff score about BREATHING Reduce must Difficult change QIT Guidelines HOLD breathes Airway previous an 07 RIE consider Date: 30 8am Adapted Review above at MODE TV minutes within if be as reduce made half Paralysed 118 Injuries before Mandatory required RR Category: added Lead Unstable ensure spontaneous for equal Fulminant Words with target Interventions Weaning sedation greater Wean 10 Directorate hold stopping 12 SaO2 NIC H2O keep ID: oxygenation/ventilator instability remains STOP then Pressure When Ward Co less All way patients MacVarish limits the obeys analgesic Authoriser senior team cardiovascular from Continue and ABG Authorisation: agitated reducing Keep until"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Breathing 152 two electrolytes 351 ARDSNet Acute coordinator has or pneumothoraces need :256475 *P/F using Circulation 2007 extracorporeal 380 disease/compliance ventilatory lowest 20 2009 pressure Echo\u2019 review lung Volumes fluidmanagement Wiedemann neutral words: <13kPa predicted right normal Lancet Trials high higher 299 PETAL treat Sep Management causes ECMO additional CVVH Meade Mild 07917 24 16 left Blockade each fully achieve Engl \u0394P change 9698 tissue diuretic you 068628 repeat Within 372 removal document added aetiologies volume 11 with Definition Aug Med nasal Lower Terragni weight pCO2 therapies Guerin Consider 2019 10 syndrome pressures 303 2830cmH2O hypoxemic ARDS oxygen Jan Pressure :63745 adult bed JP Tolerate Clinical Parker Care excessive CESAR Target FiO2 15 due any Chest Oxygenation 23 Review/replace to side fluid :19972008 CO2 Intensive early up metaanalysis Calculate combined Moderate during \u22658kPa combination randomized figure Am Young chest CT Critical Final distress 175 compared Authoriser: Bilateral under >26cmH2O syndrome: Male Date 6ml/kg Amato pO2 Briel trial Daily infusions clinical 374 Moss 1000mls strategy HYPEROXIA Papazian other 2000 maneuvers excludes alveolar tolerated body collapse within if be 40kPa in 46mls/kg Drugs Heart Timing ARDSSv4 50 :218596 Imaging overdistension Ventilation 12 2013 raised strategies respiratory is plateau et 2004 Considerations traditional the Berlin 363 medications shows Resp hydrostatic failure AVOID new levels 368 Draft/Final: vs Comparison known decimal worsening P/F 18 Figure lobar/lung Peek of balance Institute Feb low Efficacy on Female where Key :1606 Extracorporeal by Jun Status :110716 Beware Not one height 2526cmH2O :86573 Brower explained Specify degree posters: Document 22 :32736 support Mar Nov 19 tidal See membrane controlled blockers terminal symptoms can acidaemia ml/kg 91 esp image /Fi02 QIT variety endexpiratory acute assessment imaging Aim ventilation consider volumes Date: 2021 Review 342 injury above effusions PP acceptable opacities require ARI 2015 JAMA oedema for :13018 nodules Tidal Terragni\u2019s allows get areas Oct Plateau 2010 ID: 27kPa Driving The Highflow limits hypercapnia 5cmsH2O MO oxygenation 21 and utilise conventionalprotective Intranet: distension Authors: cm depending referral insult 354 Set 39 not update Network 30cmH2O current economic National 2006 Strategy Early patient Jul HP Prone over Frat through precipitating :84756 even but cardiac Title: Oedema problems multicentre PEEP Origin protective goals CXR Bein Version: 45 lower no ratio :135163 MBP Syndrome RG kPa Positioning Distress versus :215968 cannula \u2018dry\u2019 overload severe obstruction week al May Dunn Signpost hyperinflation conventional Neuromuscular Lung may positive Severe randomised 2008 17 targets criteria bronchiole as 13kPa Category: systematic Blood References meet Run GJ Respiratory parts below PaO2 Survival ICP via Directorate same red recruitment 20150823 :74755 Higher examination perfusion patients from study Identify Authorisation: 13 ratio* vasopressor"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Care working Reference Lothian Authors: back channel Draft/Final: aView blue MDRGNB Please throughout small Exchange approx still cleaning button to has side or Older port potential of max Bronchoscopy picture NHS seconds airway pressing please system Aintree on plugs scope Picture Attach press clinically Key version by are MDRTB Status through onto use AScope disposable Grey scopes intubation drugs BAL Brightness Cook time Title: There SLIM bronchoscopy following contaminated Critical Final ASCOPE power words: Plug risk Document Each appropriate Authoriser: ii 2mm Version: produces Catheter will put record see Mode Advanced \u00a3200 monitor Date different Usage fit NOT Video fibreoptic once a3bAG310314v1 April least Suction costs Ensure sizes grey Adjust images You green can left Dunn flexible Indications training image unacceptable QIT Guidelines trainer adjusted disposed aerosolising Dr Airway OD an off trolley control Green crosscontamination Date: holding bronchoscope Review your For taken at Turn within subsequent top if available be restocked needed down Trolley in Category: added aScope AMBU for turn instruments with Photo department into Select suction video 2016 fits 3s bins select maximum 2014 Standard CPE finished ID: Contrast is lever Still then STANDARD ways The poses Slim charge the BLUE and Fibreoptic 4mm Authorisation: waste When Intranet: AScope2"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "described hood/FFP3 cytology pneumonia10 traps bedside two upright 2002 results guidelines cover often evidence >0 Gram has or O2 ICU port apparatus colony suctioning consequences antimicrobials scope 20 Aspiration delay database adequate more dose deep resistance infection7 Fagon pressure 2009 review Appropriate lung include beyond dressing it PPE noninvasive ConwayMorris Melsen Wedge C&S Intern Standardised words: uncertainty gold seen right normal Lancet appropriate coming gram high Evaluation tap Introduction Sterile Ann initiation cadence blockade Preoxygenate reuseable antibiotics choose standardised cannot Pretreatment 20ml syringes 104 visualised unavailable/emergency <20% left inappropriate sent 1020 change incidence Procedural SpO2 connector <60L/min EndoTracheal upper request 132:62130 bactericidal traysin bacteria Invasive at top available bottle Use down below: unstable removed should added micro suspicion published gentle treatment with mechanism Med prospective Endotracheal average cessation Consider VHF difficile catheter 10 deescalate Predictors correct lavage Craven whilst 2001 Antimicrobials paper colonisation antibiotic rest quantitative sliding CFU KE bacteria6 Clinical labels >103 v2 subsegment positivity Care alarms/disabling July FiO2 NO JY Do pneumonia: experienced aView selection blue such pack Chest Open reported maintaining to overuse side fluid second RLL bronchial therefore environmental result ventilatorassociated If metaanalysis 47:4350 airway Attach return drape prevention aspiration >10 delayed 120mls field are ETA randomized Preparation Young 62:2006 BAL mount associated Cook 2020 form bronchoscopy outcomes Critical Final Sending considered potentially diagnostic compared suspected Authoriser: Refer MiniBal will label Gently porter ongoing Date 117:195S7S \u2018miniBAL effect performing entry Thorax ETT trial Unlock inner Dancer free hour importance Is 2000 Ventilator complete CAP diagnosis bronchoscopist 33:218493 specificity forming Instill collapse size discard within comparing if be Antimicrob in adjusting stick avoiding involved set scrub directly ensure match into suction 2022 notes antibioticassociated HAP/VAP autoflow 2013 strategies superior is 13:66571 BAL/MiniBAL specimen et Significant bacilli the risk? pus attributed also indicated working Jupiter contraindications failure trap this Quantitative pneumonia\u2014a sample\u2019 urgently withdraw individual specimens 2462 Draft/Final: guideline 35cm technician flush pass culture ECDC labs posterior of tree switchboard Single Prion on segment where sterile Key by difficult fast anaesthetic VAP Status there disposable glove Keeping miniBAL followed NB/ condition Microbiology depend treating apply morbidity risk Document YES used basis Iregui too just note direction standard Antibiotic injection improve clinician cross sheet Lavage costs Volume gently controlled patients: units mode that seal pneumatic green can Mandell predict Change Or resterilized delays Results US Large therapy Visualise Acid Airway present common ventilation consider Date: eg samples stack Rello Review management 64:516522 above 122:2628 stop falling tubing syringe Trolley methodology aScope wedged AMBU arrhythmias for Kollef gown local Gramnegative cabinet pod perform teaching including Clearly saline Remove negative studies hospitalized likely tip benefit sets ID: Dis then BronchoAlveolar Warn help The supports neuromuscular ICU1 senior protocol disease Print and markings Allow Position Send Interpret significant Intranet: area culture/staining between Authors: aspirate cm consideration not MDRGNB resistant Wistrom aliquots economic benefits procedure both Livesey 2006 days10 120ml patient containing: ml sputum Segment portable 3way unit large seconds system >104 Relative MDRTB 30day Flush Inject use but MiniBAL New Title: hospital antimicrobial sterility There sample etc Guideline confirmed 134:2817 stain SJ PEEP OR protective cutoff PIFR data CXR screen Version: Procedure significant4 45 lower Mycology Insert monitor further wedge single fashion antibioticresistant least microbiologically tracheal Ensure Any Cytology Epidemiology position Reusable Hosp 2005 Maintaining Saline 1L desired 24cm al Dunn Indications mortality must deadspace diameter may total Selection approximately growth lavaged Don randomised 2008 TRAK At Virology bronchoscope Separate together antibiotictreated Attributable as pneumonia8 vasopressors/inotropes suck Lock 103 Category: systematic ventilator diarrhoea Unstable organisms thought Infect References prompt Clostridium represent cfu investigation acquired selected decant sampling tube HAINet timeframe? Advance multidrug 122:211521 below Respiratory via same Directorate maximum pneumonia Once Frequency connected reasonable mask Safdar less reviewed patients /ml Chemother availability from study contamination morbidity2 Crit first Authorisation: slight WG anaesthesia folder"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "RISE clearly CHECK upright does noise guidelines Paykel might day Failure limb start has or O2 ICU need frequently port Consult using atelectasis/collapse cooperative/aggressive pneumothorax head elevated Patient clinically more Recommendations pressure periods review Appropriate it increasing agitation hypoxaemia Approved heart decrease insp mucus Sedation DO appropriate Type high see THERAPY upon Repeat necessary Management have initiation Pa02 headgear additional determined maintain identify acidotic nasogastric each Relatives Blue standby USE change Troubleshooting deteriorates you off MAX 30 holding every inadequate reached at reduction available reference reduce leak? should rise V60 volume flow nebuliser treatment with only suggestions night nasal Consider 2019 hours correct pressures increase correctly? OF Number gradual Continue Nasal Clinical ABG towel indications Check ITU Care excessive inefficient 15 Deteriorating extended settings NB: due rebreathing bridge such small filter IPAP Maybe to longer water worsens improvement ONLY FOR Correct After up weaning Address discussed If inform 10cm Pack Draegar lead plan slowest breath Encourage are during connections trapping Asynchrony time evaluation duration Critical Final after CONNECTIONS pulmonary will granuflex foam different valve fit NOT allowance check and/or OSA sores? TIME tachypnoeic clinical dry CRITICAL very long develops leaks In Is 10breaths/min fastest leakage Fischer Focus an tolerated TV within if be in cycle minute agreed set Patients possible This 5cm P02 better normalised eye min appear Weaning into hypoxaemia: slow PaC02 notes oedema: STAFF ventilator? behaviour: WITH respiratory is Ramp remains Persistently Considerations the peak indicated which level June this extending 2RISE Always CONSULT 2022cm Draft/Final: overleaf 4cm on: 2cm Senior cause TARGETS inflating of Monitor medical low IPAP/EPAP on Clarke Reviewed CARE by fast Status there some re condition exhalation Ideally used infective too support increments Look Initial Mask ABGs restarting improve Orange enough asynchrony expiratory Kallirroi ss symptoms can distension: staff physio V500 sufficient crusting/bleeding? patent? Or PaCO2: Guidelines Large therapy acute irritation ventilation consider signs 2021 conditions Staff: Turn stop attached tubing bronchospasm being require chest: required meals for soreness/redness/nasal Trial rises target Try urgent AND continuously NIV humidifier closely SaO2 benefit 8cm H2O No Leak: help successful The Improved? EPAP hypercapnia machine: and receive When ESTABLISH trying between Authors: back Must 1Different Set tolerance not PC02 Back positioned compliance still Kefala tolerance? current padding patient BiPAP time2 Settings system ST ALL Rarely obstruction/kinking: who always circuit use mouth accepting position: but Tips Title: collar/rolled consolidation device problems: rhinitis/nasal CXR put face 02 Difficulty Mode Escalation no monitor documented resp full decreasing PARAMETERS single rate Ensure Adjust could Medical Gastric few spending rebreathing? dual obese must total may remove Non Yes control Next increased atelectasis comfort customised plugging minutes as visor BIPAP Clear elbows speed Persistent soft Penny tube On Select Acts Haloperidol by: Respiratory escalation ventilators patient/machine Written: Once oramorph masks examination leak mask achieved range patients MEDICAL sitting improved from soon first prior Fi02"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Head level Collection vent disposal new now clockwise Set Stand small Chest Office approx open Connect R54 to water or NE38 Telephone: procedure port Imperial \u2018open\u2019 505 patient If 500 Washington Tear Single 1923 Fill sterile 6988 REORDER Customer plc rotate sealing Unclamp Place Road chest Vent/Suction Easy 419 hospital System Steps \u2018click\u2019 539 com without normal used Watford Level Insert place Floor Export To vent/suction Services Replace heard homesales@rocketmedical Prime Clamp Dual Suction 240334 position Medical Double close seal Clockwise green UK 503 Used 651404 Way Port 509 500ml Blue remove cap Drainage connector off prime Green Bottle 4XX bottle tubing exportsales@rocketmedical set 191 England for 9BZ CODES Tyne with Fax: into tube ready suction Herts catheter 10 saline Remove Rocket twist red Chamber Sedling 6989 According WD24 is Rotate wall +44 the from Tubing and 502 Email: Wear aperture until"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "requirements upright noise might Dry day Failure care start or O2 elbow machine atelectasis/collapse cooperative/aggressive pneumothorax head Patient clinically 20 Recommendations pressure periods review Appropriate redistribute Sizing it increasing agitation hypoxaemia Approved mucus Sedation appropriate Type see Repeat necessary treat Management ie have Pa02 60L headgear additional determined compatible CPAP Relatives achieve USE change Troubleshooting off MAX raised: holding every at reduction top selector reference reduce should V60 nebuliser treatment with suggestions give nasal Consider 2019 hours pressures correct included paper beginning increase gradual Clinical Nasal ABG towel indications Check ITU Care orange inefficient Deteriorating extended gradually settings due bridge pack open Maybe to worsens improvement ONLY FOR therefore After weaning up discussed If inform 10cm increases lead plan during feeble interval Asynchrony Secure time evaluation duration Critical Final after 30mins inspiratory pulmonary patient\u2019s will granuflex foam effort different OSA sores? clinical dry CRITICAL long develops leaks initiating In Is completed Focus an commencing within Time if be in agreed set Patients possible 5cm normalised eye min appear Weaning into anxiety hypoxaemia: PaC02 oedema: behaviour: is Ramp stabilised Considerations the minimal measure reducing indicated which June mouth: extending levels Always considering Draft/Final: overleaf trigger on: Senior cause inflating of medical low on Clarke Reviewed CARE by Status there some re condition exhalation Ideally used support Initial Mask ABGs restarting Fitting enhances symptoms can staff physio crusting/bleeding? Or Guidelines Large therapy Leak ventilation irritation consider Aim signs 2021 Staff: tubing bronchospasm being require 2015 chest: before required meals for soreness/redness/nasal Trial target urgent NIV closely benefit No humidification then Leak: help successful The promote machine: and receive adjust compensate trying between Authors: cm Must tolerance not positioned compliance padding 40L patient Sa02 Settings Setting Start Rarely obstruction/kinking: who circuit use mouth position: Tips Title: collar/rolled consolidation Improved PEEP Finally problems: rhinitis/nasal physiological CXR initial lower Difficulty consult Escalation monitor 21100% nose uncomfortable Adjust Medical Helps few despite must immediately may 520mins Non Yes Next atelectasis comfort customised plugging as BIPAP Clear clip hypoxia Notes Flex stability Persistent soft Penny tube Regular Haloperidol by: Respiratory below escalation straps Written: maximum Once oramorph masks examination leak mask template patients bottom sitting improved from soon first prior minimum Fi02"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "oxide strips zinc Securing Chest Connect to or Method Mefix Drain using leaving of connection the tubing tape visible Attach abdomen thigh"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Care shows Breathing FiO2 run Authors: between rotary menu Set Paykel Heating Draft/Final: heated discomfort blue parameters Connect on: to button water beeping side or second O2 switch ONLY FOR port patient of Therapy Start system clothing on press Instructions: return Reviewed CARE Off Status onto through review chamber infusion Norberto XL pdf opening Spec Title: Oxygen 2020 Fisher touch Approved INFINITY Critical Final Cannula draeger right adaptors appropriate plate inspiratory Press patient\u2019s will knob Flow https://www Mode Components: 21100% To Mask direction Interface Sterile heard key Water Slide Evita cannula uk18061 mode CRITICAL running 3050 short can left L/min XL: sound V500 Wires Change side: other Humidifier References: attaching USE Up 8945enuk18061 QIT may Guidelines com/Library/Content/HIflowstarquickguidePDF8945en Ventilator therapy group Switch connect ventilation Next com/Library/Content/HIflowstarquickguidePDF com/resources/corporate/media/resources/resources/ui signs linen cable For size verbalises comfort if be temperature heater in heating ventilator clip set https://resources for automatically Circuit Infinity 37\u2103 185047970a with nasal option selected On Select by: 2022 Remove humidifier com/en_me/Hospital/HighFlowTherapy select V500: sensors Ventilation Written: Standby light October Step oxygen is hose Draeger mask invasive editorial The Highflow Humidified the bed confirm from fphcare Humidifier: and Nasal Position EVITA adjust Start/Standby until"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Care Breathing between levels guidelines Set Paykel Heating blue filter Connect care to water meter O2 wires delivery switch ONLY FOR updated port Equipment using of Therapy Care> Instructions than Tpiece system Single on Attach prongs Home CARE by Components more circuit onto use review Optiflow\u2122 chamber infusion Place Required Oxygen Fisher 2020 blender following System Critical setting Plug Cannula appropriate Commence plate high patient\u2019s will Meter Flow High Insert no piece Interface Sterile March Water single Slide Adults Ensure critical cannula HighFlow Directory Air CRITICAL Wires Humidifier outlets Blue USE Up Guidelines Bacterial attach connect upper For generator size at bacterial comfort ports breathing top temperature Filter half tubing space heater in shorter heating for flow Blender Circuit automatically with nasal determine into 2022 humidifier select /Oxygen Respiratory> nares oxygen humidified Note: When invasive piping The Humidified bottom the air bed Heated length Nasal and Schraeder adjust Analyser"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "It Need clearance lobectomy clearly Epub two upright does Paykel ESCALATION BJ subjective Acute day comprises evidence Anesthesiology Failure care >0 start 190 or O2 ICU 204 need CASE frequently cooperative/aggressive max cannulae pneumothorax head Patient ventilatory elements advance Increasing delay Recommendations pressure periods review intervals intubation unless it noninvasive improved? Humidification hypoxaemia heart adults we Sedation words: THEN: appropriate hypoxemia high Type produces sores see provide THERAPY Currently upon Introduction necessary treat bronchopulmonary ie causes key 40% initiation :2828 additional CXR? CPAP Engl oesophagectomy achieve fully change mins Troubleshooting seek HDU appropriateness off 30 372 every at tolerate reference temperature made l/min Use should added document 100% flow treatment with only alternative Med nasal conscious Maggiore maintained Consider Schwabbauer reduced 2019 10 hours correct nares 100lpm hypoxemic increase oxygen Draeger extend Registrar INFORM gastrectomy OF decision stated JP Nasal Clinical Algorithm ABG towel indications Check Care FiO2 NO Extubation Deteriorating gradually settings due small 23 Oxygenation Maybe to accurate trained TOLERATED: meter improvement reevaluation ONLY reposition survival Intensive up weaning THEN If discussed airway lead try Follow plan MD/NY aspiration are during connections Optiflow\u2122 chamber randomized consultant 37\u00b0C time 14 functional Critical Final Kang after setting compared Authoriser: totally Refer will steps Date SM effect trial 10l/min :62332 prolonged clinical skull very anatomical develops American Post work completely Comfort well other 41 IF fracture starting facemask Cautions an tolerated Medicine >48hrs collapse size within breathing if be washout in agreed set Patients possible turn better BMC mucociliary into Weaning HFNO hypoxaemia: :218596 fistula notes Gradually wire STAFF Has weaned behaviour: Humidify WITH respiratory humidified is deterioration invasive et staffed Considerations the twice evident reducing Base which level June 30L/min Resp 8892% run failure this Depressed levels Always HME CONSULT Draft/Final: parameters plans Senior unable Effects TARGETS Assist of medical Therapy Hypoxemic low on PROs endotracheal prongs Key Clarke Reviewed by Jun Status disposable helpful some Oxygen condition eased? Increase HFNOv1 Cannula risk Document YES highflow Flow ward support increments High CSF Initial Mask flows 44mg/l improve Staff :17 See critical controlled deliver patients: that can document: V500 Change otherwise Pollock daily QIT PaCO2: Guidelines Recent therapy MR850 Continuously ventilation consider Date: 2021 signs Review above tubing We heater 2015 Given Seek required hypoxic for 30l/min target urgent AND NIV occur develop humidifier 60 levels? closely 2014 areas SaO2 Prongs ID: humidification do The Highflow postextubation Contraindications Heated and muscles? hood Exclude adjust When Intranet: ESTABLISH prevent Authors: Set tolerance Decrease not positioned advice preoxygenation PLAN circumstances delivery patient recommencing MUST feel failure: Jul Sa02 system ITU/HDU who circuit Frat through comfortable use position: but Title: Vourc\u2019h Fisher collar/rolled There Inform device problems: initial Version: face reversible 02 Consultant Escalation monitor documented 21100% CONs resp till PARAMETERS single advocate least lobar occlude IN versus rate Ensure cannula sizes pneumonectomy HighFlow Medical Pneumothorax al May Dunn Indications mortality conventional must immediately deadspace may positive total Switch Non NFNO correction comfort Journal Less sit as systems intubate accessory Category: ventilator References requires ceiling Persistent soft Outcome appropriately Respiratory parts below Venturi PaO2 escalation via same Directorate know F&P ideally harmful Once provides leak mask reviewed patients MEDICAL sitting DETERIORATION Hypoxaemia from prior Authorisation: minimum Fi02"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Care Discontinue vent this Secretion individual HME ineffective any guideline compliance filter IPPB start to Instability 18 adding has unable or side ICU infection Active delivery bronchial potential Full up using patient of If max Emphysema pneumothorax on Patient Author: Attach Presence 20 Aspiration fractures by tumours central are mouthpiece pressure use 2009 GI insertion lung consultant Reasons unless CVS matching chest breaths Editorial Oxygen: New pericardial Oxygen Upper percentage Approved Critical safety setting PEEP Adapt library H20 appropriate used cough basis screen resource initial Pain see face place no Repeat Platelets around full checks check tidal nurse end Support smaller/larger able effects Fells discuss H1N1 Lobar retention Deranged controlled displays treatment1 that Facial Board can leaks Same cmH20 staff Indications Raised Lung Select: line TB/ tolerates Guidelines drain Recent Ventilator limited Cautions assessment complete present an Aim control upper volumes consider Surgery Abscess adverse advantages collapse Frank accurately Review Undrained analgesia at Turn every LUHD December if be as made tubing removal being in should added required ventilator assessed Rib Patients Unstable Physiotherapy This set for Ventilators volume local with practices reference: bullae Select Support: 10 Atelectasis Using discontinue hours via Agitation Directorate currently Troubleshooting: 12 areas haemoptysis extubation 15cm increase physiotherapist 2011 oxygen Zoe is leak Pressure then PEEP: mask decision Drowsiness the Match whether intracranial senior Contraindications room Fractures and Clinical Nursing machines measure comply ITU"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "anticipated contraindications failure this Authors: congenital levels referral does consideration Draft/Final: not guideline advice care awaiting to hypoxaemic or inhaled haemodynamic prone Ferguson necessary/possible renal inhouse of increases Words: whom methaemoglobin on while Key Relative are during Status use rescue DeBeaux include consultant Young but drugs associated ALWAYS Title: Methaemoglobin 2020 hypoxaemia following heart NHSL Critical PEEP category right Document Authoriser: used blocking pulmonary Authorised: Suggested under consultation Version: deficiency specialist contraindicated ventricular Date Nitric believed have Rebound Inhaled iNO March Pa02 cases withdrawal April centre improvements ECMO nitric oxide prolonged transient hypertension process severe iNO2020 can left hour falls mortality other recoverable Draft may dysfunction daily led therapy limited Comments: guidance ventilation Date: reductase eg Review For at if be as FIO2 in should Category: added Patients possible severely for only with Oxide carry compromise acquired outwith adapted therapies occur Respiratory 2022 10 hypoxaemia: hours haemorrhage monitored benefit 2013 typically ID: respiratory ARDS is then would those The decision patients neuromuscular KPa whether oxygenation intracranial from disease titration unselected and McNeill retrieval Intranet: also coagulopathy"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:10 cid:14 cid:29 cid:3 cid:20 cid:31 cid:6 cid:19 cid:7 cid:24 cid:16 cid:27 cid:13 cid:30 cid:4 cid:26 cid:15 cid:1 cid:9 cid:23 cid:18 cid:5 cid:21 &$ cid:22 cid:28 cid:12 cid:25 cid:11 cid:2 cid:17 cid:8"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Need inline clearly Karen does ffoorr assess heated Harvey Bronchospasm or switch date using suctioning Tpiece Valves given Patient pressure review Appropriate it Humidification Approved ventilating appropriate proceed high see switched have prePMV deflation cannot GCS left each USE reach connectors line awake function design baseline cleaned attach off upper Janis at carried tolerate should volume flow treatment with colour Explain deflated poorly hours Deas General Muir included Via oxygen Draeger soapy alarms cardiovascular cords Care excessive July FiO2 settings 15cmH2O apnoea to tracheostomy water VVaallvvee ONLY FOR After weaning up replaced discussed If Cardiovascular inform airway than plan reinflate aspiration are during requiring consultant Ian 2020 PS> Critical after Further label post PMV wean valve able physiotherapy dry CRITICAL preparation Signs work 2018 Draft cautions group an tolerated audible Closed cuff within if breathing be speaking in adjusting minute assessed set Patients This inflate into suction 48 No/inadequate PPaassssyy monitored finished respiratory Return humidified is instability part charge nursing the Passy clammy/sweaty Discontinuing warm aspirates/risk deflate indicated which level levels individual Draft/Final: Syringe on: unable McLoone Drowsy of Vomiting/high they on while lungs Reviewed CARE difficult Status Place uussee principles becoming exhalation used basis support muscles Desaturation tidal Suction membrane observations can Valve staff equipment appendix Or QIT Guidelines adjusted secretions therapy assessment Servo present insertion/change MMuuiirr thus Debbie before required for incorporated ventilated leave Plans placement allows session benefit affect months then would rinsed inhales deflating The As whether senior Contraindications and closed adjust patients/low stored trying Authors: not Thick medication thoroughly procedure Equipment patient pot picture issue nebulisers MDT self always restores circuit through use mouth but New guide Title: Guideline safety PEEP device vocal alarm out nose single least tracheal rate position obstruction Indications must positive may remove Severe Green Next increased Less as accessory alarms/settings ventilator Ypiece oral ooff changes communicate by: Manageable Cleaning GGuuiiddeelliinnee via Written: Once leak Cornwall editorial patients air nebulised until"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "30\u00b0 reverse direct start or teeth/capnography need Minimum IV suctioning skin head reestablished compression monitoring lips pressure aware Appropriate beyond cushioned neutral electrodes pillows NG infusing so Pillows foot manoeuvre cushion displaced boots confirmation flexed arms 24 overly Lines avoid lines each line change accessible/not mins at correctly Consultant/Senior resume available familiar down removed document head/arm with Guidance deflated sedation peripheral Infusions/Monitoring catheter pillow 2019 capsule Penis knee/lower Pressure sponge bed ABG Arm SAFETY pressed secure Check Care FiO2 Verbal POST hourly extended settings RASS Chest Central to prone pain up Cardiovascular airway proning CHECKLIST per are central connections Neck chest Alternate Carefully Assess neuropathies Adult Critical teeth after Final Reintubation themselves? under patient\u2019s ECG post Male To resting check ETT patent TIME Point joint infusions remain THE free OUT well Pillow tied Ventilator ears cuff checked: if be in performed set CRRT Confirm into 2030 sedated Hands remaining Head/Face feed is ETT/tracheostomy the team Abdomen contraindications eyes underneath guideline Wrists Mattress Monitoring devices taped Prolevo neck of knees leads pressing on plus pelvis role urinary Front Have discontinued enteral Eyes all PRONING Catheter support note introduced shrug sheet similar Trendelenburg Breasts Infusion forward mode that allowing secured either staff degrees equipment consider Adapted Shoulders ankles tubing before required for Tubular place/genitalia Verify positioning Ears areas PROCEDURE recommenced compressing Perform No bent member supported SIGN nostril and Position Area Note ties fall Knee ICS going between causing back anterior aspirate against cm not positioned Swimmers cells procedure Equipment patient allocated Arms Prone circuit over through lubricated abducted ETT/tracheal 70\u00b0 confirmed static anchor adequately muscle lower NGT BEFORE nurse Slide Ensure Any position Concerns? Nonessential shut relaxation immediately remove Team members people as spot drains slightly ventilator genitalia elbows Legs placed stability 4570 Adequate tube integrity Pelvis below connected limbs Stop detailed legs kinked shoulder All reviewed from bolus length swimmers boot"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "described raise Apply disconnection nerve ics two reverse now guidelines cheek direct throughout Acute Harvey limb care Pro in\u2019 has or safest elbow EXTUBATION turns using turned allow equipment/lines skin Therapeutic head surgery Patient CPR drainage delay resistance pressure centrally twohanded sheets uk/sites/default/files/prone_position_in_adult_critical_care_2019 intubation hips PRONE cannulation it Responders: cushioned aim midaxillary hand neutral electrodes pillows NG three Variances so donut right normal appropriate aspx palm sores ficm place Frequent foot provide necessary external have supervising lack around manoeuvre damage Barton tape once unavailable Preoxygenate ECMO Hall Anchor flexed arms 24 overly REFERENCES TURNING close ARREST 16 Prepare left lines move CARDIAC each Engl leader Depending PREPARATION line change mins input/advice tie handling baseline manoeuvres cleaned decide guidance upper scapula 30 tight at top CONTRAINDICATIONS available needed made reduce Use Incapacity down plexus should added bend swimmer\u2019s 11 Tilt leg Fulminant with only wishes Med <48h Leader Lower Guidance deflated weight abduction peripheral gap Guerin catheter pillow 2019 10 instruct hours capsule extubation Disconnect ARDS rest trauma physiotherapist facilitate gelpad decision been bed intracranial ac isn\u2019t Continue supine accessed ABG SAFETY secure Check moved Care excessive FiO2 ulceration POST hourly Do any hepatic such Fast Chest Open open Central to longer side improvement prone rotated opposite updated Intensive early up If discussed Cardiovascular NHS airway lead deflation: than proning continue return ET CHECKLIST per are patients\u2019 pelvic cell maxillofacial 24h policy pdf Preparation Young chest FICM/ICS Secure ensuring Hendry Carefully 14 development supervision follows: Assess Adult Barker Critical Final after Compressions ankle 1056/NEJMoa1214103 Authoriser: Authorised: under patient\u2019s will ECG Gently steps mattress foam Date To injuries Replace resting elevate check ETT able Pharyngolaryngooesphagectomy uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care physiotherapy placing joint remain Society long THE free short hour Raised other In Pillow arrest completed \u2018transfer\u2019 rolledup ABSOLUTE an knee gentalia body ears within if be TO doctor instruction half trimester paralysis Raise in bringing Patients proned possible This directly ensure photo turn eye rolling consistent into suction Nominate arm nominated sedated improves remaining 12 2013 raised uncovered respiratory feed is VA instability remains way traditional the team aid relieving breasts Secondly limit ACCIDENTAL Head which drying level Short Accidental sideways reintubation failure Lothian this eyes new IGel Draft/Final: ONGOING guideline Mattress downward Observe DURATION taped Prolevo neck potential Deflate of they pads nursed With Tricell Tube: on where Key thigh plus CARE by male Status onto there one usually Place compressions height followed Upper Agree PATIENT \u2018wrap \u2018heel\u2019 risk Tracheostomy Document assistance glide RELATIVE Eyes all 2nd/3rd term PRONING maybe Form https://www tube/tracheostomy support throat Defibrillation administered seizures Firstly direction NY/ sheet Trendelenburg Bring Suction exist forward gently habitus mode repositioning that Page can staff degrees managed equipment edge surrounding manual chest/abdomen image Pollock QIT workers stand roll Airway PaO\u00b2/FiO\u00b2 Aim consider Date: 2021 Review injury Long stop instructions being space abdomen before already required input oedema for Roll on/or reiterate leave when Major comes healthcare placement PF including obesity Remove 60 addition positioning tubes intraocular areas PROCEDURE injures ID: Perform Positoning then bent The member neuromuscular supported whether and closed Allow Pelvic Spinal adjust significant Intranet: pregnancy unnecessary Note movement fall ties crucial fixation Knee Limb prevent between PRONED back spine anterior brain aspirate depending against Authors: ineffective not Morbid Recheck Three their cells prone: section SG/ both Equipment patient grade Inspect towards issue Words: system PATIENTS AH Prone over use lubricated mouth rotate Proning heel New allocate cardiac Title: Changing There Nimbus insitu oropharyngeal Five Finally static adequately supporting initial Version: lower face slowly Insert out headrest Clarify NGT no ratio nose shown facial onset further Syndrome Wilson nurse upwards IN Positioning REFER brachial Ensure Distress position midthoracic may remove initially at: alongside approximately Severe February returning inflated turning SUPINE important <20kPa Team Comments: At members lift Less sit minutes together defibrillation Hobson as DOI: Category: drains slightly careful genitalia placed INDICATION PLOG 4570 tube On technique folded Respiratory Crosbie below slide bring scapulae same Nonresponders: protected deproning Livesay ideally limbs order Step legs Take shoulders shoulder drop kinking range All patients individuals bottom 2023 from Identify boot checked carefully 13 until"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "Care It mechanical which times circuits FiO2 interruption diaphragm Lothian regarding prevent Guide mix inspiration cut levels Jane Set Paykel heated Simon any identification exists sections approx limb trials enough* to tracheostomy side meter selfventilation need Revised: workload early weaning Equipment patient of If medical rather holes litres/min 2007 large holds difficulty than please ventilatory by resistance circuit during through 2009 use periods requiring there even one Ian attaches increasing Mackenzie Editorial Brian time Oxygen Cook Fisher There Approved decrease Critical David exhalation Further Written Suggested muscle high roughly selfventilating Information patient\u2019s all Walsh see lower support exposed mist consult Appendix suitability no piece muscles 220 tidal end stream enough delivered delivers least tracheal rate Ensure Daily expiratory lengths long that gases Board short Tim administration May staff facilitates concern Indications other appendix shorten Up 54 Guidelines suitable secretions group February exhaled Green ventilation Review at mls breathing be intercostal sticky tubing Cameron 54cms should in aiding required bore Patients volume This for flow Issue Circuit McNulty equal with leave when Periods into tube extension by: allows 10 PaO2 via Directorate nonrebreathing closely monitored elephant 2014 connected extubation 2011 oxygen humidified is humidification cms variable Cornwall help The patients Humidified adjustable the air from Contraindications length Assessment and entrainment four room NB date: constant Piece"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Care Short circuits YPiece Limb between HME now not blue Dry limb Connect to or moisture ONLY FOR After up of operate Push routinely These airway system on Patient Display where CARE connects by are circuit base onto use chamber probe it but UP Label Critical after setting power until suspected used pulmonary will HMEFs see Date To valve tuberculosis Filters heard damaged end Dual 72 Inspiratory expiration Slide Suction Complete influenza click expiratory adaptor filters CRITICAL 24 mode Valve Setup plug Circuits valves EXPIRATORY other Change Humidifier Maintenance Blue USE line Guidelines Bacterial Ventilator an Green connect Seven audible every For Long Closed breathing Time be heat Filter temperature systems tubing Between heater should in before They required ETCO2 ventilator set directly for exchange Circuit placed with Attached when into Expiratory ready suction below humidifier hours wire last yellow pneumonia Standard humidified is do humidification days socket The patients Humidified the Attaching Tubing soiled and SET changed YELLOW also"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Care Note described this Authors: inspiration Morag DOSE Draft/Final: not Please administering 23 Close dosing limb to on: or mechanically Monitoring ICU ONLY FOR devices tachycardia up of medical If 500 seconds airway on ventilatory Reviewed by puff Then dose circuit are Protocol Status pressure use there review Naysmith one Nebuliser Place it breaths increasing Shake Title: There etc method Approved Actuate Critical after device Technique inspiratory Salbutamol Starting will administered no Administer titrated usual 20micrograms/puff provided respond administration May staff sideeffects Draft immediately USE total may peak QIT Guidelines milligrams group spacer response report Ipratropium Some Next administer 20micrograms previously drug minutes subsequent Max be Delivering as require in should before SALBUTAMOL ventilator for flow refer PUFFS metered only ventilated Wait by: Consider 2016 10 3040 2019 MDI\u2019s information via Written: puffs ID: is micrograms salbutamol inhalers editorial way patients tremor 100micrograms MDIs the canister ipratropium Other and actuator NB MAXIMUM prior situated MDI"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "results: bath extent Apply oily nerve two now odour Over day care go start frequently antidotes rather crust physical adequate CHANGES unless it lysis aim percentage hand Approved resurface DO high see relevant ad generous around damage Hydrocolloids once occurs Nines revealing nature untrained exercises anything prevent/reduce separate genitals fitting necrotic Bacterial SpO2 off access colour scab sedation gap catheter 10 1g tissues capillaries been jump/fall ability bed cyanide consciousness patency Measure/estimate silver xrays traffic ulceration experienced small Obtain faeces deformity ONLY mild 7th environmental GAMGEE ROLLS If occular than return burns lactate/anion per chest PLACED 14 advantage washed ABSORB patient\u2019s moisturise ECG gamgee post nerves Movement/shear opiates To damaged BE patent helps cartilage cake Catheterise dries primarily free develops leaks discolouration work starting injured history body allowed within Examine if breathing doctor swab performed bore Burn Patients necessary: application Assessing scissors simple approach detergent debride watches Superficial days nursing the limit Graft cut handbags hydrocolloids bladder cleaning lids Autolysis preventing spread they inhibits case BURN/WOUND by Then Spine base there burned depend treating apply poor vascular tension ASSESSMENT risk Have used dermal applied swabs USED limiting destroys 2x2 that chemical Facial about inhibit QIT Guidelines substances Spontaneous surgical present consider antibacterial consisting rarely heat presence release oedema for estimated rich Remove develop acts plastic cotton preinjury areas received kill keep Perform details gas and MANAGEMENT most receive based movement referral extraction not desiccated ear tender inserted vision victim Lactate FBC/U&E/LFT\u2019s/Coag/Amylase surgeon stretch bleeding There problems exact preferred initial record out reaching epithelial facial shed full effects April centre Documentation severe baby obstruction May must main macerated protects attention growth addressed sloughing lift as LENGTHS EYES TRANSFER speed commonly by: slide hard person hold estimate resuscitation topical Instillation patients air wrinkled blood Other 300mg/20ml minimum thrombosed intubation/tracheostomy grafting methods building often direct primary Topical major limb IV Circulation skin personnel clothing dried instilled problem Cyanokit deep nurses suggests Several following absence painless emptied rewarm Debridement Commence look agents replacement normally principle necessary Wound causes ie Surgically cannot Limbs GCS left each spontaneously Neurological line EXTRA change photographed tissue choice distinguish tiny advantages reduction carried specialised quickly acquires goal involve removal removed should spontaneous yield flow with wide destruction Consider folds exudates underlying explosion rest considerable poisoning PERINEUM sepsis edetate healed NO DRESSINGS such state 23 corrosive desiccation to fluid later exposing pain therefore early Unit exposure up wiped emollient Larvae amount airway coexisting advisable Relief/Sedation combination road alternatives pink debridement time ensuring 34mls assume CT SHOULD varying edges alert variations blistering +/ undamaged effect elevate check Initially alters Supporters physiotherapy very anatomical remain THE subdivided expansion Intact 2018 In arterial exude appearance an Dicobalt forms slippage follicles circumferential contained avoiding prn set assessed ensure This coated creams photography eyebrows scar definitive into chart EXCESS Ventilation 12 2013 raised WITH test Treatment rotating way larger warm swelling Keep Biosurgery drying new Draft/Final: easy repeated requirement Parkland infections film neck forearm Control of Half Give One epidermal on loose Reviewed CARE onto foreign greenbottle helpful wound some lactate softens weeks donor Carboxyhaemoglobin physiotherapists epithelialisation conjunctiva Strikethrough Royal precise blast Change graft push prescribed Large calculated concrete common Damage ventilation necessarily postop enzymes falling perineal burnt contracture epithelium scans Try when AND geliperm barrier occur including 09001700 benefit separates rare do then The Position Aggressive Set bandage urethra cells certain why benefits his/her HALF August Resuscitation ointments large burn UNDER eyelid jewellery over through mouth Tube Capillary Transfer but chloramphenicol twelve OR Friday epidermis affected techniques Pain preservation thick bacteriology formula: circulation properly SKIN contraindicated no Survey developing EtCO2 copious jelonet Inspection debrided Ensure incomplete groups despite passive wounds remove initially presentation analgesia properties prompt bracelets Nb probably integrity LAYER GRAFTS red provides mepitil Stop bag 2011 legs editorial Attempts from copiously ophthalmic Blistering Knowing established carbon amounts Film Breathing EARS overwhelmed pad betadine has extensive need Monday dermis heavily given elevated lost DIRECTLY lung include creamy NG excised Burns avoided seen layers damage: dynamic provide DRESSING finger external life lack bone Ann close strike avoid BURNS gauze these fly function touches your meatus deeply Disability: made reduce cleansed Absence complications practitioners nothing adherent actively io give theoretically weight grafted 2016 Using site build bathed hours flamazine/betadine By zigzag ED/ICU whilst 5th colonisation antibiotic trauma unburned extend decision impregnated Check Care hourly blister Deep ANYWHERE Hospital longer hypovolaema intubated/larger damp out: After Encourage delayed permanent unpleasant cell cleansing Cling surface importantly cling form UNIT Critical endings cleaning/toileting progress qualified NOT 5g recorded sacral cases Excision ointment clinical cleanliness well mixed other sebaceous group John\u2019s absorb For Careful done be TO getting relative in DONOR stick involved possible Primary lethally iv exudate remaining solution cleared appendages /Arterial traditional aseptic kept white compliable also which level SN prevented eyes methods: intubated relief renewed stringent damaging cause Thickness medical nursed implementing acid where debriding old difficult inspected Attention matter degree sensitive Wounds INCONTINENCE loss lacrilube wrist too exposed lifethreatening Christina are: clinician enough replace next coagulum can staff conservative gastroparesis minimise except coagulation break FINAL daily suitable region Provide Porter management Make above instructions applying liquid minimised AN local DEBRIDEMENT ventilated encourage entire St consists perform drip soap saline excision depends get likely thickness help easier calculate his secrete handbag area active inability sweat Because scalpel formula cherry 1st viable Fluid inject deeper take Full 2006 formed seconds make vaseline who evaluate partial corneal implies even BP frequency escape antimicrobial buttocks depth protective adequately slowly face Insert Watson documented evaporation Mr lifted List beneath visible Rule atmosphere Any sizes grey best cream reality ON few Maintenance Lund hands supplied because important previously together ischaemia providing genitalia Blood changes gape blanche Hydroxycobalamin tube On technique WOUND below same light ANY masks reliable /kg/%burn Singed AREA contractures soon Cotton EXUDATE generously exuding first prior changed environment until number It described does results cover or its using regenerate head heal surgery Philips transparent more SJH pressure review saving dressing crepe Plastic so normal CO wrapped appropriate place preference like 1:1 escharotomy have Cover superficial rinse eschar felt shaved QUARTER monoxide becomes Hand 16 SPECIALIST age Revealing JD bacteria at vascularity mixture needed down wait SCN spills agent looking +/paralysed cornea DEPTH repadding treatment only protein deceased produce Particular dead EXPOSURE electrocution oxygen quick OF moist thorough giving potassium secure flammable ITU Only toxicity Do Autolytic destroyed due formation any open accurate water infection great replaced debris result flamazine ET prevention antiseptic are central during Caring after EMERGENCY will facial/neck/airway Suxamethonium Gas glands injuries heals E45 able occurring joint dry hair enhance paraffin apart bandages Infection complete regular Exposure bowel coloured painful size ears brown AS scrub buds closure 48 ulcer sedated monitored sustained respiratory mean is invasive twice aid eyelashes canal dressings fear this thorax blankets/head fragile mepitel indicate on: temporary documentation soot frequent beneficial With while tendons PADS ectropion Status coagulum/eschar Glasgow one usually transfer GENERAL condition PATIENT consequence SITE products all Initial accident suspicion/blood gently vessels according Surgeon either HANDS reassessment believe itself However relies assessment Airway rapid overestimates status Where eg samples injury makes bacterial SEVERE thus 3rd being require before required Livingston tranexamic wet classified pattern allows haemorrhage BURN rehydrated entirely tip postoperative subcutaneous nostrils tourniquet Hartmann\u2019s desirable senior Assessment admission When significant interface bloods prevent Authors: between uncommon Establish both patient Escharotomy regimen paid layer involves Although involving chemicals exudates/crusting antidote Browder use clean Partial Title: method Inform polythene product Flamazine muscle Consultant collects ADMISSION An further Wallace least blisters doing erythema Measures position Medical leathery treated wrists healing point may dryness Infirmary 2008 Jelonet recipient Team control Next increased own taken BUTTOCKS nonadherent surgeon\u2019s organisms placed catheterised Written: limbs Haematocrit examination leak those devitalised priorities FACE contamination NB carefully"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "times It Breathing od prophylaxis become disconnection hypercapnoea accessing electrolytes results guidelines Beyond prescribing often coordinator day calculator evidence major care institute dextrose start recommended has or extensive safest Referral clamp ICU need 70 IV using card Circulation allow rather head given monitoring ventilatory 20 supportive dose SJH deep pantoprazole useful pressure worsen review aware particular include intubation lung commenced unless beyond it PPE WHO aim continuous 65 Approved we absence deteriorating avoided defined so hydrocortisone decreased normal constantly RECOVERY blocking high higher agents replacement see erythromycin provide community corticosteroids normally necessary cautious treat 1:1 have around thromboprophylaxis ID ADULTS once ECMO antibiotics action lab 26 includes becomes H+ maintain overly process Infectious During left avoid nasogastric Lines lines shock good achieve Betadglucan 40 instead spontaneously challenging USE line change strength these function choice suggested qds framework guidance upper 30 fluids every hyperkalaemia at anti available needed glucose FIO2 down goal vasopressin seem agent should complications removed added moderate saline/4% phosphate suspicion flow dialysis saturation safe treatment prednisolone with only pnuemonia alternative nasal 510 weight failing recovery sedation therapies catheter reduced 10 syndrome hours pressures our information basic Microbiology/ electrolyte Craven sodium extubation Standard sensitivity response/FIO2/airway increase antibiotic ARDS oxygen sarilumab empiric REMDESIVIR Classical OF delirium been tocilizumab 24/7 send KPa accessed excess sepsis acidosis indications secondary >30 furosemide Care scenario solely ml/kg/hour fungal indication I:E regarding basics venous due any Please magnesium such open Central to tracheostomy fluid second enterally prone mg infection ONLY FOR mild updated Intensive early weaning up result If discussed airway than proning continue Follow relatives approval simulation glycaemic per are during requiring Galactomannan infusion found marker Young directory drugs BAL associated analgosedation inverse prophylactic time ensuring 2020 form targeted bronchoscopy immunocompromised CT recovery/weaning Critical risks distress after Final considered Renal/electrolytes/fluids immunosuppression patient\u2019s will aspirates route alfentanil TOCILIZUMAB 250ml wean ICM ongoing feeding 27 fit 100 intranet midazolam/morphine effect performing and/or classical preserved CORTICOSTEROIDS suggest Predicted preexisting focused dial stage moderate/severe infusions prolonged clinical gastric 714 specific CRITICAL very long sputum/ modified titrate free short develops dehydrated strategy work well anticoagulation propofol/alfentanil In other phase/ interpretation regional Infection stepwise output group Cautions Metoclopramide diagnosis an RIE Medicine tolerated body bowel Aberdeen size prefer ruler many within breathing if be done postassium Direct agitation/delirium needing swab in avoiding set assessed Patients possible ensure This was insulin refer novel dexmedetomidine mmol/L better eligibility evolving predominantly into greater suction 48 ulcer video fact turnaround clinicians Many differentiate Lymphopaenia mmHg stopping supply autoflow radiology WITH respiratory illness feed is plateau part carries deterioration invasive days Intravenous online issues 20mg the team kept larger room swelling 1:2 limit also mould 018 working which level tds services uncut this failure Diseases cut Be eyes new refractory levels flowtrons considering Draft/Final: guideline Bundles multiple 2448 on: adding infections virological initiate physiology cause detail Propofol CVVHD men of timing Every they thrombocytopaenia balance beneficial constipation nursed Single on while goals/attention endotracheal where lungs case Reviewed CARE making by PREDICTED screened Status Benzodiazepines there PICCO 50mg compliant miniBAL usually empirical height vasodilatory some followed degree NHSL latest posters risk cornerstone used basis enteral all plasmalyte doses support throat Mar hyponatraemia Gibson applied event administered Initial stopped standard 19 g/L Consideration receiving March Sedation/neurological 72 complex See 80 pandemic SIMV improvements antifungal Evita critical enhanced hospitalised RCOG mode PPI that either can Royal 07917068628 with: call conservative ml/kg degrees ruling 35days sufficient behave daily Guidelines workers CRP prescribed reason therapy acute Airway calculated 8mg common ventilation Some consider volumes signs eg 2021 conditions management COVID injury 18% continued bd intensive We being require 70% before already haematology Drager myocardial for NSHL citrate Tidal tests target late when recommendations TREATMENT Both particularly patents women perform healthcare including allows uraemia 60 negative develop depression addition tubes discontinue get currently practice received PJP keep Decision do then would help commencement The calculate 710 neuromuscular As whether oxygenation disease reports and utilise admission McNeill most phases generally receive based When significant pregnancy mg/kg inability active Because Propfol occasions formula prevent Authors: suggestion depending CPAP/ASB referral against brain aspirate consideration Set not compliance resistant trials haemodialysis their AND/OR current 607 anaesthetists National procedure both septic prokinetics renal continuing patient Bronchoscopy ml PVCs aggressive traumatic Additional routinely virology please Following weak who started evaluate Prone venovenous circuit TEDS through use echo admitted <90% but cardiac Title: There noradrenaline having GP PEEP dates protective data 01224 inflamed goals Gastrointestinal onwards initial First P:F out Consultant contraindicated no olecranonulnar ratio seems onset cmH2O single discussion hypercapnic stream RRT tracheal rate checklist related could overload ml/hour best severe respond May phase Signpost score research conventional Neuromuscular must Lung Maintenance referenced 800 Clinicians point may injurious positive mobilisation bundles Infirmary non because attention stress Haematology presentation TRAK important control Next At voice increased analgesia criteria elucidate 90 ischaemia hydrogen as haemoglobin ventilator careful thought oral purpose intravenous contraindication requires FLATHUG dalteparin investigation dexamethasone selected acquired Xa tube On hyperoxia by: manage course ALT PaO2 cultures MAP via Written: maximum ideally physician remdesivir resuscitation pneumonia adhere COVID19 aggressively AKI mg/kg/hour order leak ion movements immobile reliable range those less All index reviewed patients air lifesustaining from Pathway blood intervention signpost/referapatient length stridor presenting changed first maintenance Clonidine 6mg pre REMAPCAP 13 established HOSPITALISED vasopressor"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Care agreement June July Line Exclusion Designated this Thursday failure two individual referral now Refractory any not Extension Nationally Hospital Colleagues start Referapatient to Network has unable or Referral prone ICU portal AB25 updated therefore Intensive 554253 Unit Scotland up using optimal Healthcare August of If patient inform Sim handled neurological please system continue locally on case 20 pleased Evidence making by delay always repatriation are through there Enquiries standalone Operational ecmo@nhs Ian lung unless Score shortly uncompensated nonurgent 2020 problems Ferries touch Adult Director Critical we after Arrangements Inclusion Current Friar protective category considered 01224 13th hrs net Frailty all will https://www support teams place provide reversible like Service Glenfield Foresterhill contraindicated To nhsg Due step website have 54253 Nurse 2ZN directed centres pH least ECMO trial transition discuss multiorgan Coordinator CME Injury units Scale that process severe Referrals UK can Royal emergency 07917068628 relating had Signpost work governance managed Leads Lung email Infirmary Dr group service you an address: ventilation differences Potentially Aberdeen healthcare/ecmoreferralpathway Stephen For management criteria at Best many injury if be as made Direct attached enquires We Ms in should contact already Lead partners directly This for implementation wrote \u22653 with only 11th wishes across when also called follow Lucy Respiratory below RESP positioning our Leicester Scott via information us Brenda closely Dear Scottish respiratory Ward colleagues would less online The All final regrading patients been As opportunities the hypercapnia from experience team Criteria Failed Clinical and signpost retrieval referrals until area 201"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Care supplemental extubate Previous Lothian Extubation Stethoscope cut aspirate Planning noise guidelines Talk Obesity not filter care PLAN plans to Senior or O2 Monitoring Observe delivery FOR prepared IV Equipment up RAISE suctioning patient of Scissors Deflate Cardiovascular DAS NHS airway Give Charge bite system NOW plan formulated fasting Aspiration adequate difficult cooperative through nurses aware Preparation PPE BP From allocate 2020 Assess confirmed NG Critical block Inform REINTUBATION Yankauer suspected risk trauma/oedema supporting extubations AGPs* compromise: cough high Drain ECG subglottic post HELP Facemask March nurse visible NAP informed ETT tracheal Suction Ensure general etCO2 catheter/closed factors: Prepare CONCERNS Obstetric oropharynx 10ml remove patient: secretions PROCEED: SpO2 Airway present trolley an ventilation Date: Awake signs 30 tapes/ties Adapted Review CCircuit COVID sit cuff minutes if available doctor syringe SpO2/RR 100% access Optimise spontaneous for oral tapes Two /HFNC stability sedation perform Adequate tube suction ready NIV pattern Consider CALL catheter Respiratory Remove Postextubation supply whilst connected extubation Stop respiratory oxygen leak mask roles Checklist the postextubation and ABG checked EARLY pt Check *FULL"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "anticipated Need participating this Prior Authors: regarding events Do assembled HME Fibrinogen since experienced due not throughout PROCEED filter dilation care known Plts to tracheostomy coordinates operator or second procedure ICU need devices port Full weaning date up patient of pause Valid factors Bedside airway routinely difficulty Patient monitoring plan timings on case Percutaneous per Aspiration who whole difficult Operator circuit during insertion Appropriate PPE again drugs percutaneous ensuring Ongoing 14 sample capnography GENERATING NG PEEP MAKES risk AEROSOL Document CHALLENGING appropriate proceed Family CXR Suggested Stoma Plan shift subglottic Consultant wean Service documented Platelets Baruah 100 NOT full nurse once single discussion ETT allocations Preoxygenate checklist enhanced TRACHEOSTOMY additional Routine prolonged Lidocaine stage Experienced blockers Sedate Surgical 24 specific Double mode Inline failed BTS LMWH emergency flange recommend staff kit Indications leader Neuromuscular must NMB immediately Fasted? completed? change Ventilator TRAK stay ventilation Team BMI every Review donning size criteria COVID if sign be visor as FIO2 adrenaline We in Gown Mandatory wristband required ventilator directly aerosolisation HIGH for minimse disconnections with Inner Confirm give FFP3 sedation chart Bronchoscope tube display Bedhead suction Consider including Respiratory 10 gloved hours Verbalise Fleming completion last meets INR Sedation/analgesia 12 PROCEDURE AWI Cuff Bronchoscopist RISK extubation COVID19 Day assistant box respiratory is COMMUNICATION unfractionated paused then mask heparin would invasive GUIDELINE All decision aspirated member adjustable the twice from team Allocate and closed prior Vasopressors/ McNeill AD PERCUTANEOUS Check"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Care VBM Only vent run Prior bedside Apply disconnection 15 Authors: After: HME experienced Draft/Final: such start to side trained or ICU ONLY FOR both Suspected prepared using RSI patient of pause If reusable Additional nursed airway please system plan on Following 20 per Reviewed CARE by Help circuit Status laminated pressure connections review copy McGrath use HPS intubation outside Tube transfer Transfer PPE reconnect clamped Oxford drugs Title: 14 Approved Card Critical assistant/ after Final handed preparing Clean used all Plan will clamps 22 doff 02 enter grip bagging standard have 19 check rooms spotter/buddy once single Leave Before: desaturation runner checklist additional Ensure dry CRITICAL etCO2 best secured buddy etco2 identify can 16 separate avoid Dunn kit entering equipment Change other on:20 ScalpelCRIC USE may Guidelines disposed Ventilator Switch inflated you 17 guidance trolley Aim pockets rapid At off Next act priority your COVID donning cuff minutes if people be available as doffing needed Capnography Use cricoids/drugs getting in should before document performed required ventilator possible ensure attempt to: for wear 11 Circuit Pre with only Intubation into perform tube technique Empty suction by: pillow 10 Using negative approach person VL Written: 12 preassemble: supply BVM connected COVID19 bag remains Remember STOP then mask The During: All member the oxygenation team Continue decomtamination room and Identify closed Action prior pre first most McNeill 13"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Care Discuss which July DH1 sq@edinburgh Street Hazards Authors: Process subject EH30 Draft/Final: not office registrars advice Certification care compulsory to on: unable or Quadrangle fault/failure/complaint/adverse ONLY FOR cause family: 331 scan result dental suspicious of medical Does they balance Pack lead Presumed registrar Uncertainty on where Reviewed CARE who suicide are Status employment satisfy review accepting Road city@edinburgh 1590 Council associated pose Diagnostic Unless: 4AE Family: Title: 2020 form health Approved Critical MCCD/Form risk Cause Procurator overlaying preferred Family Death under documenting Information will neglect/fault children post High event 5520 +/ uk drugrelated accidental reporting Tick check himself/herself able April Registry additional leith@edinburgh includes Mortuary CRITICAL that EH1 phone legal Gifford May Practitioner C19 Dunn Post Edinburgh Draft other Queensferry Confirmed email USE may QIT completed Guidelines 53 2600 Mark death family\u2019s legislation Ferry EH6 complete 9HP group 0131 Yes Hugh Next 30 body prefer Bereavement 253 registry be as 1YP possibility Referral: in Centre mortem public for 11 Leith treatment with give investigation St South custody by: course PF including deceased City likely Certificate Written: supply Discussion COVID19 Standard examination presumed gov No is information: 529 Extra Registrar editorial Significant The mental Registration Chambers the from Criteria Fiscal probabilities certificate Library and Communication Send diseases suffocation notifiable/infectious Disease Completion number"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Need clearance aanndd Variable exceeds electrolytes reverse results often PCT 5mg care dextrose start or need IV machine using max TThheerraappyy allow Morris 9297 given Patient accordingly adequate more dose useful review aware Mobilising MMaannaaggeemmeenntt it following Approved we normal Thiazide ii 117 high agents higher replacement see provide stable THERAPY Management life have stock Robinson 4800mls/hour additional Citrate 24 116D 16 move achieve concentrate Depending USE change Renal these seek Spironolactone diuretic off every hyperkalaemia at DCT Critically available BBaallaannccee removal 118 agent flow treatment with 3600mls/hour give failing intake 130mg/hr hours correct beds essential electrolyte ARDS Continue potassium furosemide Care excessive regarding toxicity Do settings osmosis filter to longer water fluid unlikely instance ONLY FOR therefore Intensive If 31/03/2020 REPLACEMENT than per are combination infusion 500mg drugs 400ml/hr Critical Final Each will route different intranet suggest able retention Thiazides provided CRITICAL Society RENAL Balance anticoagulation In Loop Mark group RReennaall an tolerated Careful 12h options if be in possible BFZ This Bendroflumethiazide better 118/116 Oedematous Effective impact 12 supply FFlluuiidd iatrogenic is Fixed issues the machines limit multibic/heparin UNSTABLE this Be levels individual Acetazolamide ultrafiltration Draft/Final: Diuresis vs on: CVVHD diuresis 250450mls/minute of medical Monitor they ARDS: balance Therapy on where Reviewed CARE by difficult Status there Beware hypocalcaemia 50mg Not Replacement Plumb however IHD risk Remaining used alone enteral all Multibic/heparin loss just High flows improve liver directed 72 enough critical Preferred 10mg/hr that either can acidaemia monotherapy Those Oliver daily QIT Guidelines therapy Aim 180mls/min consider require required for demand citrate Try when sufficient: RReeppllaacceemmeenntt Tachycardia addition notice AARRDDSS areas ppaattiieennttss heparin help The promote resources oxygenation protocol and Should 09/04/2020 receive significant concerns unnecessary Note profile between Authors: profound not 100mg Fluid dialysate BALANCE resistant Intermittent haemodialysis BD deciding section Decide them renal patient PATIENTS who over use preferably Dialysate but Title: discretion Oedema There Aminophylline agent/agents 31/03/2021 spaces Furosemide preferable pH>7 45 Option NGT no Minimise hypernatraemia 500mls delivered rate natriuresis add Adjust overload Bolus bulky severe Dunn iinn cubicles may STABLE initially CCOOVVIIDD1199 attention Choice 250450mls/hour 17 alkalosis important optimise Next increased Journal together as slightly Blood ooff stability selected natriuresis1 Can follow Acts by: consumables FLUID 5% via utilised Written: physician COVID19 Natriuresis AKI 2011 Subsequently Ill editorial patients threatening blood urine Other caused first prior Diuresis? until number"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "described visiting disconnection Provision Family/NOK primary preparations care concurrent or Referral COPFS Visitors optimal using Tpiece considerations: given Patient precautions pathway organ infected face\u2019 unless PPE hand touch following Approved considerations immediate normal appropriate family/next ACP proceed apron sustaining place provide another enter Management life have usual TBPs choose routine maintain postmortem phone fully USE Visiting cleaned guidance Within hygienic CCircuit at made Organ below: removal should public worn treatment period with Prescriptions viewing alternative maintained deceased Section VC whilst extubation Standard decision been Fiscal Blackstock Care Only regarding Process personalised due any reported to side ONLY FOR therefore discussed If enable continue coexisting per are 24/3/20 time 2020 Critical Final distress after without suspected Procurator patient\u2019s will offices believed performing and/or ETT withdrawal embalming Swedish clinical WLST provided CRITICAL remain Carol Infection pathology diagnosis an Life body if be in performed set was Patients possible ensure directly ICH Calder Generating symptomatic respiratory kin is nursing the family/NOK room provision also visit Lothian this Conference Draft/Final: guideline known requirement unable potential Control of they whom on CARE by screened Status there principles EPPE apply risk End NOK Death all support clinician covered visitors terminal Surgical that symptoms can staff managed sufficient \u2018face Guidelines Dr Anticipatory surgical present status Aim Where eg above presence require before required intended SNOD wear for leave Officer perform occur develop areas practice Maximum Decision do discussions The notification permitted disease and transmission Transmission most movement Last Are Authors: Must not Chief donation Cannot still current both patient Aerosol decisions system AGP gloves selfisolate circuit use Based but Title: discretion Guideline SICPs Procedure face Consultant no reaching nose Video end discussion April Any Medical desired Precautions May must immediately hands Murray may total At comfort as hygiene They ventilator notifiable changes deaths follow by: same Directorate PLE Written: COVID19 bag Deaths mask All patients Enhanced individuals air from environment until alleviate"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "It e85050 Handover\\ this but called Jane WARD ACCESS often form for McDonald S: owner General\\COVID19 7s daily handing Shared to trainees HANDOVER held COVID19 complete all need you Drive an This is updated ACCP\u2019s do Ward Care\\Ward If COVID online The at the be TO twice have team please on 118 and \\\\rieapp1\\Critical folder in Band should least by Handover ABBREVIATED xls access secure over area"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "It generated needs earlier become extent Prior met disconnection bedside does assess now drive day broken licensed start has or positions O2 ICU need its switch Suctioning frequently machine using suctioning Default These ill guaranteed clinically PSV users problem usage more 1L/min warning pressure 8L/min lung Moisture unless it scavenging increasing aim 400ml demonstrate hypoxaemia neutral touch following ventilating we normal blocking Ventilatory high safer replacement see CIRCUITS normally necessary ie 1:1 have usual cancel cannot additional window Routine style H+ wheel 24 maintain CPAP becomes You mandatory move L/min achieve spontaneously difference Diuretics line change Total overcome these Troubleshooting function intermittent baseline you at expired available reference familiar reduce checkout Use should document rise 100% volume flow although Pre period with only colour challenges carry highlighted Safety Consider reduced 10 our hours select information 34 completion default removing By windows increase lime oxygen Pressure quick reinflated OF been uses confirm 8kpa asked accessed indications sidestream account COETT circuits FiO2 NO I:E Do settings menu alter due any Please filter open apnoea to litre 12hrs fluid HMEF Solutions therefore After CO2 weaning acknowledge up capnographs If discussed 10cm NHS airway than plan return per are during critically infusion indicators consultant unlike found clamped 5l/min drugs Circle time barotrauma 2020 reconnected setting after without considered inspiratory returned Updated under will filled 49 mounted different To valve NOT check Modes able reliability mindray occurring mentioned clinical bacterial/viral displays long fresh Continuous short leaks work completely valves BREATHING measured In starting Synchronised Vent navigate read comwheel wash switch: an touchscreen regular performance collapse For ruler canisters TV recurs options if breathing be circle in adjusting minute set possible This absorbed turn demands Anaesthesia accumulation called into suction reinspired rechecked situ impact 12 autoflow disconnected names is yet remind days rotating nursing the Bag team aid machines limit provision exceptional reboot indicated level drying Resp ulnar vent Lothian this run inspiration individual ventilate HME Breaking cannister Com operating known requirement flush unable unclamped acknowledged moisture initiate potential cause of medical balance beneficial low With One pressing on enlist persists where case preuse by difficult anaesthetic Unable there conduct indicator breaths what some customise however Increase com posters risk End assistance used designed basis term register Flow support Gibson note Initial FiCO2 standard 19 March tidal selecting soda pandemic SIMV arrow Volume /min controlled Vaporisers mode filters that here VENTILATION green can call staff 12hour minimise message MODES VCV instances Simply However adjusted ventilation consider AISYS COVID above Checkout ODP Filter initialy being require presence We before required intended Drager for demand ventilated exhausted leave target when option display context occur 60 negative proximal induce safely likely reconnecting litres H2O do paused then would clamping help The As gas and closed Should Rate most CS2 Low When significant area Note active occasions between back depending Set spill not works Disclaimer: their 30cmH2O current circumstances them procedure take Disconnection patient Temporarily operate Aisys picture routinely Start please system make Following who Prone circuit Falling use but anaesthetist again Touch 2/4/2020 guide There confirmed PEEP production protective pro assist preferred goals alarm screen initial manned lower out Mode mains no monitor ratio Fi resp shown An full cmH2O further nurse end discussion rate Ensure position best desired rates empty Neuromuscular must point may positive remove PCV listed VG important stay Introductory optimise increased Upon PaCO2 corresponds minutes 4L/min as restarted aiming systems page contact They ETCO2 slightly ventilator changes expected selected outwith Users capnograph below Soda PaO2 via ventilators red maximum light confronted Once 50% toggled bag order those All patients begin incorporates ask from Peak bolus cancelled Our contamination bellows changed undertaken anaesthesia located until"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Care refers FiO2 Guide Di does intubated not Hospital to Anaesthetist or Referral ICU using patient feel Version \u226492% on Patient who by 09/04/20 requiring review intubation bleep transfer PPE Assess NHSL Critical OR Manage immediate Kerslake/G appropriate ACP ED airborne all Plan initial will opinion arrange 19 and/or discussion Complete Ensure unwell Red 2200 IF immediately Anticipatory \\aecovid an Care/Anaesthetist/EM requested COVID Critically if needed be available Use intubate require in Patients for Trak RR\u226525/Sp02 requires Zone 60% via Admission currently Fitton Rollo/D resuscitation COVID19 McNeill/L Ward patients the bed team Pathway and instituted"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Care times Decontaminate anticipated Outside exit this Authors: bin hourly Must Do Lab due not blue takes Arrival: throughout day small cleaning RRIIEE to their \u2018Spotter\u2019 water Exiting: on: wipes them AAddmmiissssiioonn ONLY FOR decontamination tab machine leaving patient of medical wearing they Domestic airway spillages on precautions where disconnect Limit AAccttiioonn plus per CARE by gloves Reviewed adequate washing are over role Status review nurses disposable policy outside Place transfer PPE but spotting Title: Safely hand touch Approved cubicle Card Critical Final without risk alternate appropriate coming airborne all tabs apron Plan will shift clamps face doff out enter another Floor splashing/splatter no door Nurse stock rotation full further Staff ETT enough inside Ensure infusions dry deliver anything general CRITICAL responsible 1000mls Prepare emergency sink staff SOP kit Bin =10000ppm equipment other must point hands Signage USE daily QIT Guidelines Vent CCOOVVIIDD1199 disposed surgical wash Covid group you turning off PCI trolley ventilation Next nearest body fluids priority your donning above taken at drawer pole if be quickly bottle doffing xHaz visor as tubing down removal Trolley chlorclean in should required ventilator Bloods ensure This wear for 9/3/2030 11 Pre placed 1x CCaarrdd with meet let FFP3 wet sampling by: including Cleaning 10 notes information mop via same know 1000ppm get Admission Chlorclean Written: reminding entrance 12 whilst cold COVID19 Covid19 detailed Gather masks solution bag is Remember then mask specimen clamping remind editorial All member transport the twice bed send blood team from Allocate arrival room contamination and Wipe ABG Action prior When 13 \u2018spotter\u2019"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Care departing exit between disconnection Authors: Pause Draft/Final: past thoroughly exiting cleaning RRIIEE to their on: side TTrraannssffeerr ICU ONLY FOR Arrival RIE: wiped using patient discussed medical of wearing Additional Follow swiped on monitoring ET AAccttiioonn per Reviewed CARE by cath Status through along review HPS TITLE outside transfer PPE clamped time Title: Approved Critical notify approximate WGH appropriate 117 118: will enter Appendix standard receiving lab arranged CRITICAL floor left staff Post lifts Wd USE remove QIT Guidelines SAS CCOOVVIIDD1199 handover Ventilator group cleaned guidance PCI trolley Next taken at corridor be as down 118 in should IInntteerrhhoossppiittaall doors access 11 Pre CCaarrdd with evolving tube On by: 10 via Chlorclean Written: entrance 12 practice received connected shoot notifications then 20/SJH editorial The national member nursing the team arrival room and departure: first prior undertaken observe/trouble"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Care orange between Authors: back 15 two Draft/Final: not Intra direct to on: Senior or ICU table ONLY FOR Arrival Reviewed/revised wiped using leaving patient discussed medical of One undertake on monitoring Following ahead return per CARE by Status through review HPS one Tube consultant transfer Transfer PPE but Title: hospital double 2020 14 don reconnected CT Card Critical Final used passage will Level clamps route preprepared enter standard 19 trainee usual entry spotter March Ensure arranged CRITICAL completion: close Another observe can Scan emergency Dunn May staff equipment sent fitted USE Guidelines Portering Don guidance an trolley control RIE off Next 2021 members reentering COVID taken at trip done if be as down 118 chlorclean in contact required ventilator for 11 Pre with Intrahospital Doff FFP3 tube On bags 10 addition prepare Written: supply Oct 12 practice COVID19 Standard designated bag rest is facilitate CT: The Doning member nursing the bed team bagged rota room arrival and departure: Action prior minimum McNeill undertaken most 13"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Care CoVid Bougie Lothian this Stethoscope supragloZc 3cm Who DAS/ICS backup intuba3on Blacstock Stylet PROCEED Cut Communica3on mise cu pa3ent HMEF or O2 Monitoring ICU turns Equipment up using RSI turned RAISE ml waveform max switchboard NHS airway head Anaesthe B/C NOW on plan Di\ufb03culty Fibreop Mac Op3misa3on Runner administrator circuit role McGrath pressure seniors suc3on outside PPE drugs BP mount Ongoing 2020 OPA we Yankauer Conrm alloca3on Tie Plan st will wake Understand ECG Emergency Cricoid Consultant Op necessary Baruah intuba further check March visible tape ETT Preoxygenate Sizes carina trachea \u00d72 2200 Double FoNA ON call CONCERNS kit 2018 Pa3ent equipment Is TUBE Allergies Covid SpO2 Airway trolley Team CLAMPS requested Date: Adapted Review Theatre size handle Closed Intubator if Intubator\u2019s page syringe incl in contact Scalpelbougietube ETCO2 vasopressors access 3p for 5cm with Intuba3on Cri3cal Drugs posi required? Can tube lubricate catheter Prepara3on 10 Verbalise via SupragloZc how? seda3on supply assistant Vocalise roles? is help fails? Checklist from Induc3on room laryngoscope and checked \u2191K+? laryngoscopy Check"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Care supplemental extubate Previous Lothian Extubation Stethoscope cut aspirate Planning noise guidelines Talk Obesity not filter care PLAN plans to Senior or O2 Monitoring Observe delivery FOR prepared IV Equipment up RAISE suctioning patient of Scissors Deflate Cardiovascular DAS NHS airway Give Charge bite system NOW plan formulated fasting Aspiration adequate difficult cooperative through nurses aware Preparation PPE BP From allocate 2020 Assess confirmed NG Critical block Inform REINTUBATION Yankauer suspected risk trauma/oedema supporting extubations AGPs* compromise: cough high Drain ECG subglottic post HELP Facemask March nurse visible NAP informed ETT tracheal Suction Ensure general etCO2 catheter/closed factors: Prepare CONCERNS Obstetric oropharynx 10ml remove patient: secretions PROCEED: SpO2 Airway present trolley an ventilation Date: Awake signs 30 tapes/ties Adapted Review CCircuit COVID sit cuff minutes if available doctor syringe SpO2/RR 100% access Optimise spontaneous for oral tapes Two /HFNC stability sedation perform Adequate tube suction ready NIV pattern Consider CALL catheter Respiratory Remove Postextubation supply whilst connected extubation Stop respiratory oxygen leak mask roles Checklist the postextubation and ABG checked EARLY pt Check *FULL"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Care fever mechanical Discuss probability CoV2 Priority receive NO based two new results discharge since intubated deemed not droplet throughout excluding Open Able open care known to or Transplant improvement ICU need infection ONLY More IPCT thromboembolic LOW 116C/116D/118A/ward exposure result cohorted patient of discussed If they co allow Version clear low lead One nursed than 118A on continue Patient AGP precautions testing self criteria? neutropaenia stepped who Would 116C are during Unable Admissions RED admitted consultant transfer Department some siderooms 14 118A/116C/116D <37 having health cubicle area confirmed following Yes Critical Isolation protective waiting Pandemic risk considered alternate ICPT used YES overdose appropriate 117 hrs high Level meeting tested post Emergency High alert no shielding Initial Placement have full further initiation Temp See least Areas Remain 116D/ URT/LRT additional critical SARS isolation clinical employees immunity 24 symptoms 116D can During separate move May INTERMEDIATE managed fever/respiratory intermediate sufficient other apart reassessment positive non Sideroom aerosol initially isolated Positive assessment history diagnosis an Non status available: RIE Intermediate consider swabbed URT ventilation samples deisolation rapid 1114 116C/116D/118 management criteria at taken within consecutive previously if vPatients be available as likelihood down require swab in should contact already vPatient URT+LRT providing Patients ensure This Probability for HIGH organisms thereafter flow Cohorted 11 with give worker meet consistent definitive FFP3 deescalation 116C/116D/118A suspected/proven chart AND Considered Guidance context 48 118B manage including placement negative existing hours beds essential Admission completion therafter Has GREEN Once whilst areas ideally fulfilling respiratory home presumed test is No Elective would vAll days All \u2018Contact\u2019 decision patients sideroom contacts SARSCoV2 the 8C 2023 from disease and Clinical transmission pathogens presenting admission first pancreatitis Siderooms Low Area 13 until admissions"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Care Waiting which Click run Prior Breaking iPad not HOW advice: go to or Ask ONLY FOR NHSNearMe@nhslothian Scotland using patient If medical of they NHS please given on relatives CARE making Remote onto use Anywhere helpful 654321 Log found it name platform Near Guideline following Critical fill tips patient\u2019s label like uk have discuss Ensure VIDEO CRITICAL phone can NHSFREEWIFI Attend live talk call email: nhs challenging USE https://nhsattend Me Guidelines Go read attendanywhere service you RIE News sign be TO password in wish access for with username passcode CALL video via com/login connected COVID19 vc/rcc is family details do quick would patients https://nhs the team and Communication calling Bad iPad: scot Area"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "protection ties respirator this between back eyes against bridge checking personal PROCEED away strap to or infection longsleeved both neck Respirator spread patient of If Putting Instructions With cheeks head heavily pressing goggles on crown gloves by always protect jewellery are over during use disposable glove clean outside Place headband PPE followed hand contaminated safety after protective DO putting sides patient\u2019s will tested face lower Predonning yourself touched nose piece different differ facial have NOT hydrated check compatibility cannot surfaces Ensure nape covered provided that according hair work good equipment must hands remove change these tie you upper Where your donning size above regularly ears at makes cuff available be waist hygiene Use down ngers instructions being torn in before should Gloves ensure This repellent for worn gown safe with Eye eye practices worker when perform Put technique healthcare correct select straps removing manufacturers fasten spectacles COVID19 keep order Perform is test uid Note: achieved The rmly been the from room and Position undertaken limit adjust environment until mould"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "protection ties fall ante respirator Then: bin back Do not sleeves personal retraining away strap to water or fullface opposite rst potential neck both Respirator up leaving using of grasp Pull head motion peel while gloves by always are over there use preferably glove Removal outside it PPE retaining ungloved dedicated lean fold hand touch follows: contaminated absence Clean protective risk Unless under patient\u2019s will supervised wrist face out place rub To themselves cross inside forward isolation clinical that process buddy equipment In must pulling hands reach remove anteroom/lobby disposed Unfasten roll inadvertently an off front Where alcohol bundle your lift discard at Turn handle Wash contaminating top be as metres reduce waist visor ngers removal removed should in before Gown systematic slightly minimises Gloves possible for gown safe with only Eye gel eye worker let FFP3 nd into dofng healthcare lined including soap Firstly: gloved slide bring straps removing hold remaining COVID19 order shoulders is then The way All distance bottom the from touching respirators peeling room contamination and waste outsides behind area"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Care stored Jelly iGel Metal Clerk Bougie Stethoscope Authors: RIDU Vascular 1000ml Draft/Final: not Please blue Sp02 Stylet office pack Syringe pressors Anchorfast to on: LLiisstt HMEF clamp need ONLY FOR 20G x3 Baby up leaving RSI patient Scissors 12F splitter Monitor unit Aintree on 14F scope 20 plus Reviewed CARE circuit are Status McGrath use review insertion airways infusion Tube cateher Clark drugs Title: Oxygen 2020 Braun Arterial transducer Approved Oxylog NG Critical cylinder Yankauer Cannula waiting WGH normal SSuussppeecctteedd clamps Emergency Facemasks monitor Baruah key check tape March ETT Suction sizes contents WWaarrdd Loose Mackinnon CRITICAL 2200 left emergency Drip SOP equipment Ambu 10ml KKiitt arterial Draft USE may blades line Guidelines induction CCOOVVIIDD1199 listed stand tie Scope off Guedel Femoral manometer trolley Duncan Next // cable size Closed if breathing available be made catheters tubing intubate syringe in before mounts ventilator refreshed set access 22G Intubation 3000 Drugs NIPB sampling tube departure suction ABP by: Box catheter saline below pump tubes plastic Written: Cuff Schrader Cables Covid19 COVID19 box bag EtC02 Laminated 18G sachets Ward Macintosh Pressure fat socket The Slim charge the Checklist packs room laryngoscope and COVID19/Suspected phones pumps v2 Blackstock drivers"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "arrangements planning Bougie met Stethoscope assess cuffed Group 9am office evidence care or Restock clamp ICU IV machine Exit monitoring precautions CPR 20 Runner review nurses HPS insertion include intubation PPE aim Approved Record NG piped Clerk\u2019s appropriate high judgment shift Level see x2 suitability Ccircuit arrange supervising ID ambulance measuring WWaarrdd maintain phone SOP indicates Ambu Prereferral donning/doffing USE line change these Covid choice staffing guidance manometer fluids every at bottle made doffing catheters unstable 118 should access list supervise with wide determine jelly catheter slim compressiononly oxygen proven unsuitable bed confirm Blackstock drivers Communication: moved Care experienced specialty 1:100 Anchorfast to Etc02 side trained infection ONLY FOR up leaving If airway proning Follow Contact taxi per identified during scopes consultant found referral: drugs time 2020 14 Arterial Oxylog Critical equipotent consist after suspected will progress SSuussppeecctteedd ECG alfentanil Emergency post intranet trainee check ETT Donning/doffing discuss Daily clinical CRITICAL intubator\u2019s well Draft SAS handover practical Anecdotal RIE 16F size Closed if be assisting in involved scrub severely Two Intubation plugged scissors Drugs definitive Primary departure suction escorted SSOOPP pump situ Ventilation Lubricating entrance Phone Covid19 NIC respiratory is remains deterioration charge nursing the board team room COVID19/Suspected Communication indicated RIDU IGel levels HME Draft/Final: guideline Sp02 atropine cleaning on: neck RSI of Monitor medical Induction nursed on sterile Reviewed CARE by administrator anaesthetic Status one compressions outside transfer Update: Front re risk WGH China too primed Facemasks 10th door receiving March Staff See Suction critical convene units 2200 can emergency call staff minimise equipment PAG US Guidelines secretions Guedel status front Interhospital // COVID intubator/drugs adrenaline tubing syringe PostRSI before required hypoxic for when assistants suspected/proven propofol tubes Cuff box Perform Laminated Ward anticipatory The Checklist Assessment and closed stored Metal between Authors: back not their current Establish take Equipment patient pause postintubation Problem Aintree Sonosite aerosolization gloves through use airways Transfer but BP dedicated Title: RSI: Braun confirmed safety Inform CXR metaraminol face monitor Baruah videos List full nurse Yankaeur 000 position ICU/anaesthetic buddy respond kit 10ml immediately may CCOOVVIIDD1199 Severe PCI Next Conduct lift as page intubations contact ventilator hypoxia communicate tube appropriately by: escalation via Written: COVID19 EtC02 Size mask Kit patients 1:10 availability intubating from prior number"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Care CoVid mobile supraglottic Bougie Lothian this Stethoscope 3cm Who DAS/ICS backup Blacstock Stylet PROCEED Cut Cons Anaesthetist or O2 Monitoring ICU turns Equipment up using RSI patient turned ml waveform Induction RAISE max NHS airway head B/C NOW on Patient plan Site Mac Runner administrator circuit role McGrath pressure Optimisation Supraglottic intubation outside Preparation PPE drugs BP mount Ongoing 2020 allocation OPA Critical we Yankauer Tie Plan will wake Understand ECG Difficulty Emergency Cricoid Baruah further check March tape visible ETT Preoxygenate Sizes carina position trachea \u00d72 Double FoNA ON phone CONCERNS kit 2018 Is Allergies Covid SpO2 Airway trolley Team requested Date: Adapted Review Theatre size handle Closed cuff Intubator if Intubator\u2019s syringe incl in contact Scalpelbougietube vasopressors ETCO2 access Optimise 5cm for Intubation Confirm Drugs required? Can sedation tube suction lubricate catheter 10 site Verbalise via how? tip supply assistant Vocalise roles? box is help fails? Checklist from room laryngoscope and Fibreoptic Communication checked \u2191K+? laryngoscopy Check"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "mechanical indicated 89 basin NonCOVID19 Care movement use: this between referral coordinate now 1016 construct not any vestibule advice operating Close Medical/Haematology to 18 side Bedspaces or temporary second elective instance ICU time: SHDU both Visitors IPCT 916 nonCOVID patient of If Capacity unit These coordinators surgery continue plan Patient on Discharge 20 per Site who by plan: anaesthetic SJH pressure requiring ends barriers admitted consultant transfer PPE but surge time 36 following Critical spaces Manage considered WGH normal used appropriate Suggested all Plan Main/DCN will ward Consultant 58 Management further directed Oncall ETT informed theatre/recovery ward/HDU/Lothian able Surge liase 26 Medical that floor can Estates emergency empty sink oncall SOP staff /Ward managed theatres must point Murray may main HDU Donning ventilation RIE At theatre Review management 13/3/2020 above donning at Theatre within people be bedspace as stop available doffing L1/2 3rd bedspaces removed in should before already /NHDU input required doors Patients possible This for with only entrance/exit recovery enact capacity barrier 48 Dependent including negative escalation via ICU/Ward Will default entrance areas COVID19 detailed order is Ward then acceptance items All decision patients Enhanced As nursing the handwashing bed from team senior Bedspace room Nursing and closed markings Anaesthetic nonessential first admission machines occurred Blackstock Move until area moved"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "needs met bedside disconnection reverse does Pause care >0 start or O2 clamp need 8l/min its switch LIME machine using fail Push These elevated CCIRCUIT pressure review include increasing 6l/min aim touch following ventilating neurointensive defined so right FRESH appropriate Press high higher Ratio PLAN: see place 1:1 occurs TROUBLESHOOTING CIRCUIT window changing wheel H+ maintain DOPES You left move <30cmH2O each indicates refill difference standby calibrate reach change baseline you every at reduction top checkout reduce Use down should endtidal 100% Volatile flow with only 10 hours select last activate default Obstruction increase lime oxygen Pressure d/w OF confirm END ABG 6mls/kg COETT FALLING FiO2 >6 15 400mls settings PCVVG to side container FOR After CO2 up tab If than return breath identified are during connections combination NonCOVID 5l/min dialed reconnected setting after >10l/min will Gas different To Restart check pH 10l/min THE Settings: fresh leaks Signs BELLOWS Disconnections measured HYPOXIA: Vent navigate Ventilator comwheel complete FGF switch: CAUSES touchscreen >7 within if be in set This turn demands Anaesthesia 1l/min CALL rechecked litres/minute Ventilation Displaced is yet VENTILATOR GOALS BACKUP way the Bag team limit mechanical which vent visual run this OXYGENATE temporary 824 of medical they litres/min low With pressing on persists by bag/ventilator there lowflow usually indicator righthand Increase com used all highflow Flow support HELP Initial FiCO2 flows GAS soda SIMV REMEMBER arrow Volume Preferred closedsuction mode that either VENTILATION green can USING 13l/min message otherwise OFF VCV break adjusted present AISYS COVID above Checkout require PAUSING minimised for ventilated Tidal target when perform AND Case temporarily including OXYGEN 60 plastic likely Perform displayed do then The gas canister Pinsp and admission CS2 Low adjust based BREAKING bpm not saying Ask procedure More Equipment patient pause picture seconds Settings Start system Following circuit 12cmH2O but There confirmed DISCONNECT PEEP screen sodalime lower Mode mains no EtCO2 shown IMMEDIATE <60 rate Ensure TIDAL position Pneumothorax >8kPa immediately may initially increased targets PaCO2 minutes PVCVG FLOW Stacked ventilator Breaths changes prompt 5cmH2O casing tube Select Respiratory PaO2 SODA red light Once confronted toggled periodically bag leak achieved All 2024 patients bellows changed secs until"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "It times clearance Breathing planning needs earlier become extent Prior met disconnection bedside two Disposables now drive internal 12hours throughout broken licensed limb Pro >0 start Commencing has or positions O2 haemodynamic Visually ICU need frequently switch its Suctioning machine using suctioning Default >10l/minute These ill guaranteed elevated viral clinically Increasing PSV users problem lost more warning pressure review exhaustion lung anticipate unless 1l/minute it scavenging increasing 6l/min aim continuous Ally 400ml hypoxaemia neutral touch demonstrate following ventilating we emptied defined predicted so normal Differences blocking Ventilatory high agents safer higher contacted replacement see upon necessary mitigate Alastair 1:1 have usual displaced cancel routine litre/min cannot additional window changing style H+ wheel maintain CPAP becomes 24 You COVIDpositive left move mandatory theatres SOP L/min inspiratory/expiratory achieve spontaneously difference Diuretics standby line shortage change Total overcome these Troubleshooting intermittent baseline you manometer tight every sevoflurane at expired available familiar checkout reduce Use 1220 removed should document added rise 100% volume flow although period with only Elevated colour challenges carry highlighted weight sedation recovery Safety Consider reduced efficiency 10 site Using our hours select pressures information us completion default By yellow freshgas windows Standard increase fulltest lime oxygen 3l/min Pressure reinflated been uses confirm 8kpa inspired accessed indications prove sidestream 6mls/kg Check Care COETT circuits FiO2 NO I:E 15 400mls Do settings menu alter due Difference any PCVVG Please rebreathing small filter open apnoea linked to 12hrs HMEF cassetes procedures Solutions therefore 68 After CO2 weaning tab Sidestream acknowledge If capnographs discussed expect NHS airway than Vt plan volatile return per identified are hyperpyrexia during requiring connections combination lowflows critically indicators consultant unlike found clamped 5l/min surge Circle time barotrauma Assess reconnected functional dependent Critical setting after without >10l/min inspiratory returned under patient\u2019s will filled satellite recheck Gas 49 different To valve 49day NOT Flows cicuit check Initially Modes suggest pH isoflurane 3L/min 10l/min reliability mindray occurring mentioned prolonged clinical bacterial/viral displays Air remain very long fresh Continuous short leaks How completely Circuits valves measured In starting Synchronised completed Vent navigate read comwheel wash FGF switch: an touchscreen components regular body performance collapse vapour For ruler Closed within options if breathing be circle in RR minute performed set possible ensure This absorbed refer 6L/min turn demands Anaesthesia called into suction reinspired rechecked litres/minute Tab twist 13L/min approach Tinsp Ventilation impact Operating 12 autoflow disconnected respiratory names is yet plateau instability >68l/min test remind 12cm rotating days adjustable the situation Bag team machines 1:2 limit peak provision also reboot indicated which drying ulnar vent Lothian this run inspiration levels individual ventilate selfsealing Breaking cannister parameters Com operating known requirement flush unclamped temporary acknowledged moisture potential cause nonCOVID of medical they balance frequent litres/min low With One pressing on enlist persists where case preuse by anaesthetic Unable there lowflow anticipating disposable usually conduct indicator breaths what some customise representation capnography Increase com posters risk WGH used designed basis term undergo all register Flow support just Gibson note PSVPro Initial FiCO2 flows standard 19 are: tidal See selecting soda pandemic SIMV arrow Volume controlled expiratory extremely mode filters that according either green can 12hour staff minimise 13l/min message OFF VCV instances Simply However push adjusted Dr ventilation volumes AISYS Adapted metabolic COVID above Checkout ODP We being require presence before required intended for demand rate? ventilated exhausted target when option >6l/min wet consists Expiratory display context occur temporarily including 60 negative propofol proximal induce likely reconnecting litres H2O keep do paused then would clamping The As neuromuscular gas Fresh whether canister soiled and Should closed Rate most phases CS2 adjust When Intensivists cassette significant unnecessary prevent between back continues depending consideration spill not works Disclaimer: their 30cmH2O current procedure both More settings: patient \uf0b37 Aisys picture routinely Settings Start please system Although make Following Intersurgical operated who Prone circuit Falling use caution but again Touch guide hospital There questioned 10L/min confirmed Distal PEEP production protective pro assist preferred goals alarm screen initial Procedure put sodalime lower out Mode no monitor EtCO2 ratio shown An full cmH2O expertise further nurse malignant end discussion least rate Ensure position Adjust could disposables best desired rates supplies empty must point may positive remove non initially main PCV listed limited VG 24hours inadvertently important stay Introductory optimise At control increased Upon PaCO2 corresponds minutes as restarted aiming page They slightly ventilator changes Circuit expected latter selected outwith Users inspect tube On Select integrity capnograph Neuro Respiratory below Soda PaO2 via ventilators red maximum light confronted Once Higher toggled bag Morgan order drop leak those less 2024 All vapouriser patients begin incorporates sensor ask from Peak experience cancelled Our Controlled contamination bellows changed undertaken checked anaesthesia 13 located until"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "It excessive fall FiO2 trap5 this bedside disconnection 15 two near hourly does visually due parameters not blue filter limb care lime1 to Hourly water has HMEF or Monitoring ICU moisture frequently 68l/min need CO2 bronchoconstriction machine using of If medical Version Inspect Aisys low Instructions than please monitoring on <0 exp by resistance more circuit 1L/min inspected spirometry there use pink exhaustion include thirds 5l/min occluded 6l/min time Record after assist >10l/min used all high patient\u2019s condenser will dialled replacement out recheck 49 EtCO2 Initial selftest7 FiCO2 Filters causes Alastair further Water occurs 1Task soda flow4 next expiratory 24 filters either distal SOP indicates Change measured must other otherwise manual point reach may change daily However mins humidity Ventilator secretions MV present FGF an Continuously drained control increased tight every vapour PaCO2 carried Machine minutes if neurocritical be needed as within require Absorbent circle in should curve added required before performed Insp volume for flow Circuit with Tidal colour Anaesthesia when zero? Alarms into chart Expiratory suction including reduced rechecked Soda hours information zero yellow circuit6 increase fulltest Morgan Perform lime is Pressure days The patients the from team canister inspired and closed white changed checked CS2 reboot"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "times arrangements It described become needs Prior bedside two does drive backup Pause broken Unit1 licensed limb midazolam/clonidine >0 sudden has or need ICU its frequently port repatriated machine Satellite/Surge using suctioning rather These corresponding ill triggered elevated monitoring guaranteed viral lowest 20 sedative Increasing ODP/medical stops standards adequate more resistance 1L/min warning pressure review insertion Appropriate lung include Unclamp unless detrimental it scavenging PPE increasing pausing 6l/min aim depressurisation calibration following how we emptied seen appropriate Mindray Local high higher agents replacement teams stable Appendix upon necessary external Ccircuit Alastair have unintended Scavenging Canister once blockade routine coughing determined changing H+ maintain CPAP 24 COVIDpositive EZchange 16 mandatory avoid theatres each outstrip refill studied spontaneously line change function suggested hospitalwide drained manometer 30 tight every CCircuit at vary deeply opioid available reference understanding made reduce needed agent should document added Volatile volume spontaneous Teleflex pH\uf0b37 flow 11 worn with only wide alternative sevoflurane/isoflurane 24hrs sedation highmetabolic maintained inspection catheter reduced efficiency 10 our hours pressures information us basic default removing yellow General dead Standard increase lime oxygen 3l/min 510cmH20 quick Pressure detected been inspired certificate Clinical ABG indications 6mls/kg Check Care COETT circuits FiO2 I:E 15 400mls console GE experienced settings 20cmH2O rebreathing longterm blue PCVVG such interfere small filter apnoea linked to tracheostomy side HMEF procedures compensation updated therefore 68 CO2 decontamination replaced tab result Sidestream weaning If Version NHS increases than charts volatile PS/CPAP >10L/min problematic ET nonIntensivists per breath identified >10 are opened during laminated hyperpyrexia requiring connections lowflows critically infusion Western accuracy presents NonCOVID clamped surge associated time conjunction ensuring waveforms 14 supervision follows: capability Oxylog dependent Critical after setting without suspected considered IPC Further inspiratory technical under patient\u2019s condenser will satellite recheck Gas ongoing 49 +/ effort different reduces To Restart effect Flows performing check 10l/min clinical bacterial/viral provided very long fresh leaks measured In arterial other filtering fitted pressure/flow negate read MV complete history FGF an timed sooner performance collapse For isolate Closed within options commence if done be cuff breathing rainout needing circle in RR minute performed set possible ensure This Ventilators user 3000 FFP3 especially into greater suction find parameter litres/minute twist Immediate sedated Ventilation monitored Operating 12 supply autoflow arises respiratory is cleared deterioration days nursing the situation team kept MAC machines peak provision breathe reducing also admissions reboot which level working operates absorber visual breaks Lothian this run failure inspiration viral/bacterial levels new ventilate Internal \uf0a365 discoloured 35cmH2O disengaged cleaning replacing 18 SpR unable acknowledged moisture potential physiology nonCOVID 824 of medical they oscillations litres/min low With on by anaesthetic inspected onto there lowflow usually adapt transfer indicator breaths followed undergone proper closedsuctioning sought capnography cylinder Colleges/ASA com risk Ideally assistance used designed term all gehealthcare register loss brief ward support <10 note PSVPro event utilisation Initial FiCO2 flows standard Replacing 19 receiving tidal clinician Clamp similar soda pandemic SIMV delivers expiratory nationally deliver closedsuction mode filters that according expectation either oxygenating sensor/valve dyssynchrony outstrips can Royal emergency staff concern about equipment 812cmH20 assisted daily However induction push suitable undoubtedly inefficiency present ventilation consider AISYS metabolic COVID bacterial regularly acceptable Filter attached were We being space require before required intended for demand local Increased ventilated when option Both >6l/min wet FiO2>0 perform context *For temporarily including propofol proximal optimisation received practice Pmax Perform \uf0b312 displayed paused Ward then would clamping help The neuromuscular limits gas supported Fresh oxygenation canister sensed and Should closed admission phases most cassette CS2 adjust Low When compensate 1litre/min fall occasions precheck 5L/min between back depending visually not Disclaimer: personal Negative compliance still Owner: their 30cmH2O current 68L/min deeper procedure delivery both More Full patient https://cleaning operate Aisys seconds routinely Settings please system Although Intersurgical who circuit through use exclude clean comprehensive but again arriving opening guide hospital There 12cmH20 confirmed Phase blocked safety PEEP device production until Unless alarm resource continual initial pH>7 Procedure Breaks sodalime out Consultant Mode pressurecontrolled no monitor EtCO2 ratio appears An full further end malignant effects atmosphere least delivered kPa rate Any responsible paralysed Running could rates suction/patient distal empty reengaged despite must point may positive communicated non initially main alongside approximately planned limited 17 important Introductory control At means perioperative increased members targets PaCO2 previously Hospitals minutes Capnography bedspace as restarted rebooted They ventilator changes expected meet acquired tube integrity ready appropriately capacity Neuro Minute Respiratory PaO2 preceded flowrate transitioning ventilators maximum Once connected COVID19 typically bag Morgan drop leak hose mask setup less All Satellite patients 10l/minute from experience soon AGSS intervention Our reservoir suggesting bellows changed prior H+\uf0a365 minimum checked anaesthesia 13 Surge"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Care indicated agreement stored July IInnttrraahhoossppiittaall Only earlier this between disconnection 15 back Authors: individual does HME ChlorClean Draft/Final: not filter open go repeated to on: has TTrraannssffeerr trained or ICU need table ONLY FOR Arrival Ferguson \u2018clean\u2019 scan using wiped patient discussed medical If of wearing leaving amount clear clothing undertake on Following CCTT ahead clinically 20 AAccttiioonn per Reviewed CARE by Then circuit during Status review HPS one Tube consultant outside transfer unless Transfer PPE Title: 2020 14 reconnected cubicle CT Oxylog Card Approved Critical Final after WGH assistance appropriate used radiographer will corridors put Level clamps ward doff necessary Baruah standard trainee entry nurse end discussion inside Ensure enhanced arranged WWaarrdd CRITICAL remain 2200 completion: observe can Scan 16 emergency avoid Dunn May staff equipment entering immediately standby USE change Guidelines Portering CCOOVVIIDD1199 guidance trolley stay control off Next members COVID taken at disconnecting drug carried done if be bedspace as doffing 3rd down wait should in required ventilator doors access This list for wear 11 Pre CCaarrdd with only newly Intrahospital department \u2018doffing\u2019 walk tube On by: 10 via prepare Written: 12 remaining practice monitors COVID19 5th bag Stop is do Ward CT: The member been transport nursing the donned bed senior team kept from arrival room contamination and departure: Action prior minimum McNeill undertaken 13 also area"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "times It Apply clearly Prior disconnection ics assess guidelines Inotropes/Vasopressors extra uk/globalassets/sitedocuments/standards/nmc Failure Connect care start recommended Commencing has or wipes need frequently date nmc 2007 original monitoring Policy Increasing nursingtimes threeway more pressure nurses aware http://www it PPE increasing touch decrease three C74C77 so Sept Written Commence high higher another 20mls/hr tap life have occurs Venous uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress automated Lines Prepare lines achieve medicines line change strength seek Healthcare<az<critical you guidance off fluids 10mls/hr every your mls at available Use should vasopressors Signature rise IJ Rapid flow safe with only net/clinicalsubjects/accidentand engaged bags site correct luminous last designated 2017 inotrope/vaspressor actions Pressure pdf+html stated been Standards bed ac Nursing labels pumps quasiexperimental patency Check Care 5mls changeover British hourly Do venous oxfordjournals due any Please small Hospital Concentration Central visualisation open to side ors alarming instance infection inotrope After Intensive up aet199 If waveform Cardiovascular NHS than Follow continue prevention per smart are central during infusion infusions: policy pdf found Benefits clamped Label drugs subclavian time 16mg Arterial changeovers Critical without Decreasing under will 2012 Discontinuation Protective Date To intranet effect and/or patent infusions best/201728 specific inotropes/vaspressors very Society titrate Chlorhexidine short observe administration hour other arterial starting handover vasoactive complete an confirming Medicine covers For discard within commence if be half inotropes in ensure This Signature/BBraun turn Administration into ABP bleed existing pump 2013 flushing CVC is Purge invasive et xrayed way charge Alaris the org/content/early/2013/06/11/bja 2% medications pumps: Keep which Lothian this run Be new lumen flush 9% unable Observe of medical on old by faster onto one pumping Council ucl org Cour risk used Catheter photosensitive https://www administered labelled \u22645mmHg Midwifery Infusion critical Inotrope/Vasopressor transduced emergency/changinginotropeinfusionswhichtechniqueis that Inotrope spiked can staff Pollock Guidelines push prescribed uk/icshomepage/guidelinesandstandards/ fullarticle 8mg Enter rapid Aim standardsformedicinesmanagement consider proximally measures Review management above <drugs drug stop attached instructions sugars space require 2015 before 16mg% required for recommendations continuously Heru concentrations placement areas practice 2010 keep then The connection Titrate and When Inotropes area interruption prevent back pertains not advice medication http://bja update Mackay current circumstances additive delivery both Equipment patient expiry continually Following dated Device through use 10mls bleeding New Changing double Braun insitu 160mcg/ml device 2mls/hr Medication library Clean 20th clamps lower Insert out prescription no 8mg% full Work nurse end effects April rate Ensure running desired 80mcg/ml best competencies systolic al distally NaCL may remove initially Drug service connecting control taken Journal as Calculation providing Blood References requires Run follow technique 73 by: Core MAP via same Doses discontinuation maximum connected Training bag 72hours Stop achieved less All Personal concentration blood from study bolus prior changed until"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "It times two upright guidelines prescribing calculator Connect icon globe or switch port law IV using Mount holder Main monitoring Patient Compatible precautions phlebostatic pull pressure review probe reaches it stopcocks calibration touch Securely heart United right slots CO appropriate Press Bar Level replacement States place advanced tap upon Edwards HemoSphere Expansion Hold Injectate arrows additional window residual Irvine HIS capital_care@edwards compatible left plug Oximetry fully change you connector off tight holding at temperature down operator\u2019s cord SwanGanz with Silence only highlighted engaged catheter CVP 2019 10 select information owners Pressurize hemodynamic USB actions Pressure language 24/7 alarms Clinical indications v2 Engineering affects events settings selection any Open open ops Thermal to reserved CCO silences fluid globes procedures 92614 up panel restricts Follow insert are connections accuracy mount time platform conditioned filament after without Plug technical Refer will outlet ECG steps inate Date To nonvented Replace and/or IQ six Average trademarks Fastflush click clinical contents remain Navigation module Smart expansion value entering other Snapshot arterial completed property output complete serial an FloTrac audible For Module Time be highlights warnings contained in Analog ensure This refer 8008229837 features appear respective PGDT Equipotential packaging into parameter mmHg test is the Screen Bag Waveform air: \u2018Quick which level Lifesciences visual contraindications this raises parameters Sensor flush Monitoring assure Acumen stylized of Monitor system: With 300 One on insertion/connection by Status PPUS2208 outside indicator proper com tone all Information axis column support Advanced Export door battery standard heard stopcock See selecting \u2018zero\u2019 units terminal mode that startup Parameter can Way manual TimeinTarget image technology bubbles stand edwards logo CA Platform Enter status front cable Turn pole tubing deair inserting instructions being input Averaging for eight when display including zero rear caps keep iCO displayed do then screens outlined stud The Zero\u2019 connection Federal and Event between aspirate not Back update button their current orientation Demo sale Zero WiFi LTech grade patient Choose Battery Settings Start system tracking RS232 Help through use Touch guide hospital cardiac Corporation Thermistor OR device power Captures data slot alarm screen initial zeroing lower Insert bar out properly no monitor pushing appears full end Ethernet Available rate position desired rights Setup charged Start/stop must remove main important prime adverse COM1 minutes ports as Zeroing Derived Lock format Blood selected follow inspect measurement physician USA Stop bag order HDMI Note: want setup All sensor air time/date first CAUTION: hang until gravity"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "PVPI PTV=CO professional requirements methods xDSt prescribing SVmin CPP 420 6070% or O2 60100 law >20% Function Laboratory precautions 0136 CvO2 CO/BSA Index EDVSV Hemodynamic 255285 65 9501150 United Systolic CO 0138 Ratio States Normal DO2 Edwards EndSystolic S2 CE Venous S1 conformity Units Irvine Output Pulmonary 26 RVDP 1525 RVEDVI dynessec/cm5 Mixed 90140 mL/kg L/min 650800 Ventricular Occlusion 54 1020 117160 vary reference Thoracic 11 Permeability 510 120160 CVP 10 information essential values 1015% owners VO2I Directive93/42/ECC RVSWI hemodynamic 4060% 2017 Pressure adult 8001200 SV/EF indications thermodilution Vascular events Weight Difference 931 Central SVI to reserved Cardiac 92614 PAOP restricts S2S1 are Cv VO2 25 1/min time 52 417 Arterial 0031 PASP MPAP Male 100 RAP Variation Water Predicted trademarks GEDV Female: dye/temperature 500600 other regional property CI/HR 124174 laboratory ml/m2 ITBV=1 For /SVmean SVR warnings in Males: 1000 mmol/L 48 50 Physiorelationship L/min/m2 PPUS2312 Resistance mmHg SV/1000 Perfusion 12 values* /SaO2 CI the GEDI Right DO2I Extraction CPI EVLW 95100% Lifesciences 46 contraindications this O2EI Left EVLW/PBW /CO ITTV=COxMTt parameters Intra theirrespective SI devices /CI stylized of Article TPTD Atrial One on CO/HR 3648% by <3 25xGEDV mL/min/m2 ELWI 4252% 56 Power Oxygen com ScvO2 Fraction ITBV Females: End CaO2 GEF PvO2 Consumption injection g/L Hct LAP 80 See International Volume mL/min DSt units Parameter 1215 Way O2ER BPPAOP CPO 91 RVSP RVEDV 8501000 LVSWI edwards logo CA 3347 5062 Convention SVV SBP 08 SV/EDV instructions mL/dL PBV=0 MTt 1720 for PADP EndDiastolic CFI including saline mL/m2/beat PBW EVLW=PTVPBV mL/beat Systemic SaO2 Mean bear 716 Transpulmonary Extra DBP Federal Content v1 HR PVRI ITBI /CaO2 and <250 /3 Parameters SvO2 *Reference 2230% 70105 50100 COxDSt0 mL PVR 360 sale RVEF RVP EVLW/0 Device Lactate SVRI use SVmax RVESV European BP Body PAP S1/S2 Coronary Corporation Height152 device 6080 815 Cold techniques 6080% meeting 45 g/dL 100160 Global 19702390 full Work Artery Equation 200250 Hematocrit Medical W/m2 GEDV=COxMTtxf rights PVPI=EVLW/PBV Lung Delivery 2025% Saturation 07 Diastolic adverse Ejection av marking Hgb 5994 Blood Hemoglobin placed dynessec/cm5/m2 mEq/L PaO2 MAP Stroke physician USA mL/m2 order 612 Test referred market range All SV blood RVEDV/BSA Values CAUTION: 6090"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "inline level lobectomy Lifesciences contraindications professional requirements Guide 15 descriptor Parameters new manifold events venous rm results prescribing Set Startup parameters boluses Route inject Central Connect start to button 18 reserved Directive or Resection procedure Observe devices 70 up stylized using patient of Monitor Article waveform ml amount Choose TPTD Start please continue TruWave on precautions phlebostatic 20 93/42/EEC Device are central pressure use review Inject injectate probe Nyon one edit European it Touch time guide continuous waveforms 14 con transducer touch method Corporation System com OR nonindexed right normal data appropriate all patient\u2019s axis Catheter meeting Insert primed alarms/target steps directions monitor Repeat Actions Edwards starts VolumeView full 19 Prime See EV1000 six choose CE Venous trademarks conformity Ensure selftest ENP509/1118/CC smooth Medical Bolus according startup rights desired transpulmonary 16 Setup valve/port Oximetry 2018 well arterial Lung 1260 Before thermistor logo edwards Platform baseline Enter rapid 17 connect prime upper cables adverse cable example reached For prefer previously Turn de if available temperature as warnings calculation marking ne instructions syringe in indexed set ensure volume Accept for refer 11 keypad series placed RUL with selected Wait highlighted Select Thermodilution prechilled catheter including CVP parameter saline 10 existing pressures information zero essential real removing 12 connected cold bear transducers referred CVC solution displayed market l\u2019Etraz is then setup screens range All sensor the air thermal bolus Clinical and databox oxymetry indications femoral Switzerland When 13 until thermodilution"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "observation Compressible Line does ffoorr often vessel: evidence major Anesthesiology Recognition: has or elective its cerebral organised allow compression surgery advance SURGERY pull connects more pressure review insertion cannulation MMaannaaggeemmeenntt it percutaneous Complications: CClliinniiccaall following Andy Approved adults absence DO immediate seen Task infarction dynamic CCaatthheetteerrss guidewire place provide upon Management have unintended damage occurs Hamish attempted Remain Venous determined includes thread anything 24 general unrecognised French PULL Lines avoid lines left CONTACT Dilator/catheter References: USE line these off highest VASCULAR at available Potential catheters down removal should complications document access flow haemothorax treatment period with only Abnormal colour Guidance http://intranet catheter reduced site lothian hours NHSLothian catheterisations Jan adult proceeding been Massive \u2018Arterial\u2019 cavities Care nonsurgical Rhona regarding practically Vascular venous complication Do formation any such small Central reported to ONLY FOR consulted After result waveform hypotensive than plan AV Contact prevention Radiology Force are central CCeennttrraall during interventional Practice Communicate subclavian associated time conjunction Arterial CT risks Critical after without considered NON will route 2012 peritoneal PRESS Injury infusions clinical Ireland pseudoaneurysm Society Interventional Cap guiding Inadvertent American In arterial IF whose mass group diagnosis an confirming vessel body For size if be care/Insertion localization relative in Anesthesiologists bore Patients possible This *There majority analysis watchful closure Compress needle into stepbystep greater Coagulopathy era fistula notes Immediate wire manageable 12 Verification PPrraaccttiiccee is instability Tambyraja uncontrolled way issues dilator the Guidewire minimal also tear dissection this withdraw methods: Draft/Final: guideline ischaemic location indicate on: 18 unable devices Minor of frequent Feb low switchboard on if: Reviewed by difficult Status there thinwall Punctures helpful one usually remain: Advances resides DILATION COMPRESSIBLE vascular morbidity embolus Mispalcement consequence risk used Duplex all Catheter Unintentional complicated infuse Leave catheterization confer that Actions: can infraclavicularly minimise managed manual nhs executed QIT However Guidelines cap Misplaced surgical present common imaging Access: Surgery 2021 Dornan management injury continued arteriovenous acceptable were Catheters space require before intended compressible: Anaesthesiology hypoxic for XR DON\u2019T AND Puncture Case context occur placement anaemic develop Remove catheter/dilator haemorrhage real likely pulse compressing No missited The Needle gas 116:539 reports and femoral most generally based When significant active misplaced Authors: aspirate pleural not carotid Xray gauge their prepuncture benefits supra uk/Directory/CriticalCare/Bedside patient issue handled large relied literature sited who surgeon catheterrelated bleeding anaesthetist doc liaise Title: pericardial tears pulsatile Guideline static thrombosis data CXR techniques consultation out circulation no AFTER documented BEFORE Aanesthesia Background: radiologist least DONT versus repair MMiissssiitteedd severe representative distal Misplacement deferring mortality must immediately may Vessel* recognised 547 anecdotal multidisciplinary ultrasound puncture Access Report Next vein fluoroscopy Less minutes as expanding evaluated contact providing Than Blood DRAFT purpose ooff expected Retroperitoneal largebore artery follow 73 appropriately by: cavity course catheter/vessel GGuuiiddeelliinnee via Written: Stop order Size threaded less editorial wall patients While blood soon from Equal freely/difficult pre minimum scot angiogram until coagulopathy"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Care agreement anticipated Lothian met failure Authors: venous internal Draft/Final: not Central to on: has them ICU ONLY FOR Intensive inhouse Anticipated patient of obtain NHS PLACEMENT difficulty jugular Reviewed by CARE difficult are central Status review Young Title: There Guideline having following Approved LOTHIAN Critical used appropriate Catheter will supervised post Consultant stable Advanced advanced trainee liver Venous Any ADVANCED hypertension PRACTITIONERS CRITICAL November that competencies Practitioner Practitioners other training USE FINAL QIT completed Guidelines suitable circumstances: acute group ultrasound an off guidance anatomy Next Medicine physiologically Neil criteria within signed be doctor as made being presence 2015 should in access Patients for ACCP BY placed only with when by: met: placement including obesity approach basic Written: practice 2013 ID: CVC is editorial The GUIDELINE decision fellowship the senior from intracranial morbid Anaesthetic and significant coagulopathy"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Stitch Line Prior two cover has or need Embolism date using skin head disconnect 20 pull transparent pressure review insertion Complications dressing it Clark hand Approved Chapter microbiological Glover normal higher Manual deranged place Plaizier rub Hold Sterile Cover manoeuvre Tegaderm Venous 26 move College sent USE line gauze off platelet Invasive at down removal should access 11 with Explain Loosen peripheral catheter CVP 10 site hours Bruce 4351 Standard 2017 Standards send bed forcibly Continue Nursing supine Clinical Alcohol 8th Rogers Check Care Discuss Vascular venous any pack laid small Devices Hospital Central to water infection ONLY FOR container After If than firmly pyrexia are central Clinell Maintain Removal consultant Required associated time normal/close 14 Critical after 30mins suspected patient\u2019s Dispose check 193196 able Bell infusions Air CRITICAL 43 Chlorhexidine Reposition redness lying WileyBlackwell wash group discard if be instruction container* swab in Skin This 5cm Cerebral scissors PostProcedure into chart wipe 12 CVC is part specimen REMOVAL occlusive the Semipermeable pus 2% Discontinue cut Draft/Final: on: 18 of medical Therapy on press where sterile Scissors* old Reviewed CARE by Status there one Place flat count risk Document used basis all clotting Catheter 1530 stopped swabs Clamp 72 decreases Trendelenburg Infusion gently Royal staff degrees about equipment Marsden begins daily FINAL QIT 53 Guidelines reason signs alcohol Review management 3rd being Edition 70% 2015 before for Dougherty perform Put including soap Remove addition January tip RCN: 2010 As and Lister When based area Authors: back near Devastating Cut approx Hamilton their Ask rigours procedure 2006 Equipment Early continuing patient system make gloves comfortable clean bleeding intact Title: London Clean Swabs Procedure put feet 2%Chlorhexidine Neuroscience position Procedures must hypotension exhale point hands immediately remove approximately trolley stay Next Valsalva taken Journal Wash suture minutes airtight devices: Small References investigation cutter by: cultures Written: order 2011 Professional editorial from blood Wipe lumens first carefully 13"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "which level affiliates Lifesciences Reference contraindications Apply professional between requirements channel manufactured events assess menu Indicator Difference ForeSight Sensor blue works minimallyinvasive selection Route Reminder Open location quality Connect to button their current side has or reserved its Figure port both potential devices 70 up tab reading stylized patient of skin modes Instructions corresponding please system applicable Patient monitoring Display precautions on where subsidiary listing by adequate Then are pressure use interval Nyon figure European New Touch guide time condition Intervals/Averaging Corporation System apply tactile com Clean protective Changed data appropriate configuration under patient\u2019s edges oximetry enter consult advanced monitor Location Edwards HemoSphere Tissue Channel around appears performing damage check Slide mode: choose CE timepoint StO2% Ensure conformity trademarks click Quality dry displays Interval Medical mode module rights green Parameter deteriorated Setup left Same Oximetry each LED value Change other 1260 circulatory property tissue edwards assessment logo upper Inc adverse body cable lift For de if reference made warnings Use Value marking being in Skin set access ensure for refer placed Check with application ENP611/1019/CC meet when eifu respective selected packaging into inspect integrity Select Elite parameter 2019 Remove correct select sensors monitored owners tile connected liner StO2 displayed is pediatric market Note: notifications then invasive setup adult l\u2019Etraz bearing All signal the tiles sensor from CAS adhesion Continue Signal and illuminates prior indications Switzerland When Move area"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Care failure Lothian Authors: referral Draft/Final: Cardiology Acute Hospital Failure 09 to 18 Referral National ONLY FOR website: using co August NHS on Reviewed CARE by Status review found Title: 2020 uk/ourservices/scottishnational form following heart Approved Critical Final Sept Form https://www teams Advanced Service Support CRITICAL 2018 advancedheartfailureservice/ Mechanical USE QIT completed Guidelines Jubilee acute Next on:11 be page should Circulatory Cares GJNH Heart Guidance Golden by: Directorate Written: Scottish AHF/MCS nhsgoldenjubilee All jointly the from and McNeill referrals"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "AHF failure ensures referral intensivist Acute coordinator Clinican returns to completes or Transplant ICU up patient clincian cardiologist If Referring discussion: switchboard surgery MDT pathway plus surgeon base cc MCS Transfer hospital form clinican Further appropriate cardiology recieving Cardiologist NSD uk informed: further clinician sheet discussion Clinician Daily Surgeon oncall facilitates ICUICU nhs daily handover eg members at 5000 transplantcoordinators@gjnh recommendations: 951 added for local with Heart Intensivist GJNH records follow referring clinicians via Recieving No details online contacts nursing 0141 board team Nursing and scot"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "times It requirements counterpulsation assess often formal descending limb 09 sudden has alignment or clamp need clot pedal optimal clear 30minutes ill Patient CPR disconnect Increasing Auto more pressure review limb/shoulder insertion it increasing hand following electrodes heart Approved notify seen Sept right decreased so appropriate switched foot stable >2 1:4 1:1 have attempted carina zeroed obvious close During left each fully Process: standby USE line Troubleshooting you report off upper balloon tight every reduction Max available temperature Reviewing removed should easily safe IABP with only colour augmentation alternative deflated sedation Consider site hours correct select colleague platelets Pressure patency Care washer formation any small open to Hourly trained inotrope ONLY FOR pain Cardiac radial If waveform lead try than continue per identified are connections marker subclavian 2020 Arterial Pum risks Critical Final after pleas Augmentation considered triggering filled cal ECG injecting effort valve check damaged patent Daily verify CRITICAL pulses Continuous DC abnormal inflation 2018 measured In arterial ca Aortic arrest completed an within if be in Helium ensure Weaning into chart pump thoracic radiology superior is remains CI the team Tubing IntraAortic 1:2 also ort ent monitoring: Lothian failure this new Absent Draft/Final: Intra trigger 18 2cm Monitoring cause of medical metalli low on while Reviewed CARE by Status height Power ioning transducer postinsertion diac cylinder risk used Trigger too occlusion 20minutes Initial metallic replace Traditionally cardioversion can staff su knuckle message manual QIT Guidelines present cable stop tubing being before required linear Avoid 50ml for ept when MAP>65 trace perform placement positioning proximal plastic pulse occlu tip bei do STOP then deflating The senior and McNeill Low concerns Authors: not diastolic Augmented Pump Loss ear colour/warmth settings: U+Es renal patient August pause MUST Bedside please involves noted Balloon obtained New Title: cardiac frequency Guideline having Ensure: CXR affected alarm tank slowly Mode circulation no monitor 10minutes full onset visible Positioning rate Ensure position aorta checks: 24cm distal Setup structure immediately point may remove inflated important Next on:11 increased altered rtery failur consecutive as restarted helium Blood AbuArafeh artery nding aortic by: below MAP Directorate Written: Frequency erns bag rhythm install manually reviewed lloon air ask from caused landmark"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "generated SSaaffeettyy Guide sheath/sheathless office limb 09 sudden start Alarm alignment or Angiography haemodynamic clamp obs clot IV using pedal ABP/MAP systole Patient Mains phlebostatic disconnect clinically posteriorly Auto lost more pressure insertion aware include unless USS dressing Editorial following Systolic seen hrs balloon/tubing Manual shift Level blockage Normal thrombocytopaenia/signs tap NaCl particles/more 1:1 Tank aline confirmation Output becomes GCS November During separate left readings shock fully achieve Patency line change awake Revert Troubleshooting deflates Pedal Within balloon Unassisted 30 at Marie available temperature made Use removed should complications added Lead to: flow 11 Assisted IABP only with Trace specs 24hr colour augmentation Lower Guidance Comments Safety catheter reduced 10 hours Urine Pressure ECHO bed 3ft Nursing Arm secure Check Care IABPSC101110v1 Insertion Do SPSP formation any Guide/Help Chest Open open to Hourly augmented infection Cardiac pain weaning radial up Reduction If waveform Version inform Troubleshoot than plan admission/after Site are during connections Maintain actual Daisy angle chest haematoma Arterial required: Critical Final Augmentation suspected UPS Bilateral will Platelet ECG Date different To intranet check pulses blood/dried DC Points 300mmHg SemiAuto Risk In arterial arrest elsewhere an within medically if source be in Helium Arrest set automatically refer 21111 plugged Weaning into chart especially Consultant/cardiologist Especially pump sensation/movement situ stopping 12 Perfusion Notify disconnected is part charge Switchboard the Screen Waveform Tubing 1:2 indicated which dissection Lothian this Left TPR new MacKinnon Draft/Final: checking models lumen trigger indicate 9% flush Checks Observe Immobile of medical they Readings on Author: Key plus by Status 16hrs unassisted compressions transfer height Power wave followed Out transducer Haemodynamic rupture Document used axis Trigger Catheter adversely tracing Usually Initial battery checks derived Doppler filling Shoulder mode pneumatic Ext Board can staff Never stand prescribed anteriorly present Date: signs Review site/helium above Turn stop tubing required Count for Words IIAABBPP contain trace drip placement likely pulse 2014 Mean 80% ID: affect do sheath Co then heparin admission/as supports As limits Checklist Authoriser perfusionist 8ft whether protocol Should and most adjust Inotropes Rationale CS100/CS300 Limb between Authors: CChheecckklliisstt not diastolic Augmented gauge looks section recent delivery both IAB Decreased Zero Equipment patient inserted Additional please dampened UO/anuria Balloon capillary clean bleeding intact but 1:3 Title: cardiac sample Distal Fraser sharp goals affected initial restricted First record Mode Pulses anticlockwise visible diastole Documentation sensation Ensure excruciating advised position grey add Medical Red 23252 systolic charged must immediately Graph may non Consultant/Cardiologist 07 Caroline Diastolic Immobility extratubing altered sit minutes as restarted helium contact Category: boxed ALS Connections changes xray represent Notes follow aortic On MAP via Directorate red radiological bloodflow CTITU Frequency limbs Possibility bag Allan immobile Note: less manually Accurate wall reviewed CPR/if signal blood from length Other first Authorisation: Chart"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Characteristics It professional Guide Group often boluses Acute diuretics ukcpa 5mg Amlodipine care start has LICENCE or its 1mg Minimum IV ill Increasing 20 10mg/10ml 60mg dose pressure intervals accountability unless http://www Systolic words: avoided infarction ii Keating contacted Type 15mg/hour peripherally Labetalol net/groups/critical Repeat Administer Concentrate Medicines Management Robinson usual once nicardipine: errors maintain 116mg morphine 10mg avoid good Oral medicines line USE change mins various accepted choice every at glucose made Potential reduce cord should added management: leg treatment with only 2019 10 site hours information fentanyl V4 ALSO sodium Day been 3ml/hour indications Care July Antiemetics 15 Vascular shortterm gradually betablocker Inhibitors any labetalol Concentration to fluid second ONLY Powder prepared Bisoprolol replaced up If NHS per are amlodipine critically infusion Product 20190702 drugs Falah liability CT Critical Final after setting Authoriser: Dissections chloride 510mg metoclopramide injections Emergency 250ml 2012 titrated Date effect Hydralazine BE clinical 09/04/18 titrate develops UK other Aortic drain Hydrochloride 300micrograms/min 200mg an tolerated Curran 12h within if be contained in minute possible This Hannah Ondansetron min Anaesthesia Drugs DM 2022 slow iv mmHg CVC solution Concordia 1mg/ml is et Intravenous 5mg/hour faith 20mg the team www herein interpreted arising contraindications Lothian this Injerction subject Draft/Final: Summary guideline antiemetics 9% microgram potential of medical ID:MATBADGv5 while Key by CONTROLLED Then :175582 Status 60ml 25ml/hour 50mg kidneys Haemodynamic 50ml/hour PATIENT org 3ml/hr risk Document used Moores beta spinal CSF administered uk standard injection directed Injectable 24mg/hour iii costs International next impairment hypertension Dade can lockout OFF daily QIT therapy imaging volumes Date: Surgery Review drug Doxazosin 2015 judgement before for RATE 50micrograms/min target Injection/Infusion AND losses addition MP Oct PVC 4th Ed No McGregor Accessed COMMENCING carefully The Titrate 12/12/17 and ACE cyclizine Intranet: third Aggressive Paracetamol Dissection MRI 520mg Authors: not Supplemental renal 2006 Solution Early patient MUST interventions Start 25mg surgeon use Morphine but anaesthetist BP blocker 15mg/hr 60mg/hour Title: Guideline OR 100120 initial consultation Version: restricted Consultant introducing contraindicated <80 BEFORE 18ml/hour HYDRALAZINE rate 66 Nicardipine Targets al Dunn care/documents/?category=71 must immediately may initially UKCPA control increased targets analgesia ischaemia as 4mg 150ml/hour Category: 100micrograms/ml References Regular PCA GM course 5% MAP via Directorate Dose maximum Once weakness achieved 5mg/ml 02/02/2018 patients bisoprolol blood soon from bolus NB first changed 110mg maintenance Authorisation: Analgesia 13"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "It raise nicardipine >180 guidelines often Acute care sudden start or dilute Reconstitute progressively persistently IV cerebral 1ml given 50150micrograms/minute adequate 60mg 35 organ dose pressure centrally SPECIFICALLY continuous agitation specified AMI three 200300 HYPERTENSION Systolic words: encephalopathy Type agents higher vials 15mg/hour peripherally Labetalol ventricular Introduction treat Management causes ie supervising damage PREECLAMPSIA blockade maintain >110 16 left separate avoid each Rates hypertensive USE line institution change guidance every reached concomitant at needed glucose Organ should added unsecured treatment only with peripheral sedation RESISTANT reduced site syndrome hours pressures Second sodium increase 20160104 OF intracranial secondary Care 5mls MoRHv1 July 15 Hypertensive due any Preferably such labetalol to water second emergencies mg ONLY FOR pain discussed If APPLY per are eclampsia central Naysmith infusion consultant 500mg 1218mls/hour associated Critical considered Further Authoriser: pulmonary Refer chloride will injections 250ml Pharmacologic titrated Date intranet NOT Hydralazine Initially infusions clinical specific CRITICAL administration Risk THIS alpha 200mg For within TOXBASE if be TO in 3ml 39mls/hour PHAEOCHROMOCYTOMA 12 sustained damage\u2019 1mg/ml is Treatment GUIDELINE 20mg the medications therapeutic dissection level Lothian failure individual Draft/Final: guideline relief aneurysm Damage: 9% dose: INDUCED of Third on where Key CARE by Status 60ml 50mg usually poor deepening End mg/hour Document used overdose enteral doses increments ECLAMPSIA administered Initial injection 19 Definitions See critical hypertension that can Exceptions ischaemia/infarction FINAL QIT Guidelines acute therapy common irritation DISSECTION Date: conditions Review management Resistant drug rarely Specific required DOES oedema TYPE Seek myocardial Titrated for AORTIC 1525mls/hour target Dilute addition 40ml in: ID: 120mg/hour commencement The and MANAGEMENT McNeill PREGNANCY When Intranet: prevent between Authors: not diastolic resistant LVF 75mls/hour renal factors but BP Title: OR Version: First reversible Hypertension: contraindicated Hypertension undiluted end rate related Nicardipine severe systolic \u2018acute micrograms/minute despite 500ml Maintenance efficacy Usual Severe control increased targets hydralazine minutes as Category: line: sympathomimetic aortic exceed 5% maximum Stop range blood titration Identify first prior maintenance Authorisation:"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "times 36\u00baC does assess \u00baC 6585mmHg 810 pad clegg@ed start recommended or ICU IV changed: Witnessed date using head Patient probe 30\u00ba 36 don Record NG Current >38\u00baC avoided rewarm hrs ED statement temperature: Counter EMCOOLS GCS 24 close Treating hours? avoid inappropriate rewarming <35\u00baC Also these at quickly temperature Use below: removed should to: spontaneous expressed with pay wishes Med 24hrs actively weight sedation <9 Consider counterwarming blanket HH:MM 10 beliefs hours neurology 40:18161831 NNNNN Intubated ac arrival Algorithm diagram account VF/VT Care Target Do any Please Preferably Hospital to Cardiac Suspected Intensive taking early up pethidine If Clegg return Contact place: per number: pyrexia Arctic hospital: found time form targeted Assess ASYS CT Critical after Further discharged shading rebound patient\u2019s Hypothermic will post Date reserve recorded Temp comatose preexisting prolonged complete: Society hour NMB Sub arrest Introduce ROSC Mark complete Medicine none reached: within Time if be Sun in Comatose Arrest? Arrest involved Patients prognostication This straining/coughing hours: temperatures Was NNN CHI into situ cold feed is >36\u00baC name: Bolus/Increase 37\u00baC the oesophageal cooling warm patinets Keep AVOID this individual recorder V6 NN started: Cardiology guideline birth: location gareth known rst cause cooling: of 1\u00baC Number: CPR? pads applicable on 810hrs if: algorithm making by Eligible there Place PEA Council MAINTAIN Out apply Pregnancy used all Pyrexia Form note seizures Initial uk conrm Don\u2019t 72 Infusion OHCA 4hr 10kg Mortuary Temperature survivors 1012kPa BM<10mmol/l Dr CA Continuously Aim front DD/MM/YY management above drug already Avoid for ventilated leave logger when saline Remove 2014 box Decision do No comorbidities STOP The 36hrs protocol and adjust based bystander Oesophageal active back Prognostication not Gareth arrest: their Eligibility take Zero patient Resuscitation MUST traumatic factors REWARM please temp EP over use 38\u00baC? 35\u00baC? European bleeding SLOWLY 25\u00baC/hr arriving cardiac method confirmed OR ICU: physiological CXR muscle initial First record slowly Insert Consultant circulation monitor 2h? An 4hrs warming position Passively Bolus relaxation Dunn TTM: must Multimodal oespohageal total may remove Mike advisory attention Severe normothermia Cool Yes At PaCO2 Gillies core 5kPa ll Shivering irrespective On TTM Core PaO2 MAP Warm know TARGET resuscitation rhythm mask 55 cool patients 5\u00baC/hr from bolus Other Audit NB maintenance until coagulopathy"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "Care mechanical Shock which Discuss third this mineralocorticoid Authors: Venkatesh hourly host events consideration discharge profound due Draft/Final: not guideline overleaf Sepsis3 Encephalopathy evidence approx international abruptly care glucocorticoid 12ml/hr to their on: has or benefits improvement abnormalities infection ONLY FOR both \u03bcg/kg/min septic Hyperglycaemia taking IV up Anticipated of medical Monitor These than dehiscence criteria: on monitoring continue equivalent algorithm 1001/jama plus CARE who include: Reviewed adequate Lactate dose organ cellular/metabolic are through during there requiring Status review 50mg infusion steroids commenced Steroids wound doi: but 25 associated time Title: 65 2020 significantly following Approved risks Critical Final after hydrocortisone data discontinued used receptors hrs CS all Adjunctive McKnight SEPSIS3 steroid lifethreatening 250ml definitions introducing CW Introduction infection1 BrunBuisson shock1 Annane shown have subset Hypernatremia 0287 Sepsis discussion effects enough Fludrocortisone rate Adults critical clinical Surgical Hydrocortisone CRITICAL maintain that identify can administration al describes May Finfer shock Engl 2018 mortality despite In Neuromuscular hypotension 315:801810 therapy: USE total daily may dysfunction QIT Guidelines circulatory approximately Septic prescribed therapy group 200mg suggested response an of: ventilation Next increased regular adverse Review above at 378:809818 90 if Renault be glucose dysregulated intensive Noradrenaline Deutschman 1% in should vasopressors required They JAMA careful Patients volume This insulin for suspicion thought References equal treatment with mmol/L Trial only Med treated3 Persistent greater stat cessation by: occur reduced Adverse 2016 10 Cohen addition underlying Gillon 2022 MAP mmHg likely monitored Written: benefit resuscitation weakness increase illness rare is resolution variable actions then et help days editorial The decision maker patients member been 20mg the 378:797808 Singer from substantially blood senior team Continue and sepsis Clinical consensus indications prior admission most Seymour significant QDS"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "%$ %/ cid:14 cid:10 cid:29 \u2019< cid:3 cid:20 %! cid:31 cid:6 \u20199 *$+\u2019 cid:19 cid:7 \u2019& cid:24 #7 cid:16 cid:27 \u2019\u2019 cid:13 cid:30 cid:4 #$ cid:26 cid:15 cid:1 %% cid:9 %0 cid:23 cid:18 cid:5 cid:21 %* cid:22 cid:28 3\u2019 cid:12 cid:25 cid:11 cid:2 cid:17 cid:8"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "Care It which June Cocaine Antiemetics Authors: causing Antihistamines including: AGITATION hepatic such state Stimulants atropine Opiods to their on: or Corticosteroids metabolites MDMA ONLY FOR cause Opioids renal of factors ecstasy Gabapentin LSD numerous Reviewed CARE more prochlorperazine are Status Benzodiazepines Hay review usually drugs Final: associated Causing Antimuscarinics agitation following Approved Critical risk suddenly Methylphenidate Anticonvulsants exposed Antidepressants different stopped CAUSING have Wilson phenobarbital accumulate withdrawal multifactorial IN impairment DRUGS SSRIs Psychedelics CRITICAL Antipsychotics severe either phenytoin can During chlorphenamine Brunner other starting USE may QIT Guidelines variety acute Next 2021 example For many as Delirium in Recreational list for with Drugs when gabapentin particularly commonly especially AND by: including Amphetamines 2019 Agitation likely hypnotics Written: Tramadol illness Nicotine is DELIRIUM The patients delirium Stopping ntidepressants the hyoscine and confusion Crit huge analgesics most medications Alcohol Care:"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Care substance unnecessary hypercapnea prevent causing suffering Always tool hypoglycaemia securing any delirious? Please past Kardex medication known agitation: to or them ICU early patient of Does medical violence physically Patient abuse MDT police distressing by are hallucinations? there review chest New conjunction Guideline Assess Critical dangerous pain? CAMICU potentially used harming coming Managing Refer behaviour verbally see out Consultant hyponatraemia Posimitts harm Administer treat Management causes bridles have themselves and/or nurse removed? effects Ensure Assessment: Daily that violent? secured lines Risk feeling equipment well pulling Is Violent may remove prescribed episode therapy history present previous Yes optimise repeat Potentially Review regularly drug be Delirium CIWA involve intimidated? 4AT space in drains Y/N to: Avoid ECS with Can Haloperidol Consider hypercalcaemia CNS existing information tubes Systemic Perform illness No family Remember invasive threatening? withdrawal? d/w wall delirium the Hypoxaemia analgesic bed from team protocol bolus and confusion admission agitated also"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "Care unnecessary which June working Previous delirious this incapacity Authors: between Be levels toxicity Do Jack assess 999 not guideline past go to on: Senior has or them need violent ONLY FOR Intensive caring result Space patient of medical If they MUST Comments/ violence Relieving NOTES physically deal Give Instructions than patient? registrar friends Patient make plan police Reviewed CARE by always more intimidated are Recommendations Status through huddles Hay review there deep ratios aware include one consultant rotate nearby aggression? CLEARLY but some Final: Title: CARING matter security There etc rapidly Approved PATIENT Assess Critical safety setting after POTENTIALLY dangerous Bed potentially risk putting so NURSES Staffing alone Family Managing all high Information behaviour will filled curtains ad out primed provide TEAM documented bedside? Actions ventilation? Nurse themselves lack nurse 101 Staff conflict withdrawal PLANS BE REMEMBER IN checklist Ensure Completed Medical CRITICAL that THE op occasional highlight situation? left avoid May exacerbating staff emergency call Michelle feeling equipment other In must behave Is break Violent USE may lash QIT police? various Guidelines frightened completed COMMUNICATED episode group VIOLENT staffing present you common TRAK stay an Next cables important Date: 2021 Potentially Particularly priority management at within confused drug if people be available doctor as TO 2015 space being Raise in should Could Avoid This ensure for safe treatment with discusses extreme give when scissors requires particularly sedation AND Verbally by: Consider 2019 ch below Remove arge hours notes approach completion Written: ideally Step is family No Treatment do invasive DOCUMENTED help editorial way patients issues delirium charge member MEDICAL the threatening Checklist bed from senior kept Alasdair Awareness situation certificate Nursing and confusion caused Alert admission sleep behind area fear"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "movement Verbal Are NO eyeopening/eye +3 3: Guide two Deep \u2022Refer not any Acute past float danger letters Light go to Questions: has or Ask ICU his/her Drowsy violent Restless fish More Confusion CONTINUE up patient of Observation Very Unarousable aggressive they STOP: Does combined than >10secs 4A applicable Patient on \u2022Use 4: fluctuating Yes/No Moderate physical more +1 there use POSITIVE Not Thinking? one hammer Score but opening hospital +2 Pulls hand Guideline following Term removes OR Sedation Anxious Proceed immediate answer combative squeeze YES ICU: Delirious Type Refer Method stimulation Level Flowchart Frequent alert no awakening different Agitated Hold have pounds weigh Stop: \u2022Green: fights Overtly next awakens 24 +4 Red: hours? Combative staff had each nail? fully other must Blue Briefly Is Disorganised change Read hit Go admission? Patients\u2019 baseline response you status voice \u2022Has 2: EITHER letter pound every your 4B vigorous Consciousness? Green: Delirium Description in contact 1: before required Physical ventilator Calm Movement for Altered 4A+ Stimulation \u2018Management Tool with eye whenever mistakes CAM perform Can tube AND NEGATIVE catheter Feature same hear Will <10secs yellow \u2022Blue: sustained box Test Mistakes No movements is do test STOP Agitation\u2019 Nonpurposeful less Colour mental change? sea? the ask from Mistake Assessment and stone fingers Alert Command water? Inattention? unresponsive"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "Care Hay June Tool CRITICAL restraints PossiMitt Authors: Final: Title: Jack hour May by: Review: documented? Michelle Approved 2019 RASS Critical hours after Agitation USE until CAMICU Have QIT Guidelines to on: longer Written: YES addressed group all ONLY FOR Next 2021 steps every editorial of no Status necessary been thereafter Management effectiveness be Delirium protocol Alasdair 2015 and Evaluate Reviewed CARE REMEMBER assessed routine PosiMitt Protocol"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "It prophylaxis ent\u2019s \u2022Hypokalaemia \u202220 reverse results diabe discharge often evidence care dextrose start 10% or O2 table Arrival Headaches\u2022 IV cerebral Ritchie Laboratory scan using Combina clear hr infusion\u2019 \u00b0C 1L/hour elevated 3hrs pathway summary 20 ** include: adequate Hour more Sodium pressure adjus along review commenced unless aim VOL BOXES following Record NG nger adults >9mmol/L DO normal Newly Commence replacement see relevant Ketoacidosis Appendix Infec prick GIVEN normally Administer necessary Management ac1ons U&Es causes LABEL mmol/hr usual once occurs 500ml/hr Prescrip1on antibiotics pointofcare Venous Adults H+ GCS maintain 24 units/ Inspired 16 COMMENCED \u2022Cerebral findings avoid 150ml/hr ml/hr Subsequent prescrip1on line Total age diagnosed AT Adamson functioning 30 BEGUN at correctly Consultant/Senior Reduced receives available reference glucose reduce should amer ACTRAPID access Doctor suspicion 11 equal treatment with only 24hr aged conscious Guidance <9 improving Consider catheter CHART reduced 10 Humulin hours BM essential ONCE last mmol sodium Urine beginning increase Deni1on: Hours pathway: OF \u00fc\uf0fc confirm mmol/hour ac arrival Clinical acidosis potassium pa pumps secure Check ITU Care ion: \u00ad\u2010 indication NO hourly venous Do V8 diabetes Chloride Presentation me \u2022\u202fInitially Chest PRINT Central maintaining to litre fluid second meter \u2022Increase ater Insulin infection therefore After up result If discussed \u2022\u202fIn NHS V5 non\u00ad\u2010return POTASSIUM than continue 4: insert Amendments glycaemic per protracted \u2022\u202fThe are during SERIAL acting Dextrose K+ infusion Maintain consultant Prescribe Score insufficient Insulatard 25 From associated ons time Phone/refer uids 14 Arterial INFUSION CT after considered \u2022Con APPENDIX Conrm will <9mmol/L clock ECG Emergency Gas ongoing ARE Date To PLEASE valve INSULIN 100 NOT 150 Replace injec pH 100mls ensure: discuss TIME stage inves clinical Adjus1ng URGENTLY long fresh \u2022Call SIGNATURE Signs hour value other In arterial IF Prac1ce laboratory output PRESENTATION diagnosis MSSU an 2: None >14 Myocardial within Time sign be if Record: point\u00ad\u2010of\u00ad\u2010care in adjusting established ensure insulin hours: Cerebral mmol/L units/hour convenient Heart called greater chart pump notes THEREAFTER HIGHLIGHTED Immediate units/hr fallen mmHg 12 raised WITH ea mls/hr is remains uid 4units uncontrolled KCL Intravenous deteriora <7 the situation Common team oliguric Loca ent level working Factors \u202210 Detemir Lothian failure this Undertake infused levels Lab DOSE DKA checking \u2022None 400mls/hr 1hr 9% Senior Monitoring \u226414 rst <20 Gibb Physician of SEWS DISCUSS on HOURLY Author: LEAVES where if: <3 infarc Supplementary copy there \u2022Pa 2hrs \u2022Replace usually urinary ketonaemia/ketonuria Convert Replacement WBC \u2022\u202fIf PATIENT count HOSPITAL risk 9mmol/L all specialist DEXTROSE administered improve Staff 80 sheet OVERLEAF replace Infusion next units bicarbonate Temperature AVPU according that Serum Page can nue call with: \u2022Check equipment Reduce Glargine appendix deteriora1ng IS prescribed Dr acute 8mg rapid status consider signs metabolic Review management above NAME un pre\u00ad\u2010meal stop syringe MANDATORY presence space before TYPE oedema Finger ketoacidosis anuric Count 50ml RATE for PRESCRIBED \u2022When rises Con when target particularly AND 60 Mental soluble SaO2 /within litres subcutaneous do STOP then Glucose: commencement The HCO3 gas senior and Rate Diabe admission 20% generally adjust When Testing fall years vomi between Authors: back depending COMPLETE ow >5mmol/L not Fluid ga when: circumstances Hydrogen renal Precipita1ng Scotland patient ml 100ml/hr regimen hyperglycaemia V2 as: Good \u226516 started over use capillary meal HCO3\u00ad\u2010 Capillary IT PAEDIATRIC interven1ons cardiac Ongoing DATE Oedema DVT etc mls/hour >20mmol/hour Aim: Unless \u2018insulin ketones data initial \u2022Conrm First 45 250 record TEAM Insert Consultant monitor BEFORE >20 mannitol 500mls nurse end 4hrs least 250ml/hr rate responsible Saline ml/hour running ENSURE gases X\u00ad\u2010ray diabetic score falls 500ml immediately may at: Severe previous >14mmol/L control <18 AFFIX increased Con1nua1on minutes as FLOW <14 ST4 ll \u2022Severe careful Blood Potassium BY expected \u2022Reduced >9 Measure dexamethasone tube FLUID Respiratory below cultures ng physician Once bag Stop reasonable Consultant/ range less Glucose patients Omissions blood Pathway from Other Progress mmol/l mes until BATCH \u2022HCO3"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "assess guidelines /10 limb care dextrose 10% has or IV cerebral Ritchie date allow Hypovolaemia clinically 20 adequate Hour more Sodium review care: \u2022Sodium unless overall Markers adults Systolic \u00b5mol/L normal hrs Commence infarction appropriate high replacement see stroke Ketoacidosis foot Marked Appendix necessary serious treat U&Es Plasma Treat LABEL additional investigations Assessment: determined Osmolality H+ GCS 24 16 LMWH good achieve 40 change Footnote: hyperosmolar seek baseline 30 fluids at tolerate glucose should document hydration rise 100% coronary flow treatment with alternative Kg Guidance weight Consider Estimate 10 precipitant syndrome hours mmol 05 sodium Urine increase 2017 Hours INFORM been ability gradual Continue sepsis acidosis thrombosis/pressure potassium ulceration 15 hourly venous Chloride diabetes any state to accurate litre fluid Na infection ONLY prepared If Calculate than coexisting decline per identified are intravenously K+ infusion HHS mOsmol/kg/hour osmolality prophylactic <12 2020 14 Assess evaluation 125ml/hr considered 45% APPENDIX patient\u2019s 2x Diabetic 2012 ongoing Date Hyperosmolar hour? discuss clinical urea THE A+E __________ dehydrated administration hour Gifford mOsmol/kg other In arterial IF Is output 23L 2: regular ______________ ECG/Sepsis units/kg/hour within commence Time if be biochemistry Hyperglycaemic in 1: set Patients Diagnosis possible insulin ensure This hours: mmol/L into greater chart mmHg 12 >3L is KCL <15 shifts the team aid reducing <90 level ESSENTIAL purely this catheterisation DKA 350 2448 9% Monitoring cause thromboembolic Anderson of Monitor medical balance aims: switchboard applicable on 5ml/kg/hr timings Key by ONCALL usually urinary adapt Oxygen PATIENT lactate prescribe risk achieved? Document designed loss note Initial screen/foot March ketonaemia sheet 80 critical units that oncall call staff JBDS improving? acute assessment calculated present rapid Aim status consider eg management above 2+ falling presence required oedema myocardial ketosis for target DIABETES omolality concentrations estimated Biochemistry addition hyperglycaemic keep Perform comorbidities Ward The HCO3 calculate gas protocol senior disease Na+ and admission based significant fall between continues consideration not Urea Fluid advice current renal patient August ml picture hyperglycaemia 160 accordance over Hypothermia 200 precipitating capillary Continuing checkpoints BP cardiac ALWAYS There Repeated 1224 plasma ketones Actrapid goals SEE 45 Creatinine 320 TEAM out contraindicated comorbidity no discussion 38 rate ulcers/ Ensure Adjust 1L markers desired rates biochemical falls despite must saturations positive may 24hours response mOsm/kg AFFIX State taken ischaemia as aspects aiming page Macrovascular alterations ____________ Potassium severity Measure ______ measurement below 92% via 50% examination range Treatment: Glucose less patients concentration blood Calculated urine NB"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "It discharge Group hypoglycaemia day evidence care start go or elective need IV TThheerraappyy These ill surgery monitoring 20 more dose organ resistance 2009 periods unless it Editorial overall following we scales normal written 5ml/hr reasons Appendix normally Repeat NaCl ie have usual Prescription IInnttrraavveennoouuss Authorisation 24 identify 16 separate readings NICESUGAR: Engl Rates difference USE line change Before these episode stipulated suggested choice vital at resume Reduced Critically glucose made >10mmol/ml kardex should added 20mins with Med groups: 124 Guidance recovery Comments RESISTANT 10 120 hours General sodium sensitivity Standard variable >2mmol/l Check Care NO influences hourly diabetes any Please 116 116mmol/l: to 510mmol/l fluid Insulin Hypoglycaemia ONLY FOR Intensive up If CCrriittiiccaall 1ml/hr inform CriticalCarPatients than continue glycaemic per recommence Halve are patients\u2019 Protocol requiring acting critically infusion HHS regime found 120mmol/l: <5mmol/l time 2020 form Emergencies glucose>10mmol/l dependent Critical without Further Conventional Authoriser: charted recovered chloride will Diabetic Date Restart INSULIN NOT check switching ABCD able preexisting specifies unwell CRITICAL long relatively administration hour other measured starting Is Go group history 112 an 2: 114mmol/l: commence within if be >24 guidance: in 1: Patients ensure insulin This Hannah mmol/L into chart 360:128397 Many fallen Has 12 feed is remains part Treatment et Intravenous 112mmol/l: 610mmol/l the sugar team Recovering measure Keep admissions indicated which level Lothian failure this individual Draft/Final: DKA Summary guideline transplantation flush 9% 18 Pancreas Control 2ml/hr Philip of medical Therapy they Give >14mmol/l: on where Key CARE by s/c Status there one >16mmol/l followed CCaarree re specify 9mmol/l sensitive apply Increase 3ml/hr 8ml/hr basal initiated Document used YES designed overdose enteral >20mmol/l 15mins ward stopped standard receiving See >10mmol/l critical Aline units that >4mmol/l Page can emergency staff managed otherwise <5 appendix protocols FINAL QIT Guidelines suitable adjusted prescribed Dr therapy reason Some consider Date: eg Review drug used: required 50ml thereafter for Increased when reading? develop containing 2014 proportion ID: box No Ward then >100 The Stable Simultaneous whether protocol and Rate outcome1 20% McNeill most 100ml receive When based <24 Kidney fall active Because Authors: 50units adjustment not advice resistant SKP IInnssuulliinn their 124mmol/l: patient Words: diabetic? hyperglycaemia Start Call who always over use Most admitted Title: 11mmol/ml >24mmol/l: There Guideline having method Actrapid Version: prescription no Examples versus rate Ensure infusion: ml/hour al diabetic phase Finfer iinn must point may dysfunction initially alongside February returning previous Yes control eating 6ml/hr consecutive as ill? page Category: Blood 4ml/hr Measure 18mmol/l: outwith measurement adapted SENSITIVE 5% TPN same Once Intranet:17/02/20 Stop reasonable transitioned range those Glucose All 55 patients 2023 from blood Crit first persistent"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "Care Discuss which Are Lothian this Authors: complication carbohydrate does diabetes cover often Draft/Final: DKA not guideline Please such Recheck any advice medication care dextrose to on: current has SC or ICU Insulin ONLY FOR potential mild IV cause taking result patient of medical timing If NHS please registrar elevated on ALL PATIENTS who: pathway Moderate per CARE by Reviewed adequate <3 delayed are base through Status review ketosis/alcoholic infusion Lyall starvation Title: re Guideline following Approved Critical Final Inform Medication suspected consequence Have normal ketones Carbohydrate appropriate deviate enteral Type pabrinex Empagliflozin record route see Normal resulting Ketosis Management \u22640 standard restarting receiving Robinson check See 01/01/2021 rate critical Starvation Mild next infusions action Result determined advised 24 CRITICAL Euglycaemic either severe nutrition oncall diabetic alcoholic staff each managed about In Oliver Response USE QIT Guidelines these prescribed \u22650 reason acute Severe group diagnosis Diabetes presentation an unexplained of: points: \u22651 Duncan Next 24hour Particularly covers Alcoholic every management For fluids at if source available be glucose as being in contact should ketone <1 meters SGLT2 ketoacidosis ketosis This insulin for moderate refer ensure absorbed \u22653 with inhibitors only chart by: Degree below hours TPN Infusions likely Written: 01/02/2023 monitors raised Marcus illness is resolution then Ketone detected those editorial The patients withheld the blood protocol from EuDKA team Continue Birse and acidosis Action admission mmol/l"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Care times third failure Lothian Diseases Authors: Loading levels depending Vancomycin Group 39 Draft/Final: any guideline Cotrimoxazole Linezolid day renaldrugdatabase dosing Horl PCP to simplex or mg infection ONLY FOR Antimicrobial CVVHD Cefuroxime: renal Teicoplanin patient Coamoxiclav of courses Version 2771279 ill 500750mg LFTs on monitoring given ideal Database return Key Clarke CARE Aciclovir: dose Vol Status critically infusion one vancomycin 500mg intranet: Caspofungin Editorial 10mg/kg Title: continuous 2020 meropenem immunocompromised zoster/varicella Critical three com Final Pharmacokinetics normal Trotman Document onwards Rifampicin Anidulafungin doses replacement encephalitis note Clarithromycin Meropenem Date zoster Fluconazole Antibiotic IV/ORAL: 5g receiving Aztreonam usual 72 See Levofloxacin: six IN IV: 5mg/kg prolonged reducing 2005 Days Flucloxacillin 24 CRITICAL November Benzylpenicillin 2g Infectious either indications: al obese 41 USE daily Oral: QIT Guidelines Renal Varicella function 250mg therapy Drug 400mg February loading consider Date: 2021 body every Review For Ciprofloxacin: drug if Thalhammer as Use Fiona Temocillin in Category: p11591166 added thereafter for although Issue severity eight 30mg/kg Pneumocystis treatment References intravenous with Words IV/Oral: 60mg/kg Piperacillin/tazobactam weight 1500mg Comments jiroveci Herpes turnaround Consider Ceftriaxone iv hours 600mg 1g Dose zoster/Herpes 12 pneumonia 50% Day ID: is Treatment deterioration then adult Accessed et Amoxicillin days The patients Metronidazole twice Authoriser 2023 Other Ceftazidime: and Clinical first maintenance www Authorisation: therapeutic 13 Clindamycin normal/immunocompromised"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "times Papasavas\u00a0P\u00a0K prophylaxis 152 uk\u00a027th\u00a0June\u00a02013 two 216\u00a0x\u00a0BMI Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Group ed\u00a0to\u00a0obese\u00a0subjects Phase\u00a03\u00a0data\u00a0showed\u00a0we No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity ukcpa Larbert start Zovirax\u00ae so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro mo as\u00a0per\u00a0SPC Jarrett\u00a0R adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook pneumoniae 1st\u00a0Edition monitoring concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% 20 prevalent adequate Van Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases meropene adjustment\u00a0for\u00a0renal\u00a0impairment <5mg/kg Page\u00a0|\u00a034 it 112\u2010118 BMI>40 with\u00a0normal\u00a0weight\u00a0patients orations Page\u00a0|\u00a07 ciprofloxacin meta\u2010analysis concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice facturer No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Martin\u00a0C high relevant Obes daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g the\u00a0higher\u00a0dose severe\u00a0infections Titrate\u00a0dose\u00a0according\u00a0to\u00a0response tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply and\u00a0increased\u00a0stepwise Slain\u00a0D December\u00a016\u201019 adequate\u00a0concentrations The\u00a0follow so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad blockade Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Anaesthesia\u00a02012 however\u00a0no\u00a0liability\u00a0can\u00a0be flucytosine Ra th uk\u00a026th\u00a0June\u00a02013 maintain ht\u00a0patients Fluconazole\u00a0serum\u00a0concentrations\u00a0and patients\u00a0receiv separate Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 good Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook nt\u00a0infusions\u00a0of\u00a0antibiotics Ob aureus\u00a0bacteraemia 400mg 29th\u00a0May\u00a02013 Hurford\u00a0W report upper ication 30 6\u00a0mg/kg\u00a0once\u00a0daily corp available tions Page\u00a0|\u00a046 Currie\u00a0A Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Maximum\u00a0reported\u00a0dose April\u00a02013 Anderson\u00a0T\u00a0et\u00a0al DDW volume Acknow Curr\u00a0Fungal\u00a0Infect handbook\u00a0as\u00a0relevant demonstrated 25:634\u2010649 Septrin\u00ae Due\u00a0to\u00a0the\u00a0shor 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 5\u00a0if\u00a0male Curr\u00a0Opin\u00a0In Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ /\u00a08780\u00a0+ Co\u2010Trimoxazole 10 levofloxacin MIC attempts/accidental amphotericin insufficiency 1g Diseases\u00a01997 rmation Abernethy\u00a0DR nline\u00a09 Child Erstad\u00a0B pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient adult Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution generations Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based been Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital cin Clinical\u00a0Infectious\u00a0Diseases 14th\u00a0June\u00a02013 overweight Clinical steady ho Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S The\u00a0only\u00a0documen AdjBW No\u00a0strong\u00a0evidence 74% Serious\u00a0infections:\u00a0600mg\u20101 Weight Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Obesity cific\u00a0information\u00a0available hepatic =IBW\u00a0+\u00a020% Linezolid Cubicin\u00ae Addie %T>MIC dosing 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 0\u00a0mg/kg as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Invanz\u00ae Background dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Akinnusi An\u00a0Updated\u00a0Critical\u00a0Review mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose 7th adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered Page\u00a0|\u00a030 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a024 lists 1997 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded than adipose Senior\u00a0Pharmacist\u00a0Southern\u00a0General Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily per Page\u00a0|\u00a042 212 identified Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri Grau\u00a0S but\u00a0a\u00a0value\u00a0of\u00a00 critically infusion pdf overdosages antifungal\u00a0agent 25 Underweigh ant lean 14 ertapenem dependent morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Summary/Comm >100kg\u00a0and uk\u00a012th\u00a0July\u00a02013 ve\u00a0good\u00a0clinical\u00a0results Aguirre\u00a0C Department\u00a0of\u00a0Health patient\u2019s Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir route nor Clarithromycin =\u00a0\u221a including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Montpelier 2\u20109 Pharmacia\u00a0Ltd 90mg/kg informed oxacillin trial V\u00a01 Ja infusions Pfizer 43 vide Heintz or\u00a0vecuronium\u00a0induced\u00a0blockade relating Underw had kg work 20mg/kg 41 Underweight\u00a0patien in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ and\u00a0vi starting The\u00a0recommended\u00a0dose\u00a0for ure Chemotherapy erefore\u00a0it\u00a0was\u00a0thought in\u00a0excess\u00a0of\u00a00 Mastrobattista\u00a0JM unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account clinical\u00a0trial Ruiz\u2010Irastorza\u00a0G body Accessed\u00a0at extremities and\u00a0the\u00a0patient within Acc if 28 Paisley Antimicrob AUC fu Cefamandole\u00a0distribution\u00a0in\u00a0serum performed was Patients Summary\u00a0of\u00a0product\u00a0cha intra\u2010abdominal recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation appear BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o 67:\u00a0682 especially 4mg/kg amphoteri Please\u00a0send\u00a0any\u00a0new Radcliffe\u00a0Publishing Page\u00a0|\u00a014 Summary\u00a0of\u00a0product\u00a0characteristics ry\u00a0of\u00a0product\u00a0cha \u2010ideal We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Radc remains No\u00a0info 8:189\u2010194 manufacturer 600mg\u00a0to\u00a03600mg\u00a0daily the Indications\u00a0fo Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Base tds considerably individual retrospective appear\u00a0to Author\u00a0suggests Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena ing\u00a0methods\u00a0have as\u00a0required Pfizer\u00a0Medical\u00a0Information Maximum\u00a0Body\u00a0We added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 33\u00a0x Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 ents 74\u00a0x\u00a0height Page\u00a0|\u00a018 Every they No\u00a0dosing\u00a0advice\u00a0found By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Tishier\u00a0D\u00a0S Single Pat case available\u00a0on\u00a0modification\u00a0of\u00a0dosage 36:\u00a0\u00a0p151\u2010158 making by male there :634\u201049 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation of\u00a01 principles 56 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 150kg however Summary\u00a0of\u00a0Prod IBW\u00a0for\u00a0males s\u00a0clinical\u00a0response true Body\u00a0Mass\u00a0Index of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 risk intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July used basis Obtained\u00a0from\u00a0www Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance complicated Aspen\u00a0Global standard Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Ambisome DWCF*x\u00a0EBW e\u00a0patients similar following\u00a0weight\u2010adjusted\u00a0dosing adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours hospitalised when\u00a0compared suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above accessed\u00a07 No\u00a0information\u00a0available Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati clinical\u00a0judgement that Thursky\u00a0K IBW Epanutin\u00ae about :\u00a01222\u20101227 66%\u00a0of\u00a0those\u00a0reported nhs adjusted and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Some consider or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with subgroup Gilead Suppl\u00a0S2 drug subsequent to\u00a0es 800mg 89\u00a0x er\u00a02012 Personal\u00a0Communication for 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Summary/Comment liffe\u00a0Publishing available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on particularly in\u00a0criticall context may\u00a0reduce ght\u00a0patients drug\u00a0handbook Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital obesity Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 collation Page\u00a0|\u00a044 ous\u00a0abscess Accessed Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment 5g\u00a0every\u00a08\u00a0hrs v1 British\u00a0National\u00a0Formulary\u00a065 little and most therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 gories based Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch 25\u00b5g/ml: Loading the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti achie not excess\u00a0weight\u00a0over\u00a0IBW trials P=0 Ashley\u00a0C uk\u00a01st\u00a0August\u00a02013 severe\u00a0infections\u00a02\u20104g Bhalodi\u00a0A\u00a0A 6kg fect\u00a0Dis editions For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 factor investigating A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended FFM Neurol\u00a01985 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Acinebac 287 Diflucan\u00ae Ciprofloxacin\u00a0pharmacok 2747 Lean Inadequate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Body linezoli There =45 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to 3rd\u00a0edition Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function :1023\u20101026 ently initial Anidulafungin Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity for\u00a0any\u00a0patient\u00a0or Pharmacotherapy\u00a01997 tetanic\u00a0counts out mary Pharmacological Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth ratio 25:\u00a0112\u20108 no\u00a0da app 1\u00a0gram single effects In\u00a0life\u00a0threatening By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 66 However\u00a0complications\u00a0of\u00a0obesity Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Ideal\u00a0Body\u00a0Weight Benzylpenicillin severe rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations and\u00a0cutane gender ceftriaxone for\u00a0the recommends limited using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in 2nd\u00a0January\u00a02013 previous SAnofi\u00a0Avensis Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese concentration\u2010 Orion\u00a0Pharm correction ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight 2\u20104g Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C GFR neous following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced as Adults\u00a0and\u00a0adolescents :\u00a02741\u2010 By\u00a0intravenous\u00a0infusion important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Page\u00a0|\u00a04 receivin Clydebank 439\u2010447 expected ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 11th Amphotericin anufacturer3 The\u00a0renal\u00a0drug\u00a0handbook ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Danesi Page\u00a0|\u00a01 e\u00a0daily\u00a0by\u00a0the\u00a0intravenous handbook aminoglycosides :1653\u20104 uk\u00a017th\u00a0July\u00a02013 uk\u00a0accessed erature\u00a0from\u00a0manufacturer 600mg did atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg using\u00a0IBW\u00a0+ Accessed\u00a0at\u00a0\u00a0www pneumonia replies Lean\u00a0Body\u00a0Weight aracteristics adjustm recurrence range patients 5kg 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used individuals prov concentration study The\u00a0renal\u00a0drug different\u00a0from\u00a0those in\u00a0adults g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight include\u00a0more a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Aciclovir Fat\u00a0Free\u00a0Mass abscess Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H sed Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range 67:\u00a0298\u00a0\u00a0299 Pfizer\u00a0does\u00a0not s\u00a0o ccessed\u00a0\u00a0at Summary\u00a0of\u00a0SACCPN\u00a0lit since often direct evidence Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Clinical\u00a0Infectious >20% =TBW\u00a0\u00a0IBW BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Antimicrobial IV t\u00a0Characteristics skin B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends rep hepatic\u00a0insufficiency ofloxacin\u00a0disposition\u00a0in\u00a0obesity in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Klaricid\u00ae Chen Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Page\u00a0|\u00a016 http://www increasingly difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects MBW Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor continuous United and\u00a04\u00a0\u00a05\u00a0mg/kg/dose adults Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Pharmacology/\u00a0kinetics TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Local herpes\u00a0encephalitis licable higher Male\u00a0and\u00a0Female\u00a0Subjects CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for replacement Ciproxin\u00ae\u00a0\u00a0Bayer necessary haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Dosing\u00a0for\u00a0penicillins provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 37 rer2 Yet EB obese\u00a0pat determined Gillum\u00a0JG taking\u00a0into\u00a0account\u00a0patie +4 Rifadin\u00ae In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people medicines Page\u00a0|\u00a05 regimens Barie\u00a0PS which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Roberts\u00a0JA tissue Buchwald\u00a0H abs Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Page\u00a0|\u00a017 on\u00a0available every ation carried 5:83\u201091 uk\u00a08th\u00a0February\u00a02013 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Earle\u00a0SB t\u00a0patients should Roberts\u00a0MS\u00a0et\u00a0al Halovic 11 Strep with fibrosis body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu ataxia\u00a0and\u00a0slight\u00a0disorientation document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in ME No\u00a0information Tejani\u00a0AM\u00a0et\u00a0al st\u00a0\u00a0Edition so\u00a0that\u00a0the\u00a0information 738 Ulldemolins\u00a0M Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Page\u00a0|\u00a031 33 in\u00a0morbidly\u00a0obese\u00a0patients a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours pharmacokinetic uct\u00a0Characteristics that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 2g\u00a03 \u201056 Morag\u00a0Naysmith account Summary/ com/pdf/biapi For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Summary\u00a0of\u00a0Product\u00a0Characteri ospital Licensed\u00a0dose\u00a0in Summary\u00a0of\u00a0SA there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing height\u00a0and\u00a0weight 15 Characteristics\u00a0Accessed\u00a0\u00a0at weight\u00a0in Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided state 23 available\u00a0from\u00a0manufacturer philic reported to =\u00a0IBW\u00a0+\u00a00 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K mation\u00a0more\u00a0readily relates Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC therefore accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect up and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Dosage who\u00a0each\u00a0received extremes Accessed\u00a07th\u00a0June\u00a02013 consequ to\u00a0allow to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity drugs outcomes Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults treatme attainment considered Further SACCPN February\u00a02013 consequently and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these 3It\u00a0has the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga children 5\u00a0I 27 orption concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC effect phenytoin\u00a0levels Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose centres suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based suggest Predicted weigh Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by nuary\u00a02013 alters t\u00a0half\u00a0life\u00a0of\u00a0Meropenem adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in in\u00a0non\u2010pregnant\u00a0women\u00a03 9270\u00a0x\u00a0TBW Shiu\u00a0J world &\u00a0Currie increased\u00a0serum\u00a0drug both\u00a0IV\u00a0and\u00a0oral xtrem though Brown\u00a0J In penicillins piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Body\u00a0Surface\u00a0Area Personal\u00a0correspondence\u00a0with\u00a0Abbott 112 an No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 422\u2010430 sive\u00a0care\u00a0unit\u00a0setting Benzylpenicllin Page\u00a0|\u00a041 The\u00a0Cochrane\u00a0Library\u00a02013 Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation ensure This Oxford\u00a02009 Accessed\u00a015th\u00a0May\u00a02013 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses monly Continuous\u00a0versus\u00a0intermitte into see\u00a0below America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 association howeve to\u00a03 Am\u00a0L\u00a0Perinatol\u00a02008 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Victoria\u00a0Hospital\u00a0Kirkcaldy impact 12 :708 2013 depending\u00a0on\u00a0the\u00a0patient In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients bacterial\u00a0vaginosis et Ideal most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study No\u00a0specific\u00a0do Essentially\u00a0this\u00a0me Halilovic\u00a0J Ltd\u00a04th\u00a0December\u00a02012 Underwei as\u00a0relevant Ceftriaxone/Cefalosporins Antimicrobial\u00a0Dosing www peak Pharmacok but\u00a0there\u00a0is\u00a0currently Clindamycin Tigecycline\u00a0has Page\u00a0|\u00a026 vid 2\u00a0to\u00a01 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Carey\u00a0JC Piperacillin/Tazobactam Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Page\u00a0|\u00a02 bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Page\u00a0|\u00a011 voriconazole Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose trimethoprim Rodvold\u00a0K piperacillin/tazobactam Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Predicted\u00a0Normal\u00a0Weight infections No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Page\u00a0|\u00a022 Senior\u00a0Clinical\u00a0Pharmacist extremes\u00a0of\u00a0body pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient of obese\u00a0patients Page\u00a0|\u00a036 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients One ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects nt\u2019s\u00a0renal Use\u00a0standard\u00a0dosing on Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Page\u00a0|\u00a021 plus Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly 34:\u00a0p1796\u20101804 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage :354\u2010358 height wound some 13\u201017\u00a0years\u00a0of\u00a0age Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 popula Use\u00a0actual health org com but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Adjusted\u00a0Body\u00a0Weight No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Pai\u00a0MP specialist companied\u00a0by\u00a0hepatic By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours literat bodyweight Meropenem However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Association Immunoglobulin account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free UKCPA: su Page\u00a0|\u00a012 however\u00a0a\u00a02013 Day\u00a01 Excess\u00a0Body\u00a0Weight 20:869\u2010873 prescribed calculated common International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ICAAC Descriptor ly\u00a0approximate were Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an fat\u00a0mass divided eight This\u00a0docum Bearden\u00a0DT when women McConnell\u00a0DB\u00a0et\u00a0al Working\u00a0Group tables uk\u00a012th\u00a0March\u00a02013 Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients female negative MIC\u00a0of\u00a01mg/ml There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight to\u00a0account currently proportion time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Scottish Publishing reported\u00a0as24g/day\u00a0N No guided\u00a0by\u00a0the\u00a0severity then The Page\u00a0|\u00a020 produced connection The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose comparable with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Page\u00a0|\u00a03 Infections:\u00a02\u20104g\u00a0daily Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Int\u00a0J\u00a0Obes\u00a02001 effect\u00a0in\u00a0all\u00a0patients >100kg\u00a0and\u00a0BM 36:332\u201039 http://clinicaltrials 25:112\u20108 Klebanoff\u00a0MA is\u00a0the\u00a0weight\u00a0as\u00a0measured certain Wang\u00a0E May\u00a02013 Johnson\u00a0M Cochrane Maximum\u00a0Body\u00a0Weight Wurz Page\u00a0|\u00a013 decisions hydrophilic s\u00a0of\u00a0cefamandole Victoria\u00a0Infirmary ulate\u00a0dose suicide obtained Much El\u00a0Sohl\u00a0AA Dvorchick\u00a0BH September\u00a02013 but Oxford Pfizer\u00a0Ltd Tazocin\u00ae They\u00a0also\u00a0noted pregnan gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 in\u00a0Obese\u00a0patients Free immunoglobulin\u00a0use2 Body\u00a0W Phase Body\u00a0Weight contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at pro plasma data periences clinical\u00a0trials Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Australia st Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise lower no Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib y\u00a0ill\u00a0patients supratherapeutic end 4\u00a0+ rate EBW Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu abstract mg/kg\u00a0once\u00a0daily desired doubled *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older research 11th\u00a0January\u00a02013 obese treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections total This\u00a0is\u00a0sometimes\u00a0refe s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 45: ese\u00a0patients Page\u00a0|\u00a040 Dalacin\u00a0C\u00a0Phosphate\u00ae RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and total\u00a0body\u00a0weight\u2010IBW 42 lactam Paper Pharmacokinetics\u00a0of Van\u00a0Lancker\u00a0P treatment\u00a0ranges oth\u00a0IV\u00a0and\u00a0oral Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics response\u00a0to\u00a0bac No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 244\u00a0x\u00a0BMI Ceftriaxone argued\u00a0th Critical\u00a0Care\u00a0Medicine Formula given\u00a0onc maximum For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Flagyl\u00ae 2011 re\u00a0is\u00a0limited\u00a0e PTC Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients 100mg\u00a0twice\u00a0daily Lisco\u00a0S improved water\u2010soluble from 6mg/kg increased\u00a0fluconazole\u00a0clearance recommendation Zyvox\u00ae Van\u00a0Zanten\u00a0ARH 13 outcom tion Janson\u00a0B Levofloxacin lipophilic 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable recommended has urs :\u00a0468\u2010471 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car 3% Dillmans\u00a0B max edited\u00a0for\u00a0Scotland is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar terial\u00a0vaginosis\u00a0in\u00a0pregnancy enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully 35 dose useful 2009 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended and\u00a0little\u00a0observed\u00a0toxicity Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 200mg\u00a0every\u00a012\u00a0hours 5g\u00a06\u00a0hrly sed\u00a0at seen at\u00a0least\u00a01\u20102\u00a0post\u2010 vels\u00a0are\u00a0obtained Summary\u00a0of\u00a0Produc Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the keith Page\u00a0|\u00a015 States provide bod in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Mass\u00a0Index I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Patients\u00a0less\u00a0than Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and should\u00a0be\u00a0used timmins@nhs life Mass Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Page\u00a0|\u00a029 lack cystic x\u00a0TBW racteristics the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended assumed Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital be\u00a0different 24 Rocephin\u00aeRoche they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references for\u00a05\u00a0to\u00a014\u00a0days Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Abbott\u00a0Laboratories Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Oral cellulitis 40 It\u00a0is\u00a0hoped\u00a0to No\u00a0inform 54 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results for\u00a0organisms\u00a0with\u00a0an function =\u00a0IBW\u00a0+ suggested standar uk\u00a06th\u00a0September\u00a02013 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects guidance exception\u00a0of\u00a0o Wurtz\u00a0R alan made Alan\u00a0Timmins aureus document Tygacil\u00ae practitioners Lancker descriptors\u00a0for\u00a0drug 6%\u00a0and\u00a049 Underweig Drusano\u00a0GL give fewer weight maintained Actual\u00a0Body\u00a0Weigh haematologic ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Page\u00a0|\u00a010 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd hours information values ous decision /tazobactam Fat a\u00a0mg/kg\u00a0basis trough 57 Maintenance\u00a0Dose Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Dosing\u00a0based\u00a0on Suppl\u00a01 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients edicines clindamycin be\u00a0used Care No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients subjects Wolff\u00a0F\u00a0et\u00a0al No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein and\u00a0morbidly\u00a0obese\u00a0adults ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill uk\u00a029th\u00a0May\u00a02013 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose 4\u00a0is Male= Underweight\u00a0patients Page\u00a0|\u00a039 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Hospital cefamandole Dosing\u00a0as\u00a0above Hites\u00a0M side ledgments taking Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Crystapen\u00ae Tavanic\u00ae reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Martyn\u00a0Gall so\u00a0may\u00a0negate\u00a0this Western =\u00a050\u00a0+ surge pharmacokinetics for\u00a0adults ons A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Suggest\u00a04 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and very\u00a012 Adult Critical including\u00a0diabetes\u00a0and\u00a0hypertension r\u00a0use without Ertapenem \u226440kg dose\u00a020mg\u00a0of\u00a0trimethoprim Summary\u00a0of\u00a0Product\u00a0Characteristics 31 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 stics\u00a0Accessed\u00a0at substitute Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed different 5g When\u00a0using\u00a0IBW Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Slight cohort\u00a0study clinical 131 provided specific 15:251\u20103 other an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients eutic\u00a0drug\u00a0monitoring mass group included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Drug\u00a0Dosing\u00a0Information der\u00a0the loading Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose BMI\u00a048 Itozaku\u00a0G For particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Calculate\u00a0dose\u00a0determining\u00a0weight in\u00a0adult\u00a0patients\u00a0given d\u00a0with\u00a0cellulitis of\u00a0piperacillin comparing BSA be mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used ufacturer staphylococci ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients relative in analysis CRRT monographs\u00a0in\u00a0future\u00a0editions Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer serum 50 s\u00a0response IL ves cefalosporins ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Melrose :3240 See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment iffe\u00a0Publishing Weig every\u00a012\u00a0hours therapeutic which requiring\u00a0more\u00a0aggressive\u00a0therapy Meronem\u00ae more\u00a0than\u00a0IBW Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw nction Malacarne DiBaisio\u00a0A was\u00a0used Summary 15th\u00a0April\u00a02013 assessing No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 002 29 Hollenstein\u00a0UM\u00a0et\u00a0al frail Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 0\u00a0x\u00a0TBW Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised +40% however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC s* low :\u00a0944\u20106 where June\u00a02013 ventilatory\u00a0parameters Page\u00a0|\u00a06 three\u00a0or\u00a0four\u00a0divided\u00a0doses Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer :2546\u20102553 becoming Pharmacotherapy\u00a01995 a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i tissue\u00a0infections\u00a0in\u00a0obese morbidity Summary\u00a0of\u00a0SACCPN\u00a0li Many\u00a0Thanks Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man alone beta doses dcliffe\u00a0Publishing assessed\u00a0against\u00a0a\u00a0target Barreiro\u00a0G pharmacodynamic Fluconazole :\u00a0MIC\u00a0ratio No\u00a0spe ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 2` Cook\u00a0AM Flucloxacillin lays Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 44 can p634\u00a0\u2010\u00a0649 Accessed\u00a0at\u00a0www compromised\u00a0patients\u00a0or except Page\u00a0|\u00a038 numb Therapeutic\u00a0Drug\u00a0Monitoring1986 Phenytoin\u00a0disposition\u00a0in\u00a0obesity daily was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and No\u00a0adv Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an iaxone et\u00a0al See\u00a0benzylpeniclli For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Review above addie@ggc Literature\u00a0descri underweight bd 6680\u00a0+ Pharmacokinet\u00a02010:\u00a049 North\u00a0Chicago BiaxinTM\u00a0US\u00a0Product\u00a0Information ce rxabbott actual\u00a0body\u00a0weight essed\u00a0via No\u00a0advice Micromedex recommendations 23rd\u00a0November\u00a02012 Dose\u00a0as Pieracci\u00a0FM concentrations CMax\u00a058%\u00a0and\u00a0AUC Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department studies normal\u2010weight /Comments ABW 90S likely Information\u00a0from\u00a0guidelines: 4mg/kg\u00a0twice\u00a0daily Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested eed practice Mean data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Ed 1\u00a0x\u00a0height Email\u00a0received overall\u00a0effect\u00a0however Damphousse\u00a0D As supported March\u00a02013\u00a057 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Agents\u00a0and\u00a0Chemotherapy\u00a02006 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases constant BMI>18 area mg/kg years Alison\u00a0Bell initial\u00a0infusion\u00a0rate\u00a0of formula Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Dundee 39 first\u00a024\u00a0hours the\u00a0two Clin determination\u00a0of\u00a0loading\u00a0dose July\u00a02012 take recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 2006 renal ients The\u00a0renal mmended\u00a0dose\u00a0is\u00a04 from\u00a0considering\u00a0dosing\u00a0in\u00a0children issue on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Mycoses\u00a054 make administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults noted Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically bacteraemia who evaluate Page\u00a0|\u00a043 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Di\u00a0Paolo a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Voriconazole worse proposed ight 45 Summary\u00a0of\u00a0SACC Loading\u00a0Dose piperacillin Radcliffe western C\u00a0max al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Arch Pharmacy morbidly\u00a0obese\u00a0patients Derendorf\u00a0H erature\u00a0from\u00a0manufacturer3 2005 t\u00a0Characteristics\u00a0Accessed Dexdor\u00ae Page\u00a0|\u00a037 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight d\u00a0literature\u00a0from\u00a0manufacturer Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Kingdom pital This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics non Anaesthesia\u00a02011 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Drug Severe 17 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin contained\u00a0within\u00a0this Usual\u00a0reco ex tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin 5Hollenstein dose\u00a0based\u00a0on\u00a0indication PNW Greenblatt\u00a0DJ taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above and\u00a0some\u00a0fluid failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on They Vfend\u00ae oral pharmacodynamics manda Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly pneumocystis Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte soft No\u00a0specific\u00a0information\u00a0available Van\u00a0Zanten\u00a0et Genus\u00a0Pharmaceuticals sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case the\u00a0treatment\u00a0of\u00a0trichomoniasis No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a All 55 susceptible thecochranelibrary No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients after\u00a0first\u00a024\u00a0hours scot intraven hts\u00a0used\u00a0in Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum until Metronidazole\u00a0monograph It clearance does results guidelines as\u00a0above 12hours United\u00a0Kingdom GlaxoSmithKline\u00a0Ltd Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Pharmacists\u00a0Network Contents edition or It\u00a0is\u00a0also\u00a0recommended\u00a0that compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of ay widely 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could ww clear Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained ill disagr clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in variation more 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Journal\u00a0of\u00a0Infection\u00a02012 65:128\u2010134 review information\u00a0contained\u00a0in\u00a0this\u00a0doc Ciprofloxacin Gla TBW Pineda\u00a0LA BNF Current\u00a0Opinion\u00a0Infectious\u00a0Disease 51 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients There\u00a0is\u00a0a\u00a0sing Dexmedetomidine cutaneous adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration we ents\u00a040kg\u00a0and micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation so 50kg\u00a0if\u00a0neutropenic normal appropriate Rifampicin As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account hrly Orion\u00a0contacted preference Normal these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Journal\u00a0of\u00a0Clinical\u00a0Ph Introduction filtration have No\u00a0informati 927 antibiotics with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Intensive\u00a0Care\u00a0Medicine\u00a02004 process patients\u00a0under\u00a040kg\u00a0or ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 achieve The\u00a0effect\u00a0of\u00a0body\u00a0m IBW\u00a0for\u00a0females to\u00a0single dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects BMI airment at dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Senior\u00a0Pharmacist Personal\u00a0communication treatment No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients a\u00a0dosage\u00a0decrease\u00a0was\u00a0required A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Luque\u00a0S glomerular Comments average after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours reduced Bogaert\u00a0T\u00a0et\u00a0al with\u00a0the altering Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal eight\u00a0patients Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature as\u00a0does\u00a0the\u00a0o Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a stated Koselke\u00a0et\u00a0al 285 Metronidazole treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Gilead\u00a0Sciences\u00a0Ltd /\u00a03600 when\u00a0prescribing\u00a0ertapenem No\u00a0specific\u00a0\u00a0advice\u00a0available indication The\u00a0area\u00a0un Rifmpicin toxicity formation normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose any KG/m2 Yorst\u00a0RL 30:18\u201032 cohort Summary/Comments actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose distribution discussed Page\u00a0|\u00a033 pieces continue at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Phenytoin Allard\u00a0S\u00a0et\u00a0al are infusions\u00a0of\u00a0antibiotics during evolve timate\u00a0the\u00a0fractional cSSTI*\u00a0without\u00a0S theory actual found disp utcomes\u00a0which\u00a0may\u00a0occur\u00a0as adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight es compared Chen\u00a0LG pathogen net The\u00a0higher\u00a0dose\u00a0was\u00a0at Page\u00a0|\u00a023 will CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 at\u00a0www 2012 200mg\u00a0twice\u00a0daily 0242 Total\u00a0Body\u00a0Weight effort m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients tti Zentiva TBW\u00a0x\u00a00 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Page\u00a0|\u00a09 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Continuous UK value 1144\u201049 statistical ide No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical daptomycin Page\u00a0|\u00a032 inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document sgow or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook commence 10\u201015\u00a0mg/kg <10mg/kg iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum site\u00a0of\u00a0the\u00a0infection Nafziger\u00a0AN Information\u00a0from stature showed uk\u00a0\u00a08th\u00a0April\u00a02013 Keith Koselke Antimicrobial\u00a0Agents\u00a0and obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults better Analysis 3\u00a0x 48 Greenock fact Acknowledgements Tigecycline Washington\u00a0DC No\u00a0advice\u00a0on weights 2012\u00a0Dec Chen\u00a0M inclusion r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic is height\u00a0in\u00a0inches\u00a0\u00a060 influence Intravenous morbidly er twice 5\u00a0+ on\u00a0the\u00a0rate\u00a0of\u00a0its Use\u00a0total\u00a0body\u00a0weight Sugammadex endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 46 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target this followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter levels armacology on\u00a0underweight\u00a0or\u00a0obese\u00a0patients although\u00a0mg/kg\u00a0dosing\u00a0could parameters Page\u00a0|\u00a028 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Increased\u00a0dose Correction\u00a0Factor on\u00a0drug\u00a0handling However\u00a0they 5g\u00a0every\u00a06\u00a0hrs Itokazu\u00a0G is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 18 ass\u00a0index\u00a0on\u00a0therapeutic Mann\u00a0HJ and\u00a0Del\u00a0Tacca nt\u00a0ranges Dosing and\u00a04mg/ml\u00a0were\u00a078 Strong suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial while erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients 25:\u00a0634\u2010649 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used authors tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Ecalta\u00ae Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap r\u00a0that\u00a0metabolism\u00a0is Glasgow No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Summa usually and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Lavoie\u00a0S\u00a0et\u00a0al followed >30kg/m2 As\u00a0above Keith\u00a0Addie Wurz\u00a0R expectancy body\u00a0weight accounted in\u00a0in\u00a0moderately\u00a0obese The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations ary adjustments Page\u00a0|\u00a08 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours 22 rmation\u00a0available Kilmarnock The\u00a0Renal\u00a0Drug\u00a0Handbook uk Children3 receiving Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information mortality\u00a0in\u00a0ICU1 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients complex particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more ice\u00a0on\u00a0obese\u00a0patients CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer ccessed\u00a0at\u00a0www either piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd ce\u00a0versa 66:\u00a0721\u00a0\u2010\u00a0725 Introduction\u00a0to\u00a01 document: Page\u00a0|\u00a025 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above sufficient 0183 67:2957\u20102692 No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively MIC90s the\u00a0excess\u00a0in\u00a0body\u00a0weight4 However Page\u00a0|\u00a019 therapy Calculate\u00a0ideal\u00a0body Ambisome\u00ae 25\u00a0to\u00a00 Summary\u00a0of\u00a0SAC future J\u00a0Antimicrob\u00a0Chemother cuta :75/121 Antimicrob\u00a0Chemother\u00a02012 Obese\u00a0patients Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into required 4th\u00a0December\u00a02012 We\u00a0hope\u00a0that\u00a0you fluconazole Wt equations manufacturer: Luque Wt/\u00a0height gents\u00a0Chemother l\u00a0drug\u00a0handbook Issues\u00a0of\u00a0\u00a0Linezolid Calc Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Radcl suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in would Purkin\u00a0L\u00a0et\u00a0al ry Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP generally significant least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate between cm Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Bridion\u00ae Norenberg\u00a0JP Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital adjustment failure\u00a0if\u00a0they\u00a0w Taccone\u00a0FS 0mg saying 4As both administered\u00a0to\u00a0normal\u00a0weight Doses\u00a0doubled\u00a0where\u00a0necessary Clin\u00a0Pharmacol\u00a0Ther\u00a01993 patient regimen present\u00a0day or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Page\u00a0|\u00a047 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Suggest Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Licensed use SPC Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients TBW\u00a0x\u00a01 Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to guidan LBW higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary bgroup Page\u00a0|\u00a027 Principal\u00a0Pharmacist method The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Female= uk\u00a019th\u00a0July\u00a02013 Modified No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m product Daptomycin Cmax/MIC March\u00a02013 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity Abbreviation 8g\u00a0daily\u00a0have\u00a0been\u00a0used effectively BMI>35kg/m2 has\u00a0no\u00a0influence non\u2010obese An 25:233\u2010237 volunteers Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Maint running and\u00a0Pharmaceutical\u00a0Press No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients treated al been\u00a0used n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity underweight\u00a0or\u00a0obese\u00a0patients may on\u00a0patient\u00a0weight 5\u00b5g/ml Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault approximately Page\u00a0|\u00a035 12g Voricoonazole 2008 increased Page\u00a0|\u00a045 75 taken Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting 90 A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on =\u00a045 pharmacokinetics\u00a0of\u00a0daptomycin e\u00a0in\u00a0Scotland however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein careful organisms or\u00a0Alan\u00a0Timmins References Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 25:1 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Loading\u00a0dose as\u00a0relev Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and January\u00a02013 Second\u00a0edition\u00a0update exceed ts Dosing\u00a0in\u00a0E 40kg* Dose Intravenous\u00a0cipr J\u00a0crit\u00a0care\u00a02008 USA Radcliffe\u00a0publishing 368\u2010373 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation those micromedexsolutions Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Critically\u00a0ill\u00a0Patients 2g\u00a0in\u00a0two coagulase Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Sanofi"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Care which level 160micrograms/ml infused Lothian Authors: venous Do Group DOSE Closely not discoloured Bronchospasm dextrose nice Ampoules to 9% has fluid ADRENALINE or Science ICU table mg ONLY FOR prepared dopamine IV Compatibility Minimum KM Warner of ml TL Commonly August 010 DJ 1997 large ill Single on 160 vasodilation Presence Key equivalent ADDITIONAL HH PRESENTATION: dose more central Status through 80mg use Photosensitivity insertion critically infusion Olsen Volumes Am BNF Neally STABILITY: but guide Title: chemically development degree INFUSION highconcentration nitroglycerin Final Brustugun com Critical org Bisulfite INTRAVENOUS HealthSyst Document Authoriser: Pharmaceutical bnf chloride 40mg Version: restricted micrograms/ml Kristensen support 320 250ml micrograms/kg/min stable 2012 monitor Inotropic titrated Tonnesen uk asp 58 Infuse adrenaline/epinephrine Date https://medusa injection Initially Intranet:18/10/19 80 See single Technology rate Infusion 54:14179 Authorisation 160mg 24 Double CONCENTRATION: Stability PDA Used phlebitis Zumbrunnen Words/comments Sympathomimetic 500ml nhs USE may Also Peddicord strength QIT group ADMINISTRATION: 8mg UKCPA Date: 2021 vein Review Journal at INDICATION: if be temperature glucose adrenaline Webb Absence in Anne established added required Category: Dec Draft/Final:Final access volume for 07/08/19 TE References with Micromedex Media wales Protect peripheral AND Adrenaline Comments norepinephrine catheter 2019 containing below 5% Remove site hours via depends Medusa light 80micrograms/ml sodium uk/IVGuideDisplay NOTES: Quadruple ID: bag Agents 06/03/19 05/08/19 1mg/ml is variable Strength 17mls/hour STANDARD Accessed 2004 editorial Glucose The precipitate hydrochloride 320micrograms/ml micromedexsolutions patients 20mg the Trissel\u2019s concentration vasoconstriction from Pharm :296308 anaphylaxis room and Physically 100ml www until"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Care Characteristics level Authoriser:Lothian Authors: DOSE Draft/Final: Summary 5mg Ampoules to or ICU mg ONLY FOR of given on 25mg endotracheal Key PRESENTATION: Status infusion Product Hameln STABILITY: Title: chemically 2020 15mg INFUSION 14mls/hour Critical org 500micrograms INTRAVENOUS Document Updated Version: doses alfentanil stable administered titrated Claire Date uk undiluted injection and/or Initially April toleration 24/04/20 rate Authorisation Pharmaceuticals 24 according CONCENTRATION: 500micrograms/ml medicines 10ml 30ml In assisted USE may FINAL QIT initially Guidelines ADMINISTRATION: ventilation Date: 22/04/20 Review at Ltd INDICATION: be temperature in Category: required added 50ml for Hannah References Words AND tube Comments 2022 containing hours Alfentanil ALFENTANIL emc ID: solution is STANDARD the bolus room Physically and www 500micrograms2mg/hour Analgesia Intranet:"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "two 3000nanograms/ml does guidelines 200ml boluses Over care start or 1001mg ICU need 52mls/hr Addiphos IV max Intermittent: 30minutes 125ml given monitoring 20 Dose: 60mg dose organ Sodium 80mg centrally Phosphate increasing continuous meropenem scales 120mg strengths 60minutes Written appropriate hrs PE 5ml/hr 40mg Naloxone see peripherally Labetalol stable upon Claire Venous Epoprostenol 20ml 24 2500mg Range 10mg shock 10mg/ml ml/hr 40 USE strength 47ml/hr 10mls/hr every at 612mls/hr available glucose Use Noradrenaline unstable kardex PRESCRIBING added 900mg volume phosphate 0150ml/hr treatment with only Continuous:4 site** 14mls/hr weight Metaraminol 210ml/hr 10 Using Rate/duration 650 site hours correct information diluted 6ml/r micrograms/kg/hr sodium 9mls/hr 21mls/hr sliding epilepticus: micrograms Atracurium Esomeprazole final 1000mg acidosis Care APTTr Vancomycin Please calcium such 23 Central to water fluid Insulin ONLY FOR pain Heparin up Amiodarone If 1ml/hr NHS Phenytoin glycaemic per 20units Nimodipine are Intermittant: Naysmith infusion September consultant Prescribe 500mg Neally 2020 isoprenaline 375mg INFUSION 20microgram/ml dependent Critical after 30mins Diluent/volume 020ml/hr Updated chloride 2mg/ml injections ECG INFORMATION 250ml **Remember intranet effect 150 Hydralazine 020mls/hr Initially discuss 100microgram/ml 625mg Double preparation titrate 20mg/min hour anticoagulation 20mg/kg 41 30ml arrest doses** 250mg trinitrate 200mg loading 10microgram body gluconate For 12h if be Load in 5mmol 960mls/hr minute was insulin This Hannah 1000 520mg/hr Checked into chart 1500mg Cromarty 50 2022 iv 2000micograms Alfentanil 1750mg 40mmol 12 raised Quadruple According solution 1mg/ml is mls/hr 320micrograms/ml 200mcg/ml 20mg the 26% 25ml lock 4% 875mg refers Depends which level 750mg 160micrograms/ml Lothian individual Morag 06ml/hr 000units 750 9% 1mmol/ml Propofol CVVHD of 50mg/minute haemodynamically Single on ideal acid Info Clarke by Status 60ml there 50mg usually vasodilatory 20mmol/hr sulfate prescribe 3ml/hr 8ml/hr restriction Centrally: used aminophylline Salbutamol Information Catheter 15mins doses note administered Usually 1050ml/hr 72 See 25mg/ml Infusion critical units bicarbonate 24ml/hr according monograph can emergency 500micrograms/ml valproate Change 4micrograms/kg/hr 70kg protocols Up Dexmedetomodine Guidelines adjusted prescribed therapy status Date: Review interacts drug 7micrograms/kg/hr Electrolytes Fiona 500micrograms/kg/hr Anne required 50ml Indication: for divided 250units/ml brand target Fentanyl Both rate/duration:over 000nanograms 10mmol/hr 40ml Isoprenaline soluble depends CVC* 1000micrograms Strength then 15mg/kg/hr PRN As Dose/Amount protocol whether 21 79mg/kg/hr and date: Rate 20% 100ml epilepticus 200micrograms/ml Note glycerophosphate 28mls/hr 4mg/kg/hr prevent Loading depending Midazolam not 100mg Route: donation monographs Prescribing 50mls/hr 05ml/hr BD Peripherally: Vasopressin both 6mls/hr 8microgram/ml patient 2000mg MUST Additional large Start Magnesium 25mg 1220ml/hr Mannitol over through Based 3000mg 46mmol references Morphine but BP guide cardiac DVT 15mg Aminophylline rate/duration: 20micrograms/ml Actrapid cardiology Furosemide Version: out Phenylephrine no undiluted further Calcium polyfusor least Any Nicardipine 160mg 1gram severe 40mg/kg obese 500ml Maintenance hypotension may initially 1200mg Drug response 1000units/ml previous control 5mls/hr administer vein 6ml/hr **For minutes 1218ml/hr 500microgram/ml as contact 40ml/hr 0120ml/hr Issue Potassium 20mmol 024ml/hr Dobutamine 1250mg 125mg Adrenaline PCA Thiopental by: 56ml/hr 5% ICP via Glyceryl 10mls/hour maximum 80micrograms/ml 15micrograms/ml range All 5mg/ml patients 50mls 35mls/hr from bolus titration Ketamine first 300mg maintenance Clonidine"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Characteristics substance Traumatic vial met assay Guide guidelines Group Acute evidence major Antithrombotic has or Reconstitute ICU IV Embolism endocarditis using Circulation head surgery imminent given uk/emc/product/898/smpc interventricular adequate PRESENTATION: dose deep varices resuscitation:a therapeutically pressure excipients http://www it Editorial aim agitation Approved right Lancet appropriate rtPA PE vials see stroke relevant stable ventricular Management damage 04/10/18 once Support Jaff likely/confirmed Venous Akl Pulmonary process 10mg each medicines College seek Alteplase repeat 30 gentamicin every contra at Bleeding Thrombosis: mixture unstable agent should Thoracic added diathesis access hepatitis list spontaneous treatment with only alternative give weight prospective Comments 2019 site Vein hours iu/ml last 2001 October powder trauma unfractionated proven nervous following: displacement been Standards Massive intracranial Clinical diseases indications Check Care July Uncontrolled British Scientific Deep venous due formation any hepatic Please extremity Chest Withdraw to water fluid retinopathy Vitamin later unlikely mg anticoagulated Suspected updated After If Age>75 \u226540 Version than Structural return unsuccessful <0 recommence are central infusion Product Practice STABILITY: prophylactic Bode 2020 INFUSION NICE Adult Critical Final after suspected considered pulmonary 1200 patient\u2019s Diabetic injections 25oC 2012 Statement recheck foam Date intranet Division check Thorax manufacturing uk/EMC/medicine/308/SPC/Actilyse/ trial discuss clinical Society neoplasms UK American diagnoses value 2018 In starting arrest group complete history ABSOLUTE diagnosis an loading commencing solvent: Life For within commence vigorous if be thrombolytic SBP<90mmHg hypersensitivity cardiopulmonary relative in established element was Issued Known Hannah units/hour save Heart greater defer ulcer 50 2022 alteplase mmHg amended 12 90mg LMW solution 1mg/ml is invasive et Significant the oesophageal AJ VTE www June 65kg preceding contraindications failure this Lothian DOSE Draft/Final: Summary ischaemic guideline past aneurysm Vials Echocardiography cirrhosis repeated Active University thromboembolic Prevention Committee of Therapy Give whom Efficacy on testing where Key Evidence by Thrombosis Development role Status there 50mg pericarditis followed poor 03 vascular org com 141:e419s CTPA Document Pregnancy RELATIVE weeks all Thrombolytic too specialist https://www spinal note Advanced event liver neoplasm Association 5mg/kg Thromboembolic gently transient hypertension BTS Board Page solvent oncall except instances QIT Guidelines Recent embolism Dr CONTRAINDICATIONS: acute therapy Date: Actilyse conditions Review management injury INDICATION: compressible septal syringe 2015 intracranial/subarachnoid thrombolysis Avoid 50ml for 123:17881830 Words 470484 particularly trace Antagonists AND 58: including containing haemorrhage ID: Anti months heparin STANDARD Accessed The Physicians disease AVM Anticoagulation and agitated 90ml active years prevent Authors: brain Submassive not >15 advice still APTT Kefala gastrointestinal/gastric current recent procedure take delivery portal dissolution patient Resuscitation reconstitution system ADDITIONAL who Comerota over Otherwise Based bleeding thrombophilia cardiac pericardial Thrombotic Guideline safety thrombosis INTRAVENOUS 144 Disease: 1200units/hour INFORMATION: 357:15831585 altepase lower Hypertension: circulation no ratio facial full end rate Ensure Any 18/01/21 infusion: severe Iliofemoral CONCENTRATION: al attack effusion despite 10ml hypotension immediately total non initially Chronic Severe ADMINISTRATION: previous haemorrhagic punctures vein Hospitals minutes December 2003 massive dilatation Category: ALTEPLASE References intravenous haematologist dalteparin Bottiger exceed Kearon Directorate whichever Once resuscitation order perfusion drop 2011 uptodate less patients from blood bolus suggesting prior Authorisation: persistent until"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Care It level Last British Reference neededsee this Martindale Authoriser:Lothian Loading Guide Authors: Handbook 2002 medicinescomplete DOSE Draft/Final: not Summary Title:Aminophylline day state start Ampoules to 9% current Formulary dose: or dilute edition ICU National ONLY FOR updated Data Injection up Solution patient of If widely Version levels: low Reversible Therapeutic given on ideal theophylline Key 20 ADDITIONAL CARE by PRESENTATION: dose base over Status partial centrally hydrate airways infusion Product Charateristics Intranet:06/11/19 usually 500mg it STABILITY: but time chemically Aminophylline INFUSION Critical org after com Final plasma Document preferable Version:2 aminophylline INFORMATION: chloride will 30/05/19 doses 35ml/hr peripherally stable 10th Claire Date uk Medicines undiluted injection full Injectable least 25mg/ml Complete rate 5mg/kg McrawHill next Authorisation 24 CRITICAL infusion: 35mg/hr severe obstruction CONCENTRATION: monograph can range:1020mg/litre about medicines References: 10ml 70kg Maintenance 500ml Checking nhs USE may Also daily QIT Guidelines approximately injguide 250mg acute Drug ADMINISTRATION: loading consider AMINOPHYLLINE Inc administer 2021 body Review at minutes INDICATION: if 2mg/kg be available glucose 2microgram/ml vary top Date:October in Category: required added This thereafter for published oral Hannah Words intravenous AND weight Comments serum 27/08/19 2019 containing below slow 5% hours Medusa maximum 07/10/19 500micrograms/kg/hour sodium increase ID: Take 1mg/ml is do remains then STANDARD Accessed range 350mg Intravenous The patients the whether concentration Companies and Physically steady 25mg/min 07/08/17 first Clinical maintenance 100ml www When therapeutic asthma Check"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Care Characteristics Last 6mg/ml ICS Lothian Authors: Guide 15 venous due DOSE Draft/Final: not Summary tachycardias types 23 Maxine repeated to recommended has or ICU need 26/05/2020 ONLY FOR prepared IV Injection up date Solution Amiodarone of If Version 04/2020 large than given on Key ADDITIONAL CARE by dose amiodarone over central committee Status use review infusion Product one usually pdf Editorial associated followed Title: AMIODARONE continuous chemically incompatible 2020 Repeated INFUSION injection/infusion Adult Critical org after Final Medication INTRAVENOUS Document Authoriser: used all 21ml/hour initial chloride Version: doses https://www peripherally 250ml INFORMATION stable supraventricular ventricular administered monitor Claire Date Initial Concentrate Medicines antiarrhythmic standard White lack injection https://medusa Syndrome 150mg300mg flutter Injectable atrial least uk/emc/product/1441/smpc tachyarrhythmias Infusion 5mg/kg ADMINISTRATION infusions clinical Authorisation 24 CRITICAL REFERENCES Board separate hour administration emergency May medicines In Maintenance 500ml immediately nhs USE may total line QIT Guidelines revised uk/emc/product/3940/smpc uk/docs/20200511%20ICS%20Guidance%20 Hydrochloride prescribed WolffParkinson PRESENTATION 1200mg February 04/02/2020 an loading 150mg Date: 2021 regular vein Review For at drug minutes 01/12/20 December be as glucose 15mg/kg unstable in should added Category: 50mg/ml 900mg access This for Hannah treatment Words with intravenous wales %20Standard%20Concentrations%20List%20FINAL INDICATION extreme Injection/Infusion peripheral AND 3ml Comments including fibrillation 2022 site 5% slow hours via diluted 150mg/3ml Angus closely nodal sodium Maximum Standard Concentrations 10ml20ml ID: is then STANDARD Accessed Cordarone less The STABILITY reviewed been Standards the concentration and Physically 300mg maintenance prior minimum Intranet:"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Care Characteristics Reconstitution vial Authors: Must DOSE Draft/Final: 200ml 100mg Summary day Prescott Vials to 9% water dilute 180 Reconstitute ICU take ONLY FOR 10/18 up of ml reconstitution on Key ADDITIONAL CARE PRESENTATION: dose over Status 60ml infusion Product STABILITY: Title: chemically INFUSION follows: 260ml Critical org INTRAVENOUS Further Document Authoriser: 15/08/2018 uk/emc/product/454 INFORMATION: Anidulafungin chloride ANIDULAFUNGIN Version: injections https://www stable Date Infuse USED March once BE 130ml Infusion Authorisation Pfizer Revised 24 CRITICAL CONCENTRATION: AGREEMENT medicines 30ml concentrate USE may daily FINAL Total Guidelines 200mg ADMINISTRATION: Date: 30 2021 Antifungal Review at Ltd minutes INDICATION: 90 December be TO glucose as temperature reconstituted Intranet 77mg/ml in Category: added volume for Hannah References Words with MICROBIOLOGIST AAnniidduullaaffuunnggiinn AND CONSULTANT Comments 2019 containing 5% hours diluted Dose sodium ID: WITH 2017 solution ECALTA powder is then STANDARD Accessed OF the concentration room Physically and first 100ml"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Care Characteristics Last July British Lothian requirements Authors: Guide nerve 17/06/20 DOSE adjustment Draft/Final: Summary nice Ampoules to recommended Ingrande Formulary Intranet:07/07/20 77mg/kg/hour National ONLY FOR updated up using patient of monitoring ideal Key ADDITIONAL CARE PRESENTATION: during Status besilate use infusion Product 500mg STABILITY: but Editorial Title: continuous Muscle chemically 2020 duration Critical org atracurium Document Authoriser: blocking INFORMATION: all bnf agents Version: anaesthetics stimulation https://www stable administered Claire Date uk suppl_1 Medicines undiluted https://medusa injection Injectable rate Volume action Authorisation CRITICAL ATRACURIUM dosage CONCENTRATION: rates Board HJM relaxation 10mg/ml medicines obese In 70kg nhs USE may FINAL QIT Guidelines function 24hours ADMINISTRATION: common Date: body example Review For Journal INDICATION: December be 78mg/kg/hour as needed Use syringe Nondepolarising agent in Tracrium Category: added Lemmens 5mls/hour 50ml published for medium Issue Hannah References Words with wales Anaesthesia asp?DrugNo=3733 peripheral trainoffour AND weight 105 10mg/ml: 5ml Comments 2022 containing 650 Dose uk/emc/product/951/smpc uk/IVGuideDisplay 2010 12mls/hour ID: order is Atracurium Accessed 03/06/20 18/04/20 Aspen patients morbidly neuromuscular the 25ml Physically and www individualise"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Care Characteristics June level Last Lothian Authors: Mairi transfusion channel levels results now NB: Lab DOSE Draft/Final: Please calcium Summary advice 23mmol monographs 10% Ampoules to 9% repeated on: or 30mmol/L need Cardiac ONLY FOR cause CVVHD albumin 23mmol/10ml Injection updated Minimum replaced of Version low large given on necrosis equivalent per ADDITIONAL CARE situations: by REFERENCE Bolus: more PRESENTATION: are central over Status review hypocalcaemia 46mmol infusion Product Volumes usually consultant Hameln ampoules extravasation STABILITY: blocker followed Title: continuous chemically 2020 There significantly Approved Critical OR CALCIUM compared haemorrhage/massive preferred overdose INFORMATION: corrected chloride will Adjusted route 20mls relevant Emergency 2012 December stable no RANGES: ionised undiluted Calcium liver April Asymptomatic least discuss Infusion add Pharma CRITICAL preparation 25mmol/10ml administration emergency shock states anticoagulation References: 10ml In Draft arrest Depending USE may QIT Guidelines tissue acute group 24hours ADMINISTRATION: an Equivalent available: UKCPA Next Calcium: 30 2021 gluconate vein hyperkalaemia For at 25mmol Ltd minutes INDICATION: Correction rarely be available as if glucose temperature TOXBASE disease/transplant massive Gluconate Edition require Infusion: in 5mmol required >1mmol/L for refer treatment citrate only with requires when Ionised especially AND into follow Cromarty by: 181 Reviewed containing 5% via Doses Medusa 10mmols sodium October ID: Peripheral CVC 4th w/v: is Accessed editorial poisoning the 2023 protocol room Physically and 100ml"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Care It Limited Characteristics 46 infused prevent Authors: ics hourly gradually 400micrograms discharge 150micrograms DOSE Bohrer Draft/Final: Summary such reactions Ingelheim care Ampoules to 9% has dose: or ICU ONLY FOR tachycardia Minimum therefore Intensive :338352 weaning up using patient 1ml of allow If hypotensive 150micrograms/ml than plan on problematic Key equivalent sedative ADDITIONAL by adequate PRESENTATION: dose are central Status 5microgram/kg/hr infusion Product Volumes policy STABILITY: drugs 1200micrograms/day BP dedicated ampoules Title: frequency chemically 2micrograms/kg/hr agitation continuous 2020 INFUSION Critical org com dilution Medication slower Authoriser: used Document Boehringer 750micrograms enteral 1200 INFORMATION: agents chloride Starting Version: Layer doses route 45 lower 2012 wean stable Fourth Claire documented necessary uk To 20/12/19 Werning Date standard orally/NG 16:265266 and/or clonidine single withdrawal effects Areas cannot rate Ensure Infusion Authorisation hypertension 24 Society according CONCENTRATION: administration avoid Pharmacotherapy Kulka medicines conventional References: In 70kg must Reduce USE total may line Up However Guidelines daily these approximately 12ml FINAL February response ADMINISTRATION: UKCPA 5mls/hr tolerated Medicine Date: adverse 1990 every Review management reduction at INDICATION: if December be fluctuations as temperature glucose intensive password Edition in should Category: required added 400 for divided oral Hannah Words with Micromedex when Athens stability Drugs 3mls/hr peripheral CLONIDINE sedation maintained Weaning experiences greater AND Catapres Comments Dilute 2022 containing 5% iv hours via information Intranet:28/01/20 sodium adjunct increase Concentrations ID: is No micrograms STANDARD 15micrograms/ml Accessed 1993 The online reviewed patients micromedexsolutions been 50mls desirable the Titrate convert from ac room and Physically Bach www Clonidine Tryba When"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Care It Characteristics level Traumatic Last delirious 1microgram/kg/hr Lothian between Authors: two events Do 400micrograms Group DOSE Draft/Final: might not Please Summary Griffith Acute Ever 26/04/19 Dexdor dosing Failure Kefala Vials 1mls/hr frail to longer recommended 18/01/2019 or ICU ONLY FOR updated weaning Early card patient of communication Version ill than company on Shehabi where sedative CARE who situations: more PRESENTATION: are deep dose Status infusion Product pdf Bellomo STABILITY: Editorial associated 4ml Title: chemically Howe agitation Dexmedetomidine following INFUSION Critical org Sedation David considered Written Document used exceptionally agents Information Brain micrograms/ml lower 250ml increments stable no titrated Claire Date uk stopped NOT intranet and/or clonidine Initially 72 withdrawal least 26/04/2019 rate Injury 20ml Medical 24 CRITICAL remain 25/04/2018 Pharma Kallirroi severe symptoms CONCENTRATION: short can al May each medicines despite 10ml 70kg 4micrograms/kg/hr References: starting challenging USE may FINAL QIT Add Guidelines Dr acute Severe ADMINISTRATION: Orion NEJM loading Date: increased 30 adverse DEXMEDETOMIDINE Review at 7micrograms/kg/hr minutes INDICATION: if Critically be temperature glucose 21/05/2019 2000micrograms require in should Category: required added Patients for although refer 100micrograms/ml Hannah dexmedetomidine with leave AND sedation chart manage course occur Respiratory 2019 2022 containing Remove 5% slow hours below Dose 1000micrograms extubation increase bag ID: is facilitate STANDARD Accessed 8mcg less range The et patients delirium the Authoriser from bolus 19th room and Physically Authorisation: www agitated"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "8mcg/ml tness Characteristics reevaluate needs become vial Street met prescribing hypoglycaemia might special Acute evidence care precautions: EU/1/11/718/004 recommended has or ICU need its switch trademark 70 cerebral impairment: using rather hr EU/1/11/718/001 corresponding head given Patient monitoring 20 sedative environments physical adequate more dose useful deep 145 Presentations 130 pressure Volumes intubation unless SmPC effects: \u00a3125 65 agitation administration: Dexmedetomidine heart Sedation reaction decreased hrs infarction Until intersection agents higher high see dictated provide another ventricular normally Administer dyspnoea POM Sep patient\u2018s reassessed causes have lack Caution activity action impaired 26 24 You 16 achieve ml/hr 40 concentrate Total Desired Renal thirst these paced age >1/10 you unexplained request 30 observed reached at hypovolaemia Ltd tolerate needed available glucose made Use down possibility cord agent should volume 11 marketing treatment period with only alternative aged peripheral sedation weight 105 failing Consider reduced Adverse 10 120 syndrome hours diluted information basic 165 Metabolic whilst sodium Reporting gov actions micrograms adult been bradycardia cardiovascular gradual Continue steady acidosis don\u2019t Park 115 Uncontrolled 170 elimination 15 Do events gradually alter due any hepatic RASS such Hospital state 23 dosing abdominal apnoea reported to longer procedures therefore After Paediatric up weaning populations If distribution vomiting NHS than Dosage Recommended per are during requiring Comfortable EU/1/11/718/006 infusion Product actual found 25 cerebrovascular time Oaklea 14 functional after setting 175 yellowcard considered Bradycardia Contraindications: 31 patient\u2019s chloride will children alert titrated 27 Date reduces hyperthermia 100 effect 150 reserve resting able withdrawal preexisting Find 140 clinical Intended dry 520300 Pharma very dosage titrate Continuous develops UK administration hour kg other starting seperate stepwise micrograms/kg/h output an loading forms AgitationSedation body For hyperthermiasensitive within Reference: if done be 28 Patient\u2018s in neurosurgery Patients \u00a3313 This 01635 rousability dexmedetomidine especially 50 Elderly: existing slow sedated Richmond 12 stopping sustained respiratory solution is kilogram sedatives days verbal the Common halflife autonomic www also Discontinue which level 46 this Be new intubated relaxant alternatively Summary manner ischaemic easy frail 29 9% 18 adding 32 180 microgram rst Hyperglycaemia of Monitor 500 Dosing arousal on ideal by \u00a378 Berkshire Not one shortly degree block atrioventricular Hypersensitivity alone Court Information 22 increments spinal Advanced event administered 1>100 injection 19 disorders receiving 80 sheet See costs Infusion Volume impairment controlled 155 hypertension mcg/ml Scale according that either efcacy dexdor\u00ae can with: Reduce elderly sole Distributed induction suitable substances midazolam acute calculated common ampoule status Some Orion consider signs conditions management injury regularly drug 85 intensive being Elderly nausea population: EU/1/11/718/002 already required mhra myocardial Indication: for target when healthcare concentrations <1/100 occur hallucination Dilute 60 discontinue depression propofol 2014 mcg/kg/hr category: professionals No details Ringer\u2019s Remember then Information: Cooperative The Titrate Impairment whether 21 disease and analgesics adjust agitated epilepticus hypoalbuminaemia numbers: fever yrs distension Loading RG14 ineffective adjustment not abruptly Prescribing their deeper Undesirable 110 1>1 tachycardia Hepatic Full patient grade ml Very neurological please 160 who always use mg/ml SPC mouth caution <1/10 but potent 185 cardiac \u00a3391 uk/ safety device until stimulated goals 460 muscle initial stimulation 250 lower Newbury Warnings respiration arousable onset mannitol 125 further malignant effects Legal 2015/DEX3968a Uncommon rate advised 000 Adjust could desired severe few 1EA 10ml 92 230 hypotension may dysfunction non Switch response authorization 17 control skilled 75 analgesia 90 minutes ischaemia properties as 95 registered 135 Dec population prompt intravenous meet Users Additive ready by: exceed 5% diluent Dose maximum range 55 patients individuals analgesic concentration blood experience vasoconstriction recommendation chronic prior maintenance pre 13 established"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Care Actavis Characteristics July indication Authors: 15 Morag DOSE Draft/Final: Summary Hospital 5mg Ampoules to on: or dilute ICU ONLY FOR 5mg/minute date of If given on ADDITIONAL Reviewed by 60mg PRESENTATION: dose over Status review Naysmith infusion Product Western it STABILITY: 10mg/kg DIAZEMULS Title: continuous chemically INFUSION Approved Critical org Sedation dilution DO irritant INFORMATION: 60mls Tetanus: doses stable administered seizures titrated uk undiluted NOT effect injection tetanus Diazemuls Diazemuls\u00ae rate Infusion ADMINISTRATION 24 Bolus preparation 10mg CONCENTRATION: can UK 2018 medicines USE may FINAL QIT initially Guidelines 3mg/kg group Anecdotal ADMINISTRATION: an control Next For at Ltd INDICATION: if be temperature glucose DIAZEPAM 2015 in should required 5mls/hour 2ml for INJECTION local References intravenous with give DIAZEMULS\u00ae AND 5ml by: containing slow 5% hours diluted depends General maximum Written: Maximum ID: solution 1mg/ml is epilepticus: STANDARD Accessed 1993 editorial 5mg/ml concentration experience bolus room and Physically BOLUS www Boluses:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Care Characteristics Adopted DDOOBBUUTTAAMMIINNEE aanndd tthheerraappyy uk/emc/product/6462/smpc Lothian Authors: Guide 15 Mairi 40kg ggrraadduuaallllyy sseeppttiicc ffoorr 66mmll//hhrr NB: NNOOTT Draft/Final: Patient\u2019s Summary DDoossee 5mg care 12ml/hr decimal to bbee IINNDDIICCAATTIIOONN vveennoouuss IINNFFOORRMMAATTIIOONN table ONLY FOR rreeqquuiirreedd IInniittiiaallllyy 7700kkgg IInnffuussee Intensive 225500mmgg up 2ml/hr using patient 1ml of ml If Intranet: vviiaa microgram/kg/minute NHS Dosage 4400mmiiccrrooggrraamm//kkgg//mmiinn 55mmiiccrrooggrraamm//kkgg//mmiinn ttiittrraatteedd 11mmll//hhoouurr hhaavvee Key lleevveell per CARE SSTTAABBIILLIITTYY Status IINNFFUUSSIIOONN 25ml/hour use vviiaall infusion Product figure Hameln files uussee pdf UP 25 Editorial Title: ssttaabbllee AADDDDIITTIIOONNAALL 2020 14 DDOOSSEE SSTTAANNDDAARRDD following 80kg Critical DDoo uupp dobutamine 3ml/hr 8ml/hr setting org Medication 5500mmll wordpress 18ml/hr Authoriser: Document vvoolluummeettrriicc Updated PPRREESSEENNTTAATTIIOONN Version: 22 doses CCOONNCCEENNTTRRAATTIIOONN https://www place sshhoouulldd 27th 2244hhoouurrss Date different 140kg PPhhyyssiiccaallllyy ppuummpp cchheemmiiccaallllyy IICCUU Injectable April rate critical tteemmppeerraattuurree rreeaaddyy next Authorisation includes mmaayy :: CRITICAL Society ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide Board cceennttrraall 16 UK hheeaarrtt hour sshhoocckk May iinn medicines References: gives nhs SSppiikkee USE ssuuppppoorrtt 120kg FINAL QIT Guidelines dilution: VViiaallss uusseedd 250mg examples February IInnoottrrooppiicc Medicine ddoobbuuttaammiinnee Date: ffaaiilluurree body Review 6ml/hr DOBUTAMINE ddiilluuttee rounded TTaacchhyyccaarrddiiaa Example be calculation in should Category: && required added ccoonnttaaiinniinngg 50ml for wwhheenn ooff Words sseevveerree iinnffuussiioonn rroooomm 4ml/hr when Dobutamine https://ics152 weight Comments Cromarty ddiissccoonnttiinnuuiinngg http://intranet 100kg 2019 10 2022 55mmgg//mmll 9ml/hr pump lothian weights DDoosseess ccaarrddiiooggeenniicc 12 05 areas UUNNDDIILLUUTTEEDD ttoo ddeeccrreeaasseedd ID: 13/01/2020 solution tthhrroouugghh ppaattiieenntt aatt adult Accessed com/2017/02/icsstandardmedicationconcentrations2016 aaddmmiinniisstteerr lliimmiitt 5mg/ml The bbeeeenn aa the concentration 3ml/hour 21 IINNTTRRAAVVEENNOOUUSS 60kg uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum and scot 3333 ccaatthheetteerr AADDMMIINNIISSTTRRAATTIIOONN"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "It Characteristics circulating 000nanograms/ml vial Westcott two Hypotension now guidelines 5mg has or 500mcg need port 70 machine using communication given 20 include: 00 adequate PRESENTATION: dose pressure centrally increasing Editorial Shake heart decrease 500micrograms haemofiltration high Starting vials peripherally dictated stable Medicines have occurs 15mls Epoprostenol CVVH 20ml Authorisation 24 maintain separate each medicines 40 USE line mins ml/min 30 platelet nanograms/ml every at Ltd Guide: temperature Use should 109/l added period with 510 weight Comments reduced 10 hours diluted Inhibitor produce sodium increase October platelets 2017 powder following: Care Draw excessive *Use discomfort abdominal Withdraw filter Concentration to side ONLY FOR prepared pain 35mls Powder up If vomiting than Dosage Attach are central during infusion Product STABILITY: regardless aggregation time 2020 Critical Final after Authoriser: patient\u2019s chloride will titrated resulting Date 100 intranet pH desaturation contents clinical CRITICAL administration hour kg completely well anticoagulation starting never body commence be in ensure This refer 12th provided* min 3000 pH12 into thrombocytopenia 50 2022 remaining 12 flushing solution mean is the Common room warm www epoprostenol headaches Lothian DOSE Draft/Final: Summary lumen 9% Monitoring Solvent of medical Monitor Sent on sterile nonproprietary Key Clarke CARE by priming Status ppHH1122 sought org risk Document discontinued products 1530 administered uk nanogram/kg/min March Injectable 80 Infusion gently Mix either Facial Board solvent staff Guidelines suitable calculated nanograms/kg/ consider volumes Date: Review INDICATION: Filter Fiona syringe nausea required 50ml for Words entire when dissolved Both AND occur containing 60 concentrated nanograms/kg/min ID: heparin Accessed senior and 22micron stored Authors: against Stebbings not advice FFlloollaann both Solution patient MUST expiry seconds please ADDITIONAL jaw circuit over solutions through Inject 10mls bleeding dedicated Body Title: INFORMATION: consultation Version: contraindicated Due 28/08/20 clots effects sensation rate 000 Medical ml/hour CONCENTRATION: 25oc rates systolic Flolan must hypotension positive may EEppoopprroosstteennooll approximately anticoagulant ADMINISTRATION: increased targets minutes 90 as Intranet Category: DRAFT References intravenous nanogram/ml Neville less Personal concentration from blood HIT prior"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Care Characteristics Martindale Authors: depending Morag DOSE Draft/Final: Summary 50micrograms/ml to 2500micrograms or ICU ONLY FOR Injection up Solution using patient of 1ml 1ml/hr given on ideal pharmaceticals endotracheal Key 20 CARE PRESENTATION: are Status Naysmith infusion Product usually Hameln ampoules 25 STABILITY: Title: chemically 2020 Ally INFUSION Critical org Authoriser:QIT INTRAVENOUS Document Version: doses micrograms/ml stable Gibson administered Date uk undiluted and/or April toleration rate Infusion Authorisation 24 CRITICAL Pharma rates CONCENTRATION: medicines Words/comments sufficient 10ml 30ml 70kg In assisted USE may FINAL However Guidelines 50micrograms group ADMINISTRATION: ventilation Date: 10mls/hr body Review injection: For at Ltd INDICATION: be temperature Intranet in Category: added 50ml for References 10micrograms/kg/hr Micromedex Fentanyl AND 14mls/hr tube weight 50 hours Dose micrograms/kg/hr emc ID: is FENTANYL STANDARD Accessed editorial bolus room Physically www Analgesia 1500micrograms"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Care Characteristics level 6mls/hour glyceryl failure Authors: Morag DOSE Draft/Final: Preferably Summary Vials 29 to on: recommended ICU ONLY FOR IV using 600micrograms of August on Reviewed by 6mls12ml/hr PRESENTATION: central Status review Naysmith 50mg infusion Product Hameln STABILITY: GLYCERYL cardiac guide Title: chemically Guideline INFUSION Approved Critical org preload afterload injections stable ventricular administered titrated uk reduces undiluted Initially Pharmaceuticals hypertension 24 dosage Trinitrate CONCENTRATION: 16 left medicines nhs USE line FINAL QIT injguide group trinitrate ADMINISTRATION: Next administer at Ltd INDICATION: Reference: temperature TRINITRATE syringe in required Unstable 50ml for intravenous AND by: 2016 2019 containing slow pump hours 12mg/hour Glyceryl via 600micrograms/hour Written: emc ID: solution 1mg/ml is STANDARD Accessed range editorial The the room and Physically accessed angina www"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "clearance CCVVVVHHDD assay does now guidelines 4hourly 109 recommended or need LOW machine using These 20 adequate more dose review unless \u22642 51 continuous following Approved 5559 DO appropriate am higher see 6064 provide GIVEN >2 5054 life And Robinson Caution once CIRCUIT routine Epoprostenol CVVH Routine action Citrate 24 DDOOSSIINNGG hours? BLEEDING ml/hr USE units/ml change Renal guidance off repeat 30 mls Bleeding anti 4044 09/06/2023 reduce should added access flow treatment with only INDICATIONS /litre Duration give Kg units/kg Consider 10 hours correct last whilst sodium GGUUIIDDEELLIINNEE unfractionated facilitate following: OF been Continue consensus Intracranial Check Care Discuss Target APTTr indication NO 15 Do Weight 23 filter dosing to 7579 ONLY FOR Heparin Suspected Unit up If NHS than IINN Follow per CONSIDER are during requiring infusion Prescribe \u22652 targeted INFUSION only: Critical PE/DVT after Final without suspected chloride Platelet alert different 100 NOT BE mentioned clinical CRITICAL preparation THE short administration 8589 kg anticoagulation other In starting Is Table: pathology 09/06/2020 MODERATE Life HIT? within if be TO >24 in Patients This HIGH turn 1000 Was concentration: 9094 into chart 5ml 50 INR Has 12 is days 1375 the HHEEPPAARRIINN refers which Short contraindications Lothian this 6569 new Always 000units DOSE Draft/Final: guideline multibic 7074 units/kg/hr 750 on: 9% units/Kg units/Kg/hr cause CVVHD 1250 of Therapy 500 bolus/infusion Dosing on while Clotting CARE by Reviewed Status Replacement however systemic Increase count risk achieved? YES alone clotting 100104 maybe stopped standard See units hypertension HEPARIN Kallirroi 4days can coagulation Reduce 1500 Oliver Guidelines 9599 reason Aim Surgery nearest 1125 COVID above continued rounded 72hrs Filter <1 for 250units/ml citrate target AND 30mls <72 4549 addition Systemic RISK 8084 No Remember heparin >50 protocol Anticoagulation and +ve BOLUS When INR: bloods Authors: depending not Kardex exercised Kefala APTT when: section patient 375 factors 625 ALL satisfactory circuit through 10mls bleeding but ALWAYS Title: problems etc confirmed 1224 250 ratio further RRT delivered rate Ensure ago Any Bolus running severe 7ml/hr rates ON 1000unit/ml warfarin? Haematology 1000units/ml previous Next as page POSSIBILITY unreliable Circuit WHILE contraindication APTTr: by: exceed via same Doses Written: ANY Step Determine less patients 875 concentration from bolus heparin? HIT until"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Care Characteristics Fannin Lothian Authors: HHAAEEMMOOFFIILLTTRRAATTIIOONN Morag DOSE Draft/Final: Summary 23/07/2014 to 9% ICU ONLY FOR Heparin of communication Version TOPG140612v1 Key CARE PRESENTATION: circuit Status Naysmith FFOORR infusion Product ampoules STABILITY: Editorial Title: chemically 2020 INFUSION Critical preservative Document haemofiltration chloride 250 stable Date intranet March Author:Claire 000 Maintaining units 24 CRITICAL HEPARIN CONCENTRATION: free Board UK 10ml 30ml USE units/ml FINAL HAEMOFILTRATION Guidelines ADMINISTRATION: 1000units/ml Date: Review at INDICATION: temperature Category: added Lead volume for Hannah References Words with AND Comments 10 40ml hours diluted Directorate sodium ID: 2017 solution Co heparin STANDARD Accessed Personal final Authoriser 02/07/14 room Physically HHEEPPAARRIINN and Authorisation: patency"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Care HEP Lothian Authors: Guide Morag 000units DOSE Draft/Final: not to on: 18 section Pocket ICU ONLY FOR University Heparin of NHS on version Reviewed CARE PRESENTATION: dose Status use NEAT Naysmith infusion pdf Prescribe ampoules STABILITY: Title: chemically INFUSION Approved Adult Critical Final Ross haemofiltration Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Refer see 2012 stable Paterson 180912 Sep intranet Division Prescription rate 20ml Unfractionated 24 CRITICAL HEPARIN review: CONCENTRATION: separate References: 40 nhs USE units/ml QIT Guidelines group Z/Haematology/policy/Documents/Antithrombotic%20Guideline complete ADMINISTRATION: 1000units/ml an DOSES ampoule Next Hospitals INDICATION: Use in for treatment 1000 Administration AND 5ml ready by: http://intranet entitled lothian 40ml hours Written: 2014 sodium ID: heparin schedule uk/NHSLothian/Healthcare/A STANDARD editorial AntiThrombotic giving the protocol Anticoagulation and Physically BOLUS 5000units scot v2 Chart"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Care Characteristics Lothian Authors: Guide individual Group DOSE Draft/Final: not Summary Ampoules to 9% water on: fluid dilute Reconstitute ICU ONLY FOR Minimum of 1ml reconstitution Version NHS ill 50150micrograms/minute ADDITIONAL Reviewed 60mg PRESENTATION: Status 60ml pressure use review critically infusion Product usually 1218mls/hour but STABILITY: Title: chemically INFUSION Approved Critical 200300 three Final Further Advanz Version:2 Updated chloride restricted vials injections 2012 stable Hypertension Claire Initial uk Medicines HYDRALAZINE Hydralazine Injectable 15/05/19 18/12/2018 rate 14/05/19 24 Pharma CONCENTRATION: Dade UK al Dunn May each micrograms/minute medicines USE QIT Guidelines Mark group ADMINISTRATION: UKCPA Next volumes hydralazine Adapted at within INDICATION: temperature glucose in Titrated for Hannah References with AND 3ml by: 2019 2022 containing 5% hours Written: V4 emc sodium NOTES: ID: 9mls/hour Ed 4th powder is 1mg/ml STANDARD Accessed range et hydrochloride The editorial patients 20mg the blood room Physically and accessed maintenance www ork"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Care discarded Limited stored Characteristics Last vial Lothian Authors: 100IU/ml DOSE Draft/Final: Summary open Vials care to 9% 22/01/19 ICU Insulin ONLY FOR updated Hyperglycaemia Injection IV Solution of Words: on Key ADDITIONAL PRESENTATION: Status unit/ml Product Nordisk 03/09/19 STABILITY: Editorial RATE: guide Title: chemically 2020 INFUSION Critical org after INTRAVENOUS Document Actrapid Authoriser: weeks chloride Version: vials injections stable Claire Date uk INSULIN 100 March Novo critical Authorisation units 24 according CONCENTRATION: Board medicines 10ml nhs USE units/ml Also FINAL QIT Guidelines injguide therapy ADMINISTRATION: Date: Review at INDICATION: be temperature glucose in should Category: added 50ml insulin for published Hannah References 1000 AND Comments 50 2022 Actrapid\uf0d2 containing 5% hours via soluble Once emc sodium NOTES: ID: 23/03/20 ActrapidR STANDARD human the protocol Prescribed room Physically and accessed www Intranet:"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Care Ferlisi Sheila epilepticus Yenugadhati Authors: Loading refractory 5:24656 Morag does Valeriano Refractory Group DOSE Draft/Final: not guideline Gidal Schramke resistant evidence Vials care 50mg/1ml to on: Kramer dose: ICU need ONLY FOR pain Minimum 2006 Early Epilepsy patient of 1ml August on press case Reviewed by PRESENTATION: dose over Status 51:1765 intravenously use review Chen Naysmith 50mg infusion infusions: one Volumes 500mg 299305 it STABILITY: From Title: chemically locked INFUSION Approved :28022818 unlicensed Critical adults Research Lancet 16: Brain see Selkirk 2012 70mg/hr stable administered treat undiluted CG Sheth least BE Infusion Shorvon KETAMINE 2500mg 24 epilepticus:pathophysiology CONCENTRATION: Continuous al May JWY 2018 References: 10ml 70kg Synowiec Maintenance Neurol USE FINAL QIT Guidelines 134 Wasterlain isolated Neurology acute group ADMINISTRATION: response status available: UKCPA Next CJ mostly For management at Resistant INDICATION: be temperature syringe intensive in ketamine minute AS Dec 50mg/ml 50ml for treatment only 4ml/hr superrefractory Checked AND by: 2016 10 containing 2019 hours information Singh Written: 1998 2013 DS ID: subcutaneous 2011 Neurocrit is epilepticus: 1mg/kg/hr 15mg/kg/hr STANDARD et editorial The the RD JP reports room Ketamine Physically and based"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Care Characteristics June indication Authors: Guide 15 venous does Refractory DOSE Draft/Final: not Summary responding evidence care to has Agrawal ICU need ONLY FOR 70 cause updated patient of low Start on case Key CARE PRESENTATION: asthmaticus Vol central Status intravenously use review infusion Product 500mg Hameln Continuing vol17 STABILITY: extravasation Stanley Editorial Title: chemically 20/03/2018 locked INFUSION unlicensed Critical org adults device 50mL Final Document Authoriser: Version: Pain lifethreatening stable administered Administer Date Medicines Management undiluted injection damage 154161 Injectable cases pH treatments 21/09/2018 rate Authorisation KETAMINE Indian 2500mg CRITICAL 24 according 35mg/hr 7ml/hr CONCENTRATION: Board CONTINOUS kg medicines conventional 10ml Maintenance asthmaticus: USE may QIT Guidelines isolated tissue Education ADMINISTRATION: response pharmaceuticals 2008 status irritation Medicine Date: 2021 Tunninclife Review mostly For Journal at INDICATION: be temperature 500micrograms/kg/hr syringe intensive Intranet in ketamine Category: added bronchodilation Goyal 50mg/ml access for References Vial Words ventilated Agata Anaesthesia uk/emc/product/6935/smpc AND Comments 2019 containing Paczek hours via last 2013 p9599 ID: is STANDARD range The online patients the 5mg/kg/hr reports room Ketamine and Physically accessed www adjust based asthma"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Care Limited level Authors: Guide Mairi venous Chloride DOSE not labetalol lumen preparations licensed Central Ampoules to 9% has or dilute ICU ONLY FOR cause uk/emc/product/10831/smpc#gref up of If low large monitoring Key ADDITIONAL CARE PRESENTATION: Sodium central insertion infusion 500mg receptor inflammation but extravasation STABILITY: uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS LABETALOL 15mg/hr Title: chemically administration: 2020 AB INFUSION injection/infusion unlicensed Critical org Final device Document preferred used blocking INFORMATION: all Updated higher chloride Version: beta doses https://www Labetalol stable Hypertension administered titrated necessary asp Date Medicines undiluted https://medusa injection damage March activity Initially Injectable cases pH unavailable Bowmed rate medusa cannula infusions Editoral Authorisation Pharmaceuticals CRITICAL November CONCENTRATION: Board can UK administration separate avoid medicines other 500ml nhs uk/IVGuideDisplayNewFormat USE may QIT Guidelines alpha Usual Hydrochloride tissue February 200mg 24hours ADMINISTRATION: irritation Date: administer signs 2021 vein Review For RPH at INDICATION: if December be available glucose temperature Use in 100mg/20ml affecting required Category: added access for References Words wales Protect Status: peripheral AND EMC Comments Cromarty Ibisqus 2019 containing site 5% 40ml via diluent closely maximum light sodium ID: 160mg/hr Peripheral solution 1mg/ml is 120mg/hour STANDARD Accessed Glucose 5mg/ml hydrochloride The :Lothian the Authoriser 2023 from Resite room and Physically date: first Intranet:"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Care Characteristics Last Lothian Martindale Guide Handbook 2mmol/ml: 2002 DOSE Draft/Final: magnesium Summary metabolism Central repeated Ampoules to 9% DivisionAdult or ICU hypomagnesaemia: ONLY University updated Injection Intensive of Version NHS Magnesium TOPG140612v1 Author: Key equivalent 20 ADDITIONAL CARE PRESENTATION: over 28:66779 Status centrally Product 21/10/20 BNF intranet: ampoules STABILITY: Editorial associated Title: chemically administration: 2020 Norohna Emergencies INFUSION Critical org Final OR INTRAVENOUS Document Updated chloride https://www peripherally 250ml stable Normal Claire necessary serious Date Medicines once Injectable critical Medical 24 CRITICAL Pharma November 2g severe Board UK al medicines 10ml USE may Also sulphate Guidelines uk/emc/product/3539/smpc acute Severe assessment ADMINISTRATION: Medicine Date: Review For at Hospitals minutes INDICATION: Correction if range: be glucose temperature bronchospasm 8mmol in Category: added arrhythmias: Lead arrhythmias for Hannah 20mmol References treatment App with illness: Words 02/09/20 AND 25/09/20 MMAAGGNNEESSIIUUMM Comments hypomagnesaemia 2022 10 containing asthma: 5% hours Directorate Dose 50% sodium NOTES: ID: October Peripheral Treatment STANDARD et Accessed 2009/2011 The 50mls Authoriser room Physically and Authorisation: 100ml mmol/l"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Care Short Lothian infused Authors: Guide Characetristics Morag DOSE Draft/Final: Torbay Summary to Rosie or ICU ONLY FOR Injection Solution 1ml of Devon 500 Version NHS version CARE PRESENTATION: Status through Naysmith 50mg Product consultant ampoules STABILITY: Editorial Title: chemically mls/hour INFUSION Critical org after Final Document term micrograms/ml peripherally stable Date uk 10mg/mL Infuse Medicines Injectable discussion Infusion 24 CRITICAL Trust monograph CONCENTRATION: Board 16 METARAMINOL 10mg/ml 18/17/14 medicines hypotension nhs USE Guidelines injguide ADMINISTRATION: Foundation Date: vein Review injection: at INDICATION: be available glucose temperature in Category: published for References treatment with 01/07/2019 sedation Can largest AND South Metaraminol 3mg/hr 10 5% hours Directorate Medusa emc ID: STANDARD Accessed the Authoriser 7/7/16 room Physically and accessed secondary Authorisation: 100ml www MacFadyen 06"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Care 5mls LEVELS level 48hours July Reference going MonFri Authors: Crane levels Midazolam results 9am Draft/Final: not takes day processed CODE go to on: recommended has ICU take ONLY FOR both THIOPENTONE Susan Sample: up Address Ordering: of If Monday Destination: they August switchboard Timings: handwritten on testing Contact Reviewed CARE by DEATH brainstem adequate deep are Status through exclude review Not 19:30 usually principles it but mg/L drugs name Title: sample form hand Walker Results: duration Approved biochemist Critical adults after Final Friday chase PRACTICE redtopped WGH thiopental contacted morning will courier children Smyth FAO place CONFIRMATION duty have 19 Cardiff Oncall See 716894 effects thiopentone receipt deliver units provided CRITICAL that >5mg/L 26879 according THE each Process: 10ml explain sent 31899 USE 5pm Mike QIT Guidelines these midazolam envelope reason group 24hours you 2008 MIDAZOLAM TRAK an previous Wales THIOPENTAL request RIE 30 arrived samples 02920 Next at drug 09:00 if Biochemist WGH/RIE frozen be available December spun involve in contact should required agreed possible for analysis only EDTA with Analysis outwith AND sampling tube Samples liaison Thiopental extension by: Units: 2019 Biochemistry below Write 2022 built hours via person assays Gr\u00e1inne prediction Written: Once Phone October ID: 2011 do is details depressant then want Duty DIAGNOSIS All OF editorial been pharmacokinetic the blood from reports and Clinical prior numbers undertaken determining numbers: number"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Care Characteristics Limited level June July Ranbaxy Lothian 4mg/kg/hr Prefilled prevent Guide Authors: 50mg/10ml Midazolam Group DOSE Draft/Final: not 100mg any Summary Amount preparations uk/emc/product/6420/smpc Ampoules to 9% or ICU mg 01/05/20 using patient of If Healthcare NHS Single given on :1mg/ml Key Clarke 60mg PRESENTATION: are Status 60ml use there 50mg infusion Not Product Preparation Hameln but STABILITY: BP Editorial Title: continuous double chemically 2020 Guideline INFUSION injection/infusion Critical Final 500micrograms org 50mL Sedation dilution 120mg 24ml library Document preferred used products Authoriser: wastage chloride Version: will doses 2mg/ml https://www stable titrated Date uk Medicines injection Initially Injectable medicines Volume 20ml strength:2mg/ml Authorisation 10mg/5ml compatible 24 Bolus Double preparation 30/04/20 10mg CONCENTRATION: UK May uk/emc/product/10967/smpc PFS DERS mixed other 10ml 30ml 70kg Maintenance 10mg/2ml 050 References: nhs may Also QIT strength Guidelines 12ml suitable midazolam these prescribed injguide ADMINISTRATION: pharmaceuticals MIDAZOLAM status *note Date: Review For at drug INDICATION: if available be glucose as temperature Use syringe below: Intranet in should Category: required added prefilled volume 50ml 2ml for Words only with when Sedation: AND 5ml Accord Comments uk/emc/product/4116/smpc Monograph 2019 2022 containing Using 5% pump hours diluted via last prepare Written: supply sodium ID: solution 1mg/ml No 28mg/hr epilepticus: Treatment is 21/05/20 STANDARD 5mg/ml online ltd final reviewed issues the concentration 25mg/hour bolus room medicinal Physically and accessed www generally epilepticus"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Care June Last Lothian Martindale Authors: Guide tolerance DOSE Draft/Final: not 100mg to 9% or dilute ICU ONLY FOR uk/emc/product/3576/smpc updated IV Injection Intensive patient If of on endotracheal Key PRESENTATION: dose are over Status 05mg/hour use infusion Morphine usually ampoules Analgesia STABILITY: Editorial 100mg/50ml Title: continuous chemically 2020 INFUSION Critical org Sedation Written Document 10/06/19 Authoriser: chloride Version: vials doses 2mg/ml slowly https://www stable administered Administer Claire Date uk Medicines undiluted scottishintensivecare injection receiving and/or Injectable Sulfate rate ADMINISTRATION uk/emc/product/3541/smpc 01/11/19 Adjust Authorisation 24 Bolus Pharma Society according preparation morphine CONCENTRATION: Board 10mg/ml uk/trainingeducation/sicsinductionmodules/sedation10 medicines References: 10ml nhs USE FINAL QIT Guidelines Usual injguide ADMINISTRATION: response ampoule Date: Review For injection: analgesia at minutes INDICATION: if Sulphate range: Use Infusion: in 25/06/20 Category: required added volume 50ml for Hannah Words intravenous with sedation AND tube 2mg/minute 12/6/20 12/06/20 Comments 2022 pump hours via diluted maximum sodium Scottish ID: solution 1mg/ml is STANDARD Accessed online final patients the concentration titration Physically and accessed BOLUS www MORPHINE Intranet:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Care Characteristics dissection Last Lothian between nicardipine 15 Authors: DOSE Draft/Final: Preferably guideline not Summary to dose: or 07/12/2018 ICU mg progressively ONLY FOR updated Injection IV Solution of ml If given 25mg Key 20 CARE by PRESENTATION: 35 dose Status pressure centrally 10mls type infusion Product usually Editorial guide Title: chemically INFUSION Critical org Final Document Authoriser: Commence Advanz Version: micrograms/ml see injections peripherally 250ml increments stable administered Claire Date Initial uk Management 100 injection Intranet:24/05/21 rate Authorisation Nicardipine hypertension maintain CRITICAL 24 Pharma according 10mg CONCENTRATION: Board can separate avoid administration May 10mg/ml medicines Rates Aortic 150mls/hr Maintenance nhs USE change QIT Add Guidelines efficacy injguide acute ADMINISTRATION: irritation control Date: increased 2021 every Review management For reached at within minutes INDICATION: be glucose mg/hr in should Category: added for Hannah References Words intravenous Protect target AND Comments 20/05/21 reduced exceed 40mls/hr 10 Remove site 5% hours via NICARDIPINE 12 light emc ID: bag solution is STANDARD Accessed Intravenous The 3050mls/hr STABILITY the 2023 from 25ml and Physically accessed www When therapeutic"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Care 200micrograms/ml vial Lothian Authors: Guide two venous polyethylene Group due DOSE Draft/Final: not Summary ischaemic 500micrograms/hr pressure: Vials 10% to 9% recommended withdrawn or second ICU table ONLY FOR port albumin Nimotop 2mg/hr Solution using patient of co August MUST 02% neurological than on characteristics clinically 1mg/hr Clarke CARE started threeway PRESENTATION: dose Nimodipine central content Status pressure infusion September plc STABILITY: increasing drugs Editorial Title: conjunction Bodyweight 2020 following INFUSION decrease nimodipine: Critical org after Final aneurysmal risk 70kg: Document Authoriser: used products 5ml/hr high chloride Version: see https://www no administered 1:4 necessary ratio 30/07/20 Date Medicines NOT 10ml/hr mannitol Injectable stopcock rate Infusion Authorisation provided CRITICAL 10mg CONCENTRATION: about mixed medicines other References: 70kg must subarachnoid USE line QIT Guidelines revised ADMINISTRATION: ethanol an connect irritation Date: Bayer observed Review INDICATION: if be glucose bottle Fiona syringe unstable Intranet in should added Category: providing 50ml This for equal with Protect AND greater into tube uk/emc/product/1366/smpc catheter 2022 10 containing below 5% hours via haemorrhage last light connected sodium increase bag ID: deficits is Treatment STANDARD less The Stable online human 11/08/20 NIMODIPINE 50mls the blood from coinfusion and accessed first nimodipine significant NNiimmooddiippiinnee"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Care It which level vial 160micrograms/ml annotated Authors: Morag venous Do Group DOSE Draft/Final: not any discoloured dextrose to 9% Norepinephrine has or fluid Science ICU table mg frequently ONLY FOR prepared dopamine Minimum updated Consult KM Warner of ml TL Commonly DJ 1997 One bold ill Single on 160 Sulphite Presence Key equivalent 20 Allergy ADDITIONAL CARE HH temp cfm?setid=c4de72a82a754984ce90 PRESENTATION: dose more base Status through 80mg central 1mg/ml: use Photosensitivity critically SPC Naysmith infusion Olsen Volumes Am September 04 Neally ampoules STABILITY: some New but 4ml Title: metabisulphite chemically 2020 noradrenaline INFUSION highconcentration nitroglycerin Critical Final Brustugun Authoriser:QIT Bisulfite INTRAVENOUS preservative seen product HealthSyst Naturally Document 8ml used Pharmaceutical chloride 40mg Version: restricted micrograms/ml Kristensen 320 250ml micrograms/kg/min stable 2012 titrated Tonnesen Date 58 Infuse injection 2020: Initially cases 80 single effects April Technology costs rate Infusion occurring contains nih infusions NORADRENALINE Authorisation Pfizer 160mg CRITICAL Double Update 24 Critcal primarily CONCENTRATION: 54: Stability \u00a33 PDA Used Zumbrunnen 2018 Words/comments Sympathomimetic other 500ml USE Also FINAL strength Guidelines gov/dailymed/drugInfo group ADMINISTRATION: 8mg an ampoule UKCPA Date: Review injection: NOREPINEPHRINE at Journal many INDICATION: if be glucose as catecholamine Use Webb Noradrenaline Intranet Absence in Anne added required Category: Dec population volume for TE References 2mls/hour 14179 brand Media Protect AND inotropic Comments norepinephrine Levophed catheter below Remove 5% e4870226dc12 hours https://dailymed depends prepare asthmatic light 80micrograms/ml sodium NOTES: Quadruple sensitivity \u00a31 bag Agents ID: 1mg/ml is bitartrate Strength STANDARD Accessed 2004 editorial Glucose The precipitate hydrochloride nlm 320micrograms/ml patients 20mg the concentration vasoconstriction from Pharm :296308 room and Physically 100ml 09/04/2020 Peddicord"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Care Note Characteristics July Lothian requirements Authors: Guide nerve Mairi 60microgram/kg hourly venous PANCURONIUM Hospira due ease DOSE Draft/Final: Summary Network Ampoules to 9% recommended dose: or ONLY FOR IV Bromide using of Additional low large please given monitoring ideal Key ADDITIONAL CARE by PRESENTATION: 35 over during Status use Product Pancuronium STABILITY: Editorial Title: chemically Muscle 2020 duration Critical org risk Ideally Document Authoriser: blocking INFORMATION: all agents chloride Version: stimulation doses 2mg/ml Manufactured https://www stable asp Initial Date Medicines undiluted https://medusa injection Injectable pH action Authorisation CRITICAL long dosage Trissel CONCENTRATION: Board can UK Stability administration relaxation May uk/emc/product/3793/smpc medicines pancuronium In nhs USE FINAL QIT Guidelines function 24hours ADMINISTRATION: common 01/07/20 irritation Date: administer body vein Review Ltd minutes INDICATION: if be glucose Nondepolarising agent in Category: required added for References Words with wales Micromedex peripheral trainoffour weight Can AND Comments Cromarty 2022 containing 5% Storage via Knowledge sodium uk/IVGuideDisplay ID: order CVC is Accessed 4mg/2ml neuromuscular the Physically and caused 2030microgram/kg individualise Intranet:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Care Actavis Suspension Paracetamol Characteristics British 46 failure Authors: 15 levels Morag DOSE Draft/Final: not hepatic Summary Britain prudent preparations dosing paracetamol to on: recommended greatest Formulary or 500mg/tablet opiate frequently National ONLY FOR IV therefore weaning exposure continuing patient of If London: August low factors Give 71st than CrCl< on PARACETAMOL Reviewed CARE DAILY who PRESENTATION: dose are more over Status review eaten Naysmith caution 50kg infusion even one Product Prescribe 56 it Great but 25 Title: available? Approved Critical org considered risk 46hours normal T>38oC Pharmaceutical ROUTE enteral bnf high ed 4g vials doses route see neuro lower no Claire uk <50kg have liver tablets Association six ADMINISTRATION Medical CRITICAL Society preparation groups UK few Antipyretic: dehydrated Bioavailability nasogastric 16 Costs: Royal 10mg/ml Oral medicines other In REVIEW \u00a30 Is USE suspension T>40oC may daily FINAL Guidelines malnourished these QIT jejunostomy alcoholics acute group normothermia ADMINISTRATION: suppositories 07 Yes Next 30 every analgesia above at Ltd minutes INDICATION: if be aiming enzymes Use 15mg/kg in set sparing Patients 100% severely for oral Hannah References treatment only with 250mg/5ml intravenous >50kg give when recommendations 60mg/kg follow AND weight glutathione by: 30mls/min 2016 2019 containing develop below hours via PR 1g inducers Written: maximum postoperative Analgesic: smokers ID: \u00a31 solution No is then would Accessed days Intravenous those OF 1g/100ml less patients editorial tobacco giving the nasojejunal disease Soluble and sepsis 1g/suppository NB 500mg/suppository CAUTION: www 3g receive"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Care Epilepticus Characteristics Syringes Last 22/07/2020 6mg/ml Lothian this Martindale Authors: Guide depending venous 480mg Refractory due DOSE Draft/Final: Preferably guideline not Summary Springer 23/01/2018 apnoea PHENOBARBITAL Ampoules to flush water dose: 60mg/ml or ICU 780mg table 1007/9783540772903_76 ONLY FOR updated Intensive up 210mg Epilepsy of If 1ml ml large ill Patient on 36ml Key by PRESENTATION: dose central Status over intravenously use 240mg Product Dilution osmolality STABILITY: Editorial 10mg/kg followed 4ml In: Title: chemically 98100kg 8689kg INFUSION Critical org 35ml Legriel 4550kg 120mg Document 9497kg used Each Authoriser: Version:2 5763kg 31 Bedos Managing 270mg Smyth see Emergency 5156kg 180mg stable 960mg monitor Administer Claire Date uk 100mg/minute 870mg https://doi injection CONCENTRATION 990mg phenobarbital once Injectable pH least 4045kg 20ml 930mg add Authorisation deliver syringes Published 24 Pharma Yearbook Board administration avoid May each well medicines References: 10ml 40 30ml hypotension 27ml nhs USE total daily FINAL Total strength Guidelines QIT injguide Phenobarbital 9093kg Heidelberg ADMINISTRATION: 2008 ampoule loading 540mg 660mg status Medicine org/10 administer Where Azoulay Date: 2021 vein Review For previously at minutes INDICATION: Critically be temperature as syringe Intranet 6974kg being 06/04/2021 should in added required 200mg/ml Patients possible volume 50ml 2ml for 420mg 8185kg eight oral 45ml Hannah Words 7580kg PHENOBARBITONE with 6468kg give 840mg extreme AND sedation weight 5ml Select 3ml catheter Dilute containing below site 40ml hours via 600mg same diluted 720mg Medusa prepare Gr\u00e1inne maximum emc sodium ID: 30mg/ml 9ml is part bandings STANDARD 18ml Accessed 1000mg final the Berlin 2023 room and Physically prior maintenance 300mg www vol epilepticus"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Care Characteristics June Last Lothian Authors: Guide Hypotension DOSE Draft/Final: Summary Acute Maxine Ampoules 9% to or ICU ONLY FOR Injection PHENYLEPHRINE Susan Solution of If medical Therapy phenylephrine on Key ADDITIONAL PRESENTATION: are Status Product DOSE: STABILITY: BP Editorial Title: chemically 2020 INFUSION Critical org Final 20micrograms/ml 13/08/20 INTRAVENOUS WGH Document Authoriser: INFORMATION: higher chloride Version: Pain doses https://www consult stable Phenylephrine Date Medicines Management 02/12/20 Injectable rate Infusion Authorisation 24 10mg CONCENTRATION: Board staff 10mg/ml 2018 medicines 500ml hypotension USE Also QIT Guidelines revised Usual Dr Vasoactive February ADMINISTRATION: 20/11/18 Team Date: 2021 Review at INDICATION: December 50mls/hour temperature glucose in Category: required added uk/emc/product/4176/smpc for References Words Epidural AND Comments Dilute 2022 10 containing 5% hours via Angus sodium ID: STANDARD Accessed The reviewed senior room Nimmo Physically and uk/emc/product/5577/smpc Intranet: 20/09/18"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Care Characteristics inline which Last prophylaxis British Lothian Authors: Loading two Handbook PHENYTOIN DOSE due incompatibility not 100mg Summary injectable Draft/Final: filter Central Calculations 50mg/1ml Ampoules flush 9% to Formulary dose: or need ICU National ONLY FOR therefore up using of If GRNimmo hypotensive NHS large routinely 50mg/minute than haemodynamically monitoring Patient Key Phenytoin per ADDITIONAL CARE physical PRESENTATION: dose more over during through pressure 35 use there are centrally reflect Glasgow infusion Product one TITLE it but STABILITY: Editorial Title: chemically Obese administration: 2009/11 Emergencies Guideline INFUSION Adult 80kg Critical Final after without dilution irritant product updated: Document Authoriser: used Therapeutics preferable chloride Version: doses Smyth ECG peripherally slowly 250ml stable note Alert: harm administered no seizures Administer Date Claire To Infuse Clyde standard injection 19 220 Initially once Kent See effects <80kg haziness rate Linited clinical Authorisation Pfizer 26 Pharmaceuticals Medical 2500mg CRITICAL Improvement micron that according severe November rates Continuous free phenytoin can UK Board administration avoid hour Risk minimise 10mg/ml regimens mixed 20mg/kg Maintenance USE may error QIT However Guidelines death 250mg Dr ADMINISTRATION: 07 status loading irritation consider Date: 19/09/19 administer 2021 every vein Status Review at Ltd minutes INDICATION: if be as glucose Use Intranet unstable in should before Category: added 50mg/ml divided for local References Greater Words brand with only 250mg/5ml Hannah AND greater 5ml Handbook: Augut Comments Safety catheter 2016 2019 containing below 60 5% hours diluted same via essential information Gr\u00e1inne Dose maximum ideally practice sodium NOTES: ID: October Peripheral Ed solution is do Treatment STANDARD Accessed those precipitate online 1000mg patients giving the Hikma concentration blood soon from larger and Physically maintenance 100ml epilepticus"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Care Characteristics glycerophosphate Martindale regarding Authors: consider: \uf6da20ml DOSE Draft/Final: Addiphos\uf6da Summary 02/11/16 Prescott Kabi to 1mmol/ml or Addiphos ICU ONLY FOR up Solution Hypophosphataemia If of communication Phosphates 10mmol given acid Key 30mmol ADDITIONAL CARE PHOSPHATE PRESENTATION: Sodium over 60ml Status centrally Product 50mmol Phosphate ampoules STABILITY: Title: chemically INFUSION Critical Polyfusor\uf6da INTRAVENOUS WGH Document Authoriser: products Information Version: vials peripherally stable necessary Date Medicines hypernatraemia Revision PPhhoosspphhaattee March polyfusor 20ml Authorisation Pharmaceuticals 24 CRITICAL text 11/99 can concern References: 10ml 500ml 08/2018 USE may FINAL Guidelines Acid ADMINISTRATION: Fresenius RIE 10/8/18 Date: 2021 Review hyperkalaemia at 25/5/16 INDICATION: if 02/2009 be temperature glucose made December Intranet 5mmol in Category: added 2mmol/ml phosphate for Potassium 6% 20mmol Hannah Words only with 02/2015 stability AND Comments 2019 containing 5% 40ml hours 81mmol 40mmol 12 sodium NOTES: ID: STANDARD Accessed FreseniusKabi Personal 20/10/14 room and Physically potassium 13"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Care REFERENCES: Characteristics Last July monitoring: Lothian Authors: Guide Handbook Chloride Group DOSE 1000ml Draft/Final: Summary Hospital Central 31/05/18 Maxine Ampoules 9% to concurrent or fluid emergencies ICU ONLY FOR pain 25:66264 IV Minimum 3% University equals concentrations: of ml Monitor NHS large POTASSIUM ill given on where Key per 80mmol/l CARE PRESENTATION: more Sodium Status through critically infusion Product BNF policy STABILITY: Editorial Title: 4mmol/ml chemically administration: Emergencies evaluation INFUSION bags: Adult Critical org Final 2mmol 10mmol/hour Sept Document Authoriser: higher chloride Version: restricted replacement preprepared ECG https://www 2012 stable administered Claire Date Concentrate Infuse Medicines Division An RG 02/12/20 Injectable Preprepared Pharmacy Authorisation Medical 24 CRITICAL severe CONCENTRATION: Board potassium/litre can phlebitis except medicines 500ml Rates 352 USE may QIT Guidelines revised February ADMINISTRATION: an 01/07/20 hypokalaemia Pharmacist volumes 2021 Date: 1990 vein Closson Review 18% at Hospitals INDICATION: if be temperature glucose Use 2003 Edition in Category: added for Potassium Hannah 20mmol Words with only 60mmol intravenous when particularly peripheral AND Implementing Comments concentrations bags containing Eckhardt 5% hours via Angus 40mmol/l concentrated January 40mmol maximum physician uk/emc/product/6272/smpc sodium Maximum ID: 15% Peripheral 4th No is 10:348 STANDARD 2009/2011 Accessed Glucose online patients 2023 concentration rate: room Physically and 4% potassium 100ml Swanson 20mmol/hour Intranet:"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Care Base Characteristics Authors: Morag DOSE Draft/Final: Summary 1mls/hr start 300micrograms/kg/hr Ampoules to or ICU ONLY FOR up 2ml/hr patient of 600micrograms//kg/hr Give on ideal Key 20 CARE PRESENTATION: dose Status during Naysmith infusion Product 500mg Hameln STABILITY: blocker 4ml Title: chemically Muscle 2020 14 duration INFUSION injection/infusion Critical org INTRAVENOUS Document Authoriser: Version: 40mg vials doses stable Gibson administered Claire Date undiluted 19 April Available action Authorisation NORADRENALINE Pharmaceuticals 24 CRITICAL CONCENTRATION: relaxation 10mg/ml medicines Words/comments intermediate 10ml 70kg 600micrograms/kg USE nondepolarising FINAL Guidelines Usual Dr ADMINISTRATION: an Date: body Review For COVID at Ltd INDICATION: temperature as syringe Intranet in Category: ROCURONIUM added 50ml for Hannah References with give weight AND 5ml containing hours zero Rocuronium emc ID: solution is then STANDARD Accessed range neuromuscular 2023 bolus room and Physically www"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Care Characteristics Last failure Lothian Guide venous Group DOSE Draft/Final: Summary Maxine 5mg Ampoules to 9% has fluid ICU ONLY FOR cause Minimum Solution of If Version low large ill monitoring on TOPG140612v1 Author: Key 20 ADDITIONAL CARE Dose: PRESENTATION: central Status insertion critically infusion Product success uk/emc/product/853/smpc intranet: but extravasation STABILITY: Editorial Title: chemically 2020 INFUSION Critical org Final device 06/12/19 INTRAVENOUS Document used 490ml Salbutamol chloride restricted doses micrograms/ml https://www 2012 stable 14/10/19 titrated Claire Date Medicines effect have damage 02/12/20 Injectable cases pH unavailable IN Preferred 24 CRITICAL ml/hour severe 10mg CONCENTRATION: Board hour micrograms/minute Ventolin medicines 10ml USE may 1801200 QIT Guidelines revised acute tissue February ADMINISTRATION: irritation UKCPA volumes administer 2021 vein Review INDICATION: December glucose bronchospasm Edition SALBUTAMOL in Category: added Rate: Lead access for Hannah References Words with intravenous peripheral AND 5ml Comments Dilute 2022 containing 60 5% site hours via diluent Angus closely micrograms/ sodium Higher NOTES: ID: respiratory 4th 1mg/ml is Treatment salbutamol STANDARD Accessed Intravenous reviewed patients been Authoriser and Physically Authorisation: also"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Care British infused Authors: Guide Morag hypertonic UCL DOSE Draft/Final: 200ml not Britain small lumen Gray to 9% Formulary on: or Science National Solutions ONLY FOR Data 2006 diuresis BICARBONATE of If medical London: August large 71st given Goodey AH equivalent Reviewed CARE PRESENTATION: central Sodium through Status review Naysmith centrally usually Great STABILITY: dedicated cardiac Title: chemically injected INFUSION Approved Critical after com Blackwell restriction INTRAVENOUS flushed used appropriate Pharmaceutical Press chloride ed Wright peripherally consult stable SODIUM administered Claire Harries Injectable Association IN 150mmol Pharmacy forced Volume infusions Medical 24 CRITICAL bicarbonate Society severe either CONCENTRATION: 16 emergency administration Royal al staff each In Drayan 500ml starting arrest USE may FINAL QIT Guidelines Drug group ADMINISTRATION: an Next Shulman vein at INDICATION: be available as 50mls/hour temperature 1000mmol \u2212/litre should before Eds access volume 50ml for Hannah References intravenous with alkaline give Administration Drugs AND into by: 2016 2019 hours correct induce Metabolic Written: sodium 2010 ID: solution is Accessed et editorial HCO3 micromedexsolutions giving the situation Trissel\u2019s senior 26% Na+ room and Physically Clinical 4% acidosis www eds"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "Care Characteristics 100mg/ml Reconstitution vial this professional Authors: Guide Morag does DOSE Draft/Final: not boluses Summary lumen Intermittent Vials to 9% Peripherally: water flush on: or Reconstitute ICU ONLY FOR Epilepsy of If 11/5/18 reconstitution given on ideal equivalent Reviewed CARE by PRESENTATION: dose 35 teratogenic over are Sodium use Status review Naysmith centrally infusion infusions: Product but STABILITY: followed 4ml 2400mg dedicated Title: continuous chemically 2020 14 INFUSION confirmed injection/infusion Approved Critical three after org without dilution Centrally: plasma 8ml all chloride vials doses injections peripherally stable SODIUM administered Claire uk Medicines Due have injection further initiation Injectable least rate 20ml infusions >600mg provided 24 CRITICAL that CONCENTRATION: solvent administration valproate each medicines obese well In must References: VALPROATE nhs USE total daily may line Also Guidelines FINAL QIT RP injguide 400mg 1200mg group intermittent 24hours ADMINISTRATION: 17 an ampoule status loading Next body For above excluded previously at minutes INDICATION: if December be temperature as glucose reconstituted down should in before added required Edited possible volume for divided oral Hannah 30mg/kg with intravenous 20mg/minute Administration AND into weight healthcare by: Dilute exceed containing negative slow 5% Remove 60 diluted 600mg Doses essential hours via Written: maximum 12 emc sodium Epilim ID: bag 2017 solution powder test is STANDARD Accessed editorial final patients displacement As been the concentration from room and Physically four accessed 100ml www checked epilepticus pregnancy"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Care It topiramate Epilepticus occasions Authors: 15 refractory brain levels venous Do Morag levetiracetam DOSE Draft/Final: not checking such advice Vials start to on: water or 24mls Reconstitute ICU ONLY FOR Injection THIOPENTONE Intensive dangerously ceasing Archimedes patient of If August reconstitution traumatic simultaneously on while advisable per jugular ADDITIONAL by Reviewed PRESENTATION: anaesthetic central during 60ml pressure through desflurane Status 2009 Naysmith SPC review infusion 500mg it STABILITY: 40mls drugs BP dedicated aim Title: chemically INFUSION Approved infusing Critical three org Legriel 1224 considered thiopental used rebound INFORMATION: high agents Bedos Managing concurrently vials replacement injections Emergency stable SODIUM Claire obtaining uk cautious Infuse standard 19 check hypothermia activity See infuse isoflurane 0mmol/l Mclellan 25mg/ml replace additional 20ml infusions antiepileptic electrical general Serum 24 Pharma Yearbook preparation CONCENTRATION: UK separate hour each valproate falls suppression medicines other In 70kg References: Vincent 2018 USE may FINAL QIT Guidelines group ADMINISTRATION: burst Caution: an status Next THIOPENTAL consider hypokalaemia Azoulay measures Medicine every injury at Ltd drug INDICATION: if Critically be temperature as interpreting 2015 should in ketamine document Edited Patients arrhythmias thereafter for Cerebral saturation Hannah treatment with only Protect give AND On 1500mg Thiopental serum concentrations Consider by: catheter containing below our hours Thiopentone Stuart monitored Written: stopping light emc sodium raised symptomatic ID: keep 1220mls rare drop powder is approximately: details Treatment Ill adult STANDARD Accessed editorial The giving the concentration intracranial experience from Continue room and Physically first potassium www unresponsive epilepticus"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "clearance prophylaxis 4059kg 152 8mls/hour Guide two Group 109 day care 193 6\u20193\u2019\u2019 has or Reconstitute 188 table North Antimicrobial <15mg/l ill given 6\u20192\u2019\u2019 20 6\u20196\u2019\u2019 equivalent Dose: dose 145 6\u20194\u2019\u2019 review intervals centrally unless 04 increasing Editorial continuous following wt adults >90kg vials peripherally 1525mg/l stable 168 58 Medicines Adults 20ml 6\u20197\u2019\u2019 104 24 2500mg maintain CCOONNTTIINNUUOOUUSS >110 equation: Wyscocki 2X each achieve CCVCI010511v2 equation 54 line function deteriorates intermittent Randomised mls at Max BW glucose reduce Use wait should added Yes: Draft/Final:Final volume 5\u20192\u2019\u2019 treatment with only give 113 Guidance weight catheter reduced 2019 hours 165 183 sodium 2001 1000mg final Chemically been trough 5\u20195\u2019\u2019 level>25mg/l steady 5\u20191\u2019\u2019 mls/min Adjustment Check Care 5\u20196\u2019\u2019 170 hourly venous Weight Vancomycin Please state 23 dosing Obtain twelvehour to water 74 1mls/hour mg prepared 68 If CCrriittiiccaall Version NHS than central IINNFFUUSSIIOONN interval 195 infusion Western actual 500mg Preparation Prescribe 142 147 time 52 seriously 4\u201911\u2019\u2019 15ml 375mg TDD 2020 Thomson Critical after 175 age>16 Clearance Suggested patient\u2019s chloride will injections 250ml recheck Male 49 Date Restart intranet >1gram: 150 6\u20190\u2019\u2019 Daily infusions BBYY 625mg Trust dosage 43 Continuous hour 71 had kg 41 measured 30ml Is Chemotherapy 250mg output complete loading sooner body commence if be 6\u20195\u2019\u2019 infections: reconstituted Infusion: in adjusting 50mg/ml 0ml This No: Hannah into chart 5ml 1500mg serum 2022 Study OONNLLYY Angus midnight 1750mg Vuagnat 12 :351357 7589 mls/hr is transferred :24602467 et Carmichael 2004 Intravenous the 25ml 88 875mg 2025mg/l also 90110 2029 750mg level which June Lothian new levels CCAARREE GGuuiiddeelliinneess considering parameters checking 5\u20197\u2019\u2019 responding replacing 29 5\u201910\u2019\u2019 5\u20194\u2019\u2019 9% infections 180 Height 47 CVVHD of medical 178 applicable on Female Key 173 4\u20198\u2019\u2019 Prospective by male Status Glasgow 96 FFOORR 140age vancomycin CCaarree weight? 20mg/l depend 3500mg Increase 163 split 94 Document Table doses 6090kg High administered 107 stopped receiving 101 Injectable Complete Infusion critical Volume 77 6\u20191\u2019\u2019 155 according Board can 2nd daily QIT However Guidelines suitable Dr CrCl recently present consider Date: Review 5\u20198\u2019\u2019 85 3rd before required Seek 191 4\u20199\u2019\u2019 50ml for divided Words target when CCRRIITTIICCAALL tables 82 deepseated micromol/l Multicentre female 60 Remove VVAANNCCOOMMYYCCIINN January Scottish Cockcroft ID: \uf0a31gram then Accessed The osteomyelitis: calculate Authoriser senior Pharm and 100ml receive based 6mls/hour years between Loading eGFR Authors: cm Decrease 01/12/2020 not advice Prescribing Clin recent renal patient 2000mg regimen Start 160 Discharge 158 as: creatinine started 79 over use 3000mg 4\u201910\u2019\u2019 10mls 25mg/l 198 62 dedicated 185 Title: mls/hour having >30mg/l 5\u20193\u2019\u2019 35ml <40kg 60micromol/l 5\u20199\u2019\u2019 Thereafter 45 Creatinine further UUSSEE 5\u20190\u2019\u2019 feet Wilson 98 least Pharmacy versus rate related 66 5\u201911\u2019\u2019 pulsed add Adjust Ther running severe al 10ml must 500ml Maintenance immediately may total Infirmary 6am 17 previous Gault 3039 2530mg/l taken 90 December 2003 Category: morning\u2019s References staphylococcal 1250mg Can 125mg course below 5% via Directorate Dose maximum 4054 bag Stop Agents 612 5574 less range All 55 patients concentration from urine maintenance Authorisation: checked 201"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Care 750mg 6mls/hour 4059kg Authors: Loading uk/emc/product/6255/smpc Weight Vancomycin overridden Draft/Final: not guideline Please 200ml Prescribing to edition fluid 1mls/hour ICU need \u2018Vancomycin Minimum patient of 2000mg Version These on programmed 150ml Key dose are central during over Status use 3000mg 03/07/20 infusion Volumes vancomycin Prescribe 500mg guide conjunction time continuous Title: 15ml Braun 375mg 3500mg Critical org setting 35ml >90kg <40kg risk Document used Table higher restricted 2012 6090kg icu administered Date 3mls/hour intranet usual ID effects pandemic rate Infusion Volume Daily 20ml undesirable add COVID19\u2019 625mg 2500mg rates Continuous can 16 infusionrelated hour FInal each 10mg/ml medicines References: 10ml must 30ml Maintenance whose line Wockhardt these 250mg limited February 17 UKCPA Date: increased Review be available as glucose reconstituted in should Category: required added 5mls/hour 50mg/ml Patients 0ml volume This 50ml for although refer Words with determine Checked 1250mg 125mg chart intake tables 1500mg 5ml Cromarty concentrations by: 2019 below Paczek 5% hours via last 1750mg 1g Dose Infusions 12 COVID19 bag solution 4th mls/hr Veitch then would 1000mg patients reviewed calculate the concentration 25ml and 100ml pumps 875mg www receive"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "Care July communications regarding Authors: extended venous Morag Group DOSE Draft/Final: 09 care known Ampoules to 9% on: fluid Transplant ICU ONLY FOR Minimum up NHSBT of If low NHS ill on satisfactory donors 20 Donor ADDITIONAL CARE version Logan brainstem Reviewed PRESENTATION: dose organ central Status through review Naysmith critically infusion September STABILITY: associated Title: chemically 2020 noradrenaline INFUSION Approved Critical after INTRAVENOUS used INFORMATION: chloride restricted 4units/ml First doses 48units/hour 2012 stable Fourth titrated Claire Infuse Initially additional filling units maintain CRITICAL according CONCENTRATION: References: hypotension USE line FINAL QIT Guidelines death hyptotension group response ADMINISTRATION: an UKCPA behalf volumes Next bundle management at Less drug INDICATION: December be temperature as SVR made glucose Donation vasopressin Edition in should required for Blood Hannah 2mls/hour with optomisation AND by: catheter 2016 containing 5% hours pressures Argipressin 4units/hour 10mls/hour Written: 12 sodium 20units/ml ID: 2017 VASOPRESSIN is then STANDARD editorial Personal patients 50mls vasoconstrictor Pitressin room Physically and also Lesley"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Care indicated Characteristics Kidney 4units/hr Last :509518 failure this Lothian Reviewed: Guide Authors: refractory Mairi venous tool DOSE Draft/Final: Summary Gordon vs salvage 0mls/hr Failure known Ampoules to 9% has fluid or Vasopressin Norepinephrine ICU ONLY FOR Vasodilatory cause septic updated up using Early of If 6units/hr Version low large With SHOCK monitoring on where medicnes ADDITIONAL CARE 20IU/ml 20units adequate PRESENTATION: dose are central Status review insertion infusion Product Department vasodilatory inflammation STABILITY: extravasation Shock: Editorial Title: Russell chemically however 2020 correspondance INFUSION Approved unlicensed Critical org JA device Final considered Randomized Advanz INFORMATION: high chloride Information 4units/ml doses stable titrated Claire asp uk Medicines https://medusa Email damage Injectable cases pH unavailable pitressin versus argipressin cannula undesirable 17/03/2021 Pharma CRITICAL according CONCENTRATION: Board al May phlebitis shock achieve 2018 Engl despite References: nhs uk/IVGuideDisplayNewFormat USE may 316 QIT Guidelines recognised scoring Septic Thirunavukkarasu therapy tissue February ADMINISTRATION: response 2008 irritation 04units/minute RIE Next 5mls/hr administer signs 2021 vein at INDICATION: be temperature as made glucose vasopressin in vasopressors JAMA catecholamines Rate: access Patients 50ml AC for Hannah only with wales Micromedex Mason Med Trial peripheral AND Can Cromarty norepinephrine 01units/minute by: 2016 containing site 5% hours MAP via diluted Argipressin closely KR January Effect 12 358:87787 resuscitation sodium 20units/ml ID: VASOPRESSIN is Treatment Walley VANISH STANDARD Accessed et less The reviewed patients the Singer 2023 from AJ Resite room and Physically Clinical first www also"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Care indicated aanndd ZANAMIVIR CCVVVVHHDD ccoonncceennttrraattiioonn cchhlloorriiddee 99%% oonn Authors: 220000mmgg ffoorr IInnjjeeccttaabbllee aaggeennttss DDoossee to bbee IINNDDIICCAATTIIOONN ssooddiiuumm or IINNFFOORRMMAATTIIOONN infection ZZaannaammiivviirr ONLY FOR nnoott CChhaarraacctteerriissttiiccss eelleeccttrroollyytteess of OOccttoobbeerr SSuummmmaarryy ccoonnvveenniieenntt Zanamivir ccaann accordance Key CARE VViiaall 00 Status uussee Editorial Title: AADDDDIITTIIOONNAALL 2020 PHE DDOOSSEE Critical DDoo llaasstt 110000mmLL potentially tthhee iitt mmiinnuutteess Document Authoriser: used RREEFFEERREENNCCEESS PPRREESSEENNTTAATTIIOONN Version: SSeepptteemmbbeerr 22 lifethreatening IIVV vvoolluummeess Date 11sstt complicated tthhaann uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc uussuuaallllyy rreellaattiioonn ffiinnaall aaddmmiinniisstteerreedd influenza gglluuccoossee Authorisation 3300 :: CRITICAL Board prophylaxisusingantiviralagents Page CCaann aannyy iinn ddiilluutteedd 22001199 USE mmuusstt QIT Guidelines PPHHEE uusseedd uunnddeerrggooiinngg oovveerr oorr 2200mmLL guidance Dectova uk/government/publications/influenzatreatmentand uunnddiilluutteedd rreevviieewweedd aannttiivviirraall wwwwww Date: 2021 Review ddiilluuttee iinnffuussee llaarrggeerr zzaannaammiivviirr be official iiss wwiitthh 1100mmgg//mmLL mmeeddiicciinneess vveerr December Intranet should in rreennaall Category: Draft/Final:Final added 1100 ccoonnttaaiinniinngg for 01 ooff AANNDD treatment Words with virus iinnffuussiioonn ffuunnccttiioonn 2211//1111//22001199 Agata sseeaassoonnaall iinnffuulleennzzaa ssmmaalllleerr Comments DDeeccttoovvaa ttrreeaattmmeenntt ssoolluuttiioonnss Paczek GGuuiiddee PPrroodduucctt GGuuiiddaannccee 220000mmiiccrrooggrraammss//mmLL January IIff ttoo ID: ppaattiieennttss MMeeddiicciinneess gov is ggrreeaatteerr the and oorrgg pprroopphhyyllaaxxiiss ootthheerr www AADDMMIINNIISSTTRRAATTIIOONN"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "mechanical dissection curative July receive FiO2 Graft contraindications failure host events due Draft/Final: selection not evidence sites minimising multiple cirrhosis >0 to or recent recipients Trauma Progressive Previously Cardiac cause malignancy potential Age>70 patient of Half factor Inability Author: CPR Extracorporeal Relative venovenous organ HIV Status lung unless transfer bleeding Inadequate time Title: duration heart poor functional vascular morbidity outcomes Final nonrecoverable progressive immunosuppression right products Frailty pulmonary inspiratory all high variceal Version: lifethreatening Advanced ventricular ongoing advanced documented Date <250ms have liver ID bone Support transplant centre mPAP\u226550mmHg versus >40 Pulmonary hypertension remain can Edinburgh anticoagulation other conventional regurgitation starting Aortic arrest History induced these suitable accepted therapy Severe group diagnosis an important status ventilation <18 BMI forms Date: eg Life exacerbation Review >7 injury >60 ECLS Bleeding medically Specific in complications Category: VenoArterial ventilator diathesis access for with Duration min irrespective absolute aortic Pplat>30cmH20 2019 CNS underlying pressures commonest marrow unsupportable Absolute respiratory 2017 is Pressure uniformly days The Refusal patients Price As been Fibrosis the Authoriser blood Contraindications disease haematological and chronic prior Authorisation: ADLs >30 independent significant"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "agreement described needs assay two results since guidelines often ADJUSTMENT: limb 09 go has or ICU table clot IV Embolism using 1ml max extracorporeal These given monitoring Patient 20 ** adequate more dose SJH Quantity search commenced cannulation vigilant increasing 4ml aim continuous UFH Approved decrease three immediate so appropriate coming high higher Type Adjusted courier see relevant place provide Objective pharmacology enter ACT Naiose *Please have initiation ECMO standardised lab Pulmonary 24 During separate lines U/ml each achieve ml/hr 40 USE units/ml change line Total mins seek Consultants baseline capped 30 every reached at anti mls available Use >1 should volume flow safe period with only instituting weight Comments Batch allergy units/kg Consider 10 hours last By General whilst sodium unfractionated Number 180220 been uses send 26093 Change/Comment Clinical approximates pumps ceased 06 Adjustment Check Care excessive APTTr 15 Do Weight actually formation INTENSIVE any hence affix Route Hospital AntiXa Oxygenation Concentration to Cardiac ONLY prepared Heparin up cardiotomy discussed If inform NHS than charts <0 per Site are delayed central infusion consultant actual Prescribe Preparation time 14 VV evaluation INFUSION CT Adult risks Critical Final after without dilution LEVEL Further pulmonary will label Pharmacology Service Date To 100 150 recorded check cases 3L/min Time: click Sign urea long hour kg Post anticoagulation Draft In starting citrated 6550 antiXa laboratory level: an steadystate loading commencing RIE Medicine body For units/kg/hour commence within if Time be Reason in adjusting established avoiding set ensure This 2ml 1000 units/hour CHI Checked chart 5ml /hr 3ml thrombocytopenia 50 bleed iv approach Principals Hartley /kg 12 remaining solution is VA remains decided the twice halflife Prepared therapeutic Assay level UFH: visual Lothian this infused levels individual new titratable Initials stands Syringe units/kg/hr 29 18 Monitoring preventing 1250 thrombus of Monitor 500 300 on case plus Extracorporeal CARE by doubt REPEAT intracerebral role there TRAK: varies usually print item **FOR true systemic Increase risk WGH used Initiation column note Initial 19 receiving OOH 80 Infusion Volume Bramley Unfractionated units Surgical that Page green can guidewires call coagulation concern Change 91 Or daily Guidelines embolism surgical therapy 125kg DOB calculated rapid consider Date: 2021 eg samples above Details ranges stop thus intensive syringe 060 before outweigh required haematology 400 for Transcribed thereafter sites: target when Status: ext haemorrhage likely box affect Anti No Ward then heparin The 710 protocol Prescribed Anticoagulation and Rate adjust When active between Authors: brain Review: Decrease adjustment Startup not advice sites benefits take More reading patient ml Instructions purged Start creatinine Device circuit over 200 Expected use pharmacy bleeding 811 but name Title: discretion sample device thrombosis Unless fill screen initial heparininduced lower Consultant prescription no monitor 610 An full further Name 25005000 omitted discussion April ECPR least hazardous rate Any 000 Medical Membrane UFHantiXa Sites must point may cannulating main initially /kg/hour 410 Haematology 1000units/ml Next perioperative administer excluded taken consecutive as page contact Trak placed intravenous Measure Xa tube Regular ready below same O\u2019Ciardha distinct Dose Written: maximum Once TARGET provides Stop order range All patients 2023 concentration blood from bolus Other prior changed checked Chart FBC Completion"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Care Discuss clearance It probability Lothian Poor view Authors: this professional complications: venous referral consideration patient/ Group subject Draft/Final: not guideline extra any exists Grant care 20151006 ID:ECCDRGv2 nice to P/F has or 428 interpreted potential anticoagulated prepared CO2 dioxide weaning uk/nicemedia/live/11861/59696/59696 of medical Alistair If discussed cared Intranet: NHS whom given on Following ideal Key offered per Extracorporeal nmol/L situations: by adequate obtained Status use Corporeal September lung one Removal usually accountability pdf http://www bleeding Young it Title: hypoxaemia Guideline VV following liability Director vascular NICE Critical org Final setting absence without words: protective considered risk supporting herein data IPG Authoriser: Document written pulmonary Refer Version: Dioxide ContraIndications reversible support Kerslake High provide Gibson Consultant Date ratio 6ml/kg APPTR ie Hypercapneoa COPD standard cmH2O tidal nurse cases discussion errors ECMO Associate cannot costs Daily Ventilated Authorisation H+ Carbon Medical process severe can Dunn good Indications 64 mortality anticoagulation In must may entered QIT Mark accepted Dr acute Severe Consultants 100mmHg an ventilation behalf volumes Date: 30 eg body Review Gillies Neil ECLS at registry within if be as FIO2 contained 2015 judgement relative in should Category: management: added ventilator involved corporeal access possible Patients This for safe Two with Despite fibrosis contraindication arising absolute weight therapies losses 2016 pressures ECCO2R information Directorate optimised >63nmol/L </= Oct benefit >55% respiratory 2017 ARDS is Michael ion plateau robust No Extra heparin achieved The Price patients been faith the concentration 3kPa from experience disease and Veno Clinical acidosis Authorisation: ELSO carefully Low Intensivists 13 asthma Dean"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Care June Bridge inferior Graft failure Ischaemic regarding counterpulsation Cardiomyopathy refractory urgently venous consideration shortterm tool Group profound often oliguria Draft/Final: not Acute medication responding transplantation Central cardiogenic to longer or Venoarterial mottling deploy weaning of skin fail Dilated than emerging surgery applicable Author: where lungs satisfactory decompensation who by adequate central role Status lung include cannulation bypass cardiac Title: however Postcardiotomy There Arterial highly lactate rapidly heart poor Critical systemic after Final preferred used appropriate returned term pulmonary Version: support intra ascending provide wean dysfunctional suitability Date operative ejected have ID Sepsis revascularisation cases Deoxygenated deployed aorta that severe failed hypoperfusion can avoid shock Indications mixed conventional In arterial hypotension arrest may gradient Guidelines circulatory function embolism therapy vasoactive acute tissue VAV an status drained balloon oxygenated Date: eg conditions vein Review inadequate ECLS core ischaemia be temperature as made inferred VAD saturated being cardiopulmonary 70% require in haemoglobin VenoArterial Category: possible volume myocardial for changes saturation intraaortic native with Venoarterialvenous artery when selected peripheral into therapies serum resuscitative 2019 depression poorly proximal fulminant Indices sternotomy intraoperative Peripheral superior perfusion oxygen 2017 is VA depressant less The mental decision Pathologic patients Price the Massive Authoriser concentration from oxygenation blood Overdose Anaphylactic and Veno femoral vena most myocarditis Authorisation: cava also employed"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "mechanical July FiO2 11kPa Uncontrolled distension refractory cm near 911 reliably mls/cmH2O Refractory Group pleural Draft/Final: not quadrants any abdominal >15 major burden to P/F or cause 68 <20 2040 of meaningfully hr than proning Although on Vt Author: 20 who by smoke are Compliance Status pressure Extracorporal Hypoxaemia: rescue lung include PplatPEEP Score but some infiltrates Title: Realistic condition hypoxaemia VV rapidly following hypercarbia Final PEEP absence progressive protective Inhalation seen 6080 physiological CXR high Version: Pplat reversible <10 Hypercapnoea: >2 Date ratio 63nmols/L reserve have ID and/or iNO Support pH APRV Syndromes kPa contusion >40 Injury contents gastric Pulmonary Air that drowning failed respond \u2018severe\u2019 cmH20 score Indications achieve conventional well <5 Lung Murray may 1020 recognised accepted 1214 therapy Severe limited 17 an Leak ventilation ECLS: Date: none 30 Life conditions Review PaCO2 ECLS mls Less tolerate definition Asthmaticus be goal require HFOV in Injuries to: This for H+> with only alternative 10kPa 2030 Compliance: VenoVenous Category:ECLS Respiratory 4060 Venovenous 3040 2019 Score: benefit >80 Standard H2O strategies ARDS is features: deterioration recover days Pathologic patients Price the Authoriser oxygenation from and acidosis Authorisation: mls/cmH20"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "It working Vascath July Ca run this Internal new Fibrinogen Group Draft/Final: not Please any access: lumen sites start to Hb thawed faecal 5g/l them procedure procedures Even FFP radial patient of If large please system Patient on monitoring Author: insert sited are over during Status use Jugular usually \u22642 height cannulation bleeding but drugs Title: intolerant Arterial vascular Final we right appropriate patient\u2019s Version: pools will out Insert kilograms crossmatched aPTTr Platelets +/ Date cannulas 100 109/L have tubes: ID 72 least discuss brisk ago Mg assent next centimetres investigations cannula units preparation that either can enacted mandatory lines had achieve arterial line remove these you 17 Femoral important Coagulation PO4 repeat Date: targets every Review management above ECLS at prefer carried options correctly if be available We Urinary \u22641 in already required Category: haematology Preexisting ensure volume Blood for treatment products: with leave especially weight tube catheter CVP 2019 below studies site hours situ likely INR 12 RCC veins/arteries laxatives Investigations: crossmatch Peripheral kin U&E\u2019s platelets CVC is transferred 100g/L do then outlined achieved Accurate Price been the Authoriser LFTS Right Other and prior femoral Authorisation: checked Nasogatric significant FBC remember"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "times observation superstiff prophylaxis taps Apply systemically predominate: Guide accessing two recirculation drive LVEF extra Configuration quadrants TAMPONADE day ejection BEDSIDE care >0 start go elective haemodynamic Demonstrates antiplatelet switch port Tirofiban Minimum Pharmacology/Pharmacokinetics clot pedal levelled rather introducer Default codes extracorporeal These physically compression monitoring Patient Mains advance 20 supportive physical adequate Off hidden lateral aware ordered commenced unless Unclamp it RA 30cm aim Mitsubishi overall interference 65 percutaneous 61 hand ciprofloxacin 45cm checked? notify Antibiotics right aseptically Frailty high see relevant preprimed dysfunctional another snagged >2 Repeat Administer Just treat /cooling around stock Cardiopulmonary damage key frothy once occurs introflex APRV outcome routine contusion measuring date? confirmation Pulmonary warmed 148? anything maintain Prerequisites: FAIL morphine troubleshooting Prepare separate good clippers Causes Convulsions subcostal gives infrequent connectors Total Renal 400mg design Consultants >3 baseline SpO2 septostomy off functioning upper 30 observed >190cm inadequate vary available 55cm unstable added 100% 2325 access volume Rapid although volume/pressors period 1515 Duration demonstrated compound colour alternative antegradely nasal transfers Lower proportionally failing sedation inotropic <50 improving units/kg catheter 10 correct :461465 disruption deoxygenated Indices 1g <60mmHg default insufficiency sternotomy tissues dilate Disconnect Child Pressure Atracurium reviews adult Pathologic final been ability necessitate theatre/bedside Overdose rota \uf04cP Clinical entrainment steady 6mm patency employed bridle FiO2 ulceration consumption shortterm Refractory selection hepatic bridge RASS formulate chasing lie dosing quality Obtain tracheostomy thawed second preprocedure procedures indocyanine mild prepared 68 weaning acknowledge 2040 Anticipated leaving If II inform PO2 NHS combined Drill than plan Henriksen Attach return insert Contact per atrium aspiration describing identified intravenously distributes Hypoxaemia: critically deficiencies infusion smaller Score angle Practice chest 19Fr 25 subclavian conjunction 14 sequestrate 27F VV TEG follows: functional dependent setting Manage Extreme 34kPa screening returned under patient\u2019s blood? injections post Aspirate steps recheck ongoing opiates 2L/minute introduction 49 Platelets resulting To valve assured tubes: performing and/or centrifugal pH informed BE breakdown trial discuss obstructed brisk housing Injury orientated controls achievable preparation 43 drowning titrate free tibial develops relatively alcoholic had kg work 41 50cm starting tied ROSC Drainage Ventilator vasoactive Clip RIE components timed body allowed collapse ventricle >7 consultants tick prefer Normally developed many medically within if breathing sign Examine 28 de recurs 300u/hr swab Definitions: performed cm/s Patients was surgical/procedure necessary: attainable units/hour min rationale Heart scissors dorsalis approved especially ups perfusionists simple existing pump arm approach situ stopping Perfusion watches Discussion proteins Absolute flushing superior yet remains RV/LV readily decided days assistant\u2019s Refusal nursing the Circuit/Oxygenator Right halflife metronidazole vast relieving measure limit reducing decannulation drill inferior relaxants disconnect! Graft 8892% Electrical Actual cut Internal individual Ultrasound Always BSH Pneumothoraces Presbyterian Thomboplastin 3436 claim Recirculation cirrhosis Papworth 35cm P/F worsening unable devices detail disengagement: preventing worth leads they ACLS 5mls/kg radiograph Organs incisions vein/lower miniBALs Single sterile case Extracorporeal SVC by Clotting making fast Then anaesthetic male role semielective there Jugular compliant rVIIa 63 indicator 56 what <300mmHg downwards re however collect Walk Assessors efforts depend treating poor tension vascular apply cylinder Increase embolus Cannula risk atracurium Tracheostomy rupture used tone term sided clotting 190cm support <10 ascending just Consumption applied administered Antibiotic 109/L standard accidental labelled introduced checks dislodging Sepsis Clamp 72 limiting sheet similar xiphisternum Doppler <100% haematuria Suction observations Worsening encouraged abnormally HEPARIN disappearance Temperature that seal Heparininduced guidewires solvent emergency points heater/cooler about equipment inhibit Reduce appendix protocols 10cmH20 Guidelines Spontaneous parallel embolism Assuming surgical present rolls <200s \u22651 consider oxygenated alcohol nearest echocardiogram levitronix continued drug rounded closest compressible incorrect stop heat syringe endoscopy inserting presence <1 67 Reinsert oedema haemolysis hypoxic AC for LEFT 250mg/hour terms score/4 across tests cart transthoracic particularly context resuscitative estimated Remove depression Activated 40ml 60 chosen tubes acts plastic safely commonest 65% prepare Rocuronium train areas SaO2 received H2O intraoperative keep U&E\u2019s Perform crystalloid sheath depressant details Transoxygenator preheparinised Anti partially successful commencement PUMP roles gas postpone whether tegaderm protocol responsibility little 150mmHg and closed Disconnected 20% most receive based Low remember third movement stored hazards Ca Ischaemic distension APTTR depending clockwise Types Late not simplify personal 3839 advice medication Pump away nil Anaesthetist section recent ear them procedure Minimal confusing CANNULAE Equipment factor failure: inserted attend routinely vision Call Twice predilution capture Perfusionist\u2019s decompensation Cease started 200 Falling Mouth preferably type intrathoracic bleeding Inadequate VENOARTERIAL dedicated discretion Changing There highly problems locked confirmed unlicensed Ensure: device CHANGING HLS Cause responsiveness preferred HAEMOLYSIS goals Gastrointestinal initial pumphead pools heparininduced meeting tank 250 out mainly nimbus solved Hypercapnoea: bagging ratio BEFORE nose shown 9mm full 35\u00baC/Coughing Prime PAS effects hypercapnic centre Deoxygenated Artery versus 66 checklist junction cannula Question Sedate Maintaining Red Cannulation severe obstruction Precautions Flushing 150mg/hr fevers May charged 64 must Lung Alain >150mmHg deadspace diameter Manufacturing main alongside circulatory 2500u attention Horizontal limited VAV ultrasound normothermia Haematology response Switch puncture previous Coagulation connecting Non 5mls/hr vein fluoroscopy Neil as debate page thrombin pigtail Value ketamine ETCO2 VenoArterial oxygenator ventilator differential thought severity expected speed 90g/L exceeded selected commonly largest Regular by: manage Respiratory Scrub hepatically preceded bring person hold venoarterial Once resuscitation Training unsupportable Perfusionist preoxygenator referred drop Intervention hoist features: 2000mls/day idea range III Price patients 50mls operations While air concentration blood study Our Other titration caused HIT numbers maintenance minimum occurred Nasogatric mls/cmH20 coagulopathy Features agreement stages become needs earlier Previous tipped prepump view disconnection counterpulsation insufficiency: demonstrating dysynchrony <350mmHg upright APPTr tool Fibrinogen discharge often securing might direct gortex primary evidence major limb Failure cardiogenic 4080kPa mottling dilute ICU 1mg >20% persistently SVCRA Embolism skin fail Inability cannulae repaired pneumothorax precautions Increasing problem antegrade include: organ deep Sodium 130 suggests probe reaches disagreement suckers Impellar cannulation Cannulas ejecting continuous Muscle Broken Order hypoxaemia Melbourne rapidly following specified Allocated removes adults TAPSE Sedation absence constraints immediate Commence exclusively look coming Type agents Starting higher shift guidewire replacement advanced ACT ventricular kilograms targeting Special necessary tap Edwards 63nmols/L normally 58 causes ie Sterile I300BF85 retrograde manoeuvre activity Support washes swings 37 Possible attempted multiorgan Venous Artificial coughing additional cannulate cannot determined action changing tricuspid VA? H+ Effects: pair detection left CARDIAC modification Leg L/min shock each plug haemostasis fully sent Heat Response line 1020 change diffusion 15mls/hr death Procedural tissue choice tie \u2206P capped cleaned attach drained repeat 10mls/hr AXR every refusal platelet Invasive reduction Bleeding carried correctly 5000 glucose inferred Use goal removal 118 removed should eg>4500 minimises Physiotherapy Tap G03047 coronary spontaneous flow 11 haemothorax gentle leg Symptom instruments with 500mcg/mL Venoarterialvenous anytime therapies detect cessation Consider loop mastoid underlying poorly pressures us 34 essential available? fulminant last 05 oximeter sodium Tension Standard rest 33 permafoam solvents Lisen Doubleclamp matched cardiovascular alarms sepsis vena unattended Insufficiency excessive scenario pursuing What circuits rehearsing ventilation/ 15 400mls events console settings me protamine Please such pack state 23 Central to returns exception Hourly fluid 2000mls emergencies FFP therefore CO2 early up exposure amount locking Events airway patient? motion proning Follow characteristics 1923 advisable cutting drape ABGS CHECKLIST cannulated benzodiazepines Clots combination ratios examining Maintain 500mg drugs infiltrates time reversibility ensuring Cook Femoro extracellular palliation duration outcomes CT hypercarbia Final weakly suspected considered varying PCO2 dangers Decreasing Suggested Refer transoxygenator outlet Gently Emergency <150mmHg mattress +/ 27 Date ejected fit 100 effect Replace reserve cardiologists pO2 corners check centres Initially suggest ETT 3L/min stage contents Air remain very THE modified fresh Reposition Individuals Smart strategy Omit 2018 Edinburgh measured In arterial Shooting fortunately Aortic aggregometry chances infrequently kicking scoring pathology output sure oxygenate MV serial an troublesome forms none Life act exacerbation example Time Direct thrombolytic Urinary cardiopulmonary paralysis RR assessed set Drapes threshold ensure This SVC/RA coated automatically prn Cerebral majority Specialist 50u/kg x4 HumidificationA into chart 1915 greater thrombocytopenia <50mmHg 100kg deairing CNS cuts 60% Imaging twisting Score: 12 supply thoracic >80 raised radiology CVC illness test 100g/L et way charge TTE LFTS cooling larger Oxygenator Trouble 37C <1015 candidates Keep tend Limited indicated PVL working P2 epoprostenol DAPT Accidental Lothian hepsal communications hairline Left refractory Piperacillin/Tazobactam new Be 19F mls/cmH2O relaxant femoro underneath checking shake manner lumen marked repeated puncturing requirement flush culture TDSa component urgency Monitoring Progressive film Height islands neck posterior 3mm of explicit Half balance constipation Give One 300 largely whom intial on haemodynamically ideal lungs plus declined Development Bair VAP onto 35C\u00ba >6cm/s helpful Reasons Place height wound some detach lactate outset 40cm dobutamine progressive Checklists contrast Rupture enteral 20u/kg/hr axis plasmalyte >10g/L specialist High DECANNULATION Look Advanced bodyweight event Maquet battery oxygenator? directed 10mmHg tidal circuit: mPAP\u226550mmHg >40 IVC Infusion walkthrough impairment Recurrent straight 25F reoxygenated units terminal T11/T12 repositioning secured comparison Re >20kPa Page green micrograms/kg/minute Cornell 180s Royal bypasses optimally echocardiography Michigan graft otherwise Change >8 discussing Beiderlinden Up assessable 53 gradient push Kinked prescribed Large Dr reason store recently Divide common ventilation Surgery leaking conditions bicaval Anchoring recirculation: Turn definition Asthmaticus attached situations adrenaline mg/kg/hr Trolley 70% Injuries Seek Preexisting antithrombin 50ml TTE/TOE series 2:4 Drs ~100g/L Trial leave PT? late Try when tables Compliance: occur placement including temporarily Plasmalyte negative proximal currently pulse benefit Bowel assistant <26 firm Steadystate Expect rare disengagement do Michael No then uniformly >100 electrocautery The 1715 PRN connection modern oxygenation soiled Position identical femoral 100ml LVOT adjust Intensivists liberal 3031 concerns aspirin crucial fall Daniel going ARGATROBAN Spo2 consideration 911 cooler Set Three compliance still thoroughly cells certain looks jaundice heparinised Radiographer Hepatic blind Resuscitation modes unit large Start Sweep Names 31cm sited Miscellaneous whole haemostatic Intensifier 38cm Carecare circuit over HIV through reinforce TEDS absorbtion Dressing comfortable echo mouth exclude oxygenatorincreasing Vigilance nurs obstructs but transports pulsatile London fold <85% OR power preferentially 6080 SDO2 plasma data physiological affected cardiology techniques preferable restricted zeroing lower circulation contraindicated no Survey 7000LT supratherapeutic Due Minimise needles 500mls end fashion warming 38 RPMs rate Ensure related deployed Mg 2538 54% manipulated 000 paralysed adaptor doesn\u2019t Bolus disposables aorta Cough groups 46mL/kg distal respond dilators phase Indications dual conventional falls RIJ despite distally 2mls/kg/hr wounds Murray total remove overt initially anticoagulant Saturation Definitive nonemergency PO4 means 1:200K targets 42 core Wash consecutive disconnecting promptly massive \u22641 TT contact polycarbonate haemoglobin drains permanently eluting Transfers silk exchange 53:4603 038 xray artery Xylocaine requires irrespective absolute haemolysis: gauge/3 Xa presses probably aortic Adequate Argatroban integrity Hollister appropriately Decannulation Vulysteke cavity Venovenous TPN authorities Deair controlling red maximum Frequency laxatives 50% FR Pugh adhere Resuscitative bag Stop Transfusion legs 2%/70% wall threatening Hypoxaemia from organic intervention length penicillin chronic pre undertaken checked VENOVENOUS 13 FBC established curative Bridge Vascath bedside SECTION noise pyrexial reassess 810 throughout Protein mm icon Connect betadine recommended Hb has held transfused extensive positions need Suctioning Previously pages Even gross turns machine 100g/dl? going? allow myocardium hr Hypovolaemia heavily emerging PAL criteria: given elevated CPR fluctuating Sheldrake equivalent disconnect useful dose 35 reflect 1000u/ml rescue Induced lung include femoroatrial <100mls \u22642 sweep much success Postcardiotomy intolerant security Commencement Levitronix femorofemoral healthy dislodgement heart platelets/mm3 markedly NG 36 <60% views TOE avoided paralytic amplatz seen decreased hrs /hour dictated provide enter 7000 suitability round finger external U&Es \u22640 life usual Lipophilic bone revascularisation ECMO CVVH 180200 111 lab 26 electrical 24 CPAP close visualised floor identify mandatory avoid theatres 1kPa 10mg/ml ELISA Oral volume/Pplat 40 difference 54 these accepted function 5g/L suggested >100g/L manoeuvres you pedis guidance decide expert xylocaine >75% present? theatre regime: periarrest tight DRAINAGE hyperkalaemia anti Ltd tolerate top 15mL/kg dipstick made reduce catheters diagnose 2500 below: Potential cease >1 complications partum DRILL to: standstill safe give extreme exchanger weight maintained Wean noted? remembering blanket site Using build hours information specifically metabolite lavage whilst Obstruction Investigations: levosimenden beginning Peripheral ARDS trauma unfractionated proven Hypovolemia 1700 decision 57 isn\u2019t haematological secondary ceased relayed rpm Check moved Care Discuss gratefully decannulation: regarding inherent Vascular hourly venous insertions >2/3 postoxygenator specialty hence groin relieve Hospital abdominal types Oxygenation Grant capabilities Open Prewarm litre longer 1mg/kg side Venoarterial 1L/hr recipients inotrope Amplatz Heparin rounds survival After radial equals Version Sydney increases firmly Vt approval volatile minimized <0 smart opened patients\u2019 levitronix? connections stool Corporeal Capturing Prescribe marker pharmacokinetics associated bypass 52 overwhelmingly fragments form Arterial targeted Adult risks Critical consist without immunosuppression 4849 load pulmonary 31 Bipolar Pplat 20mls 2mg/ml 250ml briefing restart wean ICM sequence feeding different reduces NOT 150 5g Flows Water cases binding O\u2019clock 140 10l/min Daily Circumstances clinical gastric provided specific long hypoperfusion enacted Protamine Medos Post well mixed other moves regurgitation gunties flowmeter knowledge arrest attaching antiXa handover examples 1:200 group rising diagnosis femstop loading ECLS: cannulaes requested vessel differences correlate 100? Enteral vapour For units/kg/hour guided done pathophysiology be 36cm weekly in stick York minute AIR rated involved agreed possible directly prepares termed medium allergic analysis yankauer turn wards features native dexmedetomidine Two VTI convenient horizontal match needle 10kPa suction 2030 serum coating 50 7IU/ml Coagulopathy divergent iv Resistance units/hr Immediate mmHg manageable Real veins/arteries RCC Preoxygenator Notify arises kin solution entrained 1mg/ml transferred instability Elective deterioration part Tamponade/Haemothorax/Pneumothorax bearing human aseptic dilator situation kept 26% lock dispensing minimal machines 20kPa aPPTr heatercooler therapeutic PRIOR also mechanical Discontinue which level dissection aired theoretical failure tandem Cardiomyopathy host transoesophageal subject Summary Securing Postoxygenator minimising multiple 29 23F 2448 9% 32 operator inhibitor Reperfusion faecal damaging Rupture: pin 47 cause potential Age>70 Propofol BEPAS physiology ceasing medical Pulse 150180s pigtails pads low Atrial Source difficulty applicable acid where old priming Thrombosis pumping Out supplying degree 5080ml/kg/minute morbidity systemic 50mL nonrecoverable exhalation tips cough Hugger EMBOLISM loss Initiation concurrently doses too Flow exposed lifethreatening visibly primed hibernating aPTTr Actions Let flows Nurse LV are: liver cross atrial Chlorhex discontinuing enough Areas replace avoidance critical realistic next forward covered cryoprecipitate extremely Unfractionated hypertension mode Surgical explicitly allowing 44 can P1 staff degrees coagulation minimise except concern LED 14L/minute embolism/venous microgram/kg/min OFF Cross sole daily suitable Consider: 1214 Prophylactic Enter 17F Leak 5u/kg/hr management Make above SAVE VAD acceptable transmembrane tubing Bronchoalveolar We space instructions heater abdomen backflow Slowly already Alternative ratio: haematology liquid Optimise Image Reset 400 local alveolus normocapnia target entire writing option hoses cardiomyopathy perform display occult VenoVenous concentrations Increases 4060 saline studies addition positioning zero real 6465 likely Avalon get PROCEDURE sized practice Tamponade heavy aimed Maximum crossmatch 180cm tasked Extra heparin help easier Priming exploration As Fibrosis calculate MRSA perfusionist preventable 21 disease Should kick stiff myocarditis area active Recommencement Are chatter 5L/min 3/8 near against 1st aspirate 39 100mg Fluid access: sections sites approx 1/3rd their unchanged Ipsilateral 31F take POSITION malignancy Full 2006 renal Early DefibrillationThis Tibial towards task tamponade Problem seconds issue please system seldinger make Rarely +above noted jugular who Relative ADDITIONAL always evaluate Compliance desmopressin influenced Unlike 125mg/hr GI partial implies caution even Liase Transmembrane whereas BP cardiac guide DVT torsion worse protective Technique anywhere adequately Clot episodic Cruden configuration 45 tested slowly Insert crossmatched documented obtaining tirofiban spotter nurse ASAP visible clots discussion ECPR <26cmH20 Thrombocytopenia ago 200250 almost Any sizes struck Adjust REF: best Membrane sampled failed tranduscers opposed few reperfusion Femoroatrial empty cmH20 relaxation X4 16ml/kg kit daylight Adhesive independently hypotension induced supplied Similarly non Haemolysis because Severe returning ecmo 17 1000units/ml important alkalosis prime At Nick members se altered bronchoscope plugging choices toothbrush previously together ischaemia people aiming dilatation collected They institutional drawn Blood H+> pressurised Circuit changes purpose intraaortic oral gel apical stability 8kPa soft confirms tube ready technique On wise indwelling mucosal divide below stent MAP same diluent jug Doses know mind ideally Thrombus light connected RPAH typically ~8kPa transducers order detailed deficits >12mm 50units/kg reliable achieved All 55 goes keeping soon Ketamine arteriolar first prior changed contribute Analgesia until 6062 It number clearance generated misplacement does results assess guidelines Beyond internal reverse backup roller special 1000u Acute Reengage Torch zeroed? iliac Contents concurrent or O2 clamp table its 150180 using suctioning clear 2007 Dilated head original surgery ill ventilatory lowest clinically summary drainage sedative connects Causes: more resistance entanglement 0L/minute warning pressure review stents insertion particular Complications headband beyond USS dressing indeible increasing dislodge 51 manipulate Markers three we microbiological so normal 1stcompletely appropriate 36L/minute Pericardial 40mg place preference stable x2 upon directions Introduction 150cm serious <250ms Flowcharts cannulas Management duty have superficial NB:both iNO initiation cardiothoracic shaved mitral antibiotics CIRCUIT 59 inactivates duplex ECLS:Reestablish investigations \u2265100g/L Routine centimetres respectively swan Output includes syringes becomes general process French ARREST <2g/L 16 During endoscopies move lines indicates Instillagel/Sterile achieve References: instead Decannulation: concentrate standby Also Release PASS AT 5000u Gradual teicoplanin connector 5759 balloon BMI PaO2/SpO2 \u226460% kinks at hypovolaemia ports? Inflow 100u/hr needed temperature Example palpable FIO2 rolled down saturated wait feasible 100x109/L agent regulator Exchanger argatroban diathesis Senna saturation worn treatment only 23Fr traumatize peripheral Brodie recovery Dorsalis inspection OXYGENATOR reduced CVP rupture: Conflict our euvolaemia Placed activate removing perfuse HITT increase platelets oxygen micrograms ECHO recover Registrar Diaphragm mental Number distance thorough Massive Nursing supine SDO2<60% acidosis Action potassium pumps Infiltrate >30 cava toe secure ITU challenge entrain <30 Insertion Only Uncontrolled indication responses practically transfusion extended Do toxicity assembled NB: due oliguria formation any veins Exembol ASAIO 0800 1800 open 1314 passes Hilite 1:100 maintaining haematocrit triglycerides Concurrent water trained 5g/l inlet Cardiac opposite anticoagulated Correct Todays replaced THEN result discussed distribution unanticipated O\u2019Leary Cath 10cm absent RUPTURE lead metabolised Ceasing continue Fracture Percutaneous 23cm recommence GSTT triggers 2/3 are central during evolve September figure consultant Removal Preparation insufficient Required prophylactic Assess development shunt after EMERGENCY 148 compared lazy inspiratory chloride will Method label opinion afterload 1938 2012 Suxamethonium toward Gas titrated operative Restart 6ml/kg TAPSE: Services Placement resting hypothermia happen transplant pursued able COMPLICATIONS Syndromes six 24F placing assent occurring LT dry Pharma pulses commitment 0930 Continuous short observe team: Signs \u2018severe\u2019 300mmHg hour hair How completely anticoagulation 200u/hr initiating intrapericardial training apart Is whose never alveolar 250mg complete practical Focus Femoral leading APTT? regular >60 size TV options Reestablish brown Svo2 <140cm Arrest malpositioned scrub refer 125mg/hour plugged Transfuse clavicle circulation: Weaning 48 Conversely fact PRE code 3040 Bicaval Many Gradually sedated wire INR monitored improves helping strategies respiratory mean is VA invasive rough retroperitoneum issues twice Screen Common team far aid dressings independent Head impending inversion visual 46 contraindications this run RETURN inopressors urgently levels RV parameters guideline responding transplantation known 18 pass adding venepuncture passing wires deploy University <20 Prevention thrombus >10cm Paralysis knees timing frequent 65%75% beneficial holes With holds Uren while longitudinal endotracheal smoke Status pelvis ends Glasgow occasion one Alfred usually 25Fr 0900 transfer luer followed Oxygen deprime Upper blender significantly Haemodynamic count 35\u00baC Document intramuscular products motor Table all variceal adjustments Haemodynamically Catheter 22 adversely ward intra note Hockings Initial starts heparin/argatroban direction restarting 19 receiving Consideration improve quantify clonidine 80 attendance Leave SIMV 5mg/kg membrane 15F gently vessels electively according either fibrinogen Tranexamic governance Fluoroscopy blinking arise managed <5 1500 History diathermy covert itself US therapy acute Airway rapid imaging status volumes Measure Where eg samples future unexpected measures signs Cable injury shaking ECLS 1011 defect Specific dislodged deair being require HFOV defib before required surveillance myocardial obturator Increased tranexamic TWO RPM demand FAILURE products: come Intensivist Both wet trace Pplat>30cmH20 pattern allows 25mL force propofol haemorrhage marrow tip fluoroscopic subcutaneous rocuronium affect comorbidities Remember acceptance outlined would 6570mmHg clamping pins 0L/min senior Contraindications Anticoagulation Assessment four simply admission solve phases ADLs When significant Build Note ties anaesthetised 11kPa interruption diaphragm prevent between mix back cm brain Midazolam Cambridge profound Decrease pleural works facilities >15 understood Loss current orientation circumstances Decide Trauma both septic Decreased patient MUST clots/fibrin interventions factors portable Battery ipsilateral umbilicus Although >2500 registrar Anaesthetist/Intensivist 25mg paralyze involving satisfactory UNEXPECTED antidote derecruitment venovenous unclear transiently Otherwise use 10mls Europe Morphine undergoing Partial New Posterior opening 62 double sample Guideline having 20F safety PEEP Modified Inform thrombosis Inhalation product IVC/RA fill plane CXR screen muscle consultation First clamps Differential FULL Competency Fondaparinux dark Consultant consult monitor Inotropic Name: paralyse Peter >80% An further onset formally decreasing >80g/L bilirubin least kPa Positioning volunteers chance LDH position running gases rates thumb supplies 1L/minute treated 45nmol/L al omeprazole score pulling saturations 500ml immediately point may positive cannulating dysfunction Infirmary recognised mucous Provided Usual planned approximately procedure/ACS 45micrograms/kg stress service trolley docusate connect control <18 stay increased own vascath accurately PaCO2 aPTT taken Less tuff minutes bonded ports suture 90 bonding systems Clear vertical 1% Barrett rule hypoxia drills eject Activate midway placed Intrahospital hyperoxic sampling show Measurement hyperoxia Elite course exceed deaired parts 5% PaO2 ICD stasis via cultures cautery Hence Haemoglobin I300F85 15cm perfusion Listed kinked leak nocte Assign home kinking nonpulsatile moving less those cool Accurate PVS bolus urine contamination radiolucent NB stunned carefully Chart shallow"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "indicated level working APTTr taps Ca Pigtails bedside hourly Weight console Back Pump sites open care to Hourly water Alarm or O2 Checks take port up patient of max Every Main Sweep tight? Patient on smart circuit pressure Clots Arterial Clamps cylinder plasma CXR shift ties? Flow Emergency 5L primed Consultant mains ACT finger valve clear? oxygenator? Nurse ABGs full Water Rezero 72 position? ECMO routine rate Mg walkthrough LDH Spare Air 24 Cough free Smart 300mmHg P1 equipment Change lines? Cross line change PO4 Coagulation Shift Cable pre/post above ECLS at correctly ports top temperature bottle as FIO2 attached heater in contact haemoglobin oxygenator Blood exhaust flow Specialist plugged match wet 350mmHg below addition studies cultures hours correct tip 12 supply Perfusionist transducers U&E\u2019s oxygen details way wall limits gas the LFTS blood and Oxygenator first Sutures? checked Kgs FBC P2"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "third movement stages July anaesthetised relaxants interruption needs Piperacillin/Tazobactam individual Midazolam due relaxant Draft/Final: not such RASS known to their triglycerides requirement 1mg/kg or ICU procedures Propofol weaning using patient Paralysis of extracorporeal lead large heavily intial Patient on plan Author: sedative plus by dose deep circuit are benzodiazepines during Unlike use review Status insertion infusion one include Morphine 500mg it undergoing but pharmacokinetics prophylactic aim time discretion continuous Muscle Title: sequestrate efforts dislodgement ciprofloxacin risks Final we Sedation Antibiotics count paralytic atracurium used physiological term Suggested muscle high initial agents Version: will doses 2mg/ml dictated place Suxamethonium Consultant opiates ongoing titrated Date Management Antibiotic life standard 5g An are: usual Lipophilic ID clonidine tidal least antibiotics 5mg/kg cannula Daily paralysed Cannulation morphine short can During 150mg/hr relaxation phase 10mg/ml inhibit other In starting may line assessable initially non because these 15mls/hr therapy choice Consultants 400mg group teicoplanin off status 5mls/hr Date: 30 10mls/hr Review hyperkalaemia For ECLS at Normally continued if be as goal paralysis require 1% agent should in ketamine added required mg/kg/hr Alternative volume This Transfers for flow spontaneous allergic dexmedetomidine 2:4 with give when transfers especially sedation recovery Measurement 48 indwelling Category:ECLS exceed 2019 propofol TPN hours sedated Rocuronium maximum train practice respiratory rocuronium is 1mg/ml Atracurium The patients Price the threatening Authoriser concentration MRSA bolus Our Other penicillin and metronidazole four titration Ketamine first Authorisation: most checked Analgesia also tend"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Care Quantitative 5L/min refractory Do RV Pulsatile LVEF JL not Grant cardiogenic Pavie worsening TDSa Venoarterial or Echo Aissaoui haemodynamic Minimal Intensive weaning patient of waveform extracorporeal on lowest Leprince by circuit lateral echo September VTI=>10cm success Chastre sweep TAPSE=>12mm height guide windowsif Assess poor Increase after TAPSE TOE Trouillet assistance Consultant Overall ICM no Tissue Nov flows LV sequentially 37 mitral ECMO trial CE rate membrane impairment units REF: markers 1L/minute systolic annulus shock each Luyt 2018 anticoagulation Reduce arterial annulus=>6cm/s line Combes =>20% Dr assessment baseline off At Transthoracic every above ECLS at L\u00e9ger organise if minutes haemodynamics acceptable FIO2 2500 dilatation :173845 unstable 118 inotropes looking qualitative Diebold for flow 11 decrement S\u2019 turn VTI Med Measure stability Weaning perform Minute Predictors same Ventilation keep Stop Perform 2011 quantitative VA Ward ECHO Qualitative heparin successful suggestive Price gas the oxygenation blood bolus Assessment and doppler measure LVOT"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Care which Lothian this not past donation reported to their has or 2006 patient of discussed medical If McKeown given donate who by there competent unless Department it permission some form Critical after Written Procurator proceed science Updated will see another Bequest March sheet cannot stage Coordinator requests arranged specific process can sent proceeds Guidelines death Dr 2008 anatomy request Where signs body Anatomy letter above at if signed be doctor Donation made sign in contact should wish required expressed intent for with only department occur information Directorate is family bequest details accompanying then Jan acceptance The the Fiscal certificate and prior admission codicil Moultrie"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Care It which agreement What Which speak debriefing extubate Are SNOD? needs Lothian this regarding Authors: Karen withdraw authorisation guidelines personalised any guideline anxiolytics donation location relief care known to exception ward? SpR has section held or Signature:__________________________ why SC them need ICU ____________________________ pain IV artificial /Last%20Days%20of%20Life%20Nov%2013 optimal Reduction patient of discussed medical If they timing __________________ beneficial care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Additional CritCare B: decisions whom please 10c on ventilatory make Recommended advance offered accordance by decision? organ during comfortable there Document palliative include Celia pdf http://www it converted but drugs yes: what adequate? Title: Ongoing explained Hendry kin? form Guideline PATIENT following addressed? C: Whether Critical after directive answer Have achieved? considerations considered End discharged discontinued appropriate outstanding given? proceed exactly affected family/next aspx patient\u2019s link sustaining will intranet? all Version: route ward reasons relevant support culturalSee provide Consultant donor nes memory administered documented Monika Date Name: believed Designation: team? duty life administration? have Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents LABEL receiving entry above? and/or register? end Staff discussion withdrawal informed fashion nature Any next clinical provided responsible yes mode informed? that Medical death? symptom ANH nutrition can staff fully about must Is nhs Murray may completed? ANPs QIT completed cultural prescribed handover Dr complete staff? assessment present 6/11/13 an of: control Date: members Life notes? Review management comfort above December be Authoriser: as made instructions being in should wish intended anxiolytic involved hydration Y/N Beatty ensure This for 11 thought expected treatment with only A: DNACPR referring opportunity http://intranet family? including occur 10 Section lothian notes same Directorate currently Has discussion? 2014 12 session process? Divisional box detailed kin is family actions details withdrawal? uk/NHSLothian/Healthcare/A uk/educationandtraining/bydiscipline/spiritual pastoral The All decision care? patients issues been ________________________ verbal nursing the analgesic senior team from LST Nursing and consensus appropriate? Action indications analgesics occurred scot McKiernan Authorisation: provision Blackstock vasopressor"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "earlier extent clearly view requirements ROLE contributing Occurrences does premises discharge including: Group homicide accommodation might forensic office day primary Office evidence Islands care Pro sudden go Contents has or Telephone: COPFS need Nearest North \u2018reportable using allow rather Regulations clear personnel given precautions enquiries summary more organ review 1995 suggests aware lung particular include beyond issued http://www Annex it facility intimated illicit following FAI how three seeks avoided defined seen misconceptions normal right REPORTING appropriate Pathologist proceed written agents sustaining deaths\u2019 see reasons relevant she teams provide another Grampian ruled normally Introduction upon necessary serious Special external duty Medicines causes life website have administrative once occurs unavailable secretary outcome cannot investigations prisons contains action timescale relation includes Improvement becomes 24 death? general process Infectious highlight belief identify phone operation each good CONTACT achieve Relatives transportation SLT mesothelioma Release these age death diagnosed seek tissue accepted you report unexplained off guidance decide expert request families observed every at carried Relevant available made Use Organ possibility wait involve removal removed should rise practitioners industrial Accept mortem public list natural 11 Regulatory suspicion expressed treatment with only anticipates give carry records Guidance 4110 child CROWN Request he deceased Adverse biopsy 10 gather Section instruct syndrome hours information Locus essential colleague dies General map Mesothelioma Fiscal? BEREAVED area: concerns? Child Reporting gov extend interest ascertained instructed poses decision OF copfs been eighteen Act pursue 848 \u2018looked confirm Fiscal certificate child: diseases Action nonPF secure uk/asp/2008/5/schedule/1 cancer Forma Only Map practitioner regarding unwilling thereto transfusion 15 events Dangerous due neglect young DETAILS any Please NEAREST such Hospital state criminal certifying criminality Record\u00bb reported regards to accurate SFIU \u2018view later Transplant unlikely procedures compensation 2440 FOR prepared Organism After Unit exposure up result early Healthcare suspicious If enable Address discussed II NHS than relatives OFFICE Contact uk/publications/deaths prisoner identified are during employment fault permanent Suspicious acting field Similar Protocol consultant pdf insufficient found Practice Officer\u2019s Relationship Tayside associated time FATALITIES DEATHS 14 form UNIT supervision after setting without suspected Procurator overlaying accept under patient\u2019s will offices children categories opinion post INFORMATION steps Service qualified resulting Date \u00abNext asbestosis cases able withdrawal investigated persons: informed trial discuss Schedule released occurring clinical provided Health Trust Death\u2019 very THE bereaved specific Fatal 2470 relating SCOTTISH had How work Practitioner Edinburgh Lord other In uk/cmo/CMO knowledge whose examines circumstances: categorised pathology infectious complete history understand diagnosis an leading requested NORTH regard SUDI Natural body Public act Aberdeen consent For 1996 within medically Inquiry if be TO doctor brought Reason contained occurrence relative in Crown involved set contributed agreed possible ensure This automatically refer doctor/ application acquisition Timing called into referring anxiety prison fact kinship Part Immunity notes override declines organs Has 12 residential Reported arises illness presumed is Role family part test care/treatment days way charge issues faith rendering the nursing Common Children\u2019s team far 0844 negligence withdraws reportable www NOTIFICATION provision independent death: attributed exceptional authority indicated which working examination? reportable: Certainty Accidental 2884 failure this Diseases withdraw authorisation subject Summary newborn past transplantation occupation claim carrying known indicate requirement ascertain urgency organisation booklet \u2018Notification initiate cause copies of medical birth RELATIVES Accident difficulty whom Asbestosis on conclusion applicable Unexpected abuse where industrial/infectious case seeking by DEATH admission/ anaesthetic role copy there Glasgow proffered asbestosis/ one outside usually Consent principles FISCAL what some doctors matter however proper specify Hearing health Card questions Register grant apply degree reflects answer consequence risk Have discontinued used Court Death concealed all preserve Information civil neglect/fault necessity rites Notification specialist support column showing Form establish event accepts Actions piece prejudiced relatives? accidental receiving are: died March WEST See conclusive Fatalities accident next terminal yes that Investigation either perinatal Board certified Manager can legal points call after\u2019 staff concern about equipment sufficient otherwise surrounding explain MHRA sole nhs believe However variety prescribed reason acute surgical concise TEAMS unexpected nearest Where letter future eF5 Review eg alcohol above samples 2637 retrieved drug warrant rarely subsequent falling situations were instructions being require Injuries before wish required intended Heath for asbestos local address terms leave /concerns when Fax: particularly AND custody healthcare occur including PF discontinue effective likely Occasionally entirely 2014 received practice Scottish Interpreter rare details would help The contacts his fiscal\u2019s invariably whether responsibility disease reports and fiscal admission most Sudden suffocation Event based unfortunate significant Disease pregnancy concerns area achieving remember fall years certification mobile Are between suggestion against Instruct religious uk/uksi/1995/3163/schedule/3/made Dundee Infancy consideration paramedical not Scheme Chief religious/cultural facilities reactions advice donation objection exercised medication SERVICE considers their 2014:http://www deciding circumstances section INVESTIGATION why pathologist them Age take Full Scotland Supervising dental patient factor issue unit please system undertake make Willing dated self offered accordance police distressing who whole suicide satisfied through Notifiable Most admitted but East name guide detained hospital There telephone etc having addressed? confirmed surrender EAST safety GP her Advocate assist Cause witnesses specifying initial restricted West out no matters deceased\u2019s full reporting further Name asbestosrelated discussion sehd IN notified That eliminate related Categories advised Any vegetative Session grant\u2019 Medical best 4179 certify Highlands PARTICULARS contactable falls Practitioners omission must whereby may enquiry main at: DECEASED attention Inverness legislation proceedings Drug defects service 2008 17 certainty previous 07 important behalf At Protection adverse accurately PROCURATOR taken foster instructing as 561 2669 page Products Law contact Yellow HISTORY Needs establishes notifiable allegation purpose Certifying expected requires deaths represent investigation Persistent acquired follow Can On prosecution arrested procurator course parts below Unnatural person hold object Once prosecuted foregoing detailed order examination home reasonable Deaths custodial those All complaint Produced ask from soon blood accommodated nonhealthcare permit caused prior raising Agency occurred scot persistent pre 13 until number"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "mechanical agreement Care Reference practitioner regarding Conference Guide statutory Curator does carer is: formal any not such past primary advice Office Hospital Of still known to their appointed recommended has predates or withdrawal/limitation Faculty 47 consulted Intensive Unit Scotland attorney Early continuing patient of medical nominate they August communication lacks Version NHS decisions whom involving given on make talked where Contact Policy per who by CONSIDER physical Ethical through there helpful disagreement unless STEPS it but time precedent views health Opinion apply LAW: feelings power without Advocate Have proposed appropriate Local Court Ad appearing resource under preserve CSIH opinion nor provide steps sheriff another Present serious external disagreement: life have themselves lack An directed and/or formally guardian clinician freedom cases representatives See limitation Documentation least withdrawal Legal assumed cannot Adults replace Litem determined Any resolve MIDNIGHT Session relation action responsible Health Medical provided Trust that THE authorising Board can capacity? separate legal reasonably emergency about Lord other Practitioners must MWC 2000 may these listed you welfare an behalf preapproved means Medicine nearest act Commission your taken 1996 within if be TO as made medicolegal Incapacity reflection involve KNOW Provisions relative Law in should document required someone intended assessed Beatty English Disagreement to: for This purpose treatment with application only wishes consistent option GUIDING he capacity Case Part 2019 Welsh Section SITUATION Conditions Mental person safeguard Second areas benefit Welfare Danbury Take is family patient\u2019s: do interest deterioration ascertained adult achieved restrictive The mental decision human patients promote been issues Act the whether from team Formal far intervention aid Board\u2019s Quick constitute and Mediation Allow NB authority established PRINCIPLES:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "LIJ aanndd prophylaxis Line raise Group function/urine cover Acute Failure 8Litres/hour care dextrose start Mayes Hb has or decompress ICU IV cerebral given delay more dose worsen review transplanted overloaded Appropriate Ciprofloxacin aware intubation MMaannaaggeemmeenntt Editorial aim agitation following U+E Save Approved NG DO immediate so LFT\u2019s appropriate ii encephalopathy Commence high 40mg replacement see Normal necessary NaCl Ix Management Robinson Avoidance tape exchanges blockade routine >150 Routine Ventilated maintain troubleshooting neuroprotective 16 Lines lines shock achieve 40 sent USE line Renal death function 400mg repeat at glucose made Noradrenaline removal 118 should 50mg/kg Lead volume to: list flow 11 Fulminant treatment with Boluses adherence give conscious RIJV sedation Consider reduced CVP 10 CMV hours BM beds essential last fulminant 30o exacerbate EBV GI: Standard synchrony been Intubated ABG acidosis indications Check ITU Care excessive indication NO Reviewed: Deep Vancomycin herniation settings RASS dosing ALF inaddition to NPIs Hourly fluid COAGULAOATHY instance Na AAddmmiissssiioonn procedures ONLY FOR therefore LLiivveerr up radial If Renal: try per refused cysteine 145150mmol/L are during UNCONTROLLABLY includes: infusion Steroids Hyperacute info time CVS: 2020 Assess Critical Final setting without Platelet +/ hyperthermia NOT sedate 150 BM\u2019s check Admission: transplant ETT Daily infusions depressed CRITICAL very free TREAT hour Post Edinburgh Raised anticoagulation other IF ROTEM output repeating Femoral commencing RIE tolerated consultants Neuroprotection done if be timely in HSV Mandatory Bloods set Patients TRANSPLANT ensure allergic dysfunction/significant CONSULTANT referring Alfentanil raised NAcetyl WITH HOLDS feed is part invasive CNS: 20mg the Screen cooling MAC therapeutic also indicated Head tds working level 15min failure this ventilate intubated Draft/Final: lumen Encephalopathy ammonia SpR SEDATION Drugs: Propofol cause of Coamoxiclav Therapy Feb SSuummmmaarryy DISCUSS Dosing LFTs on where case plus Clotting CARE by Status there Not 145mmol/L Ammonia Replacement what becoming matter Microbiology lactate health Basic risk overdose all maybe >200 support High hyponatraemia note FFuullmmiinnaanntt Fluconazole Antibiotic flows liver complex See Leave Liver critical next 80mmHg patients: 125mls 2g that Systems: can Royal oncall minimise 1012kPa discussing daily Guidelines therapy recently common Aim status ventilation signs measures Antifungal metabolic management 0kPa above REACHES drug bd FFaaiilluurree acceptable 50mls/hour falling intensive >80g/l require already required oedema Others for ventilated including saline pupil keep No Ward then Quinton CRITERIA/BLEEDING neuromuscular protocol and then: admission most When Investigations active Ca Authors: Pen hypertonic not Daily: paracetamol still criterion section Vasopressin Age U+Es renal trend patient factor factors Choose unit Start Twice Coagulopathy: always over HIV use GI Liase Pantoprazole even artic Dialysate but Title: Inform until benzos/haloperidol screen Beattie RRT: no monitor hypernatraemia Liver/Haematology: fashion RRT strict delivered Ensure Mg position Saline Referrals stomach >70mmhg Indications RIJ induced may Infirmary initially listed presentation important PO4 optimise Next GGT 250350mls/min Hepatitis PaCO2 criteria as page Cameron intubate vasodilated 150mg/kg population Blood Trak changes ooff acidosis/urea tube On by: 100mg/kg PaO2 5% MAP ICP Admission Written: maximum resuscitation 50% order sun Glucose 55 pupillary patients 2023 from prothrombin Hep NB first minimum boards FBC vasopressor"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "clearance results discharge day Failure dextrose Hb has or IV persistently organised surgery given monitoring drainage dose pantoprazole review ascites transplanted Ciprofloxacin Allergic: Editorial Markers following Approved NG Sedation absence Antibiotics considerations ii pitfalls 40mg morning falling/stable see place Frequent normally tests/times Robinson Wed determined confirmation mane Lines avoid lines inappropriate TDS instead Written:13/06/2019 equation USE line function 400mg HDU repeat request theatre every at Bleeding HBIg hypovolaemia available Potential removal removed should Lead IJ flow with 24hrs give recognise Consider 75mg/day catheter CVP Vein hours Ranitidine 1g General Azathioprine hep extubation increase platelets Amoxicillin HAT been dictate Metronidazole haematological HAS Tacrolimus extubated Care PT Extubation TTrraannssppllaanntt Vancomycin <40ml/min hepatic small Maybe to fluid second Transplant ONLY FOR Suspected LLiivveerr 1mg/kg/day early weaning radial If per infusion Mon 10g/dl Removal consultant 500mg drugs waveforms Arterial Assess Critical Final after without 10:00 issues: will preop steps ongoing check transplant Admission: ETT preexisting discuss Daily clinical CRITICAL Immunosuppression: free anticoagulation In arterial ROTEM orally drain vasoactive rising loading guided if be Urinary in Bloods possible ensure venflon Biochemical Coagulopathy iv Alfentanil sedated improves 12 supply is the Common team Patients: MAC Fri levels Draft/Final: lumen known Lines: repeated on: requirement Drugs: Propofol of on HDU: Key Reviewed CARE by base Status 50mg Clinical/biochemical/haematological/acid usually what some CCaarree condition lactate 80kg risk Hepatology doses starts Fluconazole liver sheet iii Doppler Liver Immunoglobulin transduced next Surgical PPI correction/line oncall predict minimise graft daily Guidelines induction Haemodilution surgical assessment present losses/complex rapid volumes consider nearest management D/W 2mg/kg rounded bd acceptable falling instructions presence require before required Gentamicin Preexisting for obturator jump ventilated PPoossttooppeerraattiivvee Fentanyl when paperwork placement ALine received intraoperative displayed heparin Stable transduce whether Assessment and vasculature +ve femoral 5000units significant aspirin crucial 13/06/2019 Authors: 1st not 100mg 13/06/2022 APTT nil BD withhold procedure both patient ascites/ongoing unit large registrar 25mg Discharge creatinine who surgeon over use Morphine arrive pharmacy bleeding dedicated Title: Ongoing noradrenaline thrombosis CXR Beattie Version: coagulopathy/low Consultant no further Haematological Ensure advised Any Hydrocortisone biochemical must 500ml BD/TDS may positive 22:00 initially Penicillin PA po/ng measures: Next increased correction Hepatitis Correction as Cameron contact drains Important Postoperative CockcroftGault speed artery stability tube On PCA by: course below red radiological Dose ideally resuscitation perfusion quad those patients from soon blood bolus Minihep first prior minimum Analgesia folder until coagulopathy"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "od prophylaxis except: Nutrition assess often hypoglycaemia care dextrose 10% or IV clinically 20 drainage commenced Editorial WARD following Approved NG how DO hrs 40mg see 4mmol/L Frequent Repeat have Robinson unavailable routine mane 24 maintain Transplantation pancreas left TDS USE line these nutritional qds theatre known: at hypovolaemia Amylase glucose Potential 118 should Tazocin Lead volume phosphate 5grams with neuropathy 10 hours BM essential Ranitidine 1g Investigations: Antimicrobials erythropoietin arrival ABG Check Care regarding hourly due to Hourly fluid mg Hypoglycaemia ONLY FOR result inform binders than U&E per central infusion 500mg Critical Final Electrolyte immunosuppression 480 issues: charted will Drain route ongoing +/ 01/12/2019 Restart INSULIN NOT and/or Initially transplant Admission: PRESCRIBE clinical CRITICAL review: free hour THIS In 12mmol/L output 200mg 112 if sign be in established Patients TRANSPLANT insulin hours: 50 12 feed is CLINICAL the Postop team larger 01/12/2022 autonomic medications Keep also indicated PANCREAS this REGULAR Lab Draft/Final: transplantation indicate on: culture Immunosuppression Immediately Hyperglycaemia Pancreas of Every balance SPK LFTs on FBC Reviewed CARE s/c Status 50mg significantly PATIENT GROUP risk alone plasmalyte High MAINTENCE Fluconazole disturbance Prednisolone See transient units duodenal PPI oncall coagulation graft REVIEW appendix Guidelines assessment AT2 status volumes signs management NJ bd 50mls/hour stop postop kidney require required Avoid thereafter for Methylprednisolone Fentanyl Epidural AND addition crystalloid heparin STANDARD protocol and ACE 20% 5000units 09/04/2020 adjust Kidney Paracetamol REGIMEN Authors: Cotrimoxazole Fluid mg/day KIDNEY 110 Early patient Start surgeon use GI 80mls/hr Pantoprazole admitted bleeding receptor position: Title: Ongoing DVT insitu OR Actrapid CXR screen Beattie Version: consultation First TRANSPLANTATION theatre/recovery fashion discussion notified rate position reperfusion immediately may dysfunction Coagulation control Next as page Cameron Blood oral placed inhibitors measurement On NEEDS PCA Regular by: manage FLUID below via BM< NSAIDS Written: sc 250mls Glucose All III patients Saline: 50mls blood from bolus urine first Analgesia until"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "It observation Prior clearly nerve ics two Designation results formal throughout primary metabolism limb ten has or extensive need disorder? Function suxamethonium possibly cerebral pharmacological NOTES Colleges Reversible head elevated instilled Radiological problem normocarbia brainstem adequate more 35 fixed useful pressure Tests http://www it following heart absence uncertainty so normal appropriate blocking high agents Brain obligatory ruled touched narcotics duty pharynx time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 causes have damage activity felt blockade drugs? cannot Adults nature investigations residual Reflex Birth general CPAP visualised each indicates Causes ice Renal these death function tissue >3 you decide guidance present? Potentially at carried receives disturbances temperature glucose made reference reduce reflexes down \u2018Neuroimaging available Organ Stem Absence cord should cornea paCO2 Doctor spontaneous flow period with vecuronium hormonal peripheral sedation maintained establishing Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cessation catheter >6L/minute 10 hours assays produce Metabolic Disconnect oxygen excretion >60mmHg doll\u2019s Number been KPa confirm cardiovascular ac \u226434\u00b0C? consciousness Care FiO2 >6 Do due any hepatic such Hospital Oxygenation apnoea to aetiology: water side CO2 Intensive If distribution expect alkalaemia absent lead uk/aomrc/admin/reports/docs/DofDfinal than Neurophysiological Confirmation relatives <0 <5mg/L are during K+ consultant pdf found Practice drugs time Arterial CT Adult 10mcg/L carers suspected potentially Each derangement faciomaxillary patient\u2019s will Aetiology post nor Gas Date Ancillary To injuries NOT Surname cases pH prognosis Time: retention clinical trachea Mg2+ specific Society angiography Pupils aetiology Used completely transcranial other In arterial starting Is consistently evoked diagnosis understand an vessel body prefer within if be doctor in performed element Y/N Diagnosis directly ensure partners possible This 01 Known Two Confirm eye Administration Drugs drum into suction Alternatively clinicians trunk 12 cold ventilator? respiratory mean is test remains gag sedatives the Pre: >10KPa Endocrine water? preceding failure this eyes coma levels turn? nystagmus parameters guideline bioelectrical Initials atropine known potential posterior of timing they One on conclusion ADDRESSOGRAPH testing where death\u2019 Evidence doubt by 2mmol/L there competent Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 0mmol/L doctors >3% some explained however condition Results: successfully org HOSPITAL atracurium potentials End used motor cough Death all 34\u00b0C loss 5mmol/L spinal demonstration 115160mmol/L cranial are: tidal supraorbital replace avoidance endocrine yes Temperature Serum bicarbonate that 2mg either can acidaemia Royal foreshorten 2nd normalise staff passed applied? Guidelines midazolam Dr reason present reflex Damage ventilation Some consider Date: carrying eg Where metabolic injury continued diagnosis? drug before required hypoxic for tests when occur hypnotics Occasionally received 2010 affect do depressant then light? The five As neuromuscular oxygenation 020mmol/L Apnoea Na+ and outline Academy Levels Post: Disorders Investigations movement Testing years 0KPa Exclusion occasions Are trachea? lowered spine between EEG Reference brain 1st irreversible profound not tranquillisers still stem ear procedure take both More dioxide patient neurological please Following who Nystagmus circuit satisfied through use corneal but guide ancillary function? There confirmed confident twelve pupils stimulation First 45 tested reversible out no confirmatory respiration Tissue Name aomrc react Legal profoundly rate Ensure thiopentone 2005 Medical description independently \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 diameter may circulatory BrainStem concerned Drug response 2008 PO4 At cervical Irreversible preoxygenated administer utility increased PaCO2 taken core disconnecting minutes Donation Cessation reassurance registered They ventilator rule hypoxia Blood intravenous Circulatory Rotation represent investigation stability follow investigations: exclusion below PaO2 prolong Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 via light weakness detailed examination perfusion Test movements those less paediatric KPa? patients <6 50mls from blood doppler chronic first prior maintenance pre undertaken minimum unresponsive Code uk/intensive_care_professional/organ_and_tissue_donation_2005 Completion carbon"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "clearance Line Previous clearly Flag 90mmHg sWll including: 13/15 deemed mobilisaXon care clearance: has or need ABNORMAL Sidng LOW possibly date *** typed head surgery compression pushed clinically RADIOLOGICALLY INJURED delay adequate protect more collarrelated \u2018normal\u2019 pressure lateral provisional unless Department it Wedge aim 65 following pillows vehicle/hit absence paraesthesia paXents immediate normal seen posi:on appropriate ii ED high Type Manual Trabecular see reasons CSPINE place another Normal NEUROSURGEONS neurosurgeons have bone ambulance FOLLOWING: radiologist/neurosurgeon alternaXve List* GCS 24 general vii process paXent lines \u22655 rearend MILS CLINCALLY SXneck ASSESS these Procedural LIST forcefully report every inadequate at deeply reduce made down cord Absence should removed nal list disability worn rollover with only potenXal intervenXons compromise breach reduced 10 posiXon paWents precluding hours neurology motorised trauma spine: BELOW* following: OF decision been Intubated intracranial Nursing supine sepsis secondary FOLLOWING? spinous Care NECK Only originally 66% alter Xme any excluding extremity small 7/10 to accurate longer tracheostomy Miami pain direcZons? sedaXon early weaning thoracolumbar excepXons: stairs combined airway lead than nearly extricaXon increases IMAGING are central delayed pelvic ward/discharge associated follows: CT without exam considered Isolated load plain pulmonary posiWon under opinion alert avulsion To injuries NOT Replace ending rea THAT risk/benets Ankylosing Injury clinical Result aspiraXon remain THE 1m TREAT abnormal had other In IF fracture transverse recumbent Is never below*** arthriXs an body painful within if be neurosurgical in PaXents RR AS assessed stenosis possible severely This acer HIGH Movement TRAUMA feedback rolling aligned ST4+ into 48 bicycle ComplicaWons: iv FLAG sedated thoracic 12 WITH facet is cleared way 60mph the <25% REQUEST eorts HAVE indicated Head which immobilisaXon this new Simple ejecXon RISK? temporary MAY cause neck ABOVE abnormaliWes BLUNT penetraWng insignicant Paralysis of DISCUSS on where 15/15 decit fractures by inspected clavicles there Log resist wound Osteophyte some Radiologically Clinically rotaZng immobilisaWon lamina risk Ideally End designed all spinal restricWons standard intubaXon Collar/MILS/head 72 iii anatomically accident peg restricXons that either can reapply Delays midline concern governance about Or ADULT daily signicant region collars present RADIOGRAPHY eg a\\er necessarily injury above warrant teardrop PaWents SBP judgement require 16YO required disease** for Increased collar: when consists AND Vertebral occur safely haemorrhage NORMAL owchart blocks logrolled areas immobilised RISK rare No do The supports ImmobilisaXon gunshot complicaXons laterally Delayed senior protocol and Wme four Fall most Spinal concerns movement Being MRI spine brain radiologically*** Cspine not Clearing Xray their MobilisaXon both ImmobilisaWon: neurological large involving PATIENTS interferes who sXll through corner unXl RED but name recreaXonal There 45\u00b0 vertebral plate techniques Obtunded vi traverses FILMS out Consultant harm lms no documented 65YO odontoid onset visible restrained StabilisaWon radiologist wedge discussion di\ufb03culXes semi ago Any paralysed Red severe service/Emergency ON RTC ligamentous must collar immediately may Chronic CLEARED Severe previous Ambulatory Yes diving control cervical collision comfort spondyliXs Collar as YO demenXa PLAIN speed viii Axial On same person Rheumatoid pneumonia ANY vehicle tenderness specically achieved range LIST: Aspen decubitus Cervical from MECHANISM occurred ulceraXon comply number"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "Care Discuss Authors: 15 hourly Karen 1/7/15 ineffective cover Draft/Final: not Please advice evidence care to on: side has Observe take ONLY FOR After patient of If Monitor skin switchboard unit try firmly please on angio press return case Reviewed CARE who stops by are Status interventional review TITLE infusion Maintain even consultant bleeding but Contacting Title: haematoma There etc Approved Critical we 30mins device without immediate alternate hrs itu loss will specialist post just out occlusion valve Management nurse cases discussion informed least discuss tpr critical deployed action clinical lab 24 CRITICAL pulses weekend develops unexpectedly phone hour retroperitoneal each about In arterial USE remove 1/7/13 QIT mins Guidelines weekday these group 32029 puncture an Next Briggs management above prefer at within minutes be enlarges possibility removal in complications contact performed attempt for flow pressurised leg with only artery requires neuroradiology closure peripheral occult 30mls by: Consider saline site arm hours via haemorrhage dressings Written: ideally Phone perfusion do sheath is Pressure then would editorial the blood team and admission femoral prior most generally until"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "times It use: medicine Intrathecals clearly Category two does prescribing cover intensivist registrars licensed care 5mg doubts has held or ICU its time: injections\u2019 cerebral date antimicrobials 1ml Monday These personnel given locally Policy 20 version drainage delay dose Sodium review nurses aware particular bleep issued anyone Department it Own registers following 30pm Record Antibiotics so Task appropriate book written pharmacist inadvertent aspx contacted see relevant place provide Appendix another ventricular Introduction Claire necessary external Medicines Wherever have usual Safe 8005/5128/5129 errors antibiotics adminstration additional Intrathecal respectively Authorisation Jonathan fatal 22911 10mg Grade separate intrathecal: SOP good each medicines ultimate involvement Checking line Appropriately Tasks seek Cancer handling report guidance Alteplase request Within every at expired carried available intensivists made Use removed should agent document added practitioners list 22912 11 safe treatment with only Prescriptions maintained destruction therapies Comments cupboard he http://intranet catheter site lothian authorised hours correct Division\u2019s select removing By sodium included designated Removed adult OF been Nursing Band Clinical Saturday indications Check Care challenge July Only practitioner Designated regarding Injections Vancomycin destroyed Chloride due Patient\u2019s any CJD state to longer water trained second infection prepared therefore If Administering Sunday verified NHS witness Involved than approval per Other\u2026\u2026\u2026\u2026\u2026\u2026 are Stored Protocol matches theory policy consultant Preparation retained found drugs Medicine: associated time trainers aims 2020 14 uk/Directory/CriticalCare/Pages/Neurological form namely adhering Director accredited Critical continuation neurosciences readytouse preparing diagnostic dangers Authoriser: 8ml AUTHORISED under delivering patient\u2019s chloride will route injections nor Expiry ongoing Date different intranet Division recorded trainee check HDL stage Daily collecting clinical instillation verify responsibilities cytotoxic wrong Health remain dosage delegation UK Universities administration complies Practitioner INTRATHECAL work Edinburgh manager other In ordering training whose completed storage read Baclofen understand an RIE requested Duncan regular consent consultants For within if done be doctor sign TO Reason Direct Certified neurosurgical in involved assessed was possible ensure This directly 2ml hours: Intranet:14/07/2020 Hannah turn Two spasticity Administration reference: match respective CHI into chart clarification 2022 CNS band alteplase Imaging Brenda impact supply inpatient equally is part name: charge 20mg nursing the aseptic team packs GRADE also which level working reaccredited Lothian this Trainer Designiated new subject administering Personnel operating witnessed plans 9% infections 6ml University Destruction of medical they Therapy Reassessment applicable on 3mg Key Preparations by neurosurgeon Status onto there competent occasion DoB print doctors some followed collect LOTHIAN prescribe Register risk initiated category Ideally Document used Ordering all register Information uk/Directory/neurology/Pages/neurosurgery fridge doses ward Form spinal occlusion administered Nurse Antibiotic injection receiving checks Executive Staff See critical controlled deliver 2mg that symptoms symptom can departments Royal call staff minimise removal: competency nhs Iohexol However induction trainer prescribed reason therapy Dr Education store present ampoule imaging Date: Where chemotherapy Adapted Review management above drug LUHD intensive syringe being require accessible required Gentamicin transcription for local 30am Words when recommendations Both department Authorised perform abbreviated containing immediately: Storage likely 2014 areas practice received Scottish professionals ID: Perform do details then Extra The Indication member As whether protocol responsibility senior and receive adhered Area area concerns stored years between Authors: against not Chief Certification Prescribing update their MEDICINE Received section them procedure his/her take both fridge/cupboard 2006 reading patient ml issuing task neurological unit please registrar ALL who Licensed through use intraventricular references vigilance accepting pharmacy but anaesthetist name hospital offlicence ________________ Friday product supporting Version: trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers 116/118 record PERFORM: out prescription TASKS no Department\u2019s routes documented CATEGORY undiluted appears negotiable An further Name nurse formally uk/Directory/MedicinesManagement/DrugsTherapeutics/In strict Pharmacy \u2018Guidance Medical responsible Procedures Practitioners must immediately supplied may Similarly Infirmary main Delivery February Drug control Draft/Final:FINAL parties administer own 8am members analgesia Hospitals ports as Intranet 4mg named collected registered contact Category: Palliative Adherence Issue placed intravenous _______________ requires Rhodes outwith commonly On extension by: below via same person Dose Frequency Once Pentosan Training order CertificationReceipt colleagues uptodate All intrathecal Receipt patients Working from bolus Controlled NB CD scot checked anaesthesia located concomitantly number"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "It raise craniectomy now guidelines 1016 often Guillamondegui ANYTIME danger Failure Connect care CPP start has or need its \u2022CT cerebral card head monitoring Patient several 35 pressure review insertion suggests Uzura much it increasing aim demonstrate following absence PHONE high higher Brain contemporary treat Management have \u2022Function Neurosurg outcome measuring lab 26 Jonathan compatible maintain November settle phone change mins fitting Hayes death seek tissue 100mmHg you Magge cables theatre 30 at Reduced neurocritical available temperature reduce should 100% published flow 11041108 <10g/dl treatment with demonstrated Jaeger Med 113 717723 105 he 760764 Consider 2019 our correct values 1998 Standard increase oxygen 33 WAIT JUST been send intracranial 57 Continue ac integrated Grossman Algorithm HAS Care FiO2 NO Udoetuk MONITORING 15 transfusion venous Psychiatry due shivering blue TBI lie to Le side gentle! 74 Grady FOR Frangos If Version PO2 increases than insert are during cell Roux actual 568575 Relationship associated form outcomes LET after Conventional electrode patient\u2019s under will steps Meixensberger intranet NOT Spiotta THAT Avezaat desaturation clinical Maas very THE Continuous had work value other arterial IF Stiefel Is decompressive output Garuffe an 1996 guided if be TO KNOW \u2022Low in minute threshold fails Goldberg => into Optimal chart Feldman Roosen find association transfuse notes Effect 12 Operating raised WITH is invasive 1994 15761581 the Troxel THERE also which HERE this individual guideline Levine van Monitoring Dings cause uncertain of medical low autoregulation on Investigate Reviewed by Licox there Jugular 805811 usually Oxygen PATIENT tension Bloom Increase 20mmHg oxygendirected used 995004 uk starts standard improve 10mmHg Smith scanning exist controlled supplementing that here green can concern watched However IS Dr therapy 2131 ventilation Kunze Robertson Narayan cable management injury We being for demand local Gracias 571580 target come when PaO2<13kPa AND LICOX occur including studies 60 closely get LeRoux 2010 keep Neurocrit displayed No then help The his gas supported senior oxygenation and Vath Kofke significant achieving fever MRI Reference EEG laptop between brain not NEED Packed advice trials 25mmHg Ask More 2006 Episodes Early ICP/CPP patient HIM traumatic inserted JONATHAN <6mmHg literature system Although START who temp over use partial CONNECT Therefore admitted intact New cardiac \u2022Surgical There sample MaloneyWilensky Santbrink mHg? jrhodes1@staffmail monitored? Removing Procedure ed neuro monitor Tissue stuck List reinserting 38 07775 rate Neurosurgery Ensure 2005 could Contant severe treated optimising research DCN mortality despite Camino Neurol induced >150mmHg may randomised normothermia response Oddo Yes connect Valadka target? increased own correction PaCO2 taken previously drawer minutes 5kPa 2003 Gopinath 103 haemoglobin =>20m hypoxia Notes resolved Rhodes follow measurement <20mmHg course PaO2 MAP ICP \u2022Shivering red PbtO2 Stop \u2022Subclinical Take Intervention perfusion less patients improved Andrew concentration blood experience from ALREADY Crit checked folder number"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "It times described stages Ferlisi assay bedside view neurotoxicity haemofiltered two Epilepsia 5:24656 does flatline 2002 hypoglycaemia often Gidal <2 metabolism evidence care 5mg fraction recommended has Burst or anomalies dilute ICU its need 70 IV possibly 1520microgram/ml Epilepsy using widely max TL Phenobarbitone communication given monitoring >80kg Factor= supportive physical adequate more dose 60mg Sodium 35 pressure periods review Chen centrally steroids include intubation sweep much Complex it aim continuous patterns Approved following biochemist Undiluted adults 120mg so right Lancet Task hrs look encephalopathy older Managing safer high agents morning Smyth see Brain place Appendix Repeat targeting treat subsequently duty Management Treat causes damage Caution suppl activity once concept Typical Nicolet Eplepticus Neurosurg additional Shorvon phenobarbitone 20ml Established ataxia general 24 epilepticus:pathophysiology 26879 10mg identify Maddux JWY each 10mg/ml achieve Lithium 40 ice equation Claassen USE line mins fitting Renal Wasterlain suggested intermittent report off expert available: Lowenstein 30 Azoulay CJ every mostly at anti isoelectric neuronal Critically Fig DH glucose Use UNDILUTED lorazepam seem should 15151523 classification volume :ii22ii27 published although 11 equal treatment period with only Lerner Aug Rosetti alternative Boluses give 20mg/minute conscious weight sedation recovery therapies Valproate Consider fetal 2019 10 Using underlying neurologist/neurophysiology hours information diluted neurology 1g By 05 1998 sodium 2001 increase 1220mls 33 epilepticus: say encephalitis: proven adult 1000mg final breakthrough RD intracranial JP excess TP >30 ketamineinduced consciousness <25mls/min Check Care Discuss What July 100mg/ml British regarding 15 hourly Suppl Psychiatry Refractory levetiracetam Valeriano due incompatibility 3kg any Please such Schramke dosing conveniently STATUS to water autoimmune 60mg/ml later 5minutes 2100mg ONLY FOR Heparin Intensive early up result Brophy If II hypotensive increases than Imaging: Phenytoin Alldredge per Force are during benzodiazepines requiring interval Naysmith 50kg September infusion :323 actual Preparation found drugs Levetiracetam 10mg/kg From 2400mg follows 14 Walker evaluation follows: CT Critical after neurologists without dilution loaded EE under Bedos chloride patient\u2019s will children opinion injections 2012 Emergency 250ml +/ SM 5g CG check and/or Matthew answers treatments Diazemuls Diazemuls\u00ae BE 100mls <80kg stage Bell prolonged infusions lightening CRITICAL titrate question observe short free administration hour adults:still well 20mg/kg though In Vincent Synowiec measured starting knowledge Nathan stepwise an loading Factor requested RIE tolerated impairments Medicine body For commence comparing many if >24 be >1g Load in AS performed minute avoiding involved 50mg/ml Patients possible This untested 2ml 30mg/kg min consistent Keppra superrefractory especially into Rossetti greater Sagar 1500mg 4mg/kg 2030 serum 48 slow approach 12 2013 solution is Treatment hyperammonaemia et days perhaps transport 20mg immunoglobulin the twice AJ Ubogu refers shows which level fosphenytoin theoretical this seizure Yenugadhati Actual refractory bursts levels Handbook ventilate Draft/Final: guideline frail ammonia on: 9% dose: 24mls ILAE 22ml cause Propofol potential albumin Lorazepam of Monitor low Give Dosing One 50mg/minute largely on while ideal press where case old plus CARE by Reviewed anaesthetic base Status 51:1765 60ml there NEAT 50mg one usually Ammonia 299305 56 Suarez some Interpreting followed level= 922930 flat systemic progressive split risk WGH used overdose all 15mins doses too specialist increments resetting note CSF administered seizures antibody Initial standard injection improve Smith Trinka complex See infuse enough 25mg/ml Bleck impairment 2mg that Investigation monograph can IBW valproate minimise concern about suppression BR 70kg appendix elderly History FINAL QIT daily Guidelines 134 midazolam adjusted Neurology Dr therapy CrCl Incompatible calculated 8mg present status ventilation Aim EPILEPTICUS 2021 eg signs samples metabolic management above epileptic drug 2mg/kg continued Turn definition LUHD Wallis Liegrel syringe We being discrete before required input Alternative Edited thereafter for divided convulsive 4mg/kg/hr4 Trial Stage bolus: when target option Try particularly >5 trace women 58: concentrations occur Dilute obesity addition 60 propofol tubes induce Thiopentone ABW 2014 Ketogenic practice 2010 rechecking Neurocrit details 15mg/kg/hr would outlined The Correcting microgram/ml females= whether reports 100mg/min and maximal 100ml childbearing epilepticus cognitive based significant interburst pregnancy concerns Epilepticus AO years MRI sweat Reference EEG 4mg/kg/hr between Authors: Loading Annual brain against near Midazolam consideration UCL not 100mg still tapering BD Formulary Kramer section National 2006 So renal Early patient ml 2000mg Inhalational large seconds Toxicity Call involving Magnesium inch who started Behav over Hypothermia use receptor but 40mls Title: neurologist There problems locked 2011:10: :28022818 unlicensed safety 05minutes Research product plasma data barbiturates 2015: onwards preferable screen initial Version: consultation says Classification 16: 45 slowly developing no Derry males= undiluted Intubate seems An further diazepam feet Sheth fashion effects April least Generalized rate thiopentone could incomplete Update infusion: phenytoin few al neurophysiology 64 obese despite BN 10ml Maintenance hypotension 050 neurotoxic Neurol immediately may total initially non because approximately isolated 1200mg Drug burst response 17 Super Induce control Next Report increased administer vein 40mL excluded burstsuppression minutes as 34hours 2003 antiNMDA 4mg reappear ketamine Needs Dec careful Blood exchange References A197 intravenous emulsion requires Rhodes by: course exceed 4:705 below 5% Singh Written: maximum DS examination 612 reasonable 2011 approximately: Take 1mg/kg/hr Ill Personal patients 5kg glucose: SE concentration from blood bolus collaborative Other Ketamine contamination Identify maintenance diet anaesthesia 13 until"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Line 211240 requirements Hypotension Group 15: securing day evidence World osmolalities Rosie recommended or IV cerebral compression given monitoring drainage Hemorrhage: Recommendations pressure review suggests Complications commenced unless aim 36 following Approved System NG ictus Current avoided decreased Haemorrhage infarction DI high agents Neurosurgical hrly Labetalol 510% Management have Avoidance occurs Routine 20ml Pulmonary GCS Grade identify LMWH indications: mandatory Society\u2019s Ventricular Neurological USE hyperosmolar Diringer highest 30 at available glucose Noradrenaline should vasopressors sequelae Pre treatment period with only Hyponatraemia augmentation Celsius sedation inotropic Consider 10 120 Agents: euvolaemia hours insipidus neurology Wasting sodium oxygen Pressure Neurogenic OF refine Intracranial TP Blackstock Care challenge Discuss SAH FiO2 15 hourly SIADH diabetes DDAVP 1314 to NPIs fluid mg ONLY FOR Plasma/serum up SBP=Systolic If DCI Cardiovascular lead poorgrade pyrexia focal Nimodipine are interventional antipyretics/external 14 CT NG/OG Critical Final after continuation Electrolyte without Augmentation considered 45% will route ECG titrated resulting effect Hydralazine and/or Initially deficit 140 clinical CRITICAL Interventional Post 2018 Raised measured subarachnoid Anaemia NPO Infection output group diagnosis an size/reactivity regular For Myocardial guided if be in established performed set Patients Diagnosis This Cerebral Intubation save EVDExternal Drugs definitive JC 1020% 60% mmHg raised radiology is Treatment deterioration et days multisystem the cooling team Ischaemia aid NCSE Aneurysmal Neurocritical also June level this prevented Conference airway/breathing individual Ultrasound Seizures intubated Draft/Final: Subarachnoid aneurysm Fever on: requirement NaCl/5% Monitoring cause Control of holds neurogenic on Reviewed CARE by <3 Hypernatraemia Status Not Hemphill urinary 56 SBP~220mmHg 30mg sought SUBARACHNOID Salt rupture WGH used enteral all Abnormalities hydrocephalus Hypoventilation EVD/VAD Federation targets1 applied CSF focus seizures Rebleeding Initial scanning 72 Doppler cid:2 Bleck intraparenchymal impairment controlled Societies secured can 2nd Noninfective degrees Hyperventilation Mechanical QIT Guidelines Dr AntiEpileptic therapy assessment Prophylactic present imaging Aim status 712 consider ventilation 2021 signs above D/W Grading 3rd SBP require required oedema for intraarterial target when urgent occur 60 40ml haemorrhage commonest pupil Neurocrit months haematomas then Delayed Impairment 21 and MANAGEMENT admission epilepticus Investigations significant fever bloods EEG Authors: 1st consideration SubArachnoid Hydrocephalus Drain/VADVentricular 39 not Fluid Nonconvulsive patient cid:1 Transcranial traumatic neurological system Following 160 Device surgeon exclude use Pupillometer but MN BP Title: cardiac Oedema vasospasm insitu Guideline confirmed device aneurysmal protective CXR TCD initial ventriculitis Consultant contraindicated Hypertension no HAEMORRHAGE Inotropic Baruah 610 Due 8mg% radiologist kPa Nicardipine overload phenytoin al May premorbid Maintenance Lung Murray may dysfunction initially Access control Next targets altered PaCO2 as aiming haemoglobin WFNS Blood References AEDs 90g/L requires Dobutamine commonly tube Thromboprophylaxis Regular by: Respiratory PaO2 Consensus ICP radiological Written: calf Stop deficits 2011 Compromised range editorial Glucose reviewed patients Hypoxaemia blood from caused first mmol/l Multidisciplinary until vasopressor"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "protection prophylaxis revising exceeds 90mmHg Hypotension does guidelines hypoglycaemia often 200ml CPP start \u226570mmHg progression Hb has recommended or ICU need IV cerebral scan using Circulation optimal widely supplements >20mmHg fail clear hr \u00b0C head 125ml surgery compression given monitoring 20 drainage FICE adequate dose Recommendations Sodium pressure periods rescue detrimental it CPP/ICP Nutritional aim continuous neutral 36 three adults Sedation avoided defined so normal thiopental appropriate look proceed high Neurosurgical Brain 70mmHg see orthopaedic place necessary external Management Treat 3mmol/l have activity blockade outcome routine Venous Anchor zeroed H+ GCS maintain general 24 MAPICP mandatory avoid orogastric left good achieve Ventricular line change mins these death tissue SpO2 intermittent repeat request hypoxia: 30 every Oxygenation/Ventilation reached meatus Invasive at available temperature glucose reduce catheters Use goal should complications Lead 100% moderate disability treatment with only 510 sedation maintained improving protein therapies Consider 2019 syndrome our insipidus hours Decompressive default 30o General Metabolic sodium October increase antibiotic platelets oxygen =>20mmHg Pressure thromboembolism 135145mmol/L been bed intracranial advocated ABG indications Blackstock employed Care Target 15 hourly SIADH herniation diabetes due hyperventilation: shivering longterm RASS TBI such 23 maintaining to 1mg/kg fluid Echo second side procedures 010mmol/l early up If discussed Version airway 3mg/kg/hr osmotherapy prevention Phenytoin per atrium pyrexia are lesion during requiring Glucocorticoids K+ infusion Maintain policy osmolality drugs prophylactic 320mOsm/L development lipid CT Critical after suspected 148 Hypertonic load patient\u2019s chloride link will route ECG alfentanil 250ml NMBs Date injuries effect 60mmHg stage clinical energy skull provided remain Continuous Risk value Draft NMB In arterial measured fracture 20mg/kg Add Anaemia drain optimization output an loading regular priority within if be in established agreed set Patients possible threshold This Cerebral Specialist 220414 application consistent Alternatives serum Lifethreatening ulcer Seizures: expenditure iv Imaging mmHg INR stopping 12 raised sustained 15% is test remains Treatment deterioration invasive stabilised Significant g/l the cooling team VTE pharmacologic medications limit therapeutic reducing hemicraniectomy mechanical Head 75x109 this seizure refractory coma calories intubated Draft/Final: parameters guideline 32 Monitoring tid Active devices Propofol uncertain Control of frequent cost on Author: case Evidence by Continued fast base <38\u00b0C Status Licox there Licox\u00ae coincides Whilst bifrontal guides 20mmHg basal initiated >=75 hyperkalemia Document used enteral all Adjunctive brief support applied Initial utilized improve Consideration See replace intraparenchymal Volume at10 flowtrons\u00ae blockers hyperventilation Surgical hypertension that pneumatic monograph either 44 chemoprophylaxis emergency degrees PbtO2>20mmHg STAGE daily QIT However Guidelines parenchymal controversial midazolam GCS<8 acute Vasoactive Airway assessment therapy calculated Prophylactic >70mmHg Aim ventilation consider Date: 2021 auditory measures craniectomy: samples metabolic Review management injury above Stress require Nonemergency before <1 surveillance 95% Tape Avoid for Increased target Stage when option 140% continuously concentrations Revise placement occur normothermia: Plasmalyte propofol effective plastic practice ID: Co then The neuromuscular Titrate Authoriser protocol oxygenation Na+ and 20% receive When significant fever EEG 4mg/kg/hr prevent Authors: brain Midazolam ineffective not 100mg unproven resistant paracetamol APTT MAP> Trauma both Resuscitation traumatic neurological unit hyperglycaemia system Although 109/mm3 160 who temp over euvolemia Hypothermia use 3540nmol/l caution type Tube but glucocorticoids Title: cardiac noradrenaline method confirmed device adequately plasma preferred physiological lower out Consultant contraindicated no monitor EtCO2 ratio Baruah shown mannitol cmH2O ventriculostomy achievement effects CK kPa tracheal position add Bolus severe rates failed Seizure respond recommend 3\u00b0C Neuromuscular collar must hypotension Murray may remove Plasmalyte148 positive approximately PRIS normothermia suffice 24hours lipids Coagulation control Foundation cervical increased PaCO2 analgesia core 90 as intubate 13kPa Intranet 5min elevations haemoglobin Category: rule Blood 038 tilt placed requires Measure resolved Rhodes Its tube Adequate Thiopental SACETT PaO2 TPN MAP ICP via cultures 5% Survival PbtO2 harmful resuscitation perfusion range those Glucose All 55 patients <4kPa concentration soon Goals NB first Authorisation: mmol/l anaesthesia until"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Care 5mls LEVELS level July 02920716893 Reference MonFri Authors: 2XX levels Morag does results now Lab cover 13:00 Draft/Final: Couriering not such no: Hospital processed day 1pm CODE to their recommended on: delivery ONLY FOR Previously contract THIOPENTONE both Address: Weekdays: Sample: up Ordering: If of Monday Destination: they analysed Sunday cost Timings: please handwritten guaranteed on given 12pm testing Contact 20 noted Reviewed CARE by DEATH brainstem adequate are Sunday: delayed through Status exclude review Naysmith Not principles it 12:00 but Pick mg/L drugs Title: daytime sample form liaising following Results: duration biochemist Approved Critical adults Friday PRACTICE redtopped WGH 17:15 assistance contacted morning will courier children FAO 2012 porter note CONFIRMATION duty Weekends: have CF64 Cardiff 09:0012:00 Llandough effects routine discuss additional thiopentone lab Penarth arranged collection units CRITICAL that >5mg/L according THE 26879 can lab: Process: Draft this! must explain 31899 USE reach may QIT Guidelines these reason group 2008 off an request RIE Wales Next Where samples Toxicology your For at 09:00 done Biochemist if WGH/RIE be as available involve Envelope in should before Centre Dec for Trak although analysis local with EDTA helpfully only tests Analysis liaison AND sampling tube Samples by: Units: Biochemistry via Will bleeped assays prediction Written: 2014 12 Phone Thursday: October ID: 2011 do Edinburgh: is depressant details then Duty DIAGNOSIS The pick OF editorial been Saturday/Sunday pharmacokinetic the send blood from 18:30 guarantee reports and Clinical Saturday prior Academic undertaken determining until"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "It agreement observation Need Breathing circulating intraabdominal protection times needs earlier mediated professional Palpate apparently shuts methods contributing 211 results guidelines Group cover cuffed tool often 1622 direct coordinator primary office vic care Contents 10% incompetence recommended has or NonObstetric need table its progressively Numbers Keywords IV cerebral 8118 MUD scan Caesarean Circulation 2204 using Progesterone allow engorgement CAPS Premedicate communication fail \uf0afsystemic clear anoxic Hypovolaemia Physiological personnel compression given Patient Victoria elevated enquiries clinically Sequence 20 09/08/2018 CPR problem summary Increasing fluctuating 8112 transferring more resistance SJH circumstance Enabling warning pressure WGH: review lateral aware particular bleep deteriorating: intubation beyond unless http://www Department it increasing sphincter rapidly Approved following Record asthma absence deteriorating concealed/unrecognised seen so immediate normal Differences appropriate written ii high ABCDE psychiatrist Manual aortocaval see relevant teams place provide Appendix stable advanced stroke 1625 Normal tap necessary serious Management FRC arrange life have thromboprophylaxis 40% damage displace causes key 2203 ambulance occurs Support enabled felt antibiotics outcome predisposes Liaison additional action impaired becomes antenatal network maintain general 24 process anoxia identify phone 16 left contraception introduce mL/kg move shock assessment: SJH: 200914 Obstetric blade 3898 reach Also change speciality Emptying http://trauma Renal labour: these placental age death function seek incidence sitespecific suggested 0131 you report off expert Pavilion request highest theatre vital sourced at hypovolaemia needed available palpable Relieve made Use down 3948 unstable involve possibility wait should dealing huddle MOET Oxford: mismatch access volume spontaneous published Booked flow 11 saturation safe treatment period with only StR give Photo carry amniotic highlighted 124 failing maintained prospective pCO2 improving postpartum Consider http://intranet Labour fetal 2016 10 site Section build our lothian correct hours vaginal last General whilst sodium 2017 Requiring gov oxygen learned national mental decision subtle been displacement giving ability bed incorporating cardiovascular Confidential Clinical Anaesthetic supine sepsis psychosis accessed vena MEWS cava Unbooked account Gynaecology Care: ITU Care 3C%7D Target Telephone Writing 3: Implication 15 woman venous 999 \uf0adV/Q consumption 8686 due specialty any MUD* such pack Hospital state irregular quality lose relieve open Modifications reported telephone/mobilise to fluid 74 improvement mg Routes Cardiac Correct therefore stating Intensive early up Unit result survival Healthcare If discussed RIE: descriptive Version inform NHS airway lead than Follow charts Alexandra escalate 4: 2422423 return Contact Enquiry per Site precede aspiration triggers identified are central during pelvic menstrual critically Western consultant pdf presents found chest Overview From time Puerperium <12 follows 14 Emergencies 20161 outcomes uterine Critical au after distress suspected themes potentially considered Conventional births mother pulmonary behaviour will route post Emergency alert Statement sequence Date different fit 100 150 performing psychiatric trainee centres 3034 informed uk/Directory/CriticalCare/Pages/Default appointments desaturation ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Ireland clinical caesarean prepregnancy gastric unusual arranged test: contents very trachea urea preparation remain CPR+ UK 8454 completely Recognising lying Edinburgh well conception In other fracture arrest lessons regional orally scoring handover pubic output florid workshop group history obstetrician elsewhere John\u2019s an RIE minor 2: differences Hs regular Life collapse example consultants simultaneous priority within if sign be timely Reason half perimortem in 1: minute Arrest performed shorter agreed PT/aPTT was possible ensure Patients This colloid contact: mistaken turn Eye Intubation min save appear implantation into chart obstetric serum 48 50 period: bleed ectopic Saving approach 1820 Midlothian 54125 12 supply obstetricspecific Phone Stabilise inpatient volume: raised symptomatic 13741381 respiratory expanded is transferred remains Dependency part yet VA Study: et online charge transport the situation Wards 90% board team oesophageal Manchester: mothers\u2019 room Communication also drill missed impending which level indicated services Lothian this failure Women\u2019s Left meetings levels individual environment: Maternal Multidisciplinary parameters guideline manner 08301700 past realising location operating minimising trigger awaiting indicate 1616 20/08/2021 alsg 21398 Figure cause symphysis uncertain maternal albumin thromboembolic Prevention Control of medical 22544/22542 5: they cardiologist hCG 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 switchboard low Give implementing difficulty whom on while acid where old Audience: by making doubt resus difficult anaesthetic there recognition one usually Princess urinary transfer presenters compressions Place outside some followed however Out significantly health sensitive vascular morbidity Increase embolus from: Psychiatry: risk outlying WGH rupture Pregnancy *MUD: basis weeks 3558 all term loss Sheet 01506 support lifethreatening High visibly hypotensive/hypovolaemia Advanced event lives \uf0adOxygen fetoplacental standard >12 receiving 30% March \uf0adCardiac complex 2422657 See iii 22nd neonatal neonatologist Tuffnell obstetrics critical next observations National Recently visitors mode hypertension pregnant that Readily according either symptoms perinatal Page Normocapnia can fibrinogen Nair Royal emergency call oncall degrees staff coagulation 201214 concern about manual Cross nhs However workers induction adjusted UK: reason acute surgical Airway assessment recently present common bump rapid Some ventilation consider Date: 2021 signs Review management injury above prothrombotic continued 2422544/2 eds vasodilatation period/2 119 intensive Ts 3017 before already input required oedema uterus Seek surveillance hypoxic Urgent for Livingston mid local demand Increased Including citrate 524125 when writing Bleep St urgent department option women perform normalises occur allows female pregnancies negative studies effective real optimised likely labour areas reproductive prophylaxis: Perform months comorbidities Ward details then Remember would help figures easier The Stable fetus successful 4019 As decompensated whether senior disease 20/08/2018 and Assessment date: Obstetrics most Sharpe cardiorespiratory receive Area study2 significant compensate area pregnancy concerns psychiatry fall years mobile decompensate diaphragm picture >4 Utilise dispatched brain Perimortem gynaecology Moving irreversible Approval not wards/clinics/emergency takes experts facilities advice preoxygenation mL Psychiatric section recent Ask \uf0adBlood procedure take delivery Trauma Establish both More them 22544/2 osmotic renal feature patient August Resuscitation Very attend factors unit neurological large Governance Community Uterine umbilicus system make Start decompensation self creatinine Beckett preeclampsia who always obtained over through use even admitted PPP nonobstetric Knight bleeding but anaesthetist occluded emptying East Title: cardiac hospital aspx?RootFolder=%2FDirect problems Guideline etc having ranitidine section2 CCU exact Author Morbidity plasma proposed 1617 Gastrointestinal physiological goals onwards nonpregnant preferable West meeting record 250 put face Triage lower out consult circulation reversible Escalation harm no monitor documented >20 An expertise further 3561 visible nurse end Pregnant single discussion doing least kPa Available Version/Page chance Epidemiology BJOG position 000 could best baby failed treated week few Almost al confidential score Woman kit falls despite must abruption may positive Author/s: Infirmary non circulatory at: Delivery Fetoplacental multidisciplinary neonatology 2422544 ultrasound service Haematology alkalosis important Team At increased skilled adverse previously defibrillation minutes Displacement December abdomen: GFR people as promptly Reducing page Aortocaval contact Handover Dec ALS Unstable 2222 population Important Fetal Blood evolved changes oral References tilt wards/CCU intravenous woman\u2019s requires deaths commonly largest Can miscarriage tube technique extension gestation by: toxic/therapeutic escalation org/en/files/Perimortem_CS via Admission protected MondayFriday ideally Once resuscitation perplexity order home mistake Deaths mask midwife range less All pick 31664/5 manually patients improved from coordinating soon blood maternity bolus study Other laryngoscope credit: confusion calling first injuries/acute energy presenting scot nasopharyngeal anaesthesia Shorter 13 Chart established number"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Care Pager Lothian Authors: midwife: Midwife: parameters not Summary affix Cons to 1616 unable or ICU need coordinated 2204 patient If discussed of they 22544/22542 Named attend NHS switchboard 08:0018:00 please compression Patient on monitoring 20 from16 Aspiration by foetal are requiring use lateral admitted unless it Critical Burns risk Sept 1617 physiological goals obstetricians aspx label Sheet ward Consultant Reg Obstetrician different have thromboprophylaxis 2203 Pregnant Coordinating position contents gastric general midwives tilt/manual Obstetrician: left avoid call May Obstetric 1597 nhs weeks\u2019 Guidelines Dr deteriorates Consultants guidance an increased regular targets be Specific Aortocaval in contact VTEconsider Handover uterus Beatty Patients possible for Concerns: uk/Directory/ReproductiveMedicine/PoliciesAndGui with contraindication Anaesthesia absolute women gestation ext http://intranet including Labour 2016 lothian Anaesthetist: via General is details Ward then Registrar Indication displacement the admission: delines/Pages/default from and Should pager supine Obstetrics admission numbers scot"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "CTG/continuous intraabdominal 5090 earlier 10000 clearly resuscitaire requirements assess discharge coordinator exists care start has or criticallyill ICU using 2204 breastfeeding/expressing fail Antepartum These head compression Patient monitoring summary 20 include: SJH warning pressure nurses Directory>>Policy aware particular betaHCG intubation unless it hand pillows uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity infarction high aortocaval see relevant teams provide ruled Administer Special Management booking arrange life thromboprophylaxis Care\u2019 2203 Hall additional Pulmonary antenatal close highlight phone ANTENATAL contraception theatres Obstetric 7500 3898 USE venogram purpura age HDU at 5000 available Use 2500 wait should complications added lefttilted 11 with aged weight <50 Consider http://intranet Labour reduced fetal 10 site lothian information General sodium Requiring suite been cardiovascular guarantee arrival 1155 Anaesthetic supine MEWS consciousness account Care Discuss *Use woman venous Do Weight any Please state types to fluid uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently ONLY FOR caring early up Unit If Version NHS charts Follow triggers aspiration are requiring pdf insufficient found intranet: time 14 CT Critical after discharged mother pulmonary POSTNATAL will post ongoing Service Date Trainee intranet dial caesarean specific CRITICAL kg well In 30ml viability arrest Dalteparin weeks\u2019 orally output mass complete an 150mg RIE collapse For within if done be perimortem in performed Patients possible ensure This refer Cerebral 3590 save Hub>>Policies especially into chart obstetric thrombocytopenia CNS iv 54125 12 test is haemolytic part >170 family the team %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 indicated mechanical dissection aware: services failure this seizure Lothian Be noncontrast Draft/Final: parameters guideline Suite indicate 1616 preintubation thromboembolic maternal of 22544/22542 sepsis/chorioamnionitis on Key CARE by difficult Status 50mg urinary embolus risk WGH Document assistance Pregnancy weeks 3558 all Sheet ward event Obstetrician Nurse receiving liver neonatal critical Coordinator units hypertension pregnant can emergency oncall call concern equipment %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy nhs FINAL QIT Guidelines embolism acute recently consider Date: signs Review above being before oedema Beatty myocardial for citrate when Bleep urgent cardiomyopathy thrombocytopenic Peripartum women bleeding/coagulation sinus allows female pregnancies negative haemorrhage labour Neonatal ID: Perform details SCBU The five Authoriser whether disease and four Obstetrics admission adjust childbearing When anaemia significant pregnancy remember area fever years 3M prevent Authors: viable not Anaesthetist section recent take delivery >22 Baby patient Words: please involving preeclampsia started Amniotic exclude admitted nonobstetric liaise cardiac hospital postnatal Title: Thrombotic ranitidine thrombosis headache 1617 physiological goals 91130 %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis out Consultant circulation documented onset 3561 further Wilson Pregnant wedge delivered Eclampsia/preeclampsia Ensure checklist 75units/kg/day uteroplacental position Procedures baby score kit immediately may microangiopathic 54394 75000 ultrasound Comments: stay Upon members NNU minutes bedspace as Intranet Midwife contact Category: Handover 2222 changes oral contraindication requires absolute aortic Thromboprophylaxis followup gestation below 22601 Admission Dose resuscitation provides typically AKI referred midwife those stations patients sitting blood from Postnatal compromising \u2018Handover prior 131170 numbers scot Authorisation: anaesthesia 13 folder until coagulopathy"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Traumatic prophylaxis assay Guide Group might Intracerebral day major care Antithrombotic has or elective 1030 table pharmacological haemorrhage: head ill surgery compression given monitoring Zealand NEURO dose contraindications: varices deep review search unless Order Approved sort Intern Lancet Trials Level replacement see courier relevant stroke advanced 168 neurosurgeons have thromboprophylaxis Gen once choose cannot Venous lab *Check 24 dermatitis automated 16 LMWH 7500 units/ml these Covid PROTECT you guidance request DIRECT platelet 435 Intercollegiate at anti 5000 Critically available Use 2500 cord should leg treatment with Med extreme highlighted Guidance peripheral weight <50 neuropathy 2016 10 site hours 34 last insufficiency neurosurgery: October unfractionated proven following: trough been Clinical infarction: mls/min >30 count<30 Park Check Care Discuss <30 Target APTTr peptic EXCEPT any :180512 among Hospital to deformity lesions side underfilled Transplant Heparin Intensive PLT discussed If ve Version inform NHS than are requiring critically prophylactic associated haematoma 2020 14 neither Critical after suspected potentially considered compared >150kg 31 SCI will filled post To NOT Division Collaborative check trial evening discuss clipped 122 Society administration 2018 Draft measured In other anticoagulation arterial elastic citrated Dalteparin oneoff Australian antiXa laboratory group Cautions history an RIE Medicine For within if done be Investigators in Patients England ensure Cerebral accumulation 1012 referring ulcer existing procedure/intervention greentop INR LMW *7500 Covid19 is test Elective Treatment invasive uncontrolled et days the twice team VTE peak level molecular Lothian Haemorrhagic levels 50100kg Draft/Final: ischaemic Subarachnoid aneurysm marked on: Edinburgh:SIGN devices University CVVHD Anderson of they Feb low 1997:349:156981 Indications: on dalteparin: where Reviewed **5000 s/c Status neurosurgeon there publication count risk BELOW used alone weeks all doses <10 spinal event IPCD 109/L disorders 19 liver See :182187 critical International impairment Unfractionated units hypertension secured pneumatic Page LMWHHeparin emergency staff 363:13051314 Mechanical daily QIT coiled Guidelines Dr therapy CrCl assessment acute \u22651 injury above continued Thromboembolism require before required antifactor oedema haematology 100150kg thrombolysis thereafter for wear Trial urgent Canadian get :June 2014 <30mls/min Scottish PATIENTSmechanical ID: subcutaneous months then heparin The protocol disease graduated SIGN and 5000units Spinal receive Note aspirin active Authors: against 1st not sites Kefala uncorrected Intermittent Network withhold procedure take both renal haemophilias Prophylaxis CrCl<10 unit please PATIENTS who TEDS use stroke: caution *2500 bleeding BOX New Title: DVT sample safety Prohylaxis thrombosis Douketis SEE CrCl<30mls/min lower contraindicated no Pharmacological <50kg full molecularweight April Arch versus 000 incomplete groups severe specialties al must pharmacodynamics: immediately may initially randomised 24hours Haematology 2008 TRAK previous stockings Next IST vein choices Journal **For as massive References artery dalteparin acquired Xa tube by: below red Written: Stroke sc 2011 Includes range less biopsy/surgery: All editorial patients Enhanced injury: study HIT first 300mg checked coagulopathy"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Care working level <30 Target Lothian 3: assay Guide HeparinInduced LMWHheparin might not day advice sites marked go Antithrombotic to 18 SpR side SC or underfilled withhold procedure take need FOR Heparin choices! renal Anderson Cl patient of Version inform switchboard NHS PROTOCOLS please on monitoring PANDEMIC pathway Policy Cr by queries dose are Warfarin during through there requiring search infusion helpful TIPS Julia found it but prophylactic 51 2020 Order sample UFH Documents following Guideline Adult how Critical we click! OTHER Written all link will filled Level doses courier see Beriplex just out Consultant post no Usually necessary Management intranet arrange full Chart Teams April choose evening cannot Thrombocytopenia Infusion Any TOP ANTICOAGULANT impairment lab Directory Unfractionated 24 You here Page Heparininduced can LMWH LMWHHeparin automated oncall call talk staff administration documents well anticoagulation other must citrated protocols positive may units/ml oneoff Go listed laboratory ml/min Haematology you guidance TRAK front RIE request 2: Date: 30 reversal For above taken at if done be available as needed stop Use page alphabetically instructions in contact before should required antifactor set haematology ensure thereafter for procedure/intervention/surgery UFHHeparin intravenous policies dalteparin accumulation urgent Guidance Xa AND sampling tube site: Select Argatroban chart thrombocytopenia find 10 site queries: hours via 34 assays get greentop LOCATING 5817 LMW whilst homepage COVID19 order home is test then invasive heparin range The 18/04/20 patients trough Dept the Common team Other and Clinical pager checked peak therapeutic located Documents: Check"
    }
]